<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?DTDIdentifier.IdentifierValue http://null/schema/dtds/document/fulltext/xcr/xocs-article.xsd?><?DTDIdentifier.IdentifierType schema?><?SourceDTD.DTDName xocs-article.xsd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName ftrr2jats.xsl?><?ConverterInfo.Version 1?><?origin publisher?><?OLF?><front><journal-meta><journal-id journal-id-type="nlm-ta">Life Sci</journal-id><journal-id journal-id-type="iso-abbrev">Life Sci</journal-id><journal-title-group><journal-title>Life Sciences</journal-title></journal-title-group><issn pub-type="ppub">0024-3205</issn><issn pub-type="epub">1879-0631</issn><publisher><publisher-name>Published by Elsevier Inc.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7884924</article-id><article-id pub-id-type="pii">S0024-3205(21)00186-7</article-id><article-id pub-id-type="doi">10.1016/j.lfs.2021.119201</article-id><article-id pub-id-type="publisher-id">119201</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>COVID-19, cytokines, inflammation, and spices: How are they related?</article-title></title-group><contrib-group><contrib contrib-type="author" id="au0005"><name><surname>Kunnumakkara</surname><given-names>Ajaikumar B.</given-names></name><xref rid="af0005" ref-type="aff">a</xref><xref rid="fn0005" ref-type="fn">1</xref></contrib><contrib contrib-type="author" id="au0010"><name><surname>Rana</surname><given-names>Varsha</given-names></name><xref rid="af0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au0015"><name><surname>Parama</surname><given-names>Dey</given-names></name><xref rid="af0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au0020"><name><surname>Banik</surname><given-names>Kishore</given-names></name><xref rid="af0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au0025"><name><surname>Girisa</surname><given-names>Sosmitha</given-names></name><xref rid="af0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au0030"><name><surname>Sahu</surname><given-names>Henamayee</given-names></name><xref rid="af0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au0035"><name><surname>Thakur</surname><given-names>Krishan Kumar</given-names></name><xref rid="af0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au0040"><name><surname>Dutta</surname><given-names>Uma</given-names></name><xref rid="af0010" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="au0045"><name><surname>Garodia</surname><given-names>Prachi</given-names></name><xref rid="af0015" ref-type="aff">c</xref></contrib><contrib contrib-type="author" id="au0050"><name><surname>Gupta</surname><given-names>Subash C.</given-names></name><xref rid="af0020" ref-type="aff">d</xref></contrib><contrib contrib-type="author" id="au0055"><name><surname>Aggarwal</surname><given-names>Bharat B.</given-names></name><xref rid="af0025" ref-type="aff">e</xref><xref rid="cr0005" ref-type="corresp">&#x0204e;</xref></contrib><aff id="af0005"><label>a</label>Cancer Biology Laboratory, &#x00026; DBT-AIST International Laboratory for Advanced Biomedicine (DAILAB), Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Assam 781039, India</aff><aff id="af0010"><label>b</label>Cell and Molecular Biology Lab, Department of Zoology, Cotton University, Guwahati, Assam 781001, India</aff><aff id="af0015"><label>c</label>Integrative Research Center, Oregon 97520, USA</aff><aff id="af0020"><label>d</label>Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi 221005, India</aff><aff id="af0025"><label>e</label>Inflammation Research Center, San Diego, CA 92109, USA</aff></contrib-group><author-notes><corresp id="cr0005"><label>&#x0204e;</label>Corresponding author.</corresp><fn id="fn0005"><label>1</label><p id="np0060">Cancer Biology Laboratory and DBT-AIST International Center for Translational and Environmental Research (DAICENTER), Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati, Assam 781039, India.</p></fn></author-notes><pub-date pub-type="pmc-release"><day>16</day><month>2</month><year>2021</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="epub"><day>16</day><month>2</month><year>2021</year></pub-date><elocation-id>119201</elocation-id><history><date date-type="received"><day>8</day><month>12</month><year>2020</year></date><date date-type="rev-recd"><day>20</day><month>1</month><year>2021</year></date><date date-type="accepted"><day>30</day><month>1</month><year>2021</year></date></history><permissions><copyright-statement>&#x000a9; 2021 Published by Elsevier Inc.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder/><license><license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p></license></permissions><abstract id="ab0005"><sec><title>Background</title><p>Cytokine storm is the exaggerated immune response often observed in viral infections. It is also intimately linked with the progression of COVID-19 disease as well as associated complications and mortality. Therefore, targeting the cytokine storm might help in reducing COVID-19-associated health complications. The number of COVID-associated deaths (as of January 15, 2021; <ext-link ext-link-type="uri" xlink:href="https://www.worldometers.info/coronavirus/" id="ir0005">https://www.worldometers.info/coronavirus/</ext-link>) in the USA is high (1199/million) as compared to countries like India is low (110/million). Although the reason behind this is not clear, spices may have some role in explaining this difference. Spices and herbs are used in different traditional medicines, especially in countries such as India to treat various chronic diseases due to their potent antioxidant and anti-inflammatory properties.</p></sec><sec><title>Aim</title><p>To evaluate the literature available on the anti-inflammatory properties of some spices which might prove beneficial in the prevention and treatment of COVID-19 associated cytokine storm.</p></sec><sec><title>Method</title><p>A detailed literature search has been conducted on PubMed for collecting information pertaining to the COVID-19; the history, origin, key structural features, and mechanism of infection of SARS-CoV-2; the repurposed drugs in use for the management of COVID-19 and the anti-inflammatory role of spices to combat COVID-19 associated cytokine storm.</p></sec><sec><title>Key findings</title><p>The literature search resulted in numerous <italic>in vitro</italic>, <italic>in vivo</italic> and clinical trials that have reported the potency of spices to exert anti-inflammatory effects by regulating crucial molecular targets for inflammation.</p></sec><sec><title>Significance</title><p>As spices are derived from Mother Nature and are inexpensive, they are relatively safer to consume. Therefore, their anti-inflammatory property can be exploited to combat the cytokine storm in COVID-19 patients. This review thus focuses on the current knowledge on the role of spices for the treatment of COVID-19 through suppression of inflammation-linked cytokine storm.</p></sec></abstract><abstract abstract-type="graphical" id="ab0010"><title>Graphical abstract</title><p><fig id="f0025" position="anchor"><alt-text id="al0040">Unlabelled Image</alt-text><graphic xlink:href="ga1_lrg"/></fig></p></abstract><kwd-group id="ks0005"><title>Keywords</title><kwd>SARS-CoV-2</kwd><kwd>Cytokine storm</kwd><kwd>COVID-19</kwd><kwd>Curcumin</kwd><kwd>Spices</kwd><kwd>Inflammation</kwd></kwd-group></article-meta></front><body><sec id="s0005"><label>1</label><title>Introduction</title><p id="p0005">The ongoing novel coronavirus pandemic has taken a major toll on human lives worldwide. In December 2019, the first case of the ongoing pandemic of the novel coronavirus disease (COVID-19) was reported [<xref rid="bb0005" ref-type="bibr">1</xref>]. The epicenter of COVID-19 was identified as Wuhan, the capital of Hubei province, China. Initially, the outbreak was declared as a &#x0201c;Global Health Emergency&#x0201d; by the World Health Organization (WHO) on 30th January 2020 [<xref rid="bb0010" ref-type="bibr">2</xref>]. However, as COVID-19 spread rapidly across the globe affecting thousands of lives worldwide, the WHO finally declared it a global pandemic on 11th March 2020 [<xref rid="bb0015" ref-type="bibr">3</xref>].</p><p id="p0010">As per the weekly epidemiological update released by the WHO on 10th January 2021 at 10:00 CEST, the total number of cases worldwide is reported to be 88,387,352 with 1,919,204 deaths. In India, the total cases were reported to be 10,450,284 with 150,999 deaths [<xref rid="bb0020" ref-type="bibr">4</xref>]. The geographical distribution of the COVID-19 pandemic as per 14-day COVID-19 case notification rate per 100,000 population (as of 13th January 2021) has been illustrated in <xref rid="f0005" ref-type="fig">Fig. 1</xref>
[<xref rid="bb0025" ref-type="bibr">5</xref>].<fig id="f0005"><label>Fig. 1</label><caption><p>The geographical distribution of the COVID-19 pandemic as per 14-day COVID-19 case notification rate per 100,000 population (as of 13th January 2021) [<xref rid="bb0025" ref-type="bibr">5</xref>].</p></caption><alt-text id="al0005">Fig. 1</alt-text><graphic xlink:href="gr1_lrg"/></fig></p><p id="p0015">The causative pathogen of COVID-19 is identified as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is a novel human coronavirus (HCoV) [<xref rid="bb0030" ref-type="bibr">6</xref>]. The SARS-CoV-2 is believed to have a zoonotic origin and bats are considered as their natural reservoir host. The transmission of the virus occurs from human-to-human mostly by direct and indirect contact with cough or sneeze droplets from an infected person and contaminated surfaces, respectively. The incubation period of the virus is approximately 2&#x02013;14&#x0202f;days. Infected people may present symptoms such as fever, cough, breathlessness, <italic>etc.</italic> However, some may remain asymptomatic [<xref rid="bb0035" ref-type="bibr">7</xref>,<xref rid="bb0040" ref-type="bibr">8</xref>]. COVID-19 is usually mild; however, infected patients with comorbidities such as hypertension, diabetes, cancer, immunodeficiency, <italic>etc.</italic> are more prone to poor prognosis. In such cases, the severity of disease progression might eventually result in pneumonia, acute respiratory distress syndrome (ARDS), a multi-organ failure which may ultimately cause death [<xref rid="bb0035" ref-type="bibr">7</xref>,<xref rid="bb0045" ref-type="bibr">9</xref>].</p><p id="p0020">Although the exact pathophysiological mechanism of COVID-19 is poorly understood; clinical evidence has revealed that COVID-19 infected patients often show an elevated rise in the cytokine levels which is termed as &#x0201c;cytokine storm&#x0201d; or &#x0201c;cytokine release syndrome&#x0201d;. This abnormal level of cytokines is considered to be correlated with severe deterioration of health conditions in the infected patients [<xref rid="bb0050" ref-type="bibr">10</xref>]. Therefore, suppressing elevated inflammatory response produced during COVID-19 may prove crucial in preventing the severity of disease as well as associated health complications [<xref rid="bb0055" ref-type="bibr">11</xref>].</p><p id="p0025">Various studies have reported that naturally occurring spices as well as their isolated active components target the inflammatory pathways and induce anti-inflammatory effects in many chronic diseases [<xref rid="bb0060" ref-type="bibr">[12]</xref>, <xref rid="bb0065" ref-type="bibr">[13]</xref>, <xref rid="bb0070" ref-type="bibr">[14]</xref>].</p><p id="p0030">A recent study conducted on primary data of 163 countries worldwide in respect of total cases, deaths, and recoveries of COVID-19 revealed a close association of the total number of COVID-19 cases per million population tested and the gram of spice supplied <italic>per capita</italic> per day. This study further reported that the nation with an increased number of COVID-19 cases per million population corresponds to lower consumption of spices <italic>per capita</italic>, with some exceptions such as Luxembourg and Iceland [<xref rid="bb0075" ref-type="bibr">15</xref>]. As of 10th January 2021, the cumulative cases of COVID-19 in United States of America (USA) are 21,761,186 compared to 10,450,284 cases in India. Moreover, the cumulative cases and deaths per 100 thousand population in the USA are reported to be 6574.3 and 110.5 (1.68%), respectively, as opposed to 757.3 cumulative cases and 10.9 deaths (1.439%) in India [<xref rid="bb0020" ref-type="bibr">4</xref>]. As of 20th January 12:07&#x0202f;PM IST, in India, Lakshwadeep (0.00019%), Dadar and Nagar Havelli; Daman and Diu (0.03%), and Mizoram (0.04%) have recorded low number of cases compared to the rest of the states, while Maharashtra recorded the highest number of cases (18.82%) out of the total number of cases (10,596,449). Lakshwadeep has not reported any COVID-19 associated death so far. Further, Dadar and Nagar Havelli; Daman and Diu (0.1%), Mizoram (0.2%), Arunachal Pradesh (0.3%), and Kerala (0.4%) have recorded a low fatality ratio. Interestingly, although Kerala has reported approximately 8% of the total cases, the fatality ratio is quite low (0.4%). This low fatality ratio in Kerala can be attributed to the efficient management of the disease, healthcare system, <italic>etc.</italic> [<xref rid="bb0080" ref-type="bibr">16</xref>,<xref rid="bb0085" ref-type="bibr">17</xref>]. Moreover, as spices and herbs are rich immunity boosters and are prevalently consumed in India and other Asian countries, it might be associated with faster recovery and lower per million population death. This was evinced by study which reported that the intake of spicy food was associated with a 14% decrease in total mortality and thus suggested their inverse association. [<xref rid="bb0075" ref-type="bibr">15</xref>,<xref rid="bb0090" ref-type="bibr">18</xref>]. This review thus focuses on the anti-inflammatory role of spices as potential therapeutic agents to combat the occurrence of &#x0201c;cytokine storm&#x0201d; in COVID-19.</p></sec><sec id="s0010"><label>2</label><title>Lockdown</title><p id="p0035">The outbreak of coronavirus (COVID-19) was first reported in December in Wuhan and Hubei province. Several places are majorly affected by the COVID-19 which led to the imposition of lockdown. During this lockdown period, several activities such as travel <italic>via</italic> international flights as well as local transports, mass gatherings at public places such as schools, universities, <italic>etc.</italic>, had been restricted. Moreover, people were not allowed to go outside for any work, except for certain essential activities for a limited period with strict guidelines of social distancing. Despite, these enforcements and restrictions, the number of COVID-19 cases had increased significantly throughout the world [<xref rid="bb0095" ref-type="bibr">19</xref>,<xref rid="bb0100" ref-type="bibr">20</xref>]. Initially, India had reported fewer COVID-19 cases because it was able to enforce strict lockdown and social distancing. Moreover, the general public was strongly advised to wear a mask and wash or sanitize hands frequently with soap or sanitizers as a preventive measure throughout the country. The WHO had praised India's early implementation of nationwide lockdown as &#x0201c;tough and timely&#x0201d;. Later, when the restrictions were relaxed, the COVID-19 cases increased drastically [<xref rid="bb0105" ref-type="bibr">21</xref>,<xref rid="bb0110" ref-type="bibr">22</xref>]. Community transfer has been observed in various countries that have not implemented early lockdown. Previous studies reported that travel restrictions and isolation have played a pivotal role in the outbreaks of Ebola, SARS-CoV, and bubonic plague [<xref rid="bb0115" ref-type="bibr">[23]</xref>, <xref rid="bb0120" ref-type="bibr">[24]</xref>, <xref rid="bb0125" ref-type="bibr">[25]</xref>]. However, the implementation of lockdown alone is not the permanent solution to prevent the further spread of COVID-19 and this raised serious concerns [<xref rid="bb0095" ref-type="bibr">19</xref>].</p><p id="p0040">Some studies also reported that South Korea and Sweden have not implemented stringent lockdown and restrictions on their countries. However, the rate of infections in these countries was observed to be lower than those which had implemented strict lockdown [<xref rid="bb0130" ref-type="bibr">26</xref>,<xref rid="bb0135" ref-type="bibr">27</xref>]. One of the important reasons behind fewer infection and death rates in South Korea was believed to be the rapid testing of COVID-19 [<xref rid="bb0105" ref-type="bibr">21</xref>]. Sweden and Denmark have also followed different strategies rather than stringent lockdown to mitigate the virus spread. The authorities in those countries have appealed for strong awareness and a personal sense of responsibility and further encouraged people to work from home. The patients with comorbidities such as respiratory ailments, immune deficiency, hypertension, cancer, diabetes, diseases of the heart, liver, and kidneys were found to be more prone to the COVID-19 infection and death. Therefore, people with a high risk of COVID-19 due to comorbidities or age were strongly recommended to follow quarantine and self-isolation to &#x02018;flatten the curve&#x02019;. Moreover, the kindergartens, nurseries, schools, and colleges remained open during this period while following the norms of social distancing and awareness [<xref rid="bb0045" ref-type="bibr">9</xref>,<xref rid="bb0135" ref-type="bibr">[27]</xref>, <xref rid="bb0140" ref-type="bibr">[28]</xref>, <xref rid="bb0145" ref-type="bibr">[29]</xref>, <xref rid="bb0150" ref-type="bibr">[30]</xref>, <xref rid="bb0155" ref-type="bibr">[31]</xref>].</p><p id="p0045">The USA has recorded the highest number of COVID-19 infections and deaths. Currently, India has the 2nd highest number of COVID-19 cases and the 3rd highest number of deaths. Brazil is 3rd and 2nd in terms of the number of cases and deaths, respectively. European countries (Russia, France, Spain, UK, Italy, and Germany) have also reported a significantly higher number of COVID-19 associated deaths of COVID-19; however, many people recovered and the number of active cases has declined lately [<xref rid="bb0020" ref-type="bibr">4</xref>]. A closer look has uncovered various reasons for the spread of community transfer of COVID-19 in these countries, such as frequent international travels as well as the late and casual implementation of social distancing [<xref rid="bb0105" ref-type="bibr">21</xref>,<xref rid="bb0130" ref-type="bibr">26</xref>]. The implementation of lockdown due to the COVID-19 pandemic has given birth to certain health-related issues such as obesity, irregular sleeping behavior, anxiety, depression, <italic>etc.</italic> Moreover, it has also affected the economy very gravely throughout the world [<xref rid="bb0160" ref-type="bibr">[32]</xref>, <xref rid="bb0165" ref-type="bibr">[33]</xref>, <xref rid="bb0170" ref-type="bibr">[34]</xref>].</p></sec><sec id="s0015"><label>3</label><title>Human coronaviruses (HCoVs)</title><sec id="s0020"><label>3.1</label><title>History</title><p id="p0050">The human coronavirus (HCoV) was first characterized in the 1960s [<xref rid="bb0175" ref-type="bibr">35</xref>]. Tyrell and Bynoe from the Common Cold Unit, England, investigated samples from patients with the common cold and isolated a novel flu-like virus in the 1960s. These viruses were labeled as B814 and were reported as ether sensitive in nature. Initially, they were unable to culture B814 by utilizing the available standard culture techniques. However, in 1965, they were successful in growing B814 in organ cultures [<xref rid="bb0175" ref-type="bibr">[35]</xref>, <xref rid="bb0180" ref-type="bibr">[36]</xref>, <xref rid="bb0185" ref-type="bibr">[37]</xref>, <xref rid="bb0190" ref-type="bibr">[38]</xref>]. In 1966, Hamre and Procknow from the University of Chicago isolated and reported the presence of a novel RNA virus associated with respiratory disease. This virus was labeled 229E and it exhibited ether sensitivity like the B814 virus [<xref rid="bb0195" ref-type="bibr">39</xref>].</p><p id="p0055">The B814 and 229E viruses were characterized using electron microscopy by Almeida and Tyrell. These ether sensitive viruses were reportedly indistinguishable from one another as well as the avian infectious bronchitis virus (IBV) [<xref rid="bb0200" ref-type="bibr">40</xref>].</p><p id="p0060">These novel viruses along with other morphologically identical animal viruses such as IBV were grouped into a new genus termed &#x0201c;Coronavirus&#x0201d; (Latin word &#x0201c;corona&#x0201d; meaning &#x0201c;crown&#x0201d;) in 1968. They were named after the characteristic fringe or crown-like rounded projections on their surface (resembling the solar corona) as observed under an electron microscope [<xref rid="bb0205" ref-type="bibr">41</xref>]. In 1975, the coronaviruses were clubbed under a novel family of viruses named &#x0201c;Coronaviridae&#x0201d; [<xref rid="bb0210" ref-type="bibr">42</xref>].</p><p id="p0065">Apart from the aforementioned HCoVs, several other strains of HCoVs have been identified; some of these include the HCoV-OC43 (1967), SARS-CoV (2002&#x02013;2003), HCoV-NL63 (2004), HCoV-HKU1 (2005), Middle East respiratory syndrome (MERS)-CoV (2012), and SARS-CoV-2 (2019) [<xref rid="bb0215" ref-type="bibr">[43]</xref>, <xref rid="bb0220" ref-type="bibr">[44]</xref>, <xref rid="bb0225" ref-type="bibr">[45]</xref>].</p><p id="p0070">The HCoVs such as 229E, OC43, NL63, and HKU1 are known as endemic CoVs. They are commonly found in the human population and are known to cause mild respiratory infections [<xref rid="bb0230" ref-type="bibr">46</xref>]. However, HCOVs such as SARS-CoV, MERS-CoV, and SARS-CoV-2 are the deadlier viruses that have caused the global outbreak and infected thousands of people worldwide [<xref rid="bb0220" ref-type="bibr">44</xref>].</p><p id="p0075">Towards the latter end of 2002, the emergence of an infectious virus was reported from the Guangdong province, China. This virus was reported to transmit from human-to-human and was later identified as the SARS-CoV in 2002&#x02013;2003. The infected people mostly presented with symptoms such as fever, cough, myalgia, <italic>etc.</italic> Other symptoms included headache, dyspnea, headache, hypoxemia, vomiting, <italic>etc.</italic> [<xref rid="bb0225" ref-type="bibr">[45]</xref>, <xref rid="bb0230" ref-type="bibr">[46]</xref>, <xref rid="bb0235" ref-type="bibr">[47]</xref>, <xref rid="bb0240" ref-type="bibr">[48]</xref>, <xref rid="bb0245" ref-type="bibr">[49]</xref>]. In some cases, the occurrence of pneumonia and ARDS had also been reported [<xref rid="bb0240" ref-type="bibr">48</xref>].</p><p id="p0080">In 2012, the emergence of another novel infectious HCoV, later named MERS-CoV, was reported. The first case was reported from Saudi Arabia but soon spread across the Arabian Peninsula [<xref rid="bb0250" ref-type="bibr">50</xref>,<xref rid="bb0255" ref-type="bibr">51</xref>]. Several cases were also reported in Asia, Europe, and Africa [<xref rid="bb0260" ref-type="bibr">52</xref>]. The transmission of MERS-CoV reportedly occurs <italic>via</italic> human-to-human as well as dromedary camel-to-human. However, the cases of camel-to-human infection are comparatively less [<xref rid="bb0265" ref-type="bibr">53</xref>]. Infected people initially exhibit symptoms such as fever, headache, cough, myalgia, <italic>etc.</italic> However, the disease might progress in severe cases and cause pneumonia, ARDS, septic shock as well as multi-organ failure which can be fatal. Besides, cases of asymptomatic MERS-CoV infection have also been reported [<xref rid="bb0220" ref-type="bibr">44</xref>].</p><p id="p0085">The recently identified novel coronavirus SARS-CoV-2 belongs to the genera &#x003b2;-coronavirus of the Coronaviridae family [<xref rid="bb0270" ref-type="bibr">54</xref>]. It reportedly shares 96% and 79.6% sequence identity to the bat CoVRaTG13 and SARS-CoV, respectively [<xref rid="bb0040" ref-type="bibr">8</xref>].</p></sec><sec id="s0025"><label>3.2</label><title>Origin and structural features</title><p id="p0090">The coronaviruses (CoVs) are single, positive-strand RNA viruses. Their genome is approximately 26&#x02013;32&#x0202f;kb in length [<xref rid="bb0220" ref-type="bibr">44</xref>]. They belong to the coronaviridae family of the order nidovirales and are categorized into the genera &#x02013; alpha (&#x003b1;), beta (&#x003b2;), gamma (&#x003b3;), and delta (&#x003b4;) coronavirus [<xref rid="bb0270" ref-type="bibr">54</xref>]. The &#x003b1;- and &#x003b2;-CoVs include both human and animal CoVs. The HCoVs such as 229E, NL63 belong to &#x003b1;-CoV while the OC43, HKU1, SARS-CoV, MERS-CoV, and SARS-CoV-2 belong to the &#x003b2;-CoVs. The &#x003b3;- and &#x003b4;-CoVs primarily consists of avian coronaviruses.45.</p><p id="p0095">The viral genome of CoV encodes four important structural proteins. They are - the envelope (E), spike (S), membrane (M), and nucleocapsid (N) proteins [<xref rid="bb0270" ref-type="bibr">54</xref>]. The E, S, and M proteins are anchored in the lipid bilayer of the viral envelope [<xref rid="bb0275" ref-type="bibr">55</xref>] The M protein is approximately 25&#x02013;30&#x0202f;kDa and gives shape to the virus. The E protein is approximately 8&#x02013;12&#x0202f;kDa and promotes viral release. Together, the M and E proteins are associated with the viral assembly. Furthermore, they also facilitate the maturation of viral envelopes [<xref rid="bb0280" ref-type="bibr">56</xref>]. The N protein is involved in the formation of the nucleocapsid. It binds with the viral genome and plays an essential role in viral packaging [<xref rid="bb0275" ref-type="bibr">55</xref>]. The S protein (class I fusion protein) is approximately 150&#x0202f;kDa. It is responsible for the characteristic spike-like protrusions on the virus. It comprises S1 and S2 subunits and undergoes cleavage by furin-like protease in the host. The S1 subunit contains a receptor-binding domain (RBD). It binds to the host receptor angiotensin-converting enzyme 2 (ACE2). The S2 subunit of the viral S protein then fuses with the cell membrane of the host. This facilitates viral entry into the host cells [<xref rid="bb0280" ref-type="bibr">[56]</xref>, <xref rid="bb0285" ref-type="bibr">[57]</xref>, <xref rid="bb0290" ref-type="bibr">[58]</xref>].</p></sec><sec id="s0030"><label>3.3</label><title>Mechanism of SARS-CoV-2 entry in cells</title><p id="p0100">Till now, the mechanism of SARS-COV-2 infection is not completely elucidated. Several studies are being conducted globally on SARS-COV-2 to unravel the mechanism of infection and pathogenesis of the novel coronavirus. The &#x003b2;-CoVs - SARS-CoV and SARS-CoV-2 are substantially identical and are considered to infect humans similarly. The S protein contributes substantially to the attachment and fusion of the virus with the host cell. The RBD of the S1 subunit of the viral S protein binds to the host cell receptor which initiates the viral infection.</p><p id="p0105">Studies have reported that SARS-CoV and SARS-CoV-2 utilize the same human ACE2 (hACE2) receptor to attach themselves to the host cells [<xref rid="bb0040" ref-type="bibr">8</xref>]. The ACE2 receptor is significantly expressed in the type II alveolar, oral mucosal, and nasal epithelial cells [<xref rid="bb0295" ref-type="bibr">[59]</xref>, <xref rid="bb0300" ref-type="bibr">[60]</xref>, <xref rid="bb0305" ref-type="bibr">[61]</xref>]. The respiratory airways, cornea, heart, kidneys, <italic>etc.</italic>, also express the ACE2 receptor [<xref rid="bb0295" ref-type="bibr">59</xref>]. These organs are highly vulnerable and most affected in COVID-19 [<xref rid="bb0310" ref-type="bibr">62</xref>].</p><p id="p0110">A recent study reported that SARS-CoV-2 has a greater affinity to the hACE2 receptor than SARS-CoV. They further stated that structural alterations in the ACE2-binding ridge of SARS-CoV-2 RBD are responsible for the high affinity towards the hACE2 receptor [<xref rid="bb0315" ref-type="bibr">63</xref>]. The enzyme furin cleaves the SARS-CoV-2 S protein at the S1/S2 site and exposes the S2 subunit which mediates the fusion of viral and host membranes [<xref rid="bb0290" ref-type="bibr">58</xref>,<xref rid="bb0320" ref-type="bibr">64</xref>]. This cleavage is responsible for the pre-activation of the S protein which promotes the subsequent type II transmembrane serine protease (TMPRSS2)-dependent viral entry into host cells [<xref rid="bb0320" ref-type="bibr">64</xref>]. The TMPRSS2 is considered significant for the entry of SARS-CoV in the host cell. A broader expression of TMPRSS2 is reported in the nasal cavity, lungs, colon, gall bladder, kidney, prostate, pancreas, heart, <italic>etc.</italic> Further, the nasal epithelial cells are enriched with TMPRSS2 as well as the ACE2 receptor [<xref rid="bb0295" ref-type="bibr">59</xref>]. The TMPRSS2 primes the ACE2 receptor-bound viral S protein leading to a conformational change [<xref rid="bb0320" ref-type="bibr">64</xref>,<xref rid="bb0325" ref-type="bibr">65</xref>]. This conformational change activates S protein and facilitates the viral entry into the host cells. Moreover, it also clears the ACE2 receptor [<xref rid="bb0290" ref-type="bibr">58</xref>].</p><p id="p0115">A study reported that TMPRSS2 is expressed specifically in ACE2<sup>+</sup> cell types. Further, they also stated that the expression of proteases such as cathepsin B (Cat B) was observed in &#x0003e;70&#x02013;90% of ACE2<sup>+</sup> cells. Altogether, their findings implied that SARS-CoV-2 might also utilize alternative pathways for entry [<xref rid="bb0295" ref-type="bibr">59</xref>]. Similar findings were also reported in another <italic>in vitro</italic> study which demonstrated that SARS-CoV-2 is dependent on both Cathepsin B/L (CatB/L) and TMPRSS2 for priming and entry into the host cell. Their study showed that inhibition of any one of these proteases leads to partial inhibition of viral entry. This suggested that in the absence of TMPRSS2, the virus may utilize CatB/L for its entry and <italic>vice-versa</italic> [<xref rid="bb0330" ref-type="bibr">66</xref>].</p><p id="p0120">Following the entry, SARS-CoV-2 liberates its genomic material (mRNA) in the cytoplasm. It takes over the protein synthesis machinery in the host and translates the mRNA in the nucleus. Besides, it also utilizes the machinery to synthesize viral proteins and subsequently initiates viral replication [<xref rid="bb0290" ref-type="bibr">58</xref>] (<xref rid="f0010" ref-type="fig">Fig. 2</xref>
).<fig id="f0010"><label>Fig. 2</label><caption><p>Mechanism of SARS-CoV-2 entry in cells. A. Binding of SARS-CoV-2 spike to the host ACE2 receptor. B. Cleavage of SARS-CoV-2 spike by TMPRSS2, membrane fusion, infection, and viral RNA release into the host cell.</p><p>Abbreviations: ACE2: Angiotensin converting enzyme-2, NTD: N-terminal domain, RBD: Receptor binding domain, S protein: Spike protein, SARS-CoV-2: Severe Acute Respiratory Coronavirus-2.</p></caption><alt-text id="al0010">Fig. 2</alt-text><graphic xlink:href="gr2_lrg"/></fig></p></sec></sec><sec id="s0035"><label>4</label><title>Cytokine storm in COVID-19</title><p id="p0125">Accumulating pieces of evidence suggest that viral infection instigates an exaggerated or hyperactive immune response in the host leading to a &#x0201c;cytokine storm&#x0201d;. The novel coronavirus infection elicits a similar response in the host. This often involves the interplay of various chemokines, colony-stimulating factors, interferons, interleukins as well as tumor necrosis factor-&#x003b1; (TNF-&#x003b1;). The cytokine storm is correlated to the severity of the infection and often causes extensive damage or injury. Furthermore, it is also considered as a leading cause of ARDS, multi-organ failure, <italic>etc.</italic> which are closely associated with the severity and progression of COVID-19. Moreover, the cytokine storm and associated complications are the major cause of death in COVID-19 patients [<xref rid="bb0050" ref-type="bibr">10</xref>,<xref rid="bb0335" ref-type="bibr">[67]</xref>, <xref rid="bb0340" ref-type="bibr">[68]</xref>].</p><p id="p0130">Several studies have investigated the clinical characteristics of the cytokine storm in COVID-19 patients [<xref rid="bb0345" ref-type="bibr">[69]</xref>, <xref rid="bb0350" ref-type="bibr">[70]</xref>, <xref rid="bb0355" ref-type="bibr">[71]</xref>].</p><p id="p0135">In the extremely severe patients, elevated levels of IL-2R, IL-6 as well as IL-10 are also observed. Moreover, a gradual reduction in the absolute count of CD4<sup>+</sup> T, CD8<sup>+</sup> T, and B cells is also observed as the severity of the disease progresses. These findings suggest that there is a correlation between immune response and severity of COVID-19 progression [<xref rid="bb0360" ref-type="bibr">72</xref>,<xref rid="bb0365" ref-type="bibr">73</xref>].</p><p id="p0140">A study conducted on 43 COVID-19 patients showed that elevated IL-6 levels were observed in severe cases and thus correlated to the severity of the disease [<xref rid="bb0370" ref-type="bibr">74</xref>]. A retrospective multicenter study investigated the deceased and discharged COVID-19 cases. The study reported that elevated IL-6 was observed in the deceased cases. Further, the cause of mortality in the deceased group was primarily due to respiratory failure (53%) [<xref rid="bb0375" ref-type="bibr">75</xref>].</p><p id="p0145">A recent study was conducted to investigate the clinical features in deceased COVID-19 patients. The study showed that a majority of deceased patients were associated with comorbidities like hypertension and cardiac anomalies. Further, the majority presented with complications such as ARDS, respiratory failure, sepsis, acute cardiac injury, heart failure, <italic>etc.</italic> Moreover, the concentrations of the IL-2 receptor, IL-6, IL-8, IL-10, and TNF-&#x003b1; were also found to be elevated [<xref rid="bb0380" ref-type="bibr">76</xref>].</p><p id="p0150">A retrospective analysis of COVID-19 patients with pneumonia demonstrated an increased expression of serum IL-6. Furthermore, a decrease in the CD3, CD4, Natural Killer (NK), and CD8 cells were also observed [<xref rid="bb0355" ref-type="bibr">71</xref>]. Cytokine profiling of the peripheral blood sample obtained from severe patients revealed an increase in the levels of the interleukins (IL) like IL-6, IL-10, IL-2, and Interferon-&#x003b3; (IFN-&#x003b3;). Besides, it was also observed that the lymphocyte and T cell (especially CD8<sup>+</sup> T) counts were substantially decreased while the neutrophil counts were increased [<xref rid="bb0350" ref-type="bibr">70</xref>]. Another study also showed increased levels of IL-2, IL-7, IL-10, and TNF-&#x003b1;. Further, it reported similar trends for Granulocyte colony-stimulating factor (GCSF), C-X-C motif chemokine 10 (CXCL10), Monocyte chemoattractant protein (MCP)-1, and Macrophage Inflammatory Protein (MIP)-1 Alpha [<xref rid="bb0345" ref-type="bibr">69</xref>].</p><p id="p0155">Transcriptomic profiling of cytokines in SARS-CoV-2 infected patients have revealed elevated levels of cytokines MCP-1, CXCL10, MIP-1A, and MIP-1B [<xref rid="bb0385" ref-type="bibr">77</xref>].</p><p id="p0160">Increased CXCL10, IL-6, IL-8, MCP-1, RANTES (regulated on activation, normal T cell expressed and secreted), and TNF-&#x003b1; was also observed in severe COVID-19 patients [<xref rid="bb0390" ref-type="bibr">78</xref>].</p><p id="p0165">The diabetic COVID-19 patients showed substantially increased leukocyte and neutrophil count. Further, the elevated level of IL-2 receptors, IL-6, IL-8, and TNF-&#x003b1; was also observed [<xref rid="bb0395" ref-type="bibr">79</xref>].</p><p id="p0170">Altogether, the aforementioned findings indicated a pivotal role of cytokine storm in COVID-19 patients. Therefore, targeting the cytokine storm might help in attenuating the severity of disease progression.</p></sec><sec id="s0040"><label>5</label><title>Molecular pathways linked to inflammation</title><p id="p0175">Inflammation is a vital cellular process or an immune response to injury, tissue damage, or infection in the body which assists in upholding the tissue homeostasis under traumatic or stressed conditions and regulates the host defense mechanism against pathogens [<xref rid="bb0400" ref-type="bibr">80</xref>]. The key molecular mediators of inflammation include inflammatory cytokines such as TNF-&#x003b1;; chemokines; inflammatory enzymes such as cyclooxygenase (cox)-1, and -2; matrix metalloproteinase (MMP)-9, 5-lipooxygenase (5-LOX); transcription factors such as signal transducer and activator of transcription 3 (STAT3) and nuclear factor kappa-B (NF-&#x003ba;B); ILs, for example, IL-1, -6, and -8. The most important mediator of inflammation is the ubiquitous expression of NF-&#x003ba;B transcription factor which play an essential role in the modulation of a wide array of genes encoding cell adhesion molecules, cytokines, and its receptors which helps in triggering inflammation [<xref rid="bb0070" ref-type="bibr">14</xref>,<xref rid="bb0405" ref-type="bibr">[81]</xref>, <xref rid="bb0410" ref-type="bibr">[82]</xref>, <xref rid="bb0415" ref-type="bibr">[83]</xref>, <xref rid="bb0420" ref-type="bibr">[84]</xref>]. NF-&#x003ba;B is a heterotrimer comprising of three subunits namely p65, p50, and an inhibitory subunit I&#x003ba;B&#x003b1;. It is mainly present in the cytoplasm, and upon activation by different inflammatory stimuli, various carcinogens, radiations such as UV-light, &#x003b3;-rays, and x-rays; several free radicals, cytokines, <italic>etc.</italic> translocates into the nucleus. After translocation into the nucleus, the activated NF-&#x003ba;B can bind to different promoter regions of several genes and activate around 400 genes which play an important role in inflammation and various other chronic diseases [<xref rid="bb0425" ref-type="bibr">[85]</xref>, <xref rid="bb0430" ref-type="bibr">[86]</xref>, <xref rid="bb0435" ref-type="bibr">[87]</xref>, <xref rid="bb0440" ref-type="bibr">[88]</xref>]. NF-&#x003ba;B activation can regulate the various hallmarks of cancer such as cancer cell proliferation, survival, angiogenesis, invasion, migration, and metastasis. They also take part in instigating chemoresistance and radiation resistance. The expression of several inflammatory mediators, for instance, cox-2, inducible nitric oxide synthase (iNOS), TNF-&#x003b1;, and ILs are regulated through NF-&#x0039a;B [<xref rid="bb0410" ref-type="bibr">82</xref>,<xref rid="bb0440" ref-type="bibr">[88]</xref>, <xref rid="bb0445" ref-type="bibr">[89]</xref>]. TNF-&#x003b1; is the most potent pro-inflammatory cytokine discovered so far. Overexpression of this cytokine can ultimately lead to inflammation and various other chronic diseases, including cancer through the regulation of the NF-&#x003ba;B pathway [<xref rid="bb0440" ref-type="bibr">88</xref>,<xref rid="bb0450" ref-type="bibr">[90]</xref>, <xref rid="bb0455" ref-type="bibr">[91]</xref>]. Hence, the TNF-&#x003b1; blockers possess immense potential to control inflammation, and the overall global market for TNF-&#x003b1; blockers was valued at US$ 43.39 billion in 2017 and expected to reach US$ 181.13 billion by 2026 [<xref rid="bb0405" ref-type="bibr">81</xref>,<xref rid="bb0450" ref-type="bibr">90</xref>,<xref rid="bb0460" ref-type="bibr">92</xref>]. The macrophages mainly release a group of cytokines known as interleukins, for example, IL-1&#x003b2;, IL-6, and IL-8 which play crucial roles in inducing an inflammatory response. It is now well evinced that the augmentation of expression of iNOS, cox-2, and abnormal expression of IL-1, -6 and -8 and TNF-&#x003b1; have been observed in case of oxidative stress that ultimately leads to inflammation [<xref rid="bb0070" ref-type="bibr">14</xref>,<xref rid="bb0405" ref-type="bibr">81</xref>,<xref rid="bb0465" ref-type="bibr">93</xref>]. IL-6 is an NF-&#x003ba;B-dependent cytokine that controls the activation of STAT3. STAT3, a transcriptional factor, is activated through Janus-activated kinase (JAK) 1, 2, and 3 which causes tyrosine phosphorylation, homodimerization, nuclear translocation of STAT3 where it binds to the DNA and is responsible for the induction of numerous inflammatory and immune responses. Moreover, several other transcription factors such as nuclear factor erythroid 2&#x02013;related factor 2 (Nrf2), activator protein-1 (AP-1), nuclear factor of activated T cells (NFAT), and hypoxia-inducible factor-1&#x003b1; (HIF-1&#x003b1;) are also regulated through various inflammatory cytokines which play a pivotal role in controlling the cellular stress responses [<xref rid="bb0070" ref-type="bibr">14</xref>,<xref rid="bb0465" ref-type="bibr">[93]</xref>, <xref rid="bb0470" ref-type="bibr">[94]</xref>, <xref rid="bb0475" ref-type="bibr">[95]</xref>]. The mitogen-activated protein kinase (MAPK) pathway can act as a molecular target for the prevention and treatment of different inflammatory diseases. The MAPK family consists of mainly three types of stress-activated protein kinase pathways <italic>viz.</italic> extracellular signal-regulated kinase (ERK), p38, and c-Jun N-terminal kinase (JNK) can regulate the IL-5 level and other cytokines during inflammation [<xref rid="bb0070" ref-type="bibr">14</xref>,<xref rid="bb0480" ref-type="bibr">96</xref>].</p></sec><sec id="s0045"><label>6</label><title>Available repurposed drugs against COVID-19</title><p id="p0180">The molecular pathogenesis of SARS-CoV-2 is not completely known and studies are conducted globally to investigate novel drugs and targets. However, at present, there are no available drugs or vaccines to treat COVID-19 specifically. Although, many studies are currently ongoing to develop and test antiviral drugs and vaccines against the causative virus SARS-CoV-2 in preclinical and clinical settings; these vaccines or novel drugs might be unavailable until 2021 [<xref rid="bb0225" ref-type="bibr">45</xref>]. In the absence of novel antiviral drugs, &#x0201c;repurposed drugs&#x0201d; are often prescribed for the treatment of COVID-19 based on the symptoms [<xref rid="bb0485" ref-type="bibr">97</xref>]. Some of the repurposed drugs that are currently used or suggested against SARS-CoV-2 as well as COVID-19 associated cytokine storms and complications are mentioned in <xref rid="t0005" ref-type="table">Table 1</xref>
.<table-wrap position="float" id="t0005"><label>Table 1</label><caption><p>Repurposed drugs against the novel coronavirus (SARS-CoV-2).</p></caption><alt-text id="al0025">Table 1</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Drug</th><th>Molecular target/mechanism of action</th><th>Company</th><th>Reference</th></tr></thead><tbody><tr><td>Acalabrutinib</td><td>Can potentially exert anti-viral and anti-inflammatory effects; BTK inhibitor</td><td>&#x02013;</td><td>[<xref rid="bb0490" ref-type="bibr">98</xref>]</td></tr><tr><td>Amphotericin B</td><td>Blocks the interaction of SARS-CoV-2 S-protein with hACE-2 receptor</td><td>&#x02013;</td><td>[<xref rid="bb0495" ref-type="bibr">99</xref>]</td></tr><tr><td>Anakinra</td><td>IL-1 inhibitor; Neutralizes SARS-CoV-2 related hyperinflammation</td><td>Swedish Orphan Biovitrum</td><td>[<xref rid="bb0485" ref-type="bibr">97</xref>,<xref rid="bb0500" ref-type="bibr">100</xref>]</td></tr><tr><td>Arbidol</td><td>Inhibit membrane fusion; Prevents the viral entry</td><td>&#x02013;</td><td>[<xref rid="bb0505" ref-type="bibr">101</xref>]</td></tr><tr><td>Atorvastatin</td><td>Attenuates NF-&#x003ba;B activation; Decreases hazard for death</td><td>&#x02013;</td><td>[<xref rid="bb0510" ref-type="bibr">102</xref>]</td></tr><tr><td>Azithromycin</td><td>Mechanism unknown; commonly used as adjunct with hydroxychloroquine</td><td>&#x02013;</td><td>[<xref rid="bb0485" ref-type="bibr">97</xref>]</td></tr><tr><td>Baricitinib</td><td>JAK1 and JAK2 inhibtor, Can potentially inhibit SARS-CoV-2 entry</td><td>&#x02013;</td><td>[<xref rid="bb0515" ref-type="bibr">103</xref>]</td></tr><tr><td>Bemcentinib</td><td>Can potentially reduce viral infection and blocks SARS-CoV-2 spike protein</td><td>BerGenBio ASA, Norway</td><td>[<xref rid="bb0485" ref-type="bibr">97</xref>]</td></tr><tr><td>Bromhexine</td><td>Transmembrane protease serine inhibitor</td><td>&#x02013;</td><td>[<xref rid="bb0520" ref-type="bibr">104</xref>]</td></tr><tr><td>Camostat mesilate</td><td>Inhibits serine protease</td><td>&#x02013;</td><td>[<xref rid="bb0330" ref-type="bibr">66</xref>,<xref rid="bb0525" ref-type="bibr">105</xref>]</td></tr><tr><td>Chloroquine</td><td>Changes the pH of endosomes; Prevents viral entry, transport and post-entry events</td><td>&#x02013;</td><td>[<xref rid="bb0530" ref-type="bibr">106</xref>]</td></tr><tr><td>Cefuroxime</td><td>Inhibits the viral RNA-dependent RNA Polymerase</td><td>&#x02013;</td><td>[<xref rid="bb0535" ref-type="bibr">107</xref>]</td></tr><tr><td>Ciclesonide</td><td>Exerts anti-viral and anti-inflammatory effects; Treated pneumonia and lung injury</td><td>&#x02013;</td><td>[<xref rid="bb0540" ref-type="bibr">108</xref>]</td></tr><tr><td>Ciprofloxacin</td><td>Binds to SARS-CoV-2 Mpro; Inhibits viral replication</td><td>&#x02013;</td><td>[<xref rid="bb0545" ref-type="bibr">109</xref>]</td></tr><tr><td>Clarithromycin</td><td>Exerts anti-viral activity; Inhibits protein synthesis by binding to the 50S ribosomal subunit</td><td>&#x02013;</td><td>[<xref rid="bb0550" ref-type="bibr">110</xref>]</td></tr><tr><td>Daclatasvir</td><td>Inhibits SARS-CoV-2 replication <italic>in vitro</italic>; Prevents the induction of pro-inflammatory cytokines</td><td>&#x02013;</td><td>[<xref rid="bb0555" ref-type="bibr">111</xref>]</td></tr><tr><td>Darunavir/cobicistat</td><td>HIV protease inhibitor</td><td>&#x02013;</td><td>[<xref rid="bb0560" ref-type="bibr">112</xref>]</td></tr><tr><td>Dasatinib</td><td>Inhibits SARS-CoV-2 3CL protease</td><td>&#x02013;</td><td>[<xref rid="bb0495" ref-type="bibr">99</xref>]</td></tr><tr><td>Dexamethasone</td><td>Reduces inflammation, modulates immune system</td><td>&#x02013;</td><td>[<xref rid="bb0565" ref-type="bibr">113</xref>]</td></tr><tr><td>Disulfiram</td><td>Inhibits 3CL protease</td><td>&#x02013;</td><td>[<xref rid="bb0570" ref-type="bibr">114</xref>]</td></tr><tr><td>Doxycycline</td><td>Decreases pro-inflammatory cytokines like IL-6, TNF-&#x003b1;; Inhibits SARS-CoV-2 papain-like protease, MMPs; Protects against lung injury</td><td>&#x02013;</td><td>[<xref rid="bb0575" ref-type="bibr">115</xref>]</td></tr><tr><td>Ergotamine</td><td>Blocks the interaction of SARS-CoV-2 S-protein with human ACE-2 receptor</td><td>&#x02013;</td><td>[<xref rid="bb0495" ref-type="bibr">99</xref>]</td></tr><tr><td>Favipiravir</td><td>Inhibits the viral RNA-dependent RNA Polymerase</td><td>Toyama Chemical, Japan</td><td>[<xref rid="bb0580" ref-type="bibr">116</xref>,<xref rid="bb0585" ref-type="bibr">117</xref>]</td></tr><tr><td>Galidesivir</td><td>Binds to the viral RNA-dependent RNA polymerase</td><td>&#x02013;</td><td>[<xref rid="bb0590" ref-type="bibr">118</xref>]</td></tr><tr><td>HCQ</td><td>Alters the pH of endosomes; prevents viral entry, transport and post-entry events</td><td>&#x02013;</td><td>[<xref rid="bb0530" ref-type="bibr">106</xref>]</td></tr><tr><td>Imatinib</td><td>Suppresses THE NF-&#x003ba;B signaling pathway; Stimulates PGE2; Decreases the release of TNF-&#x003b1;, IL1-&#x003b2; and IL-6</td><td>&#x02013;</td><td>[<xref rid="bb0595" ref-type="bibr">119</xref>]</td></tr><tr><td>Indomethacin</td><td>Blocks viral RNA synthesis</td><td>&#x02013;</td><td>[<xref rid="bb0600" ref-type="bibr">120</xref>]</td></tr><tr><td>Interferron &#x003b3;/&#x003b2;</td><td>Inhibits viral replication (SARS-CoV)</td><td>&#x02013;</td><td>[<xref rid="bb0605" ref-type="bibr">121</xref>]</td></tr><tr><td>Ivermectin</td><td>Inhibits IMP&#x003b1;/&#x003b2;1-mediated nuclear import of viral proteins</td><td>&#x02013;</td><td>[<xref rid="bb0610" ref-type="bibr">122</xref>]</td></tr><tr><td>Lactoferrin</td><td>Exerts immunomodulatory and anti-inflammatory effects; Reduces IL-6 and TNF-&#x003b1;; Inhibits viral entry by binding to the host cell surface HSPGs; Inhibits the SARS-CoV-2 invasion</td><td>&#x02013;</td><td>[<xref rid="bb0615" ref-type="bibr">123</xref>]</td></tr><tr><td>Lopinavir/Ritonavir</td><td>HIV protease inhibitor</td><td>&#x02013;</td><td>[<xref rid="bb0485" ref-type="bibr">97</xref>]</td></tr><tr><td>Losarton</td><td>Blocks AT1R</td><td>&#x02013;</td><td>[<xref rid="bb0620" ref-type="bibr">124</xref>]</td></tr><tr><td>MEDI3506</td><td>Can potentially treat respiratory failure caused by COVID, IL-33 inhibitor</td><td>&#x02013;</td><td>[<xref rid="bb0490" ref-type="bibr">98</xref>]</td></tr><tr><td>Metformin</td><td>May induce activation of AMPK which may casuse phosphorylation of ACE2 receptor, thus interfering with viral entry; Inhibition of mTOR pathway and prevention of immune hyperactivation interference with viral endocytic cycle</td><td>&#x02013;</td><td>[<xref rid="bb0625" ref-type="bibr">125</xref>,<xref rid="bb0630" ref-type="bibr">126</xref>]</td></tr><tr><td>Methylpred-nisolone</td><td>Inhibits inflammatory cascade</td><td>&#x02013;</td><td>[<xref rid="bb0635" ref-type="bibr">127</xref>]</td></tr><tr><td>Moxifloxacin</td><td>Binds to SARS-CoV-2 Mpro; Inhibits viral replication</td><td>&#x02013;</td><td>[<xref rid="bb0545" ref-type="bibr">109</xref>]</td></tr><tr><td>Nafamostat mesylate</td><td>Inhibits TMPRSS2; Prevents viral and host membrane fusion</td><td>&#x02013;</td><td>[<xref rid="bb0640" ref-type="bibr">128</xref>]</td></tr><tr><td>Niclosamide</td><td>Inhibits viral replication (SARS-CoV, MERS-CoV)</td><td>&#x02013;</td><td>[<xref rid="bb0645" ref-type="bibr">129</xref>]</td></tr><tr><td>Nitazoxanide</td><td>Supresses inflammation; Antiviral effects</td><td>&#x02013;</td><td>[<xref rid="bb0485" ref-type="bibr">97</xref>,<xref rid="bb0650" ref-type="bibr">130</xref>]</td></tr><tr><td>Pirfenidone</td><td>Inhibits IL-1&#x003b2; and IL-4</td><td>&#x02013;</td><td>[<xref rid="bb0655" ref-type="bibr">131</xref>]</td></tr><tr><td>Povidone-Iodine</td><td>Exerts virucidal activity</td><td>&#x02013;</td><td>[<xref rid="bb0660" ref-type="bibr">132</xref>]</td></tr><tr><td>Remdesivir</td><td>Inhibits the viral RNA-dependent RNA polymerase</td><td>Gilead Sciences, USA</td><td>[<xref rid="bb0665" ref-type="bibr">133</xref>]</td></tr><tr><td>Ribavarin</td><td>Binds to the viral RNA-dependent RNA polymerase</td><td>&#x02013;</td><td>[<xref rid="bb0590" ref-type="bibr">118</xref>]</td></tr><tr><td>Rivaroxaban</td><td>Inhibits SARS-CoV-2 3CL protease</td><td>&#x02013;</td><td>[<xref rid="bb0495" ref-type="bibr">99</xref>]</td></tr><tr><td>Sacubitril/</td><td>Can potentially reduce pro-inflammatory</td><td>&#x02013;</td><td>[<xref rid="bb0670" ref-type="bibr">134</xref>]</td></tr><tr><td>Valsartan</td><td>Cytokines and neutrophil count; Increases lymphocyte count; reduces hs-CRP levels</td><td/><td/></tr><tr><td>Sarilumab</td><td>Blocks IL-6 receptor</td><td>Regeneron Pharmaceuticals and Sanofi</td><td>[<xref rid="bb0485" ref-type="bibr">97</xref>]</td></tr><tr><td>Saquinavir</td><td>Inhibits SARS-CoV-2 3CL protease</td><td>&#x02013;</td><td>[<xref rid="bb0495" ref-type="bibr">99</xref>]</td></tr><tr><td>Setrobuvir</td><td>Binds to the viral RNA-dependent RNA polymerase</td><td>&#x02013;</td><td>[<xref rid="bb0535" ref-type="bibr">107</xref>]</td></tr><tr><td>Sildenafil</td><td>Inhibits SARS-CoV-2 3CL protease</td><td>&#x02013;</td><td>[<xref rid="bb0495" ref-type="bibr">99</xref>]</td></tr><tr><td>Siltuximab</td><td>IL-6 blocker</td><td>&#x02013;</td><td>[<xref rid="bb0675" ref-type="bibr">135</xref>]</td></tr><tr><td>Sirolimus</td><td>Modulates PI3K/AKT/mTOR pathway and inhibits MERS-CoV activity</td><td>&#x02013;</td><td>[<xref rid="bb0485" ref-type="bibr">97</xref>]</td></tr><tr><td>Sofosbuvir</td><td>Binds to the viral RNA-dependent RNA polymerase</td><td>&#x02013;</td><td>[<xref rid="bb0590" ref-type="bibr">118</xref>]</td></tr><tr><td>Tacrolimus</td><td>Inhibits replication and growth of the</td><td>&#x02013;</td><td>[<xref rid="bb0680" ref-type="bibr">136</xref>]</td></tr><tr><td>(FK506)</td><td>SARS-CoV, HCoV-NL63 and HCoV-229E</td><td/><td/></tr><tr><td>Tadalafil</td><td>Inhibits SARS-CoV-2 3CL protease</td><td>&#x02013;</td><td>[<xref rid="bb0495" ref-type="bibr">99</xref>]</td></tr><tr><td>Telmisartan</td><td>Blocks AT1R</td><td>&#x02013;</td><td>[<xref rid="bb0620" ref-type="bibr">124</xref>]</td></tr><tr><td>Tenofovir</td><td>Binds to the viral RNA-dependent RNA Polymerase</td><td>&#x02013;</td><td>[<xref rid="bb0590" ref-type="bibr">118</xref>]</td></tr><tr><td>Thymosin &#x003b1;1</td><td>Restores T cell exhaustion; Recovers the immune reconstitution <italic>via</italic> promoting thymus output</td><td>&#x02013;</td><td>[<xref rid="bb0685" ref-type="bibr">137</xref>]</td></tr><tr><td>Tocilizumab</td><td>Inhibits the IL-6 receptor</td><td>Roche and Chugai Pharmaceutical</td><td>[<xref rid="bb0485" ref-type="bibr">97</xref>]</td></tr><tr><td>Vancomycin</td><td>Blocks interaction of the SARS-CoV-2 S-protein with hACE-2 receptor</td><td>&#x02013;</td><td>[<xref rid="bb0495" ref-type="bibr">99</xref>]</td></tr><tr><td>Zilucoplan</td><td>C5 inhibitor; can potentially block the severe inflammatory response in COVID-19</td><td>&#x02013;</td><td>[<xref rid="bb0490" ref-type="bibr">98</xref>]</td></tr><tr><td>&#x003b1;-ketoamides</td><td>Binds to SARS-CoV-2 main protease (Mpro)</td><td>&#x02013;</td><td>[<xref rid="bb0690" ref-type="bibr">138</xref>]</td></tr></tbody></table><table-wrap-foot><fn id="sp0045"><p>Abbreviations:</p></fn><fn id="sp0050"><p>AKT: Protein kinase B; AT1R: Angiotensin receptor 1; BTK: Bruton tyrosine kinase; CoV: Coronavirus; COVID-19: coronavirus disease-19; hACE-2: Human angiotensin-Converting Enzyme-2; HCoV: Human coronavirus; HCQ: Hydroxy-chloroquine; HIV: Human immunodeficiency virus; hs-CRP: high sensitivity C-reactive protein IL: Interleukin; IMP&#x003b1;/&#x003b2;1: JAK: Janus Kinase; MERS-CoV: Middle East respiratory syndrome coronavirus; MMP: Matrix metalloproteiniases; Mpro: Main protease; mTOR: mammalian target of rapamycin; NF-&#x003ba;B: Nuclear factor kappa B; PGE2: Prostaglandin E<sub>2</sub>; PI3K: Phosphoinositide 3-kinases; SARS-CoV-2: Severe acute respiratory syndrome coronavirus-2; TNF-&#x003b1;: Tumor necrosis factor-&#x003b1;; 3CL: 3C-like protease.</p></fn></table-wrap-foot></table-wrap></p><p id="p0185">Among the available repurposed therapeutic drugs currently used against SARS-CoV-2, the most commonly prescribed drugs are anti-viral. Several antiviral drugs previously tested against Ebola, HIV, Influenza, <italic>etc.</italic>, are currently being investigated to evaluate their efficacy and safety against SARS-CoV-2 [<xref rid="bb0695" ref-type="bibr">[139]</xref>, <xref rid="bb0700" ref-type="bibr">[140]</xref>, <xref rid="bb0705" ref-type="bibr">[141]</xref>]. These antiviral drugs are used commonly to treat infected patients, in combination or alone [<xref rid="bb0710" ref-type="bibr">142</xref>].</p><sec id="s0050"><label>6.1</label><title>Arbidol</title><p id="p0190">Arbidol is an indole-derivative anti-viral drug commonly used against influenza. Besides, it also exerts inhibition against viruses such as hepatitis B and C, chikungunya, reovirus, Hantaan, <italic>etc.</italic> [<xref rid="bb0715" ref-type="bibr">143</xref>]. Arbidol efficiently inhibits SARS-CoV-2 infection in Vero E6 cells by effectively blocking the entry as well as post-entry stages of the virus [<xref rid="bb0705" ref-type="bibr">141</xref>]. A study conducted molecular dynamics simulation and structure-based studies to analyze the exact target of arbidol on SARS-CoV-2 and determine the associated mechanism. The study revealed that arbidol binds to the S2 domain of S protein on SARS-CoV-2 and thereby interferes with the trimerization, which is essential for the adhesion and fusion with the host cell membrane [<xref rid="bb0505" ref-type="bibr">101</xref>]. Further, SARS-CoV-2 infected hospitalized patients treated with arbidol (0.4&#x0202f;g, three times per day for 9&#x0202f;days) exhibited improvement in the discharge rate as well as a reduction in the mortality rate as compared to the untreated patients. The patients were administered 0.4&#x0202f;g of arbidol three times daily for 9&#x0202f;days (median duration) [<xref rid="bb0720" ref-type="bibr">144</xref>]. However, a retrospective study stated that Umifenovir does not improve the outcome of COVID-19 patients [<xref rid="bb0725" ref-type="bibr">145</xref>].</p></sec><sec id="s0055"><label>6.2</label><title>Chloroquine and hydroxychloroquine</title><p id="p0195">Chloroquine is a well-known anti-malarial drug. It is also used against lupus erythematosus and rheumatoid arthritis (RA). The hydroxylated form of Chloroquine <italic>i.e.</italic>, Hydroxychloroquine (HCQ) exhibits similar properties [<xref rid="bb0485" ref-type="bibr">97</xref>]. Chloroquine is also reported to possess antiviral activity. Various studies have reported its antiviral activity against human immunodeficiency deficiency virus (HIV)-1, hepatitis A virus, herpes simplex virus type 1, <italic>etc.</italic> HCQ exerts antiviral activity against HIV-1 [<xref rid="bb0695" ref-type="bibr">139</xref>,<xref rid="bb0730" ref-type="bibr">146</xref>].</p><p id="p0200">Chloroquine inhibits the viral infection by elevating the endosomal pH essential for viral-host cell fusion. It also interrupts the glycosylation of the SARS-CoV receptors [<xref rid="bb0530" ref-type="bibr">106</xref>]. Previously, Chloroquine was also reported to exhibit effective antiviral activity against the human coronaviruses strain OC43 (HCoV-OC43) <italic>in vivo</italic> [<xref rid="bb0735" ref-type="bibr">147</xref>]. It is also reported to be effective against the novel coronavirus infection in Vero E6 cells [<xref rid="bb0530" ref-type="bibr">106</xref>].</p><p id="p0205">An <italic>in vitro</italic> study demonstrated that Hydroxychloroquine (HCQ) and Azithromycin (AZM) exert synergistic effects against SARS-CoV-2 [<xref rid="bb0740" ref-type="bibr">148</xref>]. A retrospective study reported that early treatment of SARS-CoV-2 infected patients with HCQ and AZM resulted in low mortality rates [<xref rid="bb0745" ref-type="bibr">149</xref>]. Further, an open-label non-randomized clinical trial reported that HCQ caused a decline in the viral load in COVID-19 patients. Additionally, it was found that AZM further reinforced its effect but the mechanism by which the two drugs act is unknown [<xref rid="bb0750" ref-type="bibr">150</xref>,<xref rid="bb0755" ref-type="bibr">151</xref>]. WHO has discontinued the HCQ arm for its Solidarity Trial as it induced little or no decrease in mortality [<xref rid="bb0760" ref-type="bibr">152</xref>]. HCQ has been associated with cardiac abnormalities like QT prolongation and AZM might enhance the risk [<xref rid="bb0755" ref-type="bibr">151</xref>].</p></sec><sec id="s0060"><label>6.3</label><title>Favipiravir</title><p id="p0210">Favipiravir (T705) is an anti-influenza drug, manufactured by Toyama Chemical, Japan. It inhibits the viral RNA-dependent RNA polymerase [<xref rid="bb0585" ref-type="bibr">117</xref>]. An open-label, non-randomized, control study reported that the treatment of infected patients with a combination of favipiravir and IFN-&#x003b1; checks the disease progression and results in faster viral clearance as compared to Lopinavir/Ritonavir. Favipiravir was administered orally for 14&#x0202f;days (1600&#x0202f;mg twice on day 1 followed by 600&#x0202f;mg, twice, daily for the remaining days) while IFN-&#x003b1; was administered <italic>via</italic> aerosol inhalation (5,000,000&#x0202f;U twice, daily) [<xref rid="bb0580" ref-type="bibr">116</xref>].</p></sec><sec id="s0065"><label>6.4</label><title>Lopinavir/Ritonavir</title><p id="p0215">Lopinavir a protease inhibitor prescribed for the treatment of HIV. The oral bioavailability of lopinavir is considerably poor; therefore it is often prescribed in combination with ritonavir which boosts its exposure. It also inhibits the enzymes which metabolize lopinavir and further enhances its antiviral effect [<xref rid="bb0485" ref-type="bibr">97</xref>]. A recent <italic>in vitro</italic> study reported that lopinavir exhibits antiviral effects against HCoVs such as 229E, SARS-CoV, and MERS-CoV [<xref rid="bb0765" ref-type="bibr">153</xref>]. It is also reported to be effective against SARS-CoV-2 <italic>in vitro</italic> [<xref rid="bb0770" ref-type="bibr">154</xref>]. WHO recently discontinued the Lopinavir/Ritonavir arm for its WHO-led Solidarity Trial conducted for the treatment of COVID-19 hospitalized patients. This was done as the drug exerted little or no decrease in mortality [<xref rid="bb0760" ref-type="bibr">152</xref>].</p></sec><sec id="s0070"><label>6.5</label><title>Remdesivir</title><p id="p0220">Remdesivir (GS-5734) is a nucleoside analog of adenosine, manufactured by Gilead Sciences. It is a broad-spectrum antiviral drug that inhibits the viral RNA-dependent polymerase and thus, interferes with viral replication [<xref rid="bb0665" ref-type="bibr">133</xref>], [<xref rid="bb0700" ref-type="bibr">140</xref>]. It had been previously tested against the Ebola virus [<xref rid="bb0775" ref-type="bibr">155</xref>]. An <italic>in vitro</italic> study has also demonstrated its antiviral activity against viruses of the <italic>Paramyxoviridae</italic>, <italic>Pneumoviridae</italic> as well as <italic>Filoviridae</italic> families [<xref rid="bb0780" ref-type="bibr">156</xref>]. Remdesivir also shows promising results against SARS-CoV and MERS-CoV infection in human airway epithelial cells [<xref rid="bb0785" ref-type="bibr">157</xref>]. Therefore, various studies are conducted to investigate its efficacy against the novel coronavirus infection in both preclinical and clinical settings. An <italic>in vitro</italic> study demonstrated that Remdesivir is efficacious against novel coronavirus infection [<xref rid="bb0530" ref-type="bibr">106</xref>]. The synergistic inhibitory effect of Remdesivir with emetine (a protein synthesis inhibitor) against SARS-CoV-2 is also observed <italic>in vitro</italic> [<xref rid="bb0770" ref-type="bibr">154</xref>]. Furthermore, Remdesivir also induced substantial clinical improvement, when administered during the early stages of SARS-CoV-2 infection, in the rhesus macaque model [<xref rid="bb0790" ref-type="bibr">158</xref>]. A study reported the compassionate use of Remdesivir against COVID-19 in SARS-CoV-2 infected patients. 36 out of 53 patients intravenously treated with Remdesivir (200&#x0202f;mg of on day 1 followed by 100&#x0202f;mg for 9&#x0202f;days) showed clinical improvement [<xref rid="bb0795" ref-type="bibr">159</xref>].</p><p id="p0225">A cohort study on severe COVID-19 hospitalized patients revealed that the treatment with Oseltamivir or Ganciclovir lowered the risk of death [<xref rid="bb0800" ref-type="bibr">160</xref>]. Antiviral drugs such as Oseltamivir, Lopinavir, Ritonavir, Ganciclovir have been used commonly to treat infected patients, in combination or alone [<xref rid="bb0710" ref-type="bibr">142</xref>].</p></sec><sec id="s0075"><label>6.6</label><title>Others</title><p id="p0230">The aforementioned antiviral drugs are some of the most actively prescribed and studied repurposed drugs. However, apart from this, several other drugs are currently being tested in pre-clinical and clinical settings. Some of these drugs are anti-helminthic, corticoids, immunomodulators, protease inhibitors, anti-fibrotic, anti-inflammatory, <italic>etc.</italic> These drugs have shown effectiveness either in the hospitalized COVID-19 patients or against SARS-CoV-2 <italic>in vitro</italic>/<italic>in vivo</italic>/<italic>in silico</italic>. Moreover, some of these drugs are hypothesized to target COVID-19 associated complications such as hyper inflammation (cytokine storm), pneumonia, ARDS, <italic>etc.</italic> [<xref rid="bb0485" ref-type="bibr">97</xref>].</p><p id="p0235">Ivermectin and niclosamide are potent anti-helminthic drugs [<xref rid="bb0485" ref-type="bibr">97</xref>]. A study demonstrated that ivermectin also shows antiviral activity against SARS-CoV-2 <italic>in vitro</italic> [<xref rid="bb0610" ref-type="bibr">122</xref>]. Previously, Niclosamide had been shown effective against SARS-CoV, MERS-CoV, Ebola virus, rhinovirus, <italic>etc.</italic> Therefore, this broad-spectrum anti-helminthic drug might be quite promising in inhibiting SARS-CoV-2 [<xref rid="bb0645" ref-type="bibr">129</xref>].</p><p id="p0240">Glucocorticosteroids show anti-inflammatory effects and effectively inhibits the cytokine levels. Therefore, they might be used to combat the cytokine storm in COVID-19 patients. Dexamethasone is a synthetic glucocorticoid that has shown promising results against COVID-19. A recent study investigated the short-term treatment with dexamethasone in SARS-CoV-2 patients with hypoxic respiratory failure. The study reported that dexamethasone was well-tolerated and may help in attenuation of the hyper-inflammatory phase [<xref rid="bb0565" ref-type="bibr">113</xref>]. Methylprednisolone is an anti-inflammatory and anti-fibrotic drug [<xref rid="bb0485" ref-type="bibr">97</xref>]. It efficiently inhibits the inflammatory response. Further, methylprednisolone might also be associated with an improved outcome as well as lung function in COVID-19 patients [<xref rid="bb0635" ref-type="bibr">127</xref>]. Although these corticosteroids show effective results, their usage for the treatment of COVID-19-associated pneumonia remains controversial. As their continuous administration can suppress the immune system, it is necessary to determine the appropriate dose as well as the rationale for its usage [<xref rid="bb0485" ref-type="bibr">97</xref>,<xref rid="bb0635" ref-type="bibr">127</xref>].</p><p id="p0245">The interleukin-6 inhibitors Tocilizumab, Sarilumab, and Siltuximab are hypothesized to be effective against COVID-19 patients. These IL-6 receptors antagonists are also tested against SARS-CoV-2 in both clinical and preclinical studies [<xref rid="bb0485" ref-type="bibr">97</xref>,<xref rid="bb0675" ref-type="bibr">135</xref>]. Early treatment with Tocilizumab reportedly improves the clinical outcome as well as causes a decline in mortality in COVID-19 pneumonia patients [<xref rid="bb0805" ref-type="bibr">161</xref>]. A recent study investigated the effectiveness of Tocilizumab for the treatment of mechanically ventilated COVID-19 patients. It was observed that Tocilizumab was associated with a low death rate [<xref rid="bb0810" ref-type="bibr">162</xref>]. A study in severe COVID-19 pneumonia patients showed that treatment with Sarilumab exhibited promising results [<xref rid="bb0815" ref-type="bibr">163</xref>].</p><p id="p0250">IL-1 promotes pro-inflammatory cytokines such as IL-6 and contributes significantly to cytokine storm. Anakinra, an IL-1 receptor antagonist, blocks both IL-1 &#x003b1; and IL-&#x003b2;. It is therefore believed to be highly effective in combating COVID-19 associated cytokine storm [<xref rid="bb0820" ref-type="bibr">164</xref>]. The Ana-COVID study has shown that it reduces SARS-CoV-2 associated hyper inflammation [<xref rid="bb0500" ref-type="bibr">100</xref>].</p><p id="p0255">Baricitinib is a JAK 1 and JAK 2 inhibitor [<xref rid="bb0515" ref-type="bibr">103</xref>]. A study showed that it improved the respiratory function in COVID-19 patients who failed to respond completely to sarilumab [<xref rid="bb0825" ref-type="bibr">165</xref>]. Further, Baricitinib reportedly decreases the SARS-CoV-2 viral load pneumonia as well as the COVID-19-associated mortality rate [<xref rid="bb0515" ref-type="bibr">103</xref>].</p><p id="p0260">Bromhexine hydrochloride is a mucolytic cough suppressant that also acts as a TMPRSS2 inhibitor. As TMPRSS2 is responsible for the SARS-CoV-2 entry in the host cell, bromhexine might be effective in inhibiting the virus [<xref rid="bb0520" ref-type="bibr">104</xref>,<xref rid="bb0830" ref-type="bibr">[166]</xref>, <xref rid="bb0835" ref-type="bibr">[167]</xref>]. Nafamostat mesylate inhibited MERS-CoV infection by acting as a TMPRSS2 inhibitor. A study reported that it also efficiently inhibits the SARS-CoV-2 infection <italic>in vitro.</italic> Further, it blocked the viral S protein-mediated fusion [<xref rid="bb0640" ref-type="bibr">128</xref>]. Camostat mesylate (also known as camostat mesilate) is a serine protease inhibitor. <italic>In vitro</italic> studies have shown that camostat mesylate can prevent SARS-CoV-2 infection by inhibiting the TMPRSS2 activity. Therefore, camostat mesylate might prove promising in the treatment pf COVID-19 patients [<xref rid="bb0330" ref-type="bibr">66</xref>,<xref rid="bb0525" ref-type="bibr">105</xref>].</p><p id="p0265">Several studies have shown that the administration of the anti-diabetic drug metformin in diabetic COVID-19 patients is associated with a decrease in mortality [<xref rid="bb0840" ref-type="bibr">[168]</xref>, <xref rid="bb0845" ref-type="bibr">[169]</xref>, <xref rid="bb0850" ref-type="bibr">[170]</xref>, <xref rid="bb0855" ref-type="bibr">[171]</xref>]. A limited study has been conducted on Metformin in association with COVID-19 <italic>in vitro</italic> and therefore, the exact mechanism of action is unknown. However, a few possible mechanisms of action have been reported [<xref rid="bb0625" ref-type="bibr">125</xref>,<xref rid="bb0630" ref-type="bibr">126</xref>].</p><p id="p0270">Darunavir is a potent HIV protease inhibitor [<xref rid="bb0560" ref-type="bibr">112</xref>]. Cobicistat is an effective booster that enhances the pharmacokinetics of the anti-retroviral drugs and is hence often co-administered with darunavir [<xref rid="bb0860" ref-type="bibr">172</xref>]. A pilot study (<ext-link ext-link-type="ClinicalTrials.gov" xlink:href="NCT04252274" id="ir0010">NCT04252274</ext-link>) showed that Darunavir/cobicistat in COVID-19 patients is well-tolerated. However, it did not show any significant improvement as compared to the control group [<xref rid="bb0865" ref-type="bibr">173</xref>]. The aforementioned findings aligned with another <italic>in vitro</italic> study which showed that Darunavir/cobicistat is ineffective against SARS-CoV-2 <italic>in vitro</italic> [<xref rid="bb0560" ref-type="bibr">112</xref>].</p><p id="p0275">Indomethacin, a cox inhibitor, has been reported to exhibit anti-viral effect activity against canine CoV (CCoV) as well as SARS-CoV. It inhibits viral RNA synthesis <italic>in vitro</italic> [<xref rid="bb0600" ref-type="bibr">120</xref>]. A recent study has shown that Indomethacin is also effective against the SARS-CoV-2 <italic>in vitro</italic> as well as CCoV <italic>in vivo</italic> [<xref rid="bb0870" ref-type="bibr">174</xref>].</p><p id="p0280">Doxycycline, an antibacterial drug, reduces the pro-inflammatory cytokines such as IL-6 and TNF-&#x003b1;. This anti-inflammatory property of Doxycycline might repress cytokine storm and prove essential in preventing lung damage associated with COVID-19. Further, a computational study revealed that Doxycycline might inhibit SARS-CoV-2 papain-like protease and thereby prevent the infection [<xref rid="bb0575" ref-type="bibr">115</xref>,<xref rid="bb0875" ref-type="bibr">175</xref>].</p><p id="p0285">A retrospective study conducted on severe COVID-19 patients showed that the administration of thymosin-&#x003b1;1supplement substantially decreased the mortality of severe COVID-19 patients. Further, it also induced the reversion of exhausted T cells [<xref rid="bb0685" ref-type="bibr">137</xref>].</p><p id="p0290">Ciclesonide, an inhaled steroid, effectively inhibits SARS-CoV-2 infection <italic>in vitro</italic>. It inhibits the infection by interacting with the viral non-structural protein 13 (NSP13) [<xref rid="bb0880" ref-type="bibr">176</xref>]. A study reported three cases where ciclesonide, an inhaled steroid, attenuated COVID-19 associated pneumonia [<xref rid="bb0540" ref-type="bibr">108</xref>].</p><p id="p0295">Imatinib is an Abelson (Abl) kinase inhibitor and a potent anti-cancer drug. It also modulates immune response and exerts anti-inflammatory effects. Further, it also exhibits anti-viral effects against SARS-CoV and MERS-CoV. Therefore, it is believed that Imatinib might also be effective against SARS-CoV-2 and have an immunomodulatory effect against COVID-19 pneumonia [<xref rid="bb0595" ref-type="bibr">119</xref>,<xref rid="bb0885" ref-type="bibr">177</xref>]. Lactoferrin exerts immunomodulatory and anti-inflammatory properties. Therefore, it has been proposed lactoferrin might be used with other drugs as an adjunct to treat COVID-19 [<xref rid="bb0615" ref-type="bibr">123</xref>]. Povidone-Iodine also exhibits potent virucidal activity against SARS-CoV-2 [<xref rid="bb0660" ref-type="bibr">132</xref>]. The drug Tacrolimus (FK506) has been previously tested effective in inhibiting the replication of HCoVs such as SARS-CoV, NL63, and 229E. Therefore, it is proposed that it might be inhibitory against SARS-CoV-2 [<xref rid="bb0680" ref-type="bibr">136</xref>]. Pirfenidone is an anti-fibrotic drug which is used to treat idiopathic pulmonary fibrosis. Further, this drug inhibits IL-1&#x003b2; as well as IL-4 and thus exerts an anti-inflammatory effect, which might be effective in combating cytokine storm [<xref rid="bb0655" ref-type="bibr">131</xref>]. It also modulates the angiotensin II type 1 receptor/p38 MAPK/renin-angiotensin system (AT1R/p38 MAPK/RAS axis) [<xref rid="bb0890" ref-type="bibr">178</xref>]. Therefore, it has been hypothesized that Pirfenidone might be useful in combating COVID-19 associated cytokine storm as well as lung fibrosis [<xref rid="bb0655" ref-type="bibr">131</xref>].</p><p id="p0300">Sirolimus (rapamycin) is a commonly used immunosuppressant. It exerts inhibition on the mammalian target of rapamycin (mTOR) kinase [<xref rid="bb0485" ref-type="bibr">97</xref>,<xref rid="bb0625" ref-type="bibr">125</xref>]. A study showed that sirolimus inhibits MERS-CoV infection effectively [<xref rid="bb0895" ref-type="bibr">179</xref>]. A Phase II clinical study is initiated to investigate if sirolimus is associated with the improvement of outcomes in COVID-19 patients placebo (<ext-link ext-link-type="ClinicalTrials.gov" xlink:href="NCT04341675" id="ir0015">NCT04341675</ext-link>) [<xref rid="bb0900" ref-type="bibr">180</xref>].</p><p id="p0305">Atorvastatin treatment was also reported to be related to a reduction in the progress to death in COVID-19 patients [<xref rid="bb0510" ref-type="bibr">102</xref>].</p><p id="p0310">Another study showed that the administration of Chloroquine and Clarithromycin in a COVID-19 patient with pneumonia improved the outcome [<xref rid="bb0550" ref-type="bibr">110</xref>].</p><p id="p0315">The ACCORD study (EudraCT 2020-001736-95) is initiated to investigate the efficacy of drugs such as Bemcentinib, MEDI3506, Acalabrutinib, Zilucoplan, and Nebulised heparin in COVID-19 patients [<xref rid="bb0490" ref-type="bibr">98</xref>]. A study hypothesized that blocking the AT1R might be beneficial to COVID-19 patients. Losartan and Telmisartan effectively blocks the AT1R and might be useful against SARS-CoV-2 [<xref rid="bb0620" ref-type="bibr">124</xref>].</p><p id="p0320">Sacubitril/valsartan is an angiotensin receptor-neprilysin inhibitor [<xref rid="bb0905" ref-type="bibr">181</xref>]. Further, it has anti-inflammatory activity and hence decreases the pro-inflammatory cytokines. It has been suggested that Sacubitril/valsartan can be used for the treatment of COVID-19 patients [<xref rid="bb0670" ref-type="bibr">134</xref>].</p><p id="p0325">An <italic>in silico</italic> study shows that Disulfiram inhibits the 3CLpro enzyme. This property of disulfiram may be further tested in clinical and preclinical studies for further validation [<xref rid="bb0570" ref-type="bibr">114</xref>]. Molecular docking and simulation study also revealed that &#x003b1;-ketoamides, Ciprofloxacin, and Moxifloxacin bind to SARS-CoV-2 main protease (Mpro) <italic>in silico</italic> which might be effective in inhibiting the SARS-CoV-2 infection [<xref rid="bb0545" ref-type="bibr">109</xref>,<xref rid="bb0690" ref-type="bibr">138</xref>]. The drugs Setrobuvir and Cefuroxime effectively bind to the SARS-CoV-2 RdRp <italic>in silico</italic> and hence can be used for treatment against the virus [<xref rid="bb0535" ref-type="bibr">107</xref>]. Similar findings were observed for Ribavirin, Sofosbuvir, Galidesivir, and Tenofovir [<xref rid="bb0595" ref-type="bibr">119</xref>]. Another <italic>in silico</italic> study reported that Rivaroxaban, Saquinavir, Tadalafil, Sildenafil, Dasatinib inhibits the SARS-CoV-2 3CL protease. Further, it showed that Ergotamine, Amphotericin B, Vancomycin blocks interaction of SARS-CoV-2 S-protein with the ACE2 receptor <italic>in silico</italic> [<xref rid="bb0495" ref-type="bibr">99</xref>].</p><p id="p0330">IFN-&#x003b2; and IFN-<bold>&#x003b3;</bold> exert synergistic inhibitory effects on SARS-CoV replication [<xref rid="bb0605" ref-type="bibr">121</xref>]. Nitazoxanide is reported to inhibit inflammation. Apart from this, it also exerts antiviral activity against SARS-CoV, MERS-CoV, and influenza virus <italic>in vitro</italic> [<xref rid="bb0650" ref-type="bibr">130</xref>].</p><p id="p0335">Daclatasvir inhibits SARS-CoV-2 <italic>in vitro</italic> by inhibiting the viral replication. Further, it also prevented the production of pro-inflammatory cytokines [<xref rid="bb0555" ref-type="bibr">111</xref>].</p><p id="p0340">Various studies have also suggested that compounds derived from natural products can also be effective in treatment against COVID-19. A recent molecular docking study evaluated the binding potential of various phytochemicals to the non-structural protein 15 (Nsp15) which is associated with viral replication. The study reported that ajmalicine, alpha terpinyl acetate, curcumin, gingerol, novobiocin, piperine, rosmarinic acid, silymarin, and aranotin, sarsasapogenin, and ursonic acid exhibited binding with the Nsp15 protein. Therefore, these phytochemicals might effectively inhibit viral replication and their efficacy should be evaluated in pre-clinical as well as clinical studies [<xref rid="bb0910" ref-type="bibr">182</xref>]. Another study conducted molecular docking simulations between functional foods and SARS-CoV-2 Mpro. It reported that quercetrin exhibited inhibition against SARS-CoV-2 Mpro <italic>in silico</italic> [<xref rid="bb0915" ref-type="bibr">183</xref>]. Curcumin also demonstrated a high binding free energy for the enzymes Cat K, COVID-19 Mpro, and SARS-CoV 3 C-like protease [<xref rid="bb0920" ref-type="bibr">184</xref>].</p><p id="p0345">The natural compounds such as andrographolide, berberine, curcumin, mangiferin, nimbin, piperine, thebaine, and withaferin A exhibited a binding affinity for the ACE2 receptor and SARS-CoV-2 S protein. Further, the compounds gallic acid, luteolin, naringenin, quercetin, resveratrol, and zingiberene showed an affinity to only the ACE2 receptor. These compounds might inhibit the attachment of the SARS-CoV-2 virus to the host cell [<xref rid="bb0925" ref-type="bibr">185</xref>] (<xref rid="f0015" ref-type="fig">Fig. 3</xref>
).<fig id="f0015"><label>Fig. 3</label><caption><p>The potential of spices in suppressing SARS-CoV-2 cytokine storm-induced lung fibrosis. The binding of SARS-CoV-2 to the ACE2 receptor causes the fusion of the viral membrane and the target cell which eventually leads to the release of the viral RNA in the cytoplasm of the host cell. Following its release, the virus utilizes the host machinery to synthesize viral proteins and subsequently initiates viral replication, which is followed by packaging and assembly of the viral particles. The mature virus thus formed and released illicits aggravated inflammatory response or cytokine storm in the host which causes ARDS or lung fibrosis in severe cases. As spices are potent anti-inflammatory agents, they might prove effective in combating the SARS-CoV-2 induced cytokine storm and thus might be beneficial in preventing cytokine storm-induced complications such as ARDS or lung fibrosis.</p><p>Abbreviations: ACE2: Angiotensin converting enzyme-2, SARS-CoV-2: Severe Acute Respiratory Coronavirus-2.</p></caption><alt-text id="al0015">Fig. 3</alt-text><graphic xlink:href="gr3_lrg"/></fig></p></sec></sec><sec id="s0080"><label>7</label><title>Anti-inflammatory role of spices</title><p id="p0350">Mother Nature has bestowed us with various promising medicinal plants as well as plant-based products such as fruits, vegetables, herbs, and spices that are abundantly consumed [<xref rid="bb0930" ref-type="bibr">[186]</xref>, <xref rid="bb0935" ref-type="bibr">[187]</xref>, <xref rid="bb0940" ref-type="bibr">[188]</xref>, <xref rid="bb0945" ref-type="bibr">[189]</xref>, <xref rid="bb0950" ref-type="bibr">[190]</xref>, <xref rid="bb0955" ref-type="bibr">[191]</xref>, <xref rid="bb0960" ref-type="bibr">[192]</xref>, <xref rid="bb0965" ref-type="bibr">[193]</xref>, <xref rid="bb0970" ref-type="bibr">[194]</xref>]. Apart from their high nutritional value, these are also rich in therapeutic properties [<xref rid="bb0945" ref-type="bibr">189</xref>,<xref rid="bb0965" ref-type="bibr">193</xref>,<xref rid="bb0975" ref-type="bibr">[195]</xref>, <xref rid="bb0980" ref-type="bibr">[196]</xref>, <xref rid="bb0985" ref-type="bibr">[197]</xref>, <xref rid="bb0990" ref-type="bibr">[198]</xref>, <xref rid="bb0995" ref-type="bibr">[199]</xref>, <xref rid="bb1000" ref-type="bibr">[200]</xref>].</p><p id="p0355">Various phytochemical and natural compounds obtained from different parts of plants have been a part of traditional medicine for ages and consumed for their health benefits as well as efficacy against a plethora of diseases [<xref rid="bb1005" ref-type="bibr">[201]</xref>, <xref rid="bb1010" ref-type="bibr">[202]</xref>, <xref rid="bb1015" ref-type="bibr">[203]</xref>, <xref rid="bb1020" ref-type="bibr">[204]</xref>, <xref rid="bb1025" ref-type="bibr">[205]</xref>, <xref rid="bb1030" ref-type="bibr">[206]</xref>, <xref rid="bb1035" ref-type="bibr">[207]</xref>, <xref rid="bb1040" ref-type="bibr">[208]</xref>, <xref rid="bb1045" ref-type="bibr">[209]</xref>, <xref rid="bb1050" ref-type="bibr">[210]</xref>, <xref rid="bb1055" ref-type="bibr">[211]</xref>, <xref rid="bb1060" ref-type="bibr">[212]</xref>, <xref rid="bb1065" ref-type="bibr">[213]</xref>, <xref rid="bb1070" ref-type="bibr">[214]</xref>, <xref rid="bb1075" ref-type="bibr">[215]</xref>].</p><p id="p0360">The leaves of the plants which are utilized for culinary purposes and consumed fresh are known as herbs. Spices, on the other hand, are consumed as dried parts of a plant. It can be a bud, root, seed, bark, berries, or even stigma of a flower [<xref rid="bb0070" ref-type="bibr">14</xref>,<xref rid="bb0930" ref-type="bibr">186</xref>,<xref rid="bb1080" ref-type="bibr">216</xref>]. In addition to their usage in culinary purposes for imparting flavor and taste to food, they are also beneficial to health. Spices and herbs, as well as their active components, have been used in various traditional medicines since time immemorial. They effectively act against many diseases such as arthritis, asthma, cancer, diabetes, <italic>etc.</italic> [<xref rid="bb1085" ref-type="bibr">[217]</xref>, <xref rid="bb1090" ref-type="bibr">[218]</xref>, <xref rid="bb1095" ref-type="bibr">[219]</xref>, <xref rid="bb1100" ref-type="bibr">[220]</xref>]. In severe cases of COVID-19, cytokine storm is commonly observed and is majorly responsible for the degradation of health conditions [<xref rid="bb0050" ref-type="bibr">10</xref>]. As spices and herbs exhibit potent anti-inflammatory activities, they could be used to combat the elevated levels in COVID-19 associated cases and boost immunity with minimal or no side-effects [<xref rid="bb0070" ref-type="bibr">14</xref>]. Some of the spices, as well as their anti-inflammatory roles, are mentioned below and in <xref rid="t0010" ref-type="table">Table 2</xref>
(<xref rid="f0020" ref-type="fig">Fig. 4</xref>
).<table-wrap position="float" id="t0010"><label>Table 2</label><caption><p>Anti-inflammatory role of spices.</p></caption><alt-text id="al0030">Table 2</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Spices</th><th>Active compound/form of use</th><th>Disease</th><th><italic>In vitro</italic>/<italic>in vivo</italic></th><th>Model</th><th>Mechanism</th><th>References</th></tr></thead><tbody><tr><td>Asafetida (<italic>Ferula asafetida L.)</italic></td><td>&#x02013;<sup>A</sup></td><td>Liver cancer</td><td><italic>In vitro</italic></td><td>HepG2, SK-Hep1</td><td>&#x02193; NF-&#x003ba;B, &#x02193; TGF-&#x003b2;1, &#x02191; caspase-3, &#x02191; TNF-&#x003b1;</td><td>[<xref rid="bb1105" ref-type="bibr">221</xref>]</td></tr><tr><td/><td>&#x02013;<sup>B</sup></td><td>Breast cancer</td><td><italic>In vivo</italic></td><td>BALB/c mice</td><td>&#x02193; LOX</td><td>[<xref rid="bb1110" ref-type="bibr">222</xref>]</td></tr><tr><td/><td>&#x02013;</td><td>Breast cancer</td><td><italic>In vivo</italic></td><td>SD rats</td><td>&#x02193; cyt-P450, &#x02193; cyt b5, &#x02191; catalase, &#x02191; GSH, &#x02191; GST, &#x02191; SOD, &#x02193; TBARS, &#x02191; DT-diaphorase</td><td>[<xref rid="bb1115" ref-type="bibr">223</xref>]</td></tr><tr><td/><td>&#x02013;<sup>B</sup></td><td>&#x02013;</td><td><italic>In vivo</italic></td><td>Albino mice</td><td>&#x02193; LOX</td><td>[<xref rid="bb1120" ref-type="bibr">224</xref>]</td></tr><tr><td>Basil (<italic>Ocimum sanctum</italic>)</td><td>&#x02013;<sup>C</sup></td><td>Asthma</td><td><italic>In vivo</italic></td><td>Wistar rats</td><td>&#x02193; IL-4, &#x02193; IgE, &#x02193; PLA<sub>2</sub>, &#x02193; TP, &#x02191; IFN-&#x003b3;/IL-4 ratio</td><td>[<xref rid="bb1125" ref-type="bibr">225</xref>]</td></tr><tr><td/><td>&#x02013;<sup>C</sup></td><td>Gastric ulcer</td><td><italic>In vivo</italic></td><td>Swiss albino CD1 mice</td><td>&#x02193; TBARS, &#x02193; NO, &#x02193; H<sub>2</sub>O<sub>2</sub>, &#x02191; GSH, &#x02191; GPx, &#x02191; GST, &#x02191; catalase, &#x02191; GR, &#x02193; TNF-&#x003b1;, &#x02193; IL-6, &#x02191; PGE2, &#x02191; IL-4</td><td>[<xref rid="bb1130" ref-type="bibr">226</xref>]</td></tr><tr><td>Bay leaves (<italic>Laurus nobilis</italic>)</td><td>&#x02013;<sup>C</sup></td><td>&#x02013;</td><td><italic>In vitro</italic></td><td>BMDMs</td><td>&#x02193; p-I&#x003ba;B, &#x02193; p-STAT3, &#x02193; pro-IL-1&#x003b2;, &#x02193; procaspase-1, &#x02193; IL-1&#x003b2;, &#x02193; caspase-1, &#x02193; NLRP3 inflammasome, &#x02193; NF-&#x003ba;B signaling, &#x02193; mRNA expression of IL-6, TNF-&#x003b1;, and iNOS</td><td>[<xref rid="bb1135" ref-type="bibr">227</xref>]</td></tr><tr><td/><td>&#x02013;<sup>C</sup></td><td>ALI</td><td><italic>In vivo</italic></td><td>C57BL/6 mice</td><td>&#x02193; MPO activity, &#x02193; IL-1&#x003b2;, &#x02193; IL-6, &#x02193; TNF-&#x003b1;</td><td>[<xref rid="bb1135" ref-type="bibr">227</xref>]</td></tr><tr><td/><td>1,8-Cineole</td><td>&#x02013;</td><td><italic>In vitro</italic></td><td>BMDMs</td><td>&#x02193; IL-1&#x003b2;, &#x02193; caspase-1, &#x02193; Activation of NF-&#x003ba;B and STAT, &#x02193; mRNA expression of IL-6, TNF-&#x003b1;, and iNOS</td><td>[<xref rid="bb1135" ref-type="bibr">227</xref>]</td></tr><tr><td>Black cumin (<italic>Nigella sativa</italic>)</td><td>&#x02013;<sup>C</sup></td><td>Lung inflammation</td><td><italic>In vivo</italic></td><td>Wistar rats</td><td>&#x02193; TGF-&#x003b2;1, &#x02193; IFN-&#x003b3;, &#x02193; PGE2, &#x02191; IL-4, &#x02191; catalase, &#x02191; SOD, &#x02193; MDA, &#x02191; thiol</td><td>[<xref rid="bb1140" ref-type="bibr">228</xref>]</td></tr><tr><td/><td>&#x02013;<sup>A</sup></td><td>Low-grade inflammation</td><td><italic>In vitro</italic></td><td>THP-1 cells</td><td>&#x02193; IL-1&#x003b2;, &#x02193; MCP-1, &#x02193; gene expression of DNMT3A and HDAC1</td><td>[<xref rid="bb1145" ref-type="bibr">229</xref>]</td></tr><tr><td/><td>&#x02013;<sup>C</sup></td><td>Diabetes</td><td><italic>In vivo</italic></td><td>Wistar rats</td><td>&#x02193; mRNA expression of VCAM-1 and LOX-1, &#x02191; mRNA expression of eNOS,</td><td>[<xref rid="bb1150" ref-type="bibr">230</xref>]</td></tr><tr><td/><td>&#x02013;<sup>C</sup></td><td>&#x02013;</td><td><italic>In vivo</italic></td><td>Wistar rats</td><td>&#x02193; MDA, &#x02193; NO, &#x02193; IL-6, &#x02191; thiol, &#x02191; SOD, &#x02191; catalase, &#x02193; AST, &#x02193; ALT, &#x02193; ALP, &#x02191; serum protein, &#x02191; albumin</td><td>[<xref rid="bb1155" ref-type="bibr">231</xref>]</td></tr><tr><td/><td>&#x02013;<sup>A</sup></td><td>Allergic asthma</td><td><italic>In vivo</italic></td><td>Wistar rats</td><td>&#x02193; IL-4, &#x02193; NO</td><td>[<xref rid="bb1160" ref-type="bibr">232</xref>]</td></tr><tr><td/><td>TQ</td><td>AD</td><td><italic>In vivo</italic></td><td>SD rats</td><td>&#x02193; TLR-2, &#x02193; TLR-4, &#x02193; TNF-&#x003b1;, &#x02193; MyD88, &#x02193; IL-1&#x003b2;, &#x02193; IRF-3, &#x02193; NF-&#x003ba;B</td><td>[<xref rid="bb1165" ref-type="bibr">233</xref>]</td></tr><tr><td>Black pepper (<italic>Piper nigrum</italic>)</td><td>&#x02013;<sup>C</sup></td><td>Asthma</td><td><italic>In vivo</italic></td><td>BALB/c mice</td><td>&#x02193; IL-1&#x003b2;, &#x02193; TNF-&#x003b1;, &#x02193; IL-4, &#x02193; ROR&#x003b3;t, &#x02193;IgE, &#x02193; IL-17A</td><td>[<xref rid="bb1170" ref-type="bibr">234</xref>]</td></tr><tr><td/><td>&#x02013;<sup>C</sup></td><td>AR</td><td><italic>In vivo</italic></td><td>BALB/c mice</td><td>&#x02193; E-cadherin, &#x02191; HO-1, &#x02191; Nrf2</td><td>[<xref rid="bb1175" ref-type="bibr">235</xref>]</td></tr><tr><td/><td>&#x02013;<sup>C</sup></td><td>AR</td><td><italic>In vivo</italic></td><td>BALB/c mice</td><td>&#x02193; p-STAT3, &#x02193; IL-6, &#x02193; TNF-&#x003b1;, &#x02193; NF-&#x003ba;B p65, &#x02193; IL-1&#x003b2;</td><td>[<xref rid="bb1180" ref-type="bibr">236</xref>]</td></tr><tr><td/><td>Pipernigramides</td><td>Edema</td><td><italic>In vitro</italic></td><td>RAW 264.7</td><td>&#x02193; TNF-&#x003b1;, &#x02193; IL-1&#x003b2;, &#x02193; IL-6, &#x02193; PGE2, &#x02193; p-IKK&#x003b2;</td><td>[<xref rid="bb1185" ref-type="bibr">237</xref>]</td></tr><tr><td/><td>Pipernigramides</td><td>Edema</td><td><italic>In vivo</italic></td><td>ICR mice</td><td>&#x02193; NO, &#x02193; neutrophils infiltration</td><td>[<xref rid="bb1185" ref-type="bibr">237</xref>]</td></tr><tr><td/><td>Piperine</td><td>Lung metastasis</td><td><italic>In vivo</italic></td><td>C57BL/6 mice</td><td>&#x02193; tumor nodule formation, &#x02191; survival rate, &#x02193; SA, &#x02193; GGT</td><td>[<xref rid="bb1190" ref-type="bibr">238</xref>]</td></tr><tr><td/><td>Piperine</td><td>Bacterial sepsis</td><td><italic>In vitro</italic></td><td>J774A.1, BMDM</td><td>&#x02193; IL-1&#x003b2;, &#x02193; HMGB1, &#x02193; p-AMPK</td><td>[<xref rid="bb1195" ref-type="bibr">239</xref>]</td></tr><tr><td/><td>Piperine</td><td>Bacterial sepsis</td><td><italic>In vivo</italic></td><td>C57BL/6 mice</td><td>&#x02193; IL-1&#x003b2; release</td><td>[<xref rid="bb1195" ref-type="bibr">239</xref>]</td></tr><tr><td/><td>Piperine</td><td>AP</td><td><italic>In vitro</italic></td><td>PAC</td><td>&#x02193; MPO, &#x02193; TNF-&#x003b1;, &#x02193; IL-1&#x003b2;, &#x02193; IL-6,</td><td>[<xref rid="bb1200" ref-type="bibr">240</xref>]</td></tr><tr><td/><td>Piperine</td><td>AP</td><td><italic>In vivo</italic></td><td>C57BL/6 mice</td><td>&#x02193; p-ERK1/2, &#x02193; p-p38, &#x02193; p-JNK</td><td>[<xref rid="bb1200" ref-type="bibr">240</xref>]</td></tr><tr><td/><td rowspan="2">Piperine</td><td rowspan="2">Lupus nephritis</td><td><italic>In vitro</italic></td><td>HK-2 cells</td><td>&#x02193;p-AMPK, &#x02193; IL-1&#x003b2;, &#x02193; HMGB1, &#x02193; pro-caspase-1,</td><td>[<xref rid="bb1205" ref-type="bibr">241</xref>]</td></tr><tr><td/><td><italic>In vivo</italic></td><td>BALB/c mice</td><td>&#x02193; NLRP3 inflammasome activitation</td><td>[<xref rid="bb1205" ref-type="bibr">241</xref>]</td></tr><tr><td/><td>Chabamide</td><td>Inflammation</td><td><italic>In vitro</italic></td><td>RAW264.7</td><td>&#x02191; HO-1, &#x02191; Nrf2, &#x02193; iNOS</td><td>[<xref rid="bb1210" ref-type="bibr">242</xref>]</td></tr><tr><td>Capsicum (<italic>Capsicum annum</italic> L.)</td><td>&#x02013;<sup>C</sup></td><td>&#x02013;</td><td><italic>In vivo</italic></td><td>Wistar rats</td><td>&#x02193; ALT, &#x02193; AST, &#x02193; ALP, &#x02193; TNF-&#x003b1;, &#x02193; IL-6, &#x02193; LPO, &#x02193; Cu-Zn-SOD, &#x02193; GPx, &#x02191; CAT, &#x02191; Mn-SOD, &#x02191; GR, &#x02191; GSH, &#x02193; GST, &#x02191; G6PD, &#x02193; TG, &#x02193; CHLS, &#x02193; LDL, &#x02193; VLDL, &#x02191; HDL</td><td>[<xref rid="bb1215" ref-type="bibr">243</xref>]</td></tr><tr><td/><td>&#x02013;<sup>C</sup></td><td>Asthma</td><td><italic>In vivo</italic></td><td>BALB/c mice</td><td>&#x02193; IL-4, &#x02193; IL-5, &#x02193; IL-13, &#x02193; NF-&#x003ba;B p65</td><td>[<xref rid="bb1220" ref-type="bibr">244</xref>]</td></tr><tr><td/><td>Capsaicin</td><td>&#x02013;</td><td><italic>In vitro</italic></td><td>THP-1</td><td>&#x02193; IL-1&#x003b2;, &#x02193; IL-6, &#x02193; TNF-&#x003b1;, &#x02191; LXR&#x003b1; expression</td><td>[<xref rid="bb1225" ref-type="bibr">245</xref>]</td></tr><tr><td/><td>Capsaicin</td><td>SGI</td><td><italic>In vitro</italic></td><td>HSG</td><td>&#x02193; IL-6, &#x02193; TNF-&#x003b1;</td><td>[<xref rid="bb1230" ref-type="bibr">246</xref>]</td></tr><tr><td>Cardamom (<italic>Elettaria cardamomum</italic>)</td><td>&#x02013;<sup>C</sup></td><td>Cardiotoxicity</td><td><italic>In vivo</italic></td><td>Albino rats</td><td>&#x02193; NO, &#x02193; MDA, &#x02193; NF-&#x003ba;B, &#x02193; capase-3, &#x02191; VEGF, &#x02191; catalase, &#x02191; SOD, &#x02191; GPx</td><td>[<xref rid="bb1235" ref-type="bibr">247</xref>]</td></tr><tr><td>Celery seeds (<italic>Apium graveolens</italic>)</td><td>&#x02013;<sup>A</sup>, &#x02013;<sup>C</sup></td><td>Hyperuricemia</td><td><italic>In vivo</italic></td><td>BALB/c mice</td><td>&#x02193; ROS <italic>&#x02191;</italic> SOD, <italic>&#x02191;</italic> GPx</td><td>[<xref rid="bb1240" ref-type="bibr">248</xref>]</td></tr><tr><td/><td>&#x02013;<sup>C</sup></td><td>Gouty arthritis</td><td><italic>In vivo</italic></td><td>Wistar rats</td><td>&#x02193; IL-1&#x003b2;, &#x02193; IL-6, &#x02193; TNF-&#x003b1;, <italic>&#x02191;</italic> IL-10</td><td>[<xref rid="bb1240" ref-type="bibr">248</xref>]</td></tr><tr><td/><td>&#x02013;<sup>A</sup></td><td>Gouty arthritis</td><td><italic>In vivo</italic></td><td>Wistar rats</td><td>&#x02193; IL-1&#x003b2;, &#x02193; TNF-&#x003b1;, <italic>&#x02191;</italic> IL-10</td><td>[<xref rid="bb1240" ref-type="bibr">248</xref>]</td></tr><tr><td/><td>Sedanolide</td><td>Liver cancer</td><td><italic>In vitro</italic></td><td>J5 cells</td><td>&#x02193; PI3K-I, &#x02193; mTOR, &#x02193; Akt, &#x02191; PI3K-III, &#x02191; LC3-II, &#x02191; nuclear p53, &#x02191; DRAM, &#x02193; cytosolic p53, &#x02193; TIGAR, &#x02191; Beclin-1</td><td>[<xref rid="bb1245" ref-type="bibr">249</xref>]</td></tr><tr><td/><td>&#x02013;<sup>C</sup></td><td>AD</td><td><italic>In vivo</italic></td><td>Hairless mice</td><td>&#x02193; IL-4, &#x02193; TNF-&#x003b1;, &#x02193; IFN-&#x003b3;, &#x02193; IL-6, &#x02193; TSLP, &#x02193; IL-31</td><td>[<xref rid="bb1250" ref-type="bibr">250</xref>]</td></tr><tr><td/><td>&#x02013;<sup>C</sup></td><td>AD</td><td><italic>In vitro</italic></td><td>RAW264.7</td><td>&#x02193; NO, &#x02193; IgE</td><td>[<xref rid="bb1250" ref-type="bibr">250</xref>]</td></tr><tr><td/><td>Luteolin</td><td>AD</td><td><italic>In vitro</italic></td><td>RAW264.7</td><td>&#x02193; NO</td><td>[<xref rid="bb1250" ref-type="bibr">250</xref>]</td></tr><tr><td/><td>&#x02013;<sup>C</sup></td><td>&#x02013;</td><td><italic>In vitro</italic></td><td>RAW264.7</td><td>&#x02193; IL-6, &#x02193; TNF-&#x003b1;, &#x02193; NF-&#x003ba;B</td><td>[<xref rid="bb1255" ref-type="bibr">251</xref>]</td></tr><tr><td>Cinnamon (<italic>Cinnamom</italic> sp.)</td><td>TCA</td><td>OA</td><td><italic>In vitro</italic></td><td>SW1353, HPC</td><td>&#x02193; mRNA expression of MMP-1, -3 and -13, &#x02193; mRNA expression of ADAMTS-4 and -5, &#x02191; p-I&#x003ba;B&#x003b1;, &#x02193; NF-&#x003ba;B, &#x02193; I&#x003ba;B&#x003b1;, &#x02193; p-JNK 1/2, &#x02193; p-p38</td><td>[<xref rid="bb1260" ref-type="bibr">252</xref>]</td></tr><tr><td/><td>TCA</td><td>&#x02013;</td><td><italic>In vitro</italic></td><td>RAW 264.7</td><td>&#x02193; NO, &#x02193; iNOS</td><td>[<xref rid="bb1265" ref-type="bibr">253</xref>]</td></tr><tr><td/><td>TCA</td><td>Neuroinflammation</td><td><italic>In vitro</italic></td><td>BV2</td><td>&#x02193; NO, &#x02193; iNOS, &#x02193; cox-2, &#x02193; IL-1&#x003b2;, &#x02193; I&#x003ba;B&#x003b1;, &#x02193; NF-&#x003ba;B</td><td>[<xref rid="bb1270" ref-type="bibr">254</xref>]</td></tr><tr><td/><td>&#x02013;<sup>A</sup></td><td>Skin disease</td><td><italic>In vitro</italic></td><td>HDF3CGF system</td><td>&#x02193; MCP-1, &#x02193; MIG, &#x02193; IP-10, &#x02193; IL-8, &#x02193; VCAM-1, &#x02193; M-CSF, &#x02193; PAI-1, &#x02193; ICAM-1, &#x02193; EFGR, &#x02193; MMP-1, &#x02193; TIMP-1, &#x02193; TIMP-2</td><td>[<xref rid="bb1275" ref-type="bibr">255</xref>]</td></tr><tr><td/><td>&#x02013;<sup>C</sup></td><td>Inflammation</td><td><italic>In vitro</italic></td><td>Murine macrophage</td><td>&#x02193; mRNA expression of TNF-&#x003b1;, &#x02193; p-p38, &#x02193; I&#x003ba;B&#x003b1; degradation, &#x02193; p-ERK 1/2, &#x02193; p-JNK</td><td>[<xref rid="bb1280" ref-type="bibr">256</xref>]</td></tr><tr><td/><td>&#x02013;<sup>C</sup></td><td>Inflammation</td><td><italic>In vivo</italic></td><td>BALB/c mice</td><td>&#x02193; TNF-&#x003b1;, &#x02193; IL-6</td><td>[<xref rid="bb1280" ref-type="bibr">256</xref>]</td></tr><tr><td/><td>&#x02013;<sup>C</sup></td><td>Inflammation</td><td><italic>In vitro</italic></td><td>Splenocytes</td><td>&#x02191; IL-2, &#x02193; IL-4, &#x02193; IFN-&#x003b3;, &#x02193; p-ERK1/2, &#x02193; p-p38, &#x02193; p-STAT4, &#x02193; p-JNK</td><td>[<xref rid="bb1285" ref-type="bibr">257</xref>]</td></tr><tr><td/><td>&#x02013;<sup>C</sup></td><td>Inflammation</td><td><italic>In vivo</italic></td><td>BALB/c mice</td><td>&#x02193; IL-4</td><td>[<xref rid="bb1285" ref-type="bibr">257</xref>]</td></tr><tr><td/><td>BCA, HCA</td><td>&#x02013;</td><td><italic>In vitro</italic></td><td>Murine splenocytes</td><td>&#x02193; IFN-&#x003b3;, &#x02193; IL-2R&#x003b1;, &#x02193; IgM</td><td>[<xref rid="bb1290" ref-type="bibr">258</xref>]</td></tr><tr><td/><td>BCA, HCA</td><td>&#x02013;</td><td><italic>In vivo</italic></td><td>BALB/c mice</td><td>&#x02193; AFC response</td><td>[<xref rid="bb1290" ref-type="bibr">258</xref>]</td></tr><tr><td>Coriander (<italic>Coriandrum sativum</italic>)</td><td>&#x02013;<sup>C</sup></td><td>Inflammation</td><td><italic>In vitro</italic></td><td>RAW264.7</td><td>&#x02193; pro-IL-1&#x003b2;, &#x02193; PGE<sub>2</sub>, &#x02193; p-MAPK, &#x02193; NF-&#x003ba;B p65, &#x02193; cox-2, &#x02193; NO, &#x02193; iNOS</td><td>[<xref rid="bb1295" ref-type="bibr">259</xref>]</td></tr><tr><td/><td>&#x02013;<sup>C</sup></td><td>CD</td><td><italic>In vivo</italic></td><td>ICR mice</td><td>&#x02193; IL-1, &#x02193; IL-4, &#x02193; IL-13, &#x02193; TNF-&#x003b1;, &#x02193; IFN-&#x003b3;, &#x02193; IgE, &#x02191; GSH, &#x02191; HO-1</td><td>[<xref rid="bb1300" ref-type="bibr">260</xref>]</td></tr><tr><td/><td>&#x02013;<sup>C</sup></td><td>Arthritis</td><td><italic>In vivo</italic></td><td>Wistar rat</td><td>&#x02193; IL-1&#x003b2;, &#x02193; IL-6, &#x02193; TNF-R1</td><td>[<xref rid="bb1305" ref-type="bibr">261</xref>]</td></tr><tr><td>Cumin (<italic>Cuminum cyminum</italic>)</td><td>&#x02013;<sup>E</sup></td><td>Hypertension</td><td><italic>In vivo</italic></td><td>SD rats</td><td>&#x02193; mRNA expression of IL-6, Bax, and TNF-&#x003b1;, &#x02191; mRNA of expression TRX1, TRXR1, eNOS, and Bcl-2</td><td>[<xref rid="bb1310" ref-type="bibr">262</xref>]</td></tr><tr><td/><td>&#x02013;<sup>E</sup></td><td>Gastric ulcer</td><td><italic>In vivo</italic></td><td>SD rats</td><td>&#x02193; TNF-&#x003b1;, &#x02193; MDA, &#x02191; GSH, &#x02191; catalase, &#x02191; ATPase activity</td><td>[<xref rid="bb1315" ref-type="bibr">263</xref>]</td></tr><tr><td>Curry leaves (<italic>Murraya koenigi</italic>i)</td><td>&#x02013;<sup>C</sup></td><td>Pancreatic Inflammation</td><td><italic>In vitro</italic></td><td>RAW 264.7</td><td>&#x02191; GSH, <italic>&#x02193;</italic> MDA, <italic>&#x02193;</italic> IL-1&#x003b2;, <italic>&#x02193;</italic> IL-6, &#x02193; TNF-&#x003b1;</td><td>[<xref rid="bb1320" ref-type="bibr">264</xref>]</td></tr><tr><td/><td/><td>Pancreatic Inflammation</td><td><italic>In vivo</italic></td><td>Swiss albino mice</td><td><italic>&#x02193;</italic> MDA, &#x02191; GSH, <italic>&#x02193;</italic> IL-1&#x003b2;, <italic>&#x02193;</italic> IL-6, &#x02193; TNF-&#x003b1;, &#x02191; Nrf2, &#x02193; p65-NF&#x003ba;B activity, <italic>&#x02193;</italic> cox-2, <italic>&#x02193;</italic> ICAM-1</td><td>[<xref rid="bb1320" ref-type="bibr">264</xref>]</td></tr><tr><td/><td>&#x02013;<sup>C</sup></td><td>Breast cancer</td><td><italic>In vivo</italic></td><td>4T1-inoculated BALB/c mice</td><td>&#x02193; NF-kB, <italic>&#x02193;</italic> IL-6, <italic>&#x02193;</italic> IL-1&#x003b2;, <italic>&#x02193;</italic> IL-10, <italic>&#x02193;</italic> iNOS &#x02193; ICAM, &#x02193; c-myc</td><td>[<xref rid="bb1325" ref-type="bibr">265</xref>]</td></tr><tr><td/><td>Mahanimbine</td><td>&#x02013;</td><td><italic>In vivo</italic></td><td>Swiss albino</td><td>&#x02193; TNF-&#x003b1;, &#x02193; IL-1&#x003b2;, &#x02193; IL-6</td><td>[<xref rid="bb1330" ref-type="bibr">266</xref>]</td></tr><tr><td/><td>Girinimbine</td><td>Peritonitis</td><td><italic>In vivo</italic></td><td>ICR mice</td><td>&#x02193; TNF-&#x003b1;, &#x02193; IL-1&#x003b2;</td><td>[<xref rid="bb1335" ref-type="bibr">267</xref>]</td></tr><tr><td>Fenugreek (<italic>Trigonella foenum-graecum</italic> L.)</td><td>&#x02013;<sup>E</sup></td><td>IPF</td><td><italic>In vivo</italic></td><td>SD rats</td><td>&#x02191; mRNA expression of Nrf2 and Bcl-2, &#x02193; mRNA expression of HO-1, TNF-&#x003b1;, IL-1&#x003b2;, IL-6, TGF-&#x003b2;, IL-8, NF-&#x003ba;B, Smad-3, collagen-1, ET-1, Bax and caspase-3</td><td>[<xref rid="bb1340" ref-type="bibr">268</xref>]</td></tr><tr><td/><td>&#x02013;<sup>E</sup></td><td>Testicular damage</td><td><italic>In vivo</italic></td><td>Wistar rats</td><td>&#x02193; NF-&#x003ba;B p65, &#x02193; iNOS,</td><td>[<xref rid="bb1345" ref-type="bibr">269</xref>]</td></tr><tr><td/><td>&#x02013;<sup>E</sup></td><td>Diabetes</td><td><italic>In vivo</italic></td><td>Wistar rats</td><td>&#x02193; TNF-&#x003b1;, &#x02193; IL-1&#x003b2;, &#x02193; VEGF, &#x02193; PKC-&#x003b2;</td><td>[<xref rid="bb1350" ref-type="bibr">270</xref>]</td></tr><tr><td/><td>&#x02013;<sup>D</sup></td><td>RA</td><td><italic>In vivo</italic></td><td>SD rats</td><td>&#x02193; TNF-&#x003b1;, &#x02193; IL-6, &#x02193; cox, &#x02193; LOX</td><td>[<xref rid="bb1355" ref-type="bibr">271</xref>]</td></tr><tr><td/><td>Trigonelline</td><td>AD</td><td><italic>In vivo</italic></td><td>Wistar rats</td><td>&#x02193; TNF-&#x003b1;, &#x02193; IL-6, &#x02193; cox-2, &#x02193; GFAP, &#x02193; MDA, &#x02193; LDH, &#x02193; protein carbonyl, &#x02191; SOD, &#x02191; GSH</td><td>[<xref rid="bb1360" ref-type="bibr">272</xref>]</td></tr><tr><td>Garcinia (<italic>Garcinia indica</italic>)</td><td>Garcinol</td><td>Colitis</td><td><italic>In vivo</italic></td><td>ICR mice</td><td>&#x02193; iNOS, &#x02193; cox-2, &#x02193; PCNA</td><td>[<xref rid="bb1365" ref-type="bibr">273</xref>]</td></tr><tr><td/><td>Garcinol</td><td>Colon cancer</td><td><italic>In vivo</italic></td><td>ICR mice</td><td>&#x02193; &#x003b2; catenin, &#x02193; VEGF, &#x02193; cyclin D1, &#x02193; p-ERK1/2, &#x02193; p-Akt, &#x02193; p-p70S6K (Ser371 and Thr389), &#x02193; p-PI3K</td><td>[<xref rid="bb1365" ref-type="bibr">273</xref>]</td></tr><tr><td/><td>Garcinol</td><td>HNSCC</td><td><italic>In vitro</italic></td><td>CAL27</td><td>&#x02193; STAT3, &#x02193; c-Src, &#x02193; JAK1, &#x02193; JAK2, &#x02193; NF-&#x003ba;B, &#x02193; TAK1&#x02193; IKK, &#x02193; cyclin D1, &#x02193; Bcl-2, &#x02193; Bcl-xL, &#x02193; Mcl-1, &#x02193; survivin</td><td>[<xref rid="bb1370" ref-type="bibr">274</xref>]</td></tr><tr><td/><td>Agegarcinol</td><td>HNSCC</td><td><italic>In vivo</italic></td><td>Nude mice</td><td>&#x02193; Tumor growth</td><td>[<xref rid="bb1370" ref-type="bibr">274</xref>]</td></tr><tr><td>Garlic (<italic>Allium sativum</italic>)</td><td>&#x02013;<sup>C</sup></td><td>Asthma</td><td><italic>In vivo</italic></td><td>BALB/c mice</td><td>&#x02193; IgE, &#x02193; IgG1, &#x02191; IgG2a, &#x02193; IL-13, &#x02193; IL-5, &#x02193; IL-4, &#x02191; IL-12, &#x02191; IFN-&#x003b3;, &#x02193; TNF-&#x003b1;, &#x02193; IL-1&#x003b2;, &#x02193; IL-6</td><td>[<xref rid="bb1375" ref-type="bibr">275</xref>]</td></tr><tr><td/><td>&#x02013;<sup>C</sup></td><td>&#x02013;</td><td><italic>In vitro</italic></td><td>A549</td><td>&#x02193; IL-6/PI3K/Akt/NF-&#x003ba;B pathway</td><td>[<xref rid="bb1375" ref-type="bibr">275</xref>]</td></tr><tr><td/><td>DADS</td><td>AP</td><td><italic>In vivo</italic></td><td>Swiss albino mice</td><td>&#x02193; H2S, &#x02193; CSE, &#x02193; MPO, &#x02193; I&#x003ba;B degradation, &#x02193; TNF-&#x003b1;, &#x02193; mRNA expression of PPTA and NK1R</td><td>[<xref rid="bb1380" ref-type="bibr">276</xref>]</td></tr><tr><td/><td>DATS</td><td>RA</td><td><italic>In vitro</italic></td><td>RA-FLS</td><td>&#x02193; IL-8, &#x02193; IL-1&#x003b2;, &#x02193; p-p65, &#x02193; p-NF-&#x003ba;B, &#x02193; p-I&#x003ba;B&#x003b1;, &#x02191; I&#x003ba;B&#x003b1;, &#x02193; c-myc, &#x02193; &#x003b2;-catenin</td><td>[<xref rid="bb1385" ref-type="bibr">277</xref>]</td></tr><tr><td/><td>DATS</td><td>RA</td><td><italic>In vivo</italic></td><td>DBA/1J mice</td><td>&#x02193; IL-6, &#x02193; IL-1&#x003b2;, &#x02193; TNF-&#x003b1;</td><td>[<xref rid="bb1385" ref-type="bibr">277</xref>]</td></tr><tr><td/><td>SAC</td><td>PF</td><td><italic>In vivo</italic></td><td>C57BL/6 mice</td><td>&#x02193; &#x003b1;-SMA, &#x02193; p-Akt, &#x02193; p-p65, &#x02193; mRNA expression of &#x003b1;-SMA, TNF-&#x003b1;, iNOS, IL-6, IL-12p35, and TGF-&#x003b2;</td><td>[<xref rid="bb1390" ref-type="bibr">278</xref>]</td></tr><tr><td/><td>SAMC</td><td>ALI</td><td><italic>In vivo</italic></td><td>BALB/c mice</td><td>&#x02193; MPO, &#x02193; TNF-&#x003b1;, &#x02193; IL-1&#x003b2;, &#x02193; IL-6, &#x02193; NF-&#x003ba;B, &#x02193; cox-2, &#x02193; p-NF-&#x003ba;B p65, &#x02191; Nrf-2, &#x02191; HO-1, &#x02191; GSH, &#x02191; NQO1, &#x02191; SOD, &#x02193; MDA</td><td>[<xref rid="bb1395" ref-type="bibr">279</xref>]</td></tr><tr><td>Ginger (<italic>Zingiber officinale</italic>)</td><td>6-Shogaol</td><td>OSCC</td><td><italic>In vivo</italic></td><td>Syrian hamsters</td><td>&#x02193; c-jun, &#x02193; c-fos, &#x02193; AP-1, &#x02193; iNOS, &#x02193; TNF-&#x003b1;, &#x02193; IL-6, &#x02193; IL-1, &#x02193; cox-2, &#x02193; PCNA, &#x02193; cyclin D1, &#x02193; Ki-67</td><td>[<xref rid="bb1400" ref-type="bibr">280</xref>]</td></tr><tr><td/><td>6-Gingerol</td><td>Steatohepatitis</td><td><italic>In vitro</italic></td><td>HepG2</td><td>&#x02193; MCP-1, &#x02193; TNF-&#x003b1;, &#x02193; IL-6</td><td>[<xref rid="bb1405" ref-type="bibr">281</xref>]</td></tr><tr><td/><td>6-Gingerol</td><td>Steatohepatitis</td><td><italic>In vivo</italic></td><td>C57BL/6 mice</td><td>&#x02193; MCP-1, &#x02193; TNF-&#x003b1;, &#x02193; IL-6, &#x02193; I&#x003ba;B&#x003b1; degradation, &#x02193; NF-&#x003ba;B</td><td>[<xref rid="bb1405" ref-type="bibr">281</xref>]</td></tr><tr><td>Ginseng (<italic>Panax</italic> sp.)</td><td>Isofraxidin</td><td>ALI</td><td><italic>In vivo</italic></td><td>ICR mice</td><td>&#x02193;TNF-&#x003b1;, &#x02193; IL-1&#x003b2;, &#x02193; IL-6, &#x02193; MIP-2, &#x02193; p-PI3K, &#x02193; p-AKT</td><td>[<xref rid="bb1410" ref-type="bibr">282</xref>]</td></tr><tr><td/><td>&#x02013;<sup>C</sup></td><td>Lung injury</td><td><italic>In vivo</italic></td><td>Balb/c mice</td><td>&#x02193; p38 MAPKs, &#x02191; Akt</td><td>[<xref rid="bb1415" ref-type="bibr">283</xref>]</td></tr><tr><td/><td>PNS</td><td>HAND</td><td><italic>In vivo</italic></td><td>SD rats</td><td>&#x02193; Bax/Bcl-2 ratio, &#x02193; caspase-3, 8, and -9</td><td>[<xref rid="bb1420" ref-type="bibr">284</xref>]</td></tr><tr><td/><td>PNS</td><td>Colitis</td><td><italic>In vivo</italic></td><td>SD rats</td><td>&#x02193; M1 macrophages, &#x02193; PI3K/AKT, &#x02191; M2 macrophages</td><td>[<xref rid="bb1425" ref-type="bibr">285</xref>]</td></tr><tr><td/><td>NR</td><td>Renal injury</td><td><italic>In vivo</italic></td><td>Wistar rats</td><td>&#x02193; TNF&#x003b1;, &#x02193; TGF-&#x000df;1, &#x02193; INF-&#x003b3;, &#x02193; IL-6,&#x02191; IL-10</td><td>[<xref rid="bb1430" ref-type="bibr">286</xref>]</td></tr><tr><td/><td>GRg3</td><td>RA</td><td><italic>In vivo</italic></td><td>mice</td><td>&#x02191; CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup>Treg cells</td><td>[<xref rid="bb1435" ref-type="bibr">287</xref>]</td></tr><tr><td/><td>GRg1</td><td>Lung injury</td><td><italic>In vivo</italic></td><td>SD rats</td><td>&#x02193; TNF-&#x003b1;, &#x02193; &#x003b1;-SMA, &#x02193; Collagen I, &#x02193; TGF-&#x003b2;1, &#x02193; IL-6, &#x02193; TGF-&#x003b2;R1, &#x02193; p-Smad3</td><td>[<xref rid="bb1440" ref-type="bibr">288</xref>]</td></tr><tr><td/><td>GRg1</td><td>Lung injury</td><td><italic>In vitro</italic></td><td>MRC5</td><td>&#x02193; IL-6, &#x02193; TNF-&#x003b1;, &#x02193;-SMA, &#x02193; TGF-&#x003b2;1/Smad3</td><td>[<xref rid="bb1440" ref-type="bibr">288</xref>]</td></tr><tr><td/><td>Ginsenoside Rd</td><td>Ischemic stroke</td><td><italic>In vivo</italic></td><td>SD rats</td><td>&#x02193; NF-&#x003ba;B activity, &#x02193; I&#x003ba;B, &#x02193; MMP-9</td><td>[<xref rid="bb1445" ref-type="bibr">289</xref>]</td></tr><tr><td>Long pepper (<italic>Piper longum</italic>)</td><td>PL</td><td>Leukemia</td><td><italic>In vitro</italic></td><td>KBM-5</td><td>&#x02193; p-p65, &#x02193; cox-2</td><td>[<xref rid="bb1450" ref-type="bibr">290</xref>]</td></tr><tr><td/><td>PL</td><td>Myeloma</td><td><italic>In vitro</italic></td><td>U266</td><td>&#x02193; IL-6</td><td>[<xref rid="bb1450" ref-type="bibr">290</xref>]</td></tr><tr><td/><td>PL</td><td>LN</td><td><italic>In vitro</italic></td><td>Splenocytes</td><td>&#x02193; IL-6, &#x02193; IL-17, &#x02193; IL-23, &#x02193; TNF-&#x003b1;, &#x02193; p-STAT3, &#x02193; p-JAK1</td><td>[<xref rid="bb1455" ref-type="bibr">291</xref>]</td></tr><tr><td/><td>PL</td><td>LN</td><td><italic>In vivo</italic></td><td>MRL-Fas(lpr) mice</td><td>&#x02193; IL-6, &#x02193; IL-17, &#x02193; IL-23, &#x02193; TNF-&#x003b1;, &#x02193; IgG</td><td>[<xref rid="bb1455" ref-type="bibr">291</xref>]</td></tr><tr><td/><td>PL</td><td>RA</td><td><italic>In vivo</italic></td><td>DBA/1 mice</td><td>&#x02193; TNF-&#x003b1;, &#x02193; IL-1&#x003b2;, &#x02193; IL-23, &#x02193; IL-17</td><td>[<xref rid="bb1460" ref-type="bibr">292</xref>]</td></tr><tr><td/><td>PL</td><td>Asthma</td><td><italic>In vivo</italic></td><td>C57BL/6 mice</td><td>&#x02193; TNF-&#x003b1;, &#x02193; IL-6, &#x02193; IL-1&#x003b2;, &#x02193; I&#x003ba;B&#x003b1;, &#x02193; ICAM-1, &#x02193; IgE, &#x02193; MMP-9, &#x02193; IL-4, &#x02193; IL-5, &#x02193; IL-13</td><td>[<xref rid="bb1465" ref-type="bibr">293</xref>]</td></tr><tr><td/><td>PL</td><td>Asthma</td><td><italic>In vitro</italic></td><td>Beas-2B</td><td>&#x02193; TNF-&#x003b1;, &#x02193; IL-6, &#x02193; IL-1&#x003b2;, &#x02193; ICAM-1, &#x02193; MCP-1, &#x02193; I&#x003ba;B&#x003b1;</td><td>[<xref rid="bb1465" ref-type="bibr">293</xref>]</td></tr><tr><td/><td>PL</td><td>&#x02013;</td><td><italic>In vitro</italic></td><td>HUVEC</td><td>&#x02193; TNF-&#x003b1;, &#x02193; IL-6, &#x02193; NF-&#x003ba;B, &#x02193; p-p38, &#x02193; ICAM-1, &#x02193; VCAM-1, &#x02193; E-Selectin</td><td>[<xref rid="bb1470" ref-type="bibr">294</xref>]</td></tr><tr><td/><td>PL</td><td>&#x02013;</td><td><italic>In vivo</italic></td><td>C57BL/6 mice</td><td>&#x02193; p-p38, &#x02193;ICAM-1, &#x02193;VCAM-1, &#x02193;E-Selectin</td><td>[<xref rid="bb1470" ref-type="bibr">294</xref>]</td></tr><tr><td/><td>PL</td><td>Neuro-inflammation</td><td><italic>In vitro</italic></td><td>BV2</td><td>&#x02193; PGE2, &#x02193; NO, &#x02193; iNOS, &#x02193; cox-2, &#x02193;TNF-&#x003b1;, &#x02193;IL-6, &#x02191; IL-10</td><td>[<xref rid="bb1475" ref-type="bibr">295</xref>]</td></tr><tr><td/><td>PA</td><td>&#x02013;</td><td><italic>In vitro</italic></td><td>PBMC</td><td>&#x02193; IL-1&#x003b2;, &#x02193; TNF-&#x003b1;, &#x02193;IFN-&#x003b3;, &#x02193;IL-2</td><td>[<xref rid="bb1480" ref-type="bibr">296</xref>]</td></tr><tr><td/><td>PA</td><td>&#x02013;</td><td><italic>In vivo</italic></td><td>BALB/c mice</td><td>&#x02193; IFN-&#x003b3;, &#x02193;IL-2</td><td>[<xref rid="bb1480" ref-type="bibr">296</xref>]</td></tr><tr><td/><td>PL</td><td>AD</td><td><italic>In vitro</italic></td><td>BV2</td><td>&#x02193; cox-2, &#x02193; iNOS, &#x02193; NF-&#x003ba;B</td><td>[<xref rid="bb1445" ref-type="bibr">289</xref>]</td></tr><tr><td/><td>PL</td><td>AD</td><td><italic>In vitro</italic></td><td>Astrocytes</td><td>&#x02193; cox-2, &#x02193; iNOS, &#x02193; NF-&#x003ba;B</td><td>[<xref rid="bb1485" ref-type="bibr">297</xref>]</td></tr><tr><td/><td>PL</td><td>AD</td><td><italic>In vivo</italic></td><td>ICR mice</td><td>&#x02193; NF-&#x003ba;B, &#x02193; &#x003b2;-, &#x003b3;-secretases</td><td>[<xref rid="bb1485" ref-type="bibr">297</xref>]</td></tr><tr><td/><td>&#x02013;<sup>C</sup></td><td>&#x02013;</td><td><italic>In vitro</italic></td><td>HUVEC</td><td>&#x02193; ICAM-1, &#x02193; VCAM-1, &#x02193; NF-&#x003ba;B, &#x02193; ROS</td><td>[<xref rid="bb1490" ref-type="bibr">298</xref>]</td></tr><tr><td/><td>PL</td><td>Atherosclerosis</td><td><italic>In vitro</italic></td><td>VSMC</td><td>&#x02193; NF-&#x003ba;B p65, &#x02193; p-Akt, &#x02193; p-ERK1/2, &#x02193; p-PLC-&#x003b3;1</td><td>[<xref rid="bb1495" ref-type="bibr">299</xref>]</td></tr><tr><td/><td>PL</td><td>Atherosclerosis</td><td><italic>In vivo</italic></td><td>ApoE KO mice</td><td>&#x02193; NF-&#x003ba;B p65</td><td>[<xref rid="bb1495" ref-type="bibr">299</xref>]</td></tr><tr><td/><td>PL</td><td>&#x02013;</td><td><italic>In vitro</italic></td><td>HUVEC</td><td>&#x02193; TNF-&#x003b1;, &#x02193; IL-1&#x003b2;, &#x02193; TACE, &#x02193; p-p38, &#x02193;p-JNK, &#x02193; p-ERK1/2</td><td>[<xref rid="bb1500" ref-type="bibr">300</xref>]</td></tr><tr><td/><td>PL</td><td>&#x02013;</td><td><italic>In vivo</italic></td><td>BALB/c mice</td><td>&#x02193; EPCR shedding</td><td>[<xref rid="bb1500" ref-type="bibr">300</xref>]</td></tr><tr><td/><td>PL</td><td>COPD</td><td><italic>In vivo</italic></td><td>BALB/c mice</td><td>&#x02191; AnxA1, &#x02193; cox-2, &#x02193; NF-&#x003ba;B,</td><td>[<xref rid="bb1505" ref-type="bibr">301</xref>]</td></tr><tr><td>Mint (<italic>Mentha</italic> sp.)</td><td>&#x02013;<sup>C</sup></td><td>&#x02013;</td><td><italic>In vitro</italic></td><td>RAW 246.7</td><td>&#x02193; MDA, &#x02193; NO</td><td>[<xref rid="bb1510" ref-type="bibr">302</xref>]</td></tr><tr><td/><td>&#x02013;<sup>C</sup></td><td>&#x02013;</td><td><italic>In vivo</italic></td><td>SD rats</td><td>&#x02193; MDA, &#x02193; NO, &#x02193; cox-2, &#x02193; MAPK signaling</td><td>[<xref rid="bb1510" ref-type="bibr">302</xref>]</td></tr><tr><td/><td>&#x02013;<sup>C</sup></td><td>&#x02013;</td><td><italic>In vitro</italic></td><td>MH-S</td><td>&#x02193; NO, &#x02193; TNF-&#x003b1;, &#x02193; IL-1&#x003b1;, &#x02193; ROS, &#x02193; p38, &#x02193; JNK, &#x02193; p-p38, &#x02193; p-JNK</td><td>[<xref rid="bb1515" ref-type="bibr">303</xref>]</td></tr><tr><td>Mustard seeds (<italic>Sinapis alba</italic>)</td><td>&#x02013;<sup>C</sup></td><td>Ear edema</td><td><italic>In vivo</italic></td><td>BALB/c mice</td><td>&#x02193; MPO activity, &#x02193; TNF-&#x003b1;, &#x02193; IL&#x003b2;, &#x02193; IL-6, &#x02193; mRNA expression of TNF-&#x003b1; and IL-6</td><td>[<xref rid="bb1520" ref-type="bibr">304</xref>]</td></tr><tr><td/><td>&#x02013;<sup>E</sup></td><td>Psoriasis-like inflammation</td><td><italic>In vivo</italic></td><td>BALB/c mice</td><td>&#x02193; NLRP3, &#x02193; ASC, &#x02193; IL-1&#x003b2;, &#x02193; caspase-1 and 11, &#x02193; IL-18</td><td>[<xref rid="bb1525" ref-type="bibr">305</xref>]</td></tr><tr><td/><td>&#x02013;<sup>E</sup></td><td>Psoriasis</td><td><italic>In vivo</italic></td><td>BALB/c mice</td><td>&#x02191; CD4<sup>+</sup>/CD8<sup>+</sup> T cells ratio, &#x02191; CD4<sup>+</sup> T cells, &#x02191; GPx, &#x02193; NF-&#x003ba;B p65, &#x02193; IFN-&#x003b1;, &#x02193; IL-17, &#x02193; IL-22, &#x02191; SOD, &#x02191; catalase, &#x02193; MDA, &#x02193; iNOS</td><td>[<xref rid="bb1530" ref-type="bibr">306</xref>]</td></tr><tr><td>Nutmeg (<italic>Myristica fragrans</italic>)</td><td>&#x02013;<sup>C</sup></td><td>Cortical injury</td><td><italic>In vivo</italic></td><td>Wistar rats</td><td>&#x02193; TNF-&#x003b1;, &#x02193; IL-1&#x003b2;, &#x02193; iNOS, &#x02191; HO-1, &#x02191; Bcl-2, &#x02193; Bax</td><td>[<xref rid="bb1535" ref-type="bibr">307</xref>]</td></tr><tr><td/><td>Macelignan</td><td>Asthma</td><td><italic>In vivo</italic></td><td>C57BL/6J mice, OT-II mice</td><td>&#x02193; IL-4</td><td>[<xref rid="bb1540" ref-type="bibr">308</xref>]</td></tr><tr><td/><td>Macelignan</td><td>Leukemia</td><td><italic>In vitro</italic></td><td>RBL-2 H3</td><td>&#x02193; PGE2, &#x02193; mRNA expression of cox-2, 5-LOX, TNF-&#x003b1;, IL-4, and IL-13, &#x02191; GSH</td><td>[<xref rid="bb1545" ref-type="bibr">309</xref>]</td></tr><tr><td/><td>Macelignan</td><td>Renal I/R injury</td><td><italic>In vivo</italic></td><td>SD rats</td><td>&#x02193; IL-6, &#x02193; TNF-&#x003b1;, &#x02193; IFN-&#x003b3;, &#x02191; catalase, &#x02191; SOD, &#x02193; MDA, &#x02193; Bax, &#x02193; caspase-3, &#x02191; Bcl-2</td><td>[<xref rid="bb1550" ref-type="bibr">310</xref>]</td></tr><tr><td/><td>Myrislignan</td><td>Inflammation</td><td><italic>In vitro</italic></td><td>RAW 264.7</td><td>&#x02193; iNOS, &#x02193; IL-6, &#x02193; TNF-&#x003b1;, &#x02193; NF-&#x003ba;B activation, &#x02193; cox-2</td><td>[<xref rid="bb1555" ref-type="bibr">311</xref>]</td></tr><tr><td/><td>Myristicin</td><td>Inflammation</td><td><italic>In vitro</italic></td><td>RAW 264.7</td><td>&#x02193; NO, &#x02193; IL-6, &#x02193; IL-10, &#x02193; IP-10, &#x02193; GM-CSF, &#x02193; LIF, &#x02193; MCP-1, &#x02193; MCP-3, &#x02193; MIP-1&#x003b1;</td><td>[<xref rid="bb1560" ref-type="bibr">312</xref>]</td></tr><tr><td>Onion (<italic>Allium cepa</italic>)</td><td>&#x02013;<sup>C</sup></td><td>IBD</td><td><italic>In vivo</italic></td><td>BALB/c mice</td><td>&#x02193; p-ERK1/2, &#x02193; p-p38MAPK, &#x02193; p-Akt, &#x02193; mTOR, &#x02193; caspase-3, and -8, &#x02193; cox-2, &#x02193; cyt-c, &#x02193; Bcl-xL, &#x02193; IFN-&#x003b3;, &#x02193; TIMP-1, &#x02193; MCP-1, &#x02193; MCP-5, &#x02193; MIG, &#x02193; MIP-1&#x003b1;, &#x02193; MIP-2, &#x02193; AC<italic>E</italic>-2, &#x02193; Bcl-2,</td><td>[<xref rid="bb1565" ref-type="bibr">313</xref>]</td></tr><tr><td/><td>&#x02013;<sup>C</sup></td><td>APH</td><td><italic>In vivo</italic></td><td>Wistar rats</td><td>&#x02193; IL-6, &#x02193; IL-10, &#x02193; TNF-&#x003b1;</td><td>[<xref rid="bb1570" ref-type="bibr">314</xref>]</td></tr><tr><td/><td>Quercetin</td><td>Atherosclerosis</td><td><italic>In vitro</italic></td><td>VSMC</td><td>&#x02193; IL-1&#x003b2;, &#x02193; IL-18, &#x02193;IL-6, &#x02193;TNF-&#x003b1;, &#x02191; HO-1, &#x02191; Nrf-2, &#x02191; SOD1, &#x02191; SOD2</td><td>[<xref rid="bb1575" ref-type="bibr">315</xref>]</td></tr><tr><td/><td>Quercetin</td><td>Atherosclerosis</td><td><italic>In vivo</italic></td><td>C57BL/6 mice</td><td>&#x02191; SOD, &#x02191; HO-1, &#x02191; Nrf-2, &#x02193; MDA, &#x02193; p-NF-kB, &#x02193; TNF-&#x003b1;, &#x02193; IL-1&#x003b2;, &#x02193; ROS,</td><td>[<xref rid="bb1575" ref-type="bibr">315</xref>]</td></tr><tr><td/><td>QG, QE</td><td>Inflammation, Hyperlipidemia</td><td><italic>In vitro</italic></td><td>THP-1</td><td>&#x02193; TNF-&#x003b1;, &#x02193; IL-6, &#x02193; cox-2, &#x02193; PGE2</td><td>[<xref rid="bb1580" ref-type="bibr">316</xref>]</td></tr><tr><td/><td>QG</td><td>Inflammation, Hyperlipidemia</td><td><italic>In vivo</italic></td><td>Wistar rats</td><td>&#x02193; IL-6</td><td>[<xref rid="bb1580" ref-type="bibr">316</xref>]</td></tr><tr><td>Rosmary (<italic>Rosmarinus officinalis</italic> L.)</td><td>Rosmarinic acid</td><td>Asthma</td><td><italic>In vivo</italic></td><td>Wistar rats</td><td>&#x02193; IL-4, &#x02193; IgE, &#x02193; IFN-&#x003b3;, &#x02193; PLA2, &#x02193; TP</td><td>[<xref rid="bb1585" ref-type="bibr">317</xref>]</td></tr><tr><td/><td>Rosmarinic acid</td><td>Asthma</td><td><italic>In vivo</italic></td><td>BALB/c mice</td><td>&#x02193; IL-4, &#x02193; IL-13, &#x02193; p-JNK/JNK ratio, &#x02193; p-p38/p38 ratio,&#x02193; p-I&#x003ba;B&#x003b1;, &#x02193; mRNA expression of Ym2, CCR3 CCL11, AMCase, E-selectin</td><td>[<xref rid="bb1590" ref-type="bibr">318</xref>]</td></tr><tr><td>Saffron (<italic>Crocus sativus</italic>)</td><td>Crocin</td><td>Inflammation</td><td><italic>In vitro</italic></td><td>H9c2</td><td>&#x02193; TNF-&#x003b1;, &#x02193; PGE2, &#x02193; IL-1&#x003b2;, &#x02193; IL-6, &#x02193; mRNA expression of TNF-&#x003b1;, cox-2, IL-1&#x003b2;, IL-6, NO, iNOS</td><td>[<xref rid="bb1595" ref-type="bibr">319</xref>]</td></tr><tr><td/><td>Crocin</td><td>Osteoporosis</td><td><italic>In vivo</italic></td><td>Wistar rats</td><td>&#x02193; IL-6, &#x02193; TNF-&#x003b1;, &#x02193; TRAP, &#x02193; CTXI, &#x02191; osteocalcin, &#x02191; ALP</td><td>[<xref rid="bb1600" ref-type="bibr">320</xref>]</td></tr><tr><td/><td>Safranal</td><td>Colitis</td><td><italic>In vitro</italic></td><td>RAW264.7, BMDM</td><td>&#x02193; NO, &#x02193; iNOS, &#x02193; cox-2, &#x02193; IL-6, &#x02193; TNF-&#x003b1;, &#x02193; p-ERK, &#x02193; p-p38, &#x02193; p-JNK</td><td>[<xref rid="bb1605" ref-type="bibr">321</xref>]</td></tr><tr><td/><td>Safranal</td><td>Colitis</td><td><italic>In vivo</italic></td><td>BALB/c mice</td><td>&#x02193; IL-6, &#x02193; TNF-&#x003b1;, &#x02193; p-ERK, &#x02193; p-JNK, &#x02193; p-I&#x003ba;B&#x003b1; &#x02193; p-p38</td><td>[<xref rid="bb1605" ref-type="bibr">321</xref>]</td></tr><tr><td/><td>Safranal</td><td>AD</td><td><italic>In vivo</italic></td><td>Wistar rats</td><td>&#x02193; MDA, &#x02191; SOD, &#x02193; AChE, &#x02193; NF-&#x003ba;B, &#x02193; TNF-&#x003b1;, &#x02193; IL-6, &#x02193; IL-1&#x003b2;, &#x02193; GFAP, &#x02193; MPO, &#x02193; ROS</td><td>[<xref rid="bb1610" ref-type="bibr">322</xref>]</td></tr><tr><td/><td>Safranal</td><td>Gastric ulcer</td><td><italic>In vivo</italic></td><td>Wistar rats</td><td>&#x02191; SOD, &#x02191; TAC, &#x02193; MDA, &#x02193; TNF-&#x003b1;, &#x02193; caspase-3</td><td>[<xref rid="bb1615" ref-type="bibr">323</xref>]</td></tr><tr><td>Sesame (<italic>Sesamum indicum</italic>)</td><td>Sesamol</td><td>Asthma</td><td><italic>In vivo</italic></td><td>BALB/c mice</td><td>&#x02191; GSH, &#x02193; MDA, &#x02193; ICAM-1</td><td>[<xref rid="bb1620" ref-type="bibr">324</xref>]</td></tr><tr><td/><td>Sesamol</td><td>Asthma</td><td><italic>In vitro</italic></td><td>BEAS-2B cells</td><td>&#x02193; CCL11, &#x02193; CCL24, &#x02193; CCL5, &#x02193; MCP-1, &#x02193; IL-6, &#x02193; IL-8, &#x02193; Eotaxin, &#x02193;ROS</td><td>[<xref rid="bb1620" ref-type="bibr">324</xref>]</td></tr><tr><td/><td>Sesamin</td><td>ALI</td><td><italic>In vivo</italic></td><td>BALB/c mice</td><td>&#x02193; MPO, &#x02193; TNF-&#x003b1;, &#x02193; IL-6, &#x02193; IL-1&#x003b2; &#x02193; TLR4, &#x02193; NF-&#x003ba;B</td><td>[<xref rid="bb1625" ref-type="bibr">325</xref>]</td></tr><tr><td/><td>Sesamin</td><td>Kidney injury</td><td><italic>In vivo</italic></td><td>C57BL/6 mice</td><td>&#x02191; GSH, &#x02193; MDA, &#x02191; SOD, &#x02191; Nrf2, &#x02191; catalase, &#x02193; IL6, &#x02193; NF-&#x003ba;B, &#x02193; TLR4, &#x02193; cox-2, &#x02193; TNF&#x003b1;</td><td>[<xref rid="bb1630" ref-type="bibr">326</xref>]</td></tr><tr><td>`</td><td>Sesamin</td><td>Depression</td><td><italic>In vivo</italic></td><td>CD-1 mice</td><td>&#x02193; iNOS, &#x02193; cox-2, &#x02193; TNF-&#x003b1;, &#x02193; IL-1&#x003b2;</td><td>[<xref rid="bb1635" ref-type="bibr">327</xref>]</td></tr><tr><td/><td>&#x02013;<sup>A</sup></td><td>Asthma</td><td><italic>In vivo</italic></td><td>BALB/c mice</td><td>&#x02193; IL-1 &#x003b2;, &#x02193; IL-6, &#x02193; NO, &#x02193; iNOS, &#x02193; IgE</td><td>[<xref rid="bb1640" ref-type="bibr">328</xref>]</td></tr><tr><td>Star anise (<italic>Illicium verum</italic>)</td><td>&#x02013;<sup>C</sup></td><td>Atherosclerosis</td><td><italic>In vitro</italic></td><td>HASMC</td><td>&#x02193; TNF-&#x003b1;, &#x02193; IL-1&#x003b2;, &#x02193; NF-&#x003ba;B, &#x02193; cox, &#x02193; <italic>E</italic>-selectin, &#x02193; ICAM-1, &#x02193; VCAM-1</td><td>[<xref rid="bb1645" ref-type="bibr">329</xref>]</td></tr><tr><td/><td>&#x02013;<sup>C</sup></td><td>Atherosclerosis</td><td><italic>In vivo</italic></td><td>C57BL/6 mice</td><td>&#x02193; TNF-&#x003b1;, &#x02193; IL-1&#x003b2;, &#x02193; NF-&#x003ba;B, &#x02193; cox, &#x02193; E-selectin, &#x02193; ICAM-1, &#x02193; VCAM-1, &#x02193; iNOS</td><td>[<xref rid="bb1645" ref-type="bibr">329</xref>]</td></tr><tr><td/><td>&#x02013;<sup>C</sup></td><td>&#x02013;</td><td><italic>In vitro</italic></td><td>HaCaT</td><td>&#x02193; IFN-&#x003b3; R&#x003b1;, &#x02193; ICAM-1, &#x02191; SOCS1, &#x02193; p-JAK2, &#x02193; p-STAT1</td><td>[<xref rid="bb1650" ref-type="bibr">330</xref>]</td></tr><tr><td/><td>Anethole</td><td>ALI</td><td><italic>In vivo</italic></td><td>BALB/c mice</td><td>&#x02193; MMP-9, &#x02193;TNF-&#x003b1;, &#x02193; NO, &#x02191; I&#x003ba;B&#x003b1;, &#x02193; NF-&#x003ba;B p65</td><td>[<xref rid="bb1655" ref-type="bibr">331</xref>]</td></tr><tr><td/><td>&#x02013;<sup>C</sup>, AET</td><td>Asthama</td><td><italic>In vitro</italic></td><td>Splenocyte</td><td>&#x02193; IL-4, &#x02191; IFN&#x003b3;</td><td>[<xref rid="bb1660" ref-type="bibr">332</xref>]</td></tr><tr><td/><td>&#x02013;<sup>C</sup>, AET</td><td>Asthama</td><td><italic>In vivo</italic></td><td>BALB/c mice</td><td>&#x02193; IgE, &#x02193; IL-4, &#x02193; IL-5, &#x02193; IL-13, &#x02191; mRNA expression of Foxp3,&#x02193; mRNA expression of IL-5, and IL-13</td><td>[<xref rid="bb1660" ref-type="bibr">332</xref>]</td></tr><tr><td>Tamarind (<italic>Tamarindus indica</italic>)</td><td>&#x02013;<sup>C</sup></td><td>Pulmonary inflammation and fibrosis</td><td><italic>In vivo</italic></td><td>Wistar rats</td><td>&#x02193; ROS, &#x02193; LPO, &#x02193; PCC, &#x02193; NF-&#x003ba;B, &#x02193; p38&#x003b1; MAPK, &#x02193; NOX4, &#x02193; cox-2, &#x02191; HO-1, &#x02191; SOD2, &#x02191; catalase, &#x02191; GST, &#x02191; GSH, &#x02191; GPx</td><td>[<xref rid="bb1665" ref-type="bibr">333</xref>]</td></tr><tr><td/><td>&#x02013;<sup>C</sup></td><td>Arthritis</td><td><italic>In vivo</italic></td><td>Wistar rats</td><td>&#x02193; IL-1&#x003b2;, &#x02193; IL-6, &#x02193; IL-23, &#x02193; TNF-&#x003b1;, &#x02193; cox-2, &#x02193; MMP</td><td>[<xref rid="bb1670" ref-type="bibr">334</xref>]</td></tr><tr><td/><td>Xyloglucan</td><td>Ulcerative colitis</td><td><italic>In vivo</italic></td><td>C57Bl6 mice</td><td>&#x02193; IL-1&#x003b2;, &#x02193; IL-6, &#x02193; TLR4, &#x02193; NF-&#x003ba;B</td><td>[<xref rid="bb1675" ref-type="bibr">335</xref>]</td></tr><tr><td>Turmeric (<italic>Curcuma longa</italic>)</td><td>Curcumin</td><td>PIVP</td><td><italic>In vitro</italic></td><td>A549, BMMF</td><td>&#x02193; IL6, &#x02193; TNF-&#x003b1;, &#x02193; MCP-1, &#x02193; NF-&#x003ba;B, &#x02191; I&#x003ba;B&#x003b1;,</td><td>[<xref rid="bb1680" ref-type="bibr">336</xref>]</td></tr><tr><td/><td/><td>PIVP</td><td><italic>In vivo</italic></td><td>BALB/c mice</td><td>&#x02191; HO-1</td><td>[<xref rid="bb1680" ref-type="bibr">336</xref>]</td></tr><tr><td/><td>Curcumin</td><td>Cystic fibrosis</td><td><italic>In vitro</italic></td><td>16HBE14o</td><td>&#x02191; CFTR, &#x02193; cox-2, &#x02193; PGE2, &#x02193; IL-8</td><td>[<xref rid="bb1685" ref-type="bibr">337</xref>]</td></tr><tr><td/><td>Curcumin</td><td>Cystic fibrosis</td><td><italic>In vivo</italic></td><td>SD rats</td><td>&#x02191; CFTR, &#x02193; cox-2, &#x02193; PGE2, &#x02193; IL-8</td><td>[<xref rid="bb1685" ref-type="bibr">337</xref>]</td></tr><tr><td/><td>Curcumin</td><td>Diabetes</td><td><italic>In vivo</italic></td><td>SD rats</td><td>&#x02193; NF-&#x003ba;B, &#x02193; TNF-&#x003b1;, &#x02193; IL-1&#x003b2;, &#x02193; IL-6 &#x02193; NO, &#x02193; PGE2, &#x02193; cox-2</td><td>[<xref rid="bb1690" ref-type="bibr">338</xref>]</td></tr><tr><td/><td>Curcumin</td><td>ALI</td><td><italic>In vivo</italic></td><td>SD rats</td><td>&#x02193; TNF-&#x003b1;, &#x02193; IL-8, &#x02193; MIF</td><td>[<xref rid="bb1695" ref-type="bibr">339</xref>]</td></tr><tr><td/><td>Curcumin</td><td>Asthma</td><td><italic>In vivo</italic></td><td>BALB/c mice</td><td>&#x02193; NICD1, &#x02193; Notch 1/2 receptors</td><td>[<xref rid="bb1700" ref-type="bibr">340</xref>]</td></tr><tr><td/><td>Curcumin</td><td>Cerebral I/R injury</td><td><italic>In vivo</italic></td><td>SD rats</td><td>&#x02193; IL-1&#x003b2;, &#x02193; IL-8, &#x02191; p-JAK2, &#x02191; p-STAT3</td><td>[<xref rid="bb1705" ref-type="bibr">341</xref>]</td></tr><tr><td/><td>ATM</td><td>Psoriasis</td><td><italic>In vivo</italic></td><td>BALB/c mice</td><td>&#x02193; NF-&#x003ba;B, &#x02193; cox-2, &#x02193; p-p38 MAPK, &#x02193; TNF-&#x003b1;, &#x02193; IL-6, &#x02193; mRNA synthesis of IL-17, -22, and -23</td><td>[<xref rid="bb1710" ref-type="bibr">342</xref>]</td></tr><tr><td/><td>MTrPP</td><td>Ulcer</td><td><italic>In vivo</italic></td><td>Wistar rats</td><td>&#x02193; TNF-&#x003b1;, &#x02193; IL-8, &#x02193; NF-&#x003ba;B, &#x02193; p-p38, &#x02193; MMP-9, &#x02193; cox-1 and -2</td><td>[<xref rid="bb1715" ref-type="bibr">343</xref>]</td></tr></tbody></table><table-wrap-foot><fn id="sp0060"><p><sup>A</sup>&#x0202f;=&#x0202f;Oil; <sup>B</sup>&#x0202f;=&#x0202f;Resin; <sup>C</sup>&#x0202f;=&#x0202f;Extract; <sup>D</sup>&#x0202f;=&#x0202f;Mucilage; <sup>E</sup>&#x0202f;=&#x0202f;Seed.</p></fn><fn id="sp0065"><p>Abbreviations: AA: Arachidonic acid; Ach: Acetylcholine; AChE: Acetylcholinesterase; AD: Alzheimer's disease; ADAMTS: a disintegrin and metalloproteinase with thrombospondin motifs; AET: Trans-Anethole; AKT: Protein kinase B; ALI: Acute lung injury; ALP: Alkaline phosphatase; ALT: Alanine aminotrans-ferase; AMCase: Acidic mammalian chitinase; AMPK: Adenosine monophosphate-activated protein kinase; AP: Acute pancreatitis; AP-1: Activator protein-1; APH: Atypical prostatic hyperplasia; AR: Allergic rhinitis; AST: Aspartate aminotransferase; ATM: Aromatic-turmerone; ATPase: Adenosine triphosphatase; Bax: B-cell lymphoma 2 (Bcl-2)-associated X protein; BCA: 2&#x02032;-benzoxy-cinnamaldehyde; Bcl-2: B-cell lymphoma 2; CCL<italic>:</italic> C-C Motif Chemokine Ligand; CCR3: C-C chemokine receptor type 3; CHLS: total cholesterol; CFTR<italic>:</italic> Cystic fibrosis transmembrane conductance regulator; COPD: Chronic obstructive pulmonary disease; cox-2: cyclooxygenase-2; CSE: Cystathionine-&#x003b3;-lyase; CTXI: Collagen cross-linking carboxyterminal telopeptide, type I; DADS: Diallyl disulfide; ATS: Diallyl trisulfide; DNMT3A: DNA methyltransferase 3A; DRAM: Damage-regulated autophagy modulator; EFGR: Epidermal growth factor receptor; eNOS: endothelial nitric oxide; EPCR: Endothelial protein C receptor; ERK: Extracellular signal-regulated kinase; ET-1: endothelin-1; Foxp3: Forkhead Box Protein 3; GFAP: Glial fibrillary acidic protein; GGT: Gamma-glutamyl transpeptidase; GM-CSF: Granulocyte macrophage colony-stimulating factor; GPx: glutathione peroxidase; GR: Glutathione reductase; GRg3: Ginsenoside Rg3; GSH: Glutathione; GSK3&#x003b2;: glycogen synthase kinase 3&#x003b2;; GST: Glutathione S-transferase; G-6P-D: Glucose-6-phosphate dehydrogenase; HAND: Human immunodeficiency virus; HAND: (HIV)-associated neurocognitive disorders; HCA: 2&#x02032;-hydroxycinnamaldehyde; HDAC1: Histone Deacetylase 1; HDL: High-density lipoprotein; HO-1: Heme oxygenase-1; HMGB1: High mobility group box-1 protein; HNSCC: Squamous cell carcinoma of the head and neck; H<sub>2</sub>O<sub>2</sub>: Hydrogen peroxide; H<sub>2</sub>S: Hydrogen sulfide; ICAM-1-intercellular cell adhesion molecule-1; IFN: Interferon; IFN-&#x003b3;R&#x003b1;: IFN-&#x003b3; receptor &#x003b1;; IKK: Inhibitor of M kinase; IL: Interleukin; iNOS: Inducible nitric oxide synthase; IBD: Inflammatory bowel disease; IPF: Idiopathic pulmonary fibrosis; IP-10: Interferon-inducible protein 10; IRF-3: Interferon regulatory factor 3; I/R: ischemia-reperfusion; JAK: Janus kinase 2: JNK: c-Jun N-terminal kinase; LC3: Light chain 3; LDH: Lactate dehydrogenase; LDL: Low density lipoprotein; LIF: leukemia inhibitory factor; LN: Lupus nephritis; LOX: Lipoxygenase; LPO: Lipid peroxidation; LXR&#x003b1;: Liver X receptor &#x003b1;; MAPK: Mitogen-activated protein kinase; MDA: Malondialdehyde; MCP: Monocyte chemoattractant protein; M-CSF: Macrophage colony-stimulating factor; MIF: Migration inhibitory factor; MIG: Monokine induced by gamma; MIP: Macrophage inflammatory protein; MMP: matrix metalloproteinases; MPO: Myeloperoxidase; mTOR: mammalian target of rapamycin; MTrPP: Modified pectin polysaccharide from turmeric; MyD88: Myeloid differential factor 88; NAFLD: Non-alcoholic fatty liver disease; NF-&#x003ba;B p65: Nuclear factor-&#x003ba;B p65; NICD: Notch intracellular domain; NK1R: Neurokinin-1-receptor; NLRP3: Nucleotide oligomerization domain (NOD)-like receptor protein 3; NO: Nitric oxide; NOX4: Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 4; NR: Notoginsenoside R1; Nrf2: Nuclear factor erythroid 2-related factor 2; OA: Osteoarthritis; OSCC: Oral squamous cell carcinoma; p: phosphorylated; PA: Piperinic acid; PAI-1: Plasminogen activator inhibitor-1; PCC: Protein carbonyl content; PIVP: Primary influenza viral pneumonia; PI3K: Phosphoinositide 3-kinases; PKC-&#x003b2;: Protein kinase C-&#x003b2;; PCNA: Proliferating cell nuclear antigen; PF: Pulmonary fibrosis; PGE2: prostaglandin E2; PL: Piperlongumine; PLA2: Phospholipase 2; PNS: <italic>Panax notoginseng</italic> saponins; PPTA: Preprotachykinin A; QE: Quercetin-3-O-glucoside; QG: Quercetin-3-O-glucoside;RA: Rheumatoid arthritis; RA-FLS: Rheumatoid arthritis synovial fibroblast; ROS: Reactive oxygen species; ROR&#x003b3;t: Retinoic acid-related orphan receptor-&#x003b3;t; SA: serum sialic acid; SAC: S-allyl-L-cysteine; SD: Sprague-Dawley; SGI: Salivary gland inflammation; Smad-3: small mothers against decapentaplegic homolog 3; SMC: S-allyl-mercapto cysteine; SOCS1: Suppressor of cytokine signaling 1; SOD: Superoxide dismutase; STAT: Signal transducer and activator of transcription; STZ: Streptozotocin; TACE: Tumor necrosis factor alpha converting enzyme; TBARS: Thiobarbituric acid reactive substances; TAC: Total anti-oxidant capacity; TAK1: TGF-&#x003b2;-activated kinase 1; TCA: Trans-cinnamaldehyde; TG: Triglyceride; TGF-&#x003b2;: Transforming growth factor-&#x003b2;; TIGAR: Tp53 induced glycolysis and apoptosis regulator; TIMP-1: Tissue inhibitor of metalloproteinase; TLRs: Toll-like receptors; TP: Total protein; TRAP: Tartrate-resistant acid phosphatase; TRX1: Thioredoxin 1; TRXR1: Thioredoxin reductase 1; TSLP: Thymic stromal lymphopoietin; VCAM-1: Vascular cell adhesion protein 1; VEGF: Vascular endothelial growth factor; VLDL: Very low density lipoprotein; &#x003b1;-SMA: &#x003b1;-smooth muscle actin.</p></fn></table-wrap-foot></table-wrap><fig id="f0020"><label>Fig. 4</label><caption><p>Spices regulates the expression of different inflammatory cytokines.</p><p>Abbreviations: EPO: Erythropoetin, EGF: Epidermal growth factor, IL-Interleukin, IFN: Interferon, G-CSF: Granulocyte colony-stimulating factor, SCF: Stem cell factor, M-CSF: Macrophage colony-stimulating factor GM-CSF: Granulocyte-macrophage colony-stimulating factor.</p></caption><alt-text id="al0020">Fig. 4</alt-text><graphic xlink:href="gr4_lrg"/></fig></p><sec id="s0085"><label>7.1</label><title>Asafetida (<italic>Ferula asafetida</italic> Linn.)</title><p id="p0365">It is derived from the roots of the <italic>F. asafetida</italic> (Umbelliferae family). Several studies have reported that asafetida exhibits protective effects against cancer, obesity, hepatotoxicity, <italic>etc.</italic> [<xref rid="bb1720" ref-type="bibr">344</xref>] It has also been extensively used in traditional medicine for ages for the treatment of whooping cough, asthma, bronchitis, <italic>etc.</italic> [<xref rid="bb1725" ref-type="bibr">345</xref>] The essential oil extracted from <italic>F. asafetida</italic> induces apoptosis and cytotoxicity against hepatocarcinoma. It modulates the NF-&#x003ba;B and transforming growth factor (TGF)-&#x003b2; pathway by downregulating the expression of NF-&#x003ba;B1 and TGF-&#x003b2;1. Furthermore, it enhances the production of caspase-3 and TNF-&#x003b1; [<xref rid="bb1105" ref-type="bibr">221</xref>] Asafetida exhibits potent antitumor effects against breast cancer in BALB/c nude mice [<xref rid="bb1110" ref-type="bibr">222</xref>] It also enhances the activities of antioxidant enzymes such as catalase, glutathione (GSH), glutathione-s-transferase (GST), superoxide dismutase (SOD), in an <italic>N</italic>-methyl-N-nitrosourea (MNU)-induced breast cancer in Sprague-Dawley rats [<xref rid="bb1115" ref-type="bibr">223</xref>]. The activity of LOX is reportedly decreased by asafoetida [<xref rid="bb1110" ref-type="bibr">222</xref>,<xref rid="bb1120" ref-type="bibr">224</xref>].</p></sec><sec id="s0090"><label>7.2</label><title>Basil (<italic>Ocimum sanctum</italic>)</title><p id="p0370">Basil is a popular spice consumed all over the world [<xref rid="bb1730" ref-type="bibr">346</xref>]. It belongs to the Lamiaceae family [<xref rid="bb1735" ref-type="bibr">347</xref>]. Studies have shown that basil possesses medicinal properties such as gastroprotective, anti-oxidant, anti-microbial, <italic>etc.</italic> [<xref rid="bb1130" ref-type="bibr">226</xref>,<xref rid="bb1740" ref-type="bibr">348</xref>]. An <italic>in vivo</italic> study has also demonstrated the cardioprotective effects of basil leaves against isoproterenol-induced myocardial infarction in rats [<xref rid="bb1745" ref-type="bibr">349</xref>]. Hydro-ethanolic extract of basil leaf attenuates airway inflammation and exerts immunoprotective effects against asthma in the ovalbumin-sensitized rat model. It decreases the levels of IL-4, IgE, Phospholipase A<sub>2</sub> (PLA<sub>2</sub>), and increases the IFN-&#x003b3;/IL-4 ratio in the bronchoalveolar lavage fluid (BALF) of the rats [<xref rid="bb1125" ref-type="bibr">225</xref>]. Furthermore, the hexane extract of basil (whole plant) modulates the expression of inflammatory markers such as TNF-&#x003b1;, IL-6, Prostaglandin <italic>E</italic>-2 (PGE-2), and IL-4. It exerts anti-inflammatory as well as gastroprotective effects against an aspirin-induced gastric ulcer <italic>in vivo</italic> [<xref rid="bb1130" ref-type="bibr">226</xref>].</p></sec><sec id="s0095"><label>7.3</label><title>Bay leaf (<italic>Laurus nobilis</italic>)</title><p id="p0375">Bay leaves belong to the family Lauraceae and are commonly used in cuisine for flavoring [<xref rid="bb1135" ref-type="bibr">227</xref>,<xref rid="bb1750" ref-type="bibr">350</xref>]. The administration of <italic>L. nobilis</italic> leaf extract attenuated the lipopolysaccharide (LPS)-induced mRNA expression of IL-6, TNF-&#x003b1;, and iNOS. It also inhibited the phosphorylation of I&#x003ba;B and STAT3 <italic>in vitro</italic>. Further, it exerts the inhibition of the Nucleotide oligomerization domain (NOD)-like receptor protein 3 (NLRP3) inflammasome activation <italic>via</italic> the suppression of apoptosis-associated speck-like protein containing a CARD (ASC) oligomerization. In the BALF of the acute lung injury (ALI) model, the extract reduces the activity of the myeloperoxidase (MPO) enzyme as well as the levels of cytokines such as IL-1&#x003b2;, IL-6, and TNF-&#x003b1;. This suggests that bay leaf extract exerts ameliorative effects against ALI [<xref rid="bb1135" ref-type="bibr">227</xref>]. 1,8-Cineole is a bioactive component of L. <italic>nobilis</italic>. Similar to the leaf extract, 1,8-Cineole also downregulates the elevated LPS-induced mRNA expression of IL-6, TNF-&#x003b1;, and iNOS. It also inhibited the activation of NF-&#x003ba;B and STAT [<xref rid="bb1135" ref-type="bibr">227</xref>]</p></sec><sec id="s0100"><label>7.4</label><title>Black cumin (<italic>Nigella sativa</italic>)</title><p id="p0380">Black cumin belongs to the family Ranunculaceae. They are consumed as a spice or seasoning predominantly in the Middle Eastern as well as Mediterranean countries [<xref rid="bb1755" ref-type="bibr">351</xref>]. <italic>N. sativa</italic> plant is widely known for its medicinal properties such as anti-diabetic, anti-inflammatory, hepatoprotective, hypotensive, <italic>etc.</italic> [<xref rid="bb1760" ref-type="bibr">352</xref>]. Cumin effectively ameliorates LPS-induced lung damage as well as inflammation. It downregulates the expression of the inflammatory mediators such as IFN-&#x003b3;, TGF-&#x003b2;1, and prostaglandin 2 (PGE<sub>2</sub>) but upregulates the anti-inflammatory cytokine IL-4. It also exhibits potent antioxidant properties by enhancing the activity of SOD and catalase [<xref rid="bb1140" ref-type="bibr">228</xref>]. Besides, it attenuates low-grade inflammation <italic>in vitro</italic> by reducing the levels of IL-1 &#x003b2; and MCP-1 [<xref rid="bb1145" ref-type="bibr">229</xref>]. It also reduces the mRNA expression of endothelial nitric oxide synthase (eNOS) in a streptozotocin (STZ)-induced diabetic rat model. However, it increases the mRNA expression of vascular cell adhesion molecule-1 (VCAM-1) and LOX-1 [<xref rid="bb1150" ref-type="bibr">230</xref>]. <italic>N. sativa</italic> demonstrates renal and hepatoprotective effects in LPS-treated rats. Moreover, it also exhibits anti-inflammatory effects by decreasing the levels of cytokine IL-6 as well as NO [<xref rid="bb1155" ref-type="bibr">231</xref>]. Further, it also declines the levels of IL-4 and nitric oxide (NO) in an allergic asthma model in Wistar rats [<xref rid="bb1160" ref-type="bibr">232</xref>]. Thymoquinone (TQ) is one of the major active components of cumin seeds. Studies have shown that TQ exerts an anti-inflammatory effect on Alzheimer's disease (AD) by downregulating the expression of toll-like receptor (TLR)-2 and -4. This leads to a decrease in the production of their downstream effectors NF-&#x003ba;B and Interferon regulatory factor 3 (IRF-3). TQ also significantly reduces the expression of the pro-inflammatory cytokines TNF-&#x003b1; and IL-1&#x003b2; [<xref rid="bb1165" ref-type="bibr">233</xref>].</p></sec><sec id="s0105"><label>7.5</label><title>Black pepper (<italic>Piper nigrum</italic>)</title><p id="p0385">Black pepper from the Piperaceae family is a popular spice due to its dietary importance and beneficial agent for various chronic health ailments [<xref rid="bb1765" ref-type="bibr">353</xref>].</p><p id="p0390">The administration of ethanol extracts of <italic>Piper nigrum</italic> in ovalbumin-induced asthma mice model was observed to decrease IL-4, IL-6, IL-1&#x003b2;, retinoic acid-related orphan receptor gamma t (ROR&#x003b3;t), IL-17A, TNF-&#x003b1;, IgE, and increase IL-10, INF-&#x003b3;. It decreased the state of fibrosis and inflammatory cells infiltration and also regulated the production of cytokines like Th1, Th2, Th17. Further, the extract treatment blocked the allergy through the prevention of degranulation of peritoneal mast cells [<xref rid="bb1170" ref-type="bibr">234</xref>] Further, the effect of fruit extract from <italic>P. nigrum</italic> in allergic rhinitis ovalbumin-induced BALB/c mice model prevented allergic reactions by reducing antibodies, histamine release by mast cells. It has also decreased E-cadherin and was protective against nasal epithelial barrier impairment through increased Nrf2 leading to elevated heme oxygenase-1 (HO-1) level [<xref rid="bb1175" ref-type="bibr">235</xref>]. Similarly, the extract has also decreased the expression of STAT3, IL-6, IL-1&#x003b2;, TNF-&#x003b1;, and NF-&#x003ba;B p65 [<xref rid="bb1180" ref-type="bibr">236</xref>].</p><p id="p0395">The ethanolic extract containing pipernigramides A-G decreased iNOS-induced NO and levels of IL-1&#x003b2;, IL-6, TNF-&#x003b1;, and PGE<sub>2</sub> in RAW 264.7 cells. It also reduced the degradation of I&#x003ba;B and targets IKK-&#x003b2; that inhibits p65, which leads to decrease inflammation [<xref rid="bb1185" ref-type="bibr">237</xref>]. Further, the treatment of piperine in B16F-10-induced lung metastasis in C57BL/6 mice decreased collagen hydroxyproline in lungs, hexosamine level, uronic acid, serum sialic acid, and gamma-glutamyl transpeptidase, and it increased the lifespan of treated animals [<xref rid="bb1190" ref-type="bibr">238</xref>].</p><p id="p0400">Piperine was showed to be effective against bacterial sepsis by preventing pyroptosis through the reduction of IL-1&#x003b2; and Adenosine monophosphate-activated protein kinase (AMPK) levels, both <italic>in vitro</italic> and <italic>in vivo</italic> [<xref rid="bb1195" ref-type="bibr">239</xref>]. Piperine could reduce the condition of acute pancreatitis through reduction of TNF-&#x003b1;, IL-1&#x003b2;, IL-6, p-ERK1/2, p-p38, p-JNK, and MAPKs expressions [<xref rid="bb1200" ref-type="bibr">240</xref>]. Piperine improved lupus nephritis in HK-2 cells by inhibiting pyroptosis, NLRP3 inflammasome, HMGB1, caspase-1, and activation of AMPK. Similarly, piperine inhibited NLRP3 inflammasome and serum IL-1&#x003b2; in the BALB/c mice model of lupus nephritis [<xref rid="bb1205" ref-type="bibr">241</xref>]. The effect of Chabamide from fruits of Piper nigrum in lipopolysaccharide (LPS)-stimulated RAW264.7 cells produced an anti-inflammatory effect <italic>via</italic> the Nrf2/HO-1 pathway through the reduction in iNOS and increased Nrf2 and its targets-NAD(<italic>P</italic>)H: quinone oxidoreductase 1 and &#x003b3;-glutamyl cysteine synthetase [<xref rid="bb1210" ref-type="bibr">242</xref>].</p></sec><sec id="s0110"><label>7.6</label><title>Capsicum (<italic>Capsicum annum</italic> L.)</title><p id="p0405">Capsicum belongs to the family Solanaceae. It exerts anti-inflammatory effects against ethanol-induced inflammation in rats by reducing the expression of pro-inflammatory cytokines TNF-&#x003b1; and IL-6. Additionally, it also exerts potent hepatoprotective effects by attenuating the elevated levels of malondialdehyde (MDA) in the liver, a marker for lipid peroxidation, as well as enzymes like alanine aminotransferase (ALT), aspartate transaminase (AST) which are the markers for liver damage. Capsicum also restores the abnormal levels of cytosolic Cu-Zn-SOD, mitochondrial Mn-SOD, as well as critical antioxidant enzymes [<xref rid="bb1215" ref-type="bibr">243</xref>]. The extract of capsicum also significantly elevates the expression of Th type 2 cytokines such as IL-4, IL-5, IL-13 in an ovalbumin-induced asthma mouse model [<xref rid="bb1220" ref-type="bibr">244</xref>].</p><p id="p0410">Capsaicin is one of the major active components of capsicum. It is known to possess protective activities against asthma, cancer, diabetes, <italic>etc.</italic> [<xref rid="bb0070" ref-type="bibr">14</xref>]. It also ameliorates inflammation by reducing the levels of TNF-&#x003b1;, IL-6, and IL-1&#x003b2;. Enhanced expression of liver X receptor &#x003b1; (LXR&#x003b1;) is also regulated by capsaicin <italic>via</italic> the peroxisome proliferator-activated receptor &#x003b3; (PPAR&#x003b3;) pathway [<xref rid="bb1225" ref-type="bibr">245</xref>]. Inflammation of the salivary glands is also attenuated by capsaicin. It markedly reduces the mRNA as well as protein expression of TNF-&#x003b1; and IL-6 in HSG cells [<xref rid="bb1230" ref-type="bibr">246</xref>].</p></sec><sec id="s0115"><label>7.7</label><title>Cardamom (<italic>Elettaria cardamomum</italic>)</title><p id="p0415">Cardamom belongs to the Zingiberaceae family. It is commonly referred to as the &#x0201c;queen of spices&#x0201d; [<xref rid="bb1770" ref-type="bibr">354</xref>]. Several studies indicated that cardamom possesses different therapeutic activities such as chemopreventive, anti-diabetic, anti-cancer, gastroprotective, <italic>etc.</italic> [<xref rid="bb1770" ref-type="bibr">354</xref>], [<xref rid="bb1775" ref-type="bibr">355</xref>]. Treatment with cardamom extract ameliorates oxidative stress by enhancing the levels of antioxidant enzymes. It also attenuates inflammation by downregulating the expression of NF-&#x003ba;B and NO. Further, it also exerts protective effects against doxorubicin-induced cardiotoxicity in rats [<xref rid="bb1235" ref-type="bibr">247</xref>].</p></sec><sec id="s0120"><label>7.8</label><title>Celery seeds (<italic>Apium graveolens</italic>)</title><p id="p0420">Celery seeds belong to the Apiaceae (Umbelliferae) family. It is consumed as a spice and herbal medicine [<xref rid="bb1255" ref-type="bibr">251</xref>]. Preclinical studies conducted on hyperuricemia mice model and monosodium urate-induced gouty arthritis rats reported that the aqueous and oil extracts of celery seeds exhibit anti-inflammatory and anti-oxidant properties. The administration of the extracts reduced the pro-inflammatory cytokines like IL-1&#x003b2;, TNF-&#x003b1;, and enhanced anti-inflammatory IL-10 levels [<xref rid="bb1240" ref-type="bibr">248</xref>]. Sedanolide, celery (<italic>A. graveolens</italic>) seed essential oil, induces autophagy to kill the human hepatocarcinoma cells, due to the reduced phosphatidylinositol-3-kinase (PI3K), mTOR, Protein kinase B (Akt) expression levels in those cells [<xref rid="bb1245" ref-type="bibr">249</xref>]. Another recent study shows that the hydrolyzed celery (<italic>A. graveolens</italic>) extract suppresses the inflammation in the chronic atopic dermatitis mice model. It effectively reduces the pro-inflammatory cytokines like IL-4, TNF-&#x003b1;, IFN-&#x003b3;, IL-6, IL-31, and IgE as demonstrated from the preclinical experimental models.250 The extract of celery seeds also exerts anti-inflammatory effects by downregulating IL-6, TNF-&#x003b1;, and NF-&#x003ba;B levels [<xref rid="bb1255" ref-type="bibr">251</xref>].</p></sec><sec id="s0125"><label>7.9</label><title>Cinnamon (<italic>Cinnamomum</italic> sp.)</title><p id="p0425">The spice cinnamon is derived from the bark of plants belonging to the family Lauraceae and genus <italic>Cinnamomum</italic> [<xref rid="bb1780" ref-type="bibr">356</xref>]. It is a multipotential medicinal plant that possesses diverse properties such as antiseptic, antifungal, antiviral, anti-inflammatory, immunomodulatory, <italic>etc.</italic> [<xref rid="bb1785" ref-type="bibr">357</xref>].</p><p id="p0430">
<italic>Trans</italic>-cinnamaldehyde (TCA) is one of the components of Cinnamon. TCA inhibits NF-&#x003ba;B as well as the p38-JNK signaling pathway in the IL-1&#x003b2;-induced osteoarthritis model. Furthermore, it inhibits the activation of NF-&#x003ba;B as well as the degradation of I&#x003ba;B. It also slowed down the progression of osteoarthritis <italic>in vivo</italic> [<xref rid="bb1260" ref-type="bibr">252</xref>]. Suppression of NO due to a decrease in iNOS expression is also observed after TCA treatment in RAW 264.7 cells [<xref rid="bb1265" ref-type="bibr">253</xref>]. The administration of TCA also suppresses the production of NO in LPS-induced BV2 microglial cells. Furthermore, it also downregulates the expression of iNOS, cox-2, as well as IL-1&#x003b2; and induces NF-&#x003ba;B inactivation [<xref rid="bb1270" ref-type="bibr">254</xref>]. The essential oil extracted from cinnamon also possesses anti-inflammatory properties. A study showed that it downregulates inflammatory biomarkers such as MCP-1, interferon gamma-induced protein 10 (IP-10), interferon-inducible T-cell alpha chemoattractant (I-TAC) monokine induced by gamma interferon (MIG) as well as IL-8 in a human skin disease model [<xref rid="bb1275" ref-type="bibr">255</xref>]. The water extract of cinnamon (CWE) substantially reduces the secretion of TNF-&#x003b1; and IL-6 in LPS-induced <italic>in vivo</italic> model. In LPS-induced macrophages, the extract did not reduce the secretion of TNF-&#x003b1;; however, a substantial decrease in its mRNA expression was observed. Additionally, it also inhibits I&#x003ba;B&#x003b1; degradation as well as MAP kinase phosphorylation [<xref rid="bb1280" ref-type="bibr">256</xref>]. CWE also significantly decreases the levels of anti-CD3-induced IFN-&#x003b3; in the serum of mice model. It also decreased the mRNA expression as well as the release of IFN-&#x003b3; and IL-4 in murine splenocytes. Additionally, CWE increased the secretion of IL-2 in splenocytes [<xref rid="bb1285" ref-type="bibr">257</xref>]. 2&#x02032;-Hydroxycinnamaldehyde (HCA) and 2&#x02032;-benzoxycinnamaldehyde (BCA) are the derivatives of cinnamaldehyde. HCA and BCA both exhibit an inhibitory effect on the secretion of IgM as well as IFN-&#x003b3; in murine splenocytes [<xref rid="bb1290" ref-type="bibr">258</xref>].</p></sec><sec id="s0130"><label>7.10</label><title>Coriander (<italic>Coriandrum sativum</italic>)</title><p id="p0435">Coriander is an annual herb of the Apiaceae family [<xref rid="bb1790" ref-type="bibr">358</xref>]. It is commonly known as coriander, and its different parts are consumed worldwide. In addition to its culinary values, coriander is also often consumed as a traditional medicine against different ailments such as diabetes, cancer, hypertension, <italic>etc.</italic> [<xref rid="bb1795" ref-type="bibr">359</xref>]. It also possesses different pharmacological activities such as hepatoprotective, antihelminthic, neuroprotective, anti-microbial, <italic>etc.</italic> [<xref rid="bb1795" ref-type="bibr">[359]</xref>, <xref rid="bb1800" ref-type="bibr">[360]</xref>, <xref rid="bb1805" ref-type="bibr">[361]</xref>].</p><p id="p0440">Numerous studies have suggested that extracts prepared from different parts of coriander also induce potent anti-inflammatory effects in both <italic>in vitro</italic> as well as <italic>in vivo</italic> models [<xref rid="bb1295" ref-type="bibr">[259]</xref>, <xref rid="bb1300" ref-type="bibr">[260]</xref>, <xref rid="bb1305" ref-type="bibr">[261]</xref>]. A study demonstrated that the ethanolic extract of coriander leaves and stem downregulates the expression of inflammatory mediators, including IL-1&#x003b2;, NO, and cox-2, as well as decreases the production of PGE2 and iNOS. It further inhibits NF-&#x003ba;B activation as well as MAPK signaling in LPS-induced RAW 264.7 cells [<xref rid="bb1295" ref-type="bibr">259</xref>]. It also substantially attenuates the 2,4-dinitrochlorobenzene-induced elevated expression of IL-1, IL-4, IL-13, TNF-&#x003b1;, IFN-&#x003b3; as well as immunoglobulin E (IgE) in the contact dermatitis <italic>in vivo</italic> model [<xref rid="bb1300" ref-type="bibr">260</xref>]. The hydroalcoholic extract of coriander induces a reduced production of TNF-R1 protein as well as downregulates the levels of the cytokines IL-1&#x003b2; and IL-6 [<xref rid="bb1305" ref-type="bibr">261</xref>].</p></sec><sec id="s0135"><label>7.11</label><title>Cumin (<italic>Cuminum cyminum</italic>)</title><p id="p0445">Cumin belongs to the Apiaceae family. It is commonly used for the treatment of diseases like diabetes, cancer, hypolipidemia, <italic>etc.</italic> [<xref rid="bb1810" ref-type="bibr">362</xref>]. In the renal hypertension <italic>in vivo</italic> model, the aqueous extract of cumin seeds attenuates inflammation and oxidative stress as well as induces anti-hypertensive effects by modulating the gene expression of IL-6, TNF-&#x003b1;, thioredoxin 1 (TRX1), and eNOS [<xref rid="bb1310" ref-type="bibr">262</xref>]. The methanol extract of cumin also ameliorates inflammation and imparts protection against a diabetes-associated gastric ulcer <italic>in vivo</italic> [<xref rid="bb1315" ref-type="bibr">263</xref>].</p></sec><sec id="s0140"><label>7.12</label><title>Curry leaves (<italic>Murraya koenigii</italic>)</title><p id="p0450">Curry leaves belong to the Rutaceae family. Curry leaves are popularly used in Indian cuisine and have been a part of Indian traditional medicine for centuries due to its versatile medicinal properties [<xref rid="bb1815" ref-type="bibr">363</xref>]. A recent study showed the anti-inflammatory effect of the hydroalcoholic extract of curry leaves <italic>in vitro</italic> and <italic>in vivo</italic>. It reduced the expression of pro-inflammatory cytokines such as TNF-&#x003b1;, IL-1&#x003b2;, and IL-6 in LPS-induced macrophages. Similar effects were observed in the cerulein-induced acute pancreatitis <italic>in vivo</italic> model. Additionally, it also downregulates the activity of p65-NF&#x003ba;B as well as the expression of cox-2 and intercellular adhesion molecule-11 (ICAM-1) <italic>in vivo</italic> [<xref rid="bb1320" ref-type="bibr">264</xref>]. The aqueous extract reduced the levels of cytokines such as IL-6, IL-1&#x003b2;, and IL-10 in 4T1-inoculated mice. It also downregulated the expression of inflammation regulator NF-kB [<xref rid="bb1325" ref-type="bibr">265</xref>]. Mahanimbine is a carbazole alkaloid found in curry leaves. It attenuated the elevated levels of pro-inflammatory cytokines such as TNF-&#x003b1;, IL-1&#x003b2;, and IL-6 in high-fat diet (HFD)-induced mice, thereby exerting a potent anti-inflammatory effect [<xref rid="bb1330" ref-type="bibr">266</xref>]. Girinimbine, another carbazole alkaloid, is also a potent anti-inflammatory agent. It reduced the production of TNF-&#x003b1; and IL-1&#x003b2; in carrageenan-induced peritonitis [<xref rid="bb1335" ref-type="bibr">267</xref>].</p></sec><sec id="s0145"><label>7.13</label><title>Fenugreek (<italic>Trigonella foenum-graecum</italic> L.)</title><p id="p0455">Fenugreek belongs to the Fabaceae family [<xref rid="bb1820" ref-type="bibr">364</xref>]. It is rich in pharmaceutical and nutritional properties. It possesses different activities such as anti-carcinogenic, anti-inflammatory, anti-diabetic, <italic>etc.</italic> [<xref rid="bb1825" ref-type="bibr">365</xref>].</p><p id="p0460">Standardized fenugreek seed extract-glycoside base (SFSE-G) exhibits potent anti-inflammatory effects by downregulating the expression of inflammatory mediators, including TNF-&#x003b1;, IL-1&#x003b2;, IL-6, IL-8 in a bleomycin-induced pulmonary fibrosis model. It also inhibits the mRNA expression of the fibrotic markers such as small mothers against decapentaplegic homolog 3 (Smad-3), collagen-I, endothelin-1 (ET-1), <italic>etc.</italic> eventually leading to amelioration of pulmonary fibrosis <italic>in vivo</italic> [<xref rid="bb1340" ref-type="bibr">268</xref>]. A study has demonstrated that the extract of fenugreek seeds exerts inhibitory effects on cisplatin-induced enhanced expression of iNOS and NF-&#x003ba;B-p65 in testicular tissues of Wistar rats [<xref rid="bb1345" ref-type="bibr">269</xref>]. It also reduces the expression of retinal inflammatory markers such as TNF-&#x003b1; and IL-1&#x003b2; in STZ-induced diabetic rat retina [<xref rid="bb1350" ref-type="bibr">270</xref>]. In RA, expression of the pro-inflammatory cytokines TNF-&#x003b1; and IL-6 is significantly down-regulated by fenugreek mucilage prepared from fenugreek seeds thereby asserting its anti-inflammatory role [<xref rid="bb1355" ref-type="bibr">271</xref>] The pretreatment of, trigonelline derived from fenugreek exerts neuroprotective effects against amyloid &#x003b2;-induced AD <italic>in vivo</italic>. The mechanism is attributed to a decrease in hippocampal glial fibrillary acidic protein (GFAP) as well as pro-inflammatory cytokines [<xref rid="bb1360" ref-type="bibr">272</xref>]</p></sec><sec id="s0150"><label>7.14</label><title>Garcinia (<italic>Garcinia indica</italic>)</title><p id="p0465">
<italic>Garcinia</italic> is a spice which belongs to the family of Clusiaceae. Its fruit is commonly called kokum and it exhibits various pharmacological effects such as cardioprotective, hepatoprotective, antibacterial, anti-ulcer, anti-arthritis, <italic>etc.</italic> [<xref rid="bb1830" ref-type="bibr">366</xref>]. Garcinol is a major component of <italic>Garcinia</italic> which possesses medicinal properties such as anti-proliferative, antibacterial, anti-inflammatory, <italic>etc.</italic> [<xref rid="bb1835" ref-type="bibr">367</xref>]. A study showed that it significantly reduced the expression of inflammatory mediators like iNOS and cox-2 in a dextran sulfate sodium (DSS)-induced colitis mice model. Furthermore, it also prevents DSS/azoxymethane (AOM)-induced colon tumorigenesis by inhibiting the PI3K/Akt/p70S6K, as well as ERK signaling pathways [<xref rid="bb1365" ref-type="bibr">273</xref>]. Garcinol inhibits NF-&#x003ba;B activation in head and neck cancer cells - CAL27. It mediates the inhibition by suppressing TGF-&#x003b2;&#x02013;activated kinase 1 (TAK1) as well as an inhibitor of IkB kinase (IKK). Further, it also inhibits STAT3 as well as its upstream kinases c-Src, JAK1, and JAK2. Moreover, it exerts anti-tumor effects in nude mice with CAL27 xenografts [<xref rid="bb1370" ref-type="bibr">274</xref>].</p></sec><sec id="s0155"><label>7.15</label><title>Garlic (<italic>Allium sativum</italic>)</title><p id="p0470">Garlic is a bulbous plant belonging to the family Liliaceae. It is commonly used as a spice and flavor additive in many cuisines across the globe. Apart from this, garlic has been used since ancient times in different cultures for its medicinal values [<xref rid="bb1375" ref-type="bibr">275</xref>].</p><p id="p0475">
<italic>An in vivo</italic> study has demonstrated that the aqueous extract of garlic exerts inhibitory effects against <italic>Dermatophagoides pteronyssinus</italic> (Der p)-induced allergic asthma. The study showed that aqueous extract of garlic substantially downregulates the levels of cytokines such as IL-13, IL-5, IL-4 but upregulates the levels of IFN-&#x003b3; and IL-12 in the BALF of the experimental mice. Moreover, it also decreases the levels of pro-inflammatory cytokines such as TNF-&#x003b1;, IL-1&#x003b2;, and IL-6 and thereby induces anti-inflammatory effects [<xref rid="bb1375" ref-type="bibr">275</xref>]. The treatment of Der p-stimulated A549 cells with aqueous garlic extract also inhibits inflammation by suppressing the IL-6/PI3K/Akt/NF-&#x003ba;B pathway [<xref rid="bb1375" ref-type="bibr">275</xref>].</p><p id="p0480">Different bioactive components present in garlic are associated with its anti-inflammatory property as well as other pharmacological activities. Diallyl disulfide (DADS) is an organosulfur compound and is one of the key components of garlic. A study has shown that DADS ameliorates cerulein-induced acute pancreatitis <italic>in vivo</italic> by suppressing the substance P/neurokinin 1 receptor (SP/NK1R) signaling as well as the NF-&#x0043a;B pathway [<xref rid="bb1380" ref-type="bibr">276</xref>]. Another organosulfur compound Diallyl trisulfide (DATS), inhibits the NF-&#x003ba;B and Wnt pathway in human fibroblast-like synoviocytes (FLS) obtained from RA patients. Moreover, key inflammatory mediators such as IL-1&#x003b2;, IL-6, and TNF-&#x003b1; are also downregulated by DATS in collagen-induced arthritis (CIA) mouse model [<xref rid="bb1385" ref-type="bibr">277</xref>]. Garlic also contains S-allyl-L-cysteine (SAC), an organosulfur compound [<xref rid="bb1840" ref-type="bibr">368</xref>]. An <italic>in vivo</italic> study revealed that in a bleomycin-induced pulmonary fibrosis model, SAC reduces the mRNA expression of fibrosis markers such as &#x003b1;-smooth muscle actin (&#x003b1;-SMA), fibronectin, collagen-I, and &#x02013;III. Additionally, it also downregulates the mRNA expression of markers associated with inflammatory responses such as TNF-&#x003b1;, iNOS, IL-6, and IL-12p35. Furthermore, SAC also suppresses the Akt/NF-&#x0043a;B pathway in the <italic>in vivo</italic> model [<xref rid="bb1390" ref-type="bibr">278</xref>]. The bioactive component S-allyl-mercapto cysteine (SAMC) found in garlic also exerts potent anti-inflammatory, anti-fibrotic, anti-oxidative, as well as anti-metastatic effects [<xref rid="bb1845" ref-type="bibr">[369]</xref>, <xref rid="bb1850" ref-type="bibr">[370]</xref>]. A study demonstrated that SAMC attenuates inflammation by inducing inhibitory effects on pro-inflammatory cytokines such as TNF-&#x003b1;, IL-1&#x003b2;, IL-6 and suppressing the NF-&#x0043a;B pathway in LPS-induced ALI in mice model [<xref rid="bb1395" ref-type="bibr">279</xref>].</p></sec><sec id="s0160"><label>7.16</label><title>Ginger (<italic>Zingiber officinale</italic>)</title><p id="p0485">Ginger is a widely consumed spice which belongs to the Zingiberaceae family. It is also known for its medicinal properties such as anti-tumor, anti-inflammatory, antioxidant, <italic>etc.</italic> [<xref rid="bb0070" ref-type="bibr">14</xref>,<xref rid="bb1400" ref-type="bibr">280</xref>,<xref rid="bb1855" ref-type="bibr">371</xref>]. Some of the active components of ginger are 6-shogaol, 6-gingerol, 6-paradol, 6-gingerdiol, <italic>etc.</italic> [<xref rid="bb0070" ref-type="bibr">14</xref>].</p><p id="p0490">An <italic>in vivo</italic> study revealed that 6-shogaol exerts anti-inflammatory effects in 7,12-dimethylbenz[<italic>a</italic>]anthracene induced oral cancer mice model by modulating the NF-&#x003ba;B pathway. It downregulates the lvels of cytokines such as IL-1, IL-6, and TNF-&#x003b1; [<xref rid="bb1400" ref-type="bibr">280</xref>]. A study demonstrated that 6-gingerol shows protective effects against steatohepatitis in both <italic>in vivo</italic> and <italic>in vitro.</italic> In the HepG2 cells, gingerol reduces the enhanced levels of a pro-inflammatory cytokine such as MCP-1, TNF-&#x003b1;, and IL-6. A similar effect of 6-gingerol was observed in the methionine and choline-deficient (MCD) diet-fed animal model. Besides, the upregulated NF-&#x0043a;B level was also attenuated by 6-gingerol [<xref rid="bb1405" ref-type="bibr">281</xref>].</p></sec><sec id="s0165"><label>7.17</label><title>Ginseng (<italic>Panax</italic> sp.)</title><p id="p0495">Ginseng belongs to the Araliaceae family and is commonly used in herbal therapies. Both its extract and isolated active compounds are reported to show extensive biological properties [<xref rid="bb1860" ref-type="bibr">[372]</xref>, <xref rid="bb1865" ref-type="bibr">[373]</xref>]. For instance, an active compound, Isofraxidin (IFD), isolated from Siberian ginseng, exerted significant anti-inflammatory effects on a mouse model of ALI. The property of the compound was attributed to its ability to reduce the serum levels of various inflammatory cytokines such as TNF-&#x003b1;, IL-1&#x003b2;, IL-6, and MIP-2. Besides, IFD modulated various inflammatory factors linked to the PI3k/Akt and MAPK signaling pathways [<xref rid="bb1410" ref-type="bibr">282</xref>]. Black ginseng (BG) also displayed efficient activity against lung injury through modulation of AKT and reactive oxygen species (ROS)-induced p38-MAPK signaling [<xref rid="bb1415" ref-type="bibr">283</xref>]. Additionally, saponins isolated from <italic>Panax ginseng</italic> (PNS) displayed a wide range of efficacy against various diseases. PNS imparted protective roles against human immunodeficiency virus (HIV)-associated neurocognitive disorders (HAND) and DSS-induced colitis <italic>via</italic> regulating the levels of caspase-3, 8, 9, and PI3K/AKT signaling pathway respectively [<xref rid="bb1420" ref-type="bibr">[284]</xref>, <xref rid="bb1425" ref-type="bibr">[285]</xref>]. Further, Notoginsenoside R1 (NR), isolated from <italic>Panax notoginseng</italic>, imparted protective effects against the rat model of renal ischemia-reperfusion (I/R) injury <italic>via</italic> downregulation of certain oxidative and inflammatory factors such as TNF-&#x003b1;, TGF-&#x000df;1, IFN-&#x003b3;, and IL-6 [<xref rid="bb1430" ref-type="bibr">286</xref>]. Ginsenoside Rg3 (GRg3) induces anti-inflammatory effects and ameliorates RA <italic>in vivo via</italic> the CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup>Treg cells [<xref rid="bb1435" ref-type="bibr">287</xref>]. <italic>In vitro</italic> and <italic>in vivo</italic> studies evaluating the efficacy of ginsenosides Rg1 and Rg3 reported the anti-inflammatory efficacy of the compounds against chronic obstructive pulmonary disease (COPD). Rg1 significantly suppresses the TGF-&#x003b2;1/Smad3 signaling pathway and Rg3 mitigated neutrophilic inflammation, migration, and the levels of PI3K thus exerting protective effects [<xref rid="bb1440" ref-type="bibr">288</xref>]. Ginsenoside Rd was found to prevent neuroinflammation in the case of ischemic stroke <italic>via</italic> significantly inhibiting the NF-&#x003ba;B/MMP-9 signaling pathway [<xref rid="bb1445" ref-type="bibr">289</xref>].</p></sec><sec id="s0170"><label>7.18</label><title>Long pepper (<italic>Piper longum</italic> L.)</title><p id="p0500">The powdered dry fruits of <italic>P. longum</italic> (family Piperaceae), are used as a hot spice and seasoning. The whole plant of this spice is known to yield many biologically important chemicals, for example, alkaloids like piperine and piperlongumine (PL), piperinic acid, <italic>etc.</italic> It is used to treat numerous inflammation-mediated diseases like cancer, allergy, lupus nephritis, arthritis, asthma, inflammatory bowel disease, <italic>etc.</italic> [<xref rid="bb1450" ref-type="bibr">[290]</xref>, <xref rid="bb1455" ref-type="bibr">[291]</xref>, <xref rid="bb1460" ref-type="bibr">[292]</xref>, <xref rid="bb1465" ref-type="bibr">[293]</xref>]. This is mediated by suppressing the activity of proinflammatory cytokines such as TNF-&#x003b1; and IL-6 and inducing the anti-inflammatory cytokines like IL-10, as depicted in several pre-clinical studies [<xref rid="bb1470" ref-type="bibr">[294]</xref>, <xref rid="bb1475" ref-type="bibr">[295]</xref>, <xref rid="bb1480" ref-type="bibr">[296]</xref>]. The compound PL is known to relieve the inflammation-associated neurotoxicity upon the activation of stress-inducing molecules like NO, PGE2, <italic>etc.</italic> in the cultured LPS-stimulated BV2 cells [<xref rid="bb1475" ref-type="bibr">295</xref>,<xref rid="bb1485" ref-type="bibr">297</xref>]. The pathogenesis in the vasculature is a crucial step that leads to cardiovascular diseases, atherosclerosis, <italic>etc.</italic> which is mostly due to the modulation of NF-&#x003ba;B signaling molecules, cox-2, <italic>etc.</italic> PL is shown to reduce the expression of these inflammation mediators in VSMC (vascular smooth muscle cells) and HUVEC (human umbilical vein endothelial cells) as demonstrated <italic>in vitro</italic> [<xref rid="bb1490" ref-type="bibr">[298]</xref>, <xref rid="bb1495" ref-type="bibr">[299]</xref>]. In the disease-induced mice models of sepsis and asthma, PL and other long pepper extracts prevent the cell-adhesion and migration of leukocytes to sites of inflammation by reducing the expression of cell adhesion molecules like ICAM-1, VCAM-1, <italic>etc.</italic> [<xref rid="bb1465" ref-type="bibr">[293]</xref>, <xref rid="bb1470" ref-type="bibr">[294]</xref>,<xref rid="bb1490" ref-type="bibr">298</xref>]. The systemic downregulation of elevated expression levels of MAPK proteins like p38, ERK1/2, JNK by PL is also involved in showing anti-inflammation activity.[<xref rid="bb1470" ref-type="bibr">294</xref>,<xref rid="bb1495" ref-type="bibr">299</xref>,<xref rid="bb1500" ref-type="bibr">300</xref>]. In the ovalbumin-induced asthmatic lung tissue of mice and bronchial epithelial cell line Beas-2B, PL alleviates the overactivation of Th2 cytokines IL-4, IL -5, and IL -13 as well as the IgE levels. Besides, PL prevented the airway remodeling in the mice models caused due to extracellular matrix degradation, by reducing expression levels of MMP-9, collagen deposition, elastase, <italic>etc.</italic> [<xref rid="bb1490" ref-type="bibr">298</xref>], [<xref rid="bb1505" ref-type="bibr">301</xref>] In the collagen-induced arthritis mice model, PL is shown to suppress the expression of TNF-&#x003b1;, IL-1&#x003b2;, IL-23, and IL-17 [<xref rid="bb1460" ref-type="bibr">292</xref>].</p></sec><sec id="s0175"><label>7.19</label><title>Mint (<italic>Mentha</italic> sp.)</title><p id="p0505">Mint<italic>.</italic> belongs to the genus <italic>Mentha</italic> of the Lamiaceae family. <italic>M. spicata</italic>, <italic>M. pulegium</italic>, and <italic>M. rotundifolia</italic> are some of the species belonging to the mint family. They are commonly consumed as herbal tea and spice. It is rich in antimicrobial, anti-inflammatory, neuroprotective, cardiovascular, and antitumor properties [<xref rid="bb1870" ref-type="bibr">[374]</xref>, <xref rid="bb1875" ref-type="bibr">[375]</xref>].</p><p id="p0510">A study reported that <italic>Mentha spicata</italic> exerts ameliorative effects against acute and chronic inflammation <italic>in vivo</italic> [<xref rid="bb1880" ref-type="bibr">376</xref>]. <italic>M. arvensis</italic> reduced the levels of MDA and NO in LPS-induced RAW 246.7 cells. It also attenuated the elevated levels of NO which was induced due to immobilization stress in the rat model. Further, it also inhibited the MAPK signaling and inflammatory mediator cox-2. These results suggest that <italic>M. arvensis</italic> might attenuate stress and associated inflammation [<xref rid="bb1510" ref-type="bibr">302</xref>]. The ethyl acetate extract of <italic>M. arvensis</italic> reduced the levels of the cytokines TNF&#x003b1;, and IL-1&#x003b1;. It also modulated the LPS-activation of MAPK. Rosmarinic acid and L-menthone are some of the constituents of <italic>M. arvensis</italic>. It also decreased the LPS- or H<sub>2</sub>O<sub>2</sub>-induced ROS levels <italic>in vitro</italic> [<xref rid="bb1515" ref-type="bibr">303</xref>].</p></sec><sec id="s0180"><label>7.20</label><title>Mustard (<italic>Sinapis alba</italic>)</title><p id="p0515">White mustard belongs to the family of Brassicaceae [<xref rid="bb1885" ref-type="bibr">377</xref>]. They are widely consumed as a condiment. The dried mature seed of white mustard is also known as <italic>sinapsis</italic> semen [<xref rid="bb1520" ref-type="bibr">304</xref>]. The extract of <italic>S. alba</italic> efficiently inhibits the mRNA as well as protein expression of inflammatory cytokines such as TNF-&#x003b1;, IL-6, and IL-1&#x003b2; <italic>in vivo</italic>. Further, it also suppresses the activity of MPO, which is a marker for inflammation [<xref rid="bb1520" ref-type="bibr">304</xref>]. Mustard seeds also ameliorate inflammation in psoriasis models. They repress the expression of NLRP3 inflammasome. This further leads to the inhibition of IL-1&#x003b2; and IL-18 induced inflammation [<xref rid="bb1525" ref-type="bibr">305</xref>]. Furthermore, it induces an increased CD4<sup>+</sup> T cell count as well as a decrease in the plasmacytoid dendritic cells (pDC) and macrophages. Low levels of pDC results in a decrease in the secretion of IFN-&#x003b1;. The expression of the NF-&#x003ba;B p65 subunit, as well as the IL-17 and IL-22, were significantly inhibited which indicated that mustard seeds further abrogates inflammation. Moreover, the expression of the antioxidant enzymes such as GSH, glutathione peroxidase (GPx), and SOD are also enhanced by mustard seeds. This results in inhibition of oxidative stress which is further evidenced by a decrease in the lipid peroxidation marker MDA as well as the reactive nitrogen species (RNS) generating iNOS [<xref rid="bb1530" ref-type="bibr">306</xref>].</p></sec><sec id="s0185"><label>7.21</label><title>Nutmeg (<italic>Myristica fragrans</italic>)</title><p id="p0520">Nutmeg belonging to the Myristicaceae family is a widely consumed spice [<xref rid="bb1890" ref-type="bibr">[378]</xref>, <xref rid="bb1895" ref-type="bibr">[379]</xref>]. Many studies have been conducted to evaluate the potential of its extract and isolated phytochemicals in the treatment and prevention of different diseases. Nutmeg extracts displayed potential anti-inflammatory and antioxidant activity and thus imparted protection against cortical and liver injury <italic>in vivo</italic> [<xref rid="bb1535" ref-type="bibr">307</xref>,<xref rid="bb1900" ref-type="bibr">380</xref>]. Macelignan, an active compound of <italic>M. fragrans</italic>, was reported to exhibit anti-inflammatory effects <italic>in vivo</italic> in an asthmatic model <italic>via</italic> significantly reducing the expressions of IL-4 and Th2 cell-specific master transcription factor, GATA3 [<xref rid="bb1540" ref-type="bibr">308</xref>]. The compound was further reported to exert significant anti-allergic and anti-inflammatory effects <italic>via</italic> modulation of p-AKT, p38-MAPK, and JNK. It also inhibited the expressions of other inflammatory mediators such as cox-2, 5-LOX, IL-4, IL-13, and TNF-&#x003b1; [<xref rid="bb1545" ref-type="bibr">309</xref>]. Moreover, macelignan induces protective effects against renal I/R injury by imparting anti-oxidant activity as well as regulating the inflammatory and apoptotic mediators such as IL-6, TNF-&#x003b1;, IFN-&#x003b3; and B-cell lymphoma 2 (Bcl-2), Bcl-2-associated X protein (Bax), caspase-3, respectively [<xref rid="bb1550" ref-type="bibr">310</xref>]. Myrislignan, a lignan found in <italic>M. fragrans</italic>, also ameliorates inflammation by inhibiting the activation of the NF-&#x003ba;B pathway as well as the expression of inflammatory mediators such as IL-6, TNF-&#x003b1;, and cox-2 [<xref rid="bb1555" ref-type="bibr">311</xref>]. Myristicin is an aromatic compound isolated from nutmeg. It exerts inhibitory effects on the production of cytokines (such as IL-6, IL-10), chemokines (such as MCP-1, MCP-3, MIP-1&#x003b1;, MIP-1&#x003b2;) granulocyte-macrophage colony-stimulating factor (GMCSF), and leukemia inhibitory factor (LIF) [<xref rid="bb1560" ref-type="bibr">312</xref>].</p></sec><sec id="s0190"><label>7.22</label><title>Onion (<italic>Allium cepa</italic>)</title><p id="p0525">Onion belongs to the Liliaceae family. It is consumed widely for its flavor and nutritional value.</p><p id="p0530">Moreover, it is also used in traditional medicine for its variety of therapeutic properties such as anti-cancer, cardioprotective, anti-microbial, anti-fungal, anti-viral, <italic>etc.</italic> [<xref rid="bb1905" ref-type="bibr">381</xref>]. The extract of onion bulb exerted protective effects in the DSS-induced colitis rat model by downregulating MAPK/Akt/mTOR signaling as well as the cox-2 levels<italic>.</italic> Moreover, pro-inflammatory cytokines and chemokines were also downregulated [<xref rid="bb1565" ref-type="bibr">313</xref>]. The extract of red onion scales decreases the levels of IL-6, IL-10, and TNF-&#x003b1; in atypical prostatic hyperplasia <italic>in vivo</italic> model [<xref rid="bb1570" ref-type="bibr">314</xref>]. Quercetin is a flavonoid found in onion [<xref rid="bb1575" ref-type="bibr">315</xref>]. A recent study demonstrated that it exerted protective effects against high fructose-induced atherosclerosis in mice. The protective effect was attributed to the suppression of ROS, by modulating the expression of SOD, HO-1, Nrf-2, H<sub>2</sub>O<sub>2</sub>, O<sub>2</sub>, and MDA. Quercetin also suppressed inflammation and apoptosis by regulating the NF-&#x003ba;B and PI3K/AKT pathway, respectively. In LPS-induced VMSCs, it down-regulated the cytokines such as IL-1 &#x003b2;, IL-18, TNF-&#x003b1;, and IL-6. Additionally, it also improved LPS-induced atherosclerosis by inhibiting PI3K/AKT-regulated NF-&#x003ba;B [<xref rid="bb1575" ref-type="bibr">315</xref>].</p><p id="p0535">Quercetin-3-O-glucoside and eicosapentaenoic acid ester of quercetin-3-O-glucoside (QE) reduced the levels of TNF-&#x003b1;, IL-6, cox-2, PGE2 <italic>in vitro</italic>. The treatment of QE in hyperlipidemic control rats also decreased the expression of LPS-induced IL-6 [<xref rid="bb1580" ref-type="bibr">316</xref>].</p></sec><sec id="s0195"><label>7.23</label><title>Rosemary (<italic>Rosmarinus officinalis</italic> L<italic>.</italic>)</title><p id="p0540">Rosemary belongs to the Lamiaceae family. It possesses several therapeutic properties such as hepatoprotective, antifungal, antioxidant, antibacterial, <italic>etc.</italic> [<xref rid="bb1910" ref-type="bibr">382</xref>].</p><p id="p0545">Rosmarinic acid is one of the major components of rosemary. It is a phenolic compound that possesses anti-inflammatory, hepatoprotective, anti-hyperlipidemic property, <italic>etc.</italic> [<xref rid="bb1915" ref-type="bibr">[383]</xref>, <xref rid="bb1920" ref-type="bibr">[384]</xref>]. A study has shown that rosmarinic acid downregulates the enhanced levels of key inflammatory as well as immunological mediators such as IL-4, IgE, IFN-&#x003b3;, and PLA2 induced by ovalbumin in asthmatic rats [<xref rid="bb1585" ref-type="bibr">317</xref>]. Another study revealed that it also modulates the MAPK and NF-&#x003ba;B signaling pathways in ovalbumin-induced asthma in mice model [<xref rid="bb1590" ref-type="bibr">318</xref>]</p></sec><sec id="s0200"><label>7.24</label><title>Saffron (<italic>Crocus sativus</italic>)</title><p id="p0550">Saffron belongs to the Iridaceae family. It is known to exert therapeutic effects such as anti-convulsant, anti-depressant, anti-inflammatory, antitumor, <italic>etc.</italic> [<xref rid="bb1925" ref-type="bibr">385</xref>]. Crocin ameliorates LPS-induced sepsis as well as cardiotoxicity in H9c2 cells. It significantly downregulating the inflammatory mediators TNF-&#x003b1;, PGE2, IL-1&#x003b2;, and IL-6. It also decreases the mRNA expression of cox-2, iNOS, as well as NO [<xref rid="bb1595" ref-type="bibr">319</xref>]. Crocin exerts an osteoprotective effect by inhibiting inflammation in a metabolic syndrome (MeS)-induced osteoporosis model. It exhibits anti-inflammatory activity by reducing the levels of the pro-inflammatory cytokines IL-6 and TNF-&#x003b1;. Furthermore, it suppresses and elevates the levels of markers for bone resorption and bone formation respectively in (MeS)-induced osteoporosis model [<xref rid="bb1600" ref-type="bibr">320</xref>]. Safranal is another major component of saffron. A study shows that safranal inhibits MAPK and NF-&#x003ba;B pathways which lead to a reduction in the expression of pro-inflammatory cytokines such as IL-6 and TNF-&#x003b1;. It also inhibits the expression of iNOS and cox-2 <italic>in vitro</italic>. Furthermore, safranal exhibited similar anti-inflammatory responses in DSS-induced colitis mice [<xref rid="bb1605" ref-type="bibr">321</xref>]. Safranal also partially restored the levels of inflammatory mediators such as IL-1&#x003b2;, IL-6, TNF-&#x003b1;, and NF-&#x003ba;B to normal levels, in the hippocampus of the amyloid &#x003b2;-induced AD model. It also attenuated cognitive deficits and exhibited anti-oxidant effects in the AD model [<xref rid="bb1610" ref-type="bibr">322</xref>]. In addition to the anti-inflammatory effect, safranal also exhibits potent anti-oxidant and gastro-protective effects [<xref rid="bb1615" ref-type="bibr">323</xref>].</p></sec><sec id="s0205"><label>7.25</label><title>Sesame (<italic>Sesamum indicum</italic>)</title><p id="p0555">Sesame belongs to the Pedaliaceae family and is rich in medicinal properties such as anti-cancer, hepatoprotective, anti-hypertensive, <italic>etc.</italic> [<xref rid="bb1930" ref-type="bibr">386</xref>].</p><p id="p0560">Sesamol is an active compound of sesame. A study reported that it decreased the eosinophil infiltration in lungs, Th2 cytokines, and MDA levels in asthmatic BALB/c mice, and BEAS-2B cells. Further, it reduced the levels of eotaxin, ROS, and ICAM-1 (suppressing adherence of monocytic cell), which might attenuate inflammations in the lungs [<xref rid="bb1620" ref-type="bibr">324</xref>].</p><p id="p0565">Sesamin is a lignan isolated from <italic>S. indicum</italic> [<xref rid="bb1935" ref-type="bibr">387</xref>] The administration of sesamin attenuated LPS-induced acute lung injury by reducing the expression of NF-&#x003ba;B, TNF-&#x003b1;, IL-6, and IL-1&#x003b2;. It also inhibited the TLR4 pathway [<xref rid="bb1625" ref-type="bibr">325</xref>]. It also ameliorated renal oxidative stress and inflammation by upregulating antioxidant enzymes such as SOD, GSH, catalase, and downregulating inflammatory mediators such as TNF-&#x003b1;, IL-6, cox-2, respectively.326 Similarly, sesame oil exerted a protective effect against the asthmatic mice model by resulted in reducing the levels of IL-1 &#x003b2;, IL-6, IgE, and iNOS [<xref rid="bb1635" ref-type="bibr">327</xref>].</p></sec><sec id="s0210"><label>7.26</label><title>Star anise (<italic>Illicium verum</italic>)</title><p id="p0570">The spice star anise belongs to the Illiciaceae family [<xref rid="bb1940" ref-type="bibr">388</xref>]. It possesses a variety of pharmacological properties such as anti-bacterial, anti-nociceptive, anthelmintic, antiviral, gastroprotective, <italic>etc.</italic> [<xref rid="bb1945" ref-type="bibr">[389]</xref>, <xref rid="bb1950" ref-type="bibr">[390]</xref>].</p><p id="p0575">The extract of star anise exerted inhibitory effects on key inflammatory biomarkers such as TNF-&#x003b1;, IL-1&#x003b2;, NF-&#x003ba;B, and cox in an apolipoprotein E-knockout (ApoE<sup>&#x02212;/&#x02212;</sup>) mice. Similar findings were observed when TNF-&#x003b1;-stimulated-HASMC cells on the administration of star anise extract [<xref rid="bb1645" ref-type="bibr">329</xref>]. Another study revealed that star anise extract exhibited potent anti-inflammatory effects by substantially reducing the expression of IFN-&#x003b3; receptor &#x003b1; (IFN-&#x003b3;R&#x003b1;) as well as a suppressor of cytokine signaling 1 (SOCS1) protein in IFN-&#x003b3;-induced human keratinocytes. Moreover, it also inhibits JAK/STAT signaling and leads to a decreased production of ICAM-1 [<xref rid="bb1650" ref-type="bibr">330</xref>].</p><p id="p0580">Anethole is one of the compounds responsible for the aroma and flavor of star anise. It exerts a potent anti-inflammatory effect by inhibiting the activation of NF-&#x003ba;B. It also substantially reduces the levels of pro-inflammatory mediators such as TNF-&#x003b1;, and IL-6 [<xref rid="bb1655" ref-type="bibr">331</xref>]. <italic>Trans</italic>-anethole is another major constituent found in star anise. It attenuates the elevated level of cytokines such as IL-4, IL-5, and IL-13, in the asthmatic <italic>in vivo</italic> model. The mRNA expression of forkhead box P3 (Foxp3), a transcription factor involved in the development and function of regulatory T cells, is also downregulated by trans-anethole. Besides, it also modulated the production of IL-4 and IFN-&#x003b3; <italic>in vitro</italic> [<xref rid="bb1660" ref-type="bibr">332</xref>].</p></sec><sec id="s0215"><label>7.27</label><title>Tamarind (<italic>Tamarindus indica</italic> L.)</title><p id="p0585">Tamarind (family Fabaceae) is one of the highly diverse and ethnopharmacologically valuable plant species known to man. A recent study showed that tamarind seed coat extract (TSCE) possesses an anti-oxidant property that prevents oxidative stress-induced-erythrocyte loss. It is also known to prevent anemia, reduces lipid peroxidation, and regulates glutathione levels [<xref rid="bb1955" ref-type="bibr">391</xref>]. Besides, TSCE attenuates the pulmonary inflammation which is attributed to the reduced levels of inflammation-inducing NF-&#x003ba;B and cox-2 levels as well as oxidative stress-inducers such as nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase 4 (NOX4) and p38&#x003b1; MAPK. It also attenuated pulmonary fibrosis <italic>in vivo</italic> [<xref rid="bb1665" ref-type="bibr">333</xref>]. The seed extract also exerted anti-arthritic effects <italic>in vivo</italic> by modulating the levels of anti-inflammatory mediators such as IL-10, TNF-&#x003b1;, IL-1&#x003b2;, IL-6, cox-2, and IL-23 [<xref rid="bb1670" ref-type="bibr">334</xref>]. Its fruit extract also possesses anti-inflammatory properties [<xref rid="bb1960" ref-type="bibr">392</xref>]. The mucoadhesive tamarind xyloglucan (TXG) was shown to exert anti-inflammatory effects against ulcerative colitis <italic>in vivo</italic>. TXG inhibits the levels of pro-inflammatory cytokines IL-1&#x003b2; and IL-6 and further attenuates inflammation by inhibiting the TLR4/NF-&#x003ba;B signaling pathway [<xref rid="bb1675" ref-type="bibr">335</xref>].</p></sec><sec id="s0220"><label>7.28</label><title>Turmeric (<italic>Curcuma longa</italic>)</title><p id="p0590">Turmeric from the Zingiberaceae family has been used since ancient times in various traditional medicines. It is profoundly rich in activities such as anti-inflammatory, anti-cancer, anti-atherosclerotic, anti-depressant, anti-diabetic, anti-arthritic, <italic>etc.</italic> Its potent biological properties can be mostly attributed to one of its active components namely &#x0201c;Curcumin&#x0201d; [<xref rid="bb1965" ref-type="bibr">[393]</xref>, <xref rid="bb1970" ref-type="bibr">[394]</xref>, <xref rid="bb1975" ref-type="bibr">[395]</xref>, <xref rid="bb1980" ref-type="bibr">[396]</xref>, <xref rid="bb1985" ref-type="bibr">[397]</xref>]. Curcumin is enriched in several pharmacological activities such as anti-viral, anti-fungal, anti-cancer, <italic>etc.</italic>, and is therefore rightfully proclaimed to be the &#x0201c;Golden nutraceutical&#x0201d; [<xref rid="bb0070" ref-type="bibr">14</xref>,<xref rid="bb1970" ref-type="bibr">394</xref>,<xref rid="bb1990" ref-type="bibr">398</xref>]. Moreover, it is highly efficacious against cancer (breast, cervical, colorectal, ovarian, pancreatic, prostate, <italic>etc.</italic>) RA, inflammatory bowel disease, psoriasis, neurological diseases, <italic>etc.</italic> [<xref rid="bb1965" ref-type="bibr">393</xref>,<xref rid="bb1995" ref-type="bibr">[399]</xref>, <xref rid="bb2000" ref-type="bibr">[400]</xref>, <xref rid="bb2005" ref-type="bibr">[401]</xref>, <xref rid="bb2010" ref-type="bibr">[402]</xref>, <xref rid="bb2015" ref-type="bibr">[403]</xref>].</p><p id="p0595">Congregated evidence from various preclinical and clinical studies has shown the efficacy of curcumin in the prevention and treatment of diverse health ailments [<xref rid="bb2020" ref-type="bibr">[404]</xref>, <xref rid="bb2025" ref-type="bibr">[405]</xref>, <xref rid="bb2030" ref-type="bibr">[406]</xref>, <xref rid="bb2035" ref-type="bibr">[407]</xref>, <xref rid="bb2040" ref-type="bibr">[408]</xref>, <xref rid="bb2045" ref-type="bibr">[409]</xref>, <xref rid="bb2050" ref-type="bibr">[410]</xref>, <xref rid="bb2055" ref-type="bibr">[411]</xref>]. Studies have shown that curcumin helps in regulating the cytokine storm both <italic>in vitro</italic> and <italic>in vivo</italic> in case of influenza virus A (IAV) infection thereby relieving chronic influenza pneumonia and lung injuries associated with these conditions. It attenuated the elevated levels of IL-6, MCP-1, TNF-&#x003b1; as well as inhibited NF-&#x003ba;B, besides inhibiting the replication of IAV. Curcumin also elevated HO-1 which amelioration lung injuries [<xref rid="bb1680" ref-type="bibr">336</xref>]. An <italic>in vivo</italic> study on experimentally induced pulmonary inflammation in a rat model has evidenced that curcumin significantly upturned the expressions of various inflammatory and fibrotic mediators involved such as Cystic fibrosis transmembrane conductance regulator (CFTR) and cox-2/PGE2/IL-8 [<xref rid="bb1685" ref-type="bibr">337</xref>]. Moreover, the anti-inflammatory and anti-oxidative potential of curcumin helped in relieving lung injury in diabetic rats through the inhibition of NF-&#x003ba;B, NO, PGE2, iNOS and cox-2 [<xref rid="bb1690" ref-type="bibr">338</xref>]. An <italic>in vivo</italic> study also evidenced the efficacy of curcumin against cecal ligature puncture (CLP)-induced lung injury through the suppression of the inflammatory mediators such as TNF-&#x003b1;, IL-8, and MIF [<xref rid="bb1695" ref-type="bibr">339</xref>]. The protective effects of curcumin against asthma were also reported where the compound significantly modulated the Notch1-GATA3 signaling pathway thus inhibiting the inflammation of the airways [<xref rid="bb1700" ref-type="bibr">340</xref>]. Curcumin imparted neuroprotective effects against cerebral I/R injury as well <italic>via</italic> downregulation of IL-1&#x003b2; and IL-8 besides triggering the JAK2/STAT3 signaling [<xref rid="bb1705" ref-type="bibr">341</xref>]. Apart from curcumin, modified polysaccharides and components of essential oils obtained from <italic>C. longa</italic> were also reported to have diverse biological activities. An important component of the essential oil is aromatic-turmerone (ATM) which is reported to have strong anti-inflammatory and antioxidant properties and thus proved to be useful in the treatment of psoriasis. It significantly inhibited the expressions of NF-&#x003ba;B, cox-2, p-p38 MAPK, TNF-&#x003b1;, and IL-6. ATM further suppressed the mRNA synthesis of IL-17, IL-22, and IL-23 [<xref rid="bb1710" ref-type="bibr">342</xref>]. Furthermore, the anti-inflammatory activity of a modified pectin polysaccharide from turmeric (MTrPP) contributed to its anti-ulcer activity and thus it aided in the treatment of LPS-induced ulcer in a rat model. MTrPP worked through inhibiting the release of inflammatory markers such as TNF-&#x003b1;, IL-8, NF-&#x003ba;B, MMP-9, and cox-1, -2. It also prevented the phosphorylation of p38 thus imparting protective effects [<xref rid="bb1715" ref-type="bibr">343</xref>].</p></sec></sec><sec id="s0225"><label>8</label><title>Anti-inflammatory spices in clinical trials</title><p id="p0600">Apart from the aforementioned preclinical studies, the anti-inflammatory activity of many of these spices has been evaluated in clinical trials and these were found to be very efficacious against many diseases. The administration of spices to the patients under study, regulate cytokine storm and several other inflammatory mediators. This leads to an improvement of symptoms as well as treatment of various diseases. Some clinical studies are summarized below and are mentioned in <xref rid="t0015" ref-type="table">Table 3</xref>
.<table-wrap position="float" id="t0015"><label>Table 3</label><caption><p>Anti-inflammatory activity of spices against different diseases in clinical trials.</p></caption><alt-text id="al0035">Table 3</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Spice</th><th>Active compound</th><th>Health issues</th><th>Phase</th><th>Pts no.</th><th>Dosage ranges (mg)/day</th><th>Clinical outcome (mechanism)</th><th>References</th></tr></thead><tbody><tr><td rowspan="3">Cardamom</td><td>&#x02013;</td><td>Pre-diabetic subjects</td><td>&#x02013;</td><td align="char">80</td><td>3000</td><td>Significant anti-inflammatory and anti-oxidant effects (&#x02193; hs-CRP, &#x02193; hs-CRP:IL-6 ratio)</td><td>[<xref rid="bb2060" ref-type="bibr">412</xref>]</td></tr><tr><td>&#x02013;</td><td>T2D</td><td>&#x02013;</td><td align="char">83</td><td>3000</td><td>Improvement in clinical symptoms (&#x02193; TG, &#x02191; Sirt1)</td><td>[<xref rid="bb2065" ref-type="bibr">413</xref>]</td></tr><tr><td>&#x02013;</td><td>NAFLD</td><td>&#x02013;</td><td align="char">87</td><td>3000</td><td>Improvement in clinical symptoms, safe to use (&#x02191; Sirt1, &#x02191; irisin)</td><td>[<xref rid="bb2070" ref-type="bibr">414</xref>]</td></tr><tr><td>Cinnamon</td><td>&#x003b2;-caryo phyllene</td><td><italic>H. pylori</italic> infection</td><td>&#x02013;</td><td align="char">66</td><td>126</td><td>Improvement in clinical symptoms (&#x02193; IL-1&#x003b2;)</td><td>[<xref rid="bb2075" ref-type="bibr">415</xref>]</td></tr><tr><td>Coriander</td><td><bold>&#x02013;</bold></td><td>Erythema</td><td>&#x02013;</td><td align="char">40</td><td>0.5%<xref rid="tf0005" ref-type="table-fn">a</xref></td><td>Moderate anti-inflammatory effect</td><td>[<xref rid="bb2080" ref-type="bibr">416</xref>]</td></tr><tr><td rowspan="2">Garlic</td><td>&#x02013;</td><td>Obesity</td><td>&#x02013;</td><td align="char">51</td><td>3600<xref rid="tf0010" ref-type="table-fn">b</xref></td><td>Significant anti-inflammatory effect (&#x02193; TNF-&#x003b1;, &#x02193; IL-6, &#x02193; LDL)</td><td>[<xref rid="bb2085" ref-type="bibr">417</xref>]</td></tr><tr><td>&#x02013;</td><td>OA</td><td>&#x02013;</td><td align="char">80</td><td>1000</td><td>Relieved pain (&#x02193; Resistin)</td><td>[<xref rid="bb2090" ref-type="bibr">418</xref>]</td></tr><tr><td rowspan="4">Ginger</td><td>&#x02013;</td><td>RA</td><td>&#x02013;</td><td align="char">70</td><td>1500</td><td>Improvement in clinical symptoms (&#x02193; gene expression of NF&#x003ba;B, ROR&#x003b3;t and T-bet)</td><td>[<xref rid="bb2095" ref-type="bibr">419</xref>]</td></tr><tr><td>&#x02013;</td><td>OA</td><td>&#x02013;</td><td align="char">120</td><td>1000</td><td>Significant anti-inflammatory effect (&#x02193; IL-1&#x003b2;, &#x02193;TNF-&#x003b1;)</td><td>[<xref rid="bb2100" ref-type="bibr">420</xref>]</td></tr><tr><td>&#x02013;</td><td>TB</td><td>&#x02013;</td><td align="char">69</td><td>3000</td><td>Significant anti-inflammatory and anti-oxidant effect (&#x02193; TNF-&#x003b1;)</td><td>[<xref rid="bb2105" ref-type="bibr">421</xref>]</td></tr><tr><td>&#x02013;</td><td>CRC</td><td>&#x02013;</td><td align="char">20</td><td>2000</td><td>Well tolerated and safe (&#x02191; LTB4)</td><td>[<xref rid="bb2110" ref-type="bibr">422</xref>]</td></tr><tr><td rowspan="2">Ginseng</td><td><bold>&#x02013;</bold></td><td>CHD</td><td>&#x02013;</td><td align="char">24</td><td>1.35/kg<xref rid="tf0015" ref-type="table-fn">c</xref></td><td>Inhibition of gastrointestinal injury and inflammatory response (&#x02193; IL-6, &#x02193; LPS, &#x02193; MDA)</td><td>[<xref rid="bb2115" ref-type="bibr">423</xref>]</td></tr><tr><td><bold>&#x02013;</bold></td><td>RA</td><td>&#x02013;</td><td align="char">84</td><td>&#x02013;<xref rid="tf0020" ref-type="table-fn">d</xref></td><td>Improved anti-inflammatory immunity, and analgesic effect (&#x02193; CRP)</td><td>[<xref rid="bb2120" ref-type="bibr">424</xref>]</td></tr><tr><td rowspan="2">Saffron</td><td>&#x02013;</td><td>Asthma</td><td>&#x02013;</td><td align="char">80</td><td>100</td><td>Improvement in clinical symptoms, safe to use (&#x02193;TG, &#x02193; LDL cholesterol, &#x02193; basophil, &#x02193; eosinophil)</td><td>[<xref rid="bb2125" ref-type="bibr">425</xref>]</td></tr><tr><td>Crocin</td><td>MS</td><td>&#x02013;</td><td align="char">40</td><td>30</td><td>Significant anti-inflammatory and anti-oxidant effects (&#x02193; TNF-&#x003b1;, &#x02193; IL-17)</td><td>[<xref rid="bb2130" ref-type="bibr">426</xref>]</td></tr><tr><td>Sesame seed</td><td>&#x02013;</td><td>OA</td><td>&#x02013;</td><td align="char">50</td><td>40,000</td><td>Significant anti-inflammatory effects, safe to use (&#x02193; IL-6)</td><td>[<xref rid="bb2135" ref-type="bibr">427</xref>]</td></tr><tr><td rowspan="12">Turmeric</td><td>CU</td><td>MetS</td><td>&#x02013;</td><td align="char">117</td><td>1000<xref rid="tf0025" ref-type="table-fn">e</xref></td><td>Significant anti-inflammatory and anti-oxidant effect, Safe to use (&#x02193; hs-CRP)</td><td>[<xref rid="bb2140" ref-type="bibr">428</xref>]</td></tr><tr><td>CU</td><td>Obesity/hypertension</td><td>&#x02013;</td><td align="char">90</td><td>900<xref rid="tf0040" ref-type="table-fn">h</xref></td><td>Significant anti-inflammatory effect, improvement in general health, safe to use (&#x02193; CRP, &#x02193; TNF-&#x003b1;, &#x02193; IL-6, &#x02193; sVCAM-1)</td><td>[<xref rid="bb2145" ref-type="bibr">429</xref>]</td></tr><tr><td>Curcumin</td><td>T2D</td><td>&#x02013;</td><td align="char">118</td><td>1000<xref rid="tf0025" ref-type="table-fn">e</xref></td><td>Significant anti-inflammatory effects (&#x02193; TNF-&#x003b1;)</td><td>[<xref rid="bb2150" ref-type="bibr">430</xref>]</td></tr><tr><td>Curcumin</td><td>T2D</td><td>&#x02013;</td><td align="char">44</td><td>1500</td><td>Significant anti-inflammatory effect, reduced complications (&#x02193; hs-CRP, &#x02193; TG)</td><td>[<xref rid="bb2155" ref-type="bibr">431</xref>]</td></tr><tr><td><bold>&#x02013;</bold></td><td>KOA</td><td>&#x02013;</td><td align="char">160</td><td>500</td><td>Significant anti-inflammatory and anti-oxidant effects, improvement in clinical symptoms (&#x02193; IL-1&#x003b2;)</td><td>[<xref rid="bb2160" ref-type="bibr">432</xref>]</td></tr><tr><td><bold>&#x02013;</bold></td><td>OA</td><td>&#x02013;</td><td align="char">42</td><td>1300&#x02013;1950<xref rid="tf0030" ref-type="table-fn">f</xref></td><td>Significant anti-inflammatory effects, relieved pain, well tolerated</td><td>[<xref rid="bb2165" ref-type="bibr">433</xref>]</td></tr><tr><td>Curcumin</td><td>RA</td><td>&#x02013;</td><td align="char">36</td><td>500&#x02013;1000</td><td>Significant anti-inflammatory and analgesic effects, relieved pain, safe to use, well tolerated (&#x02193; CRP)</td><td>[<xref rid="bb2170" ref-type="bibr">434</xref>]</td></tr><tr><td>&#x02013;</td><td>CKD</td><td>&#x02013;</td><td align="char">16</td><td>&#x02013;<xref rid="tf0035" ref-type="table-fn">g</xref></td><td>Significant anti-inflammatory effects, safe to use, well tolerated (&#x02193; IL-6)</td><td>[<xref rid="bb2175" ref-type="bibr">435</xref>]</td></tr><tr><td>Curcumin</td><td>Hemodyliasis</td><td>&#x02013;</td><td align="char">71</td><td>1500</td><td>Significant anti-inflammatory effects, (&#x02193; hs-CRP, &#x02193; IL-6, &#x02193; TNF-&#x003b1;)</td><td>[<xref rid="bb2180" ref-type="bibr">436</xref>]</td></tr><tr><td>CU</td><td>SM-induced CPC</td><td>&#x02013;</td><td align="char">89</td><td>1500<xref rid="tf0050" ref-type="table-fn">j</xref></td><td>Significant anti-inflammatory and pulmonoprotective effects, safe to use, well-tolerated (&#x02193; IL-6, &#x02193; IL-8, &#x02193; TNF-&#x003b1;, &#x02193; TGF-&#x003b2;, &#x02193; hs-CRP,&#x02193; CGRP, &#x02193; MCP-1)</td><td>[<xref rid="bb2185" ref-type="bibr">437</xref>]</td></tr><tr><td>Curcumin</td><td>COPD</td><td>&#x02013;</td><td align="char">39</td><td>180<xref rid="tf0055" ref-type="table-fn">k</xref></td><td>Significant anti-inflammatory effects, safe to use <bold>(</bold>&#x02193; AT-LDL)</td><td>[<xref rid="bb2190" ref-type="bibr">438</xref>]</td></tr><tr><td>Curcumin</td><td>Migraine</td><td>&#x02013;</td><td align="char">74</td><td>80<xref rid="tf0045" ref-type="table-fn">i</xref></td><td>Significant neuromodulatory effects, relieved headache, safe to use (&#x02193;COX-2/iNOS)</td><td>[<xref rid="bb2195" ref-type="bibr">439</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: AGE: Aged Garlic Extract, AT-LDL: &#x003b1;1-antitrypsin-low-density lipoprotein, CGRP: Calcitonin gene related peptide; CHD: Congenital Heart Disease, CKD: Chronic kidney disease, COPD: Chronic obstructive pulmonary disease, cox-2: Cyclooxygenase-2, CP/CPPS: chronic prostatitis/chronic pelvic pain syndrome type III, CPM: Chronic Pulmonary Complications, CRC: Colorectal cancer, CU: Curcuminoids, CVD: Cardiovascular disease, H. pylori: Helicobacter pylori, hs-CRP: High-sensitivity C-reactive protein, IL: Interleukin, iNOS&#x0202f;=&#x0202f;Inducible nitric oxide synthase, KOA: Osteoarthritis of knee, LPS: Lipopolysaccharide, MCP-1: Monocyte chemotactic protein-1, Pts: Patients, SM&#x0202f;=&#x0202f;Sulfur Mustard; TB: Tuberculosis, TG: Triglycerides, TGF&#x003b2;: Transforming growth factor-&#x003b2;, TNF: Tumor necrosis factor, LDL: Low density lipoprotein, LTB4: Leukotriene B4, MS: Multiple sclerosis, NAFLD: Non-alcoholic fatty liver disease, OA: Osteoarthritis, RA: Rheumatoid Arthritis, Sirt1: Sirtuin-1, sVCAM-1&#x0202f;=&#x0202f;soluble vascular cell adhesion molecule-1 T2D: Type 2 diabetes, WEC: Water extract of <italic>C. longa</italic> L.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tf0005"><label>a</label><p id="np0005">Coriander oil.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tf0010"><label>b</label><p id="np0010">Aged garlic extract.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tf0015"><label>c</label><p id="np0015">Shen-fu injection (the major component&#x0202f;=&#x0202f;extract of <italic>Panax ginseng</italic>).</p></fn></table-wrap-foot><table-wrap-foot><fn id="tf0020"><label>d</label><p id="np0020"><italic>Panax notoginseng</italic> Saponins.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tf0025"><label>e</label><p id="np0025">Combination with piperine (10&#x0202f;mg/day).</p></fn></table-wrap-foot><table-wrap-foot><fn id="tf0030"><label>f</label><p id="np0030">Combination of <italic>H procumbens, C longa</italic>, and bromelain (AINAT).</p></fn></table-wrap-foot><table-wrap-foot><fn id="tf0035"><label>g</label><p id="np0035">Herbal supplement composed of purified turmeric extract (824&#x0202f;mg), curcuminoids (95%), and <italic>Boswellia serrata</italic> extract (516&#x0202f;mg), 3-acetyl-11-keto-&#x003b2;-boswellic acid (10%).</p></fn></table-wrap-foot><table-wrap-foot><fn id="tf0040"><label>h</label><p id="np0040">Combination of bisacurone (400&#x0202f;&#x003bc;g), turmeronol A (80&#x0202f;&#x003bc;g) and turmeronol B (20&#x0202f;&#x003bc;g).</p></fn></table-wrap-foot><table-wrap-foot><fn id="tf0045"><label>i</label><p id="np0045">Combination with &#x003c9;-3 fatty acids (5000&#x0202f;mg/day).</p></fn></table-wrap-foot><table-wrap-foot><fn id="tf0050"><label>j</label><p id="np0050">Curcumin C3 Complex&#x000ae; capsules containing 500&#x0202f;mg curcuminoids plus 5&#x0202f;mg bioperine&#x000ae;.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tf0055"><label>k</label><p id="np0055">Theracurmin&#x000ae; capsules.</p></fn></table-wrap-foot></table-wrap></p><sec id="s0230"><label>8.1</label><title>Cardamom</title><p id="p0605">Clinical studies on cardamom have shown that this spice is effective against metabolic disorders such as diabetes and non-alcoholic fatty liver disease (NAFLD). Randomized double-blind clinical trials evaluating the effects of cardamom on both pre-diabetic and diabetic subjects have reported significant clinical improvements. A dosage of 3&#x0202f;g cardamom supplement daily for 8&#x0202f;weeks regulated the levels of high-sensitivity C-reactive protein (hs-CRP): IL-6 ratio in pre-diabetic, obese subjects thus showing significant anti-inflammatory and anti-oxidant effects. Likewise, in the case of type 2 diabetes (T2D) patients, administration of the same dose of cardamom for 10&#x0202f;weeks regulated the serum levels of triglycerides, insulin, SIRT1 besides improving the glycemic indices [<xref rid="bb2060" ref-type="bibr">[412]</xref>, <xref rid="bb2065" ref-type="bibr">[413]</xref>]. Moreover, the efficacy of this spice was also evaluated against NAFLD where it was found that treatment with 3&#x0202f;g of supplement for 3&#x0202f;months significantly improved the grade of fatty liver in overweight or obese individuals. It further improved the clinical symptoms of the disease by modulating the levels of glucose indices, lipids, and other biomarkers of the disease. Moreover, the administration of cardamom supplement did not show any side effects and thus it was found safe to use [<xref rid="bb2070" ref-type="bibr">414</xref>].</p></sec><sec id="s0235"><label>8.2</label><title>Cinnamon</title><p id="p0610">&#x003b2;-caryophyllene, one of the active compounds of cinnamon, was found to be effective against gastrointestinal disease caused due to <italic>Helicobacter pylori</italic> (<italic>H. pylori</italic>) infections. A randomized double-blind placebo-controlled study has reported that administration of 126&#x0202f;mg &#x003b2;-caryophyllene daily for 8&#x0202f;weeks showed significant anti-inflammatory properties <italic>via</italic> downregulating the level of IL-1&#x003b2;. It further improved conditions of nausea, epigastric pain, and dyspepsia associated with the disease thereby proving that it can stand as a potential therapy against gastrointestinal ailments [<xref rid="bb2075" ref-type="bibr">415</xref>].</p></sec><sec id="s0240"><label>8.3</label><title>Coriander</title><p id="p0615">A study evaluating the potency of essential oil from coriander has evidenced that topical administration of a lipolotion (containing 0.5% coriander oil) during UV exposure reduced the risk of UV induced erythema to some extent. The treatment was found to show minimal anti-inflammatory activity and well-tolerated when applied on the skin of healthy volunteers [<xref rid="bb2080" ref-type="bibr">416</xref>].</p></sec><sec id="s0245"><label>8.4</label><title>Garlic</title><p id="p0620">Clinical trials investigating the potency of garlic extracts and its supplements against different diseases have reported that the spice showed significant anti-inflammatory and other beneficial properties. Supplementation of 3.6&#x0202f;g aged garlic extracts (AGE) daily was found to diminish the serum levels of TNF-&#x003b1; and IL-6 in obese adults, thus lessening the risk of occurrence of multiple inflammatory chronic diseases associated with obesity [<xref rid="bb2085" ref-type="bibr">417</xref>]. Garlic extract supplementation also relieved pain and other clinical symptoms associated with knee osteoarthritis. Administration of 1&#x0202f;g of the supplement for 12&#x0202f;weeks significantly reduced the level of resistin, an inflammatory cytokine, thus displaying anti-inflammatory effects [<xref rid="bb2090" ref-type="bibr">418</xref>].</p></sec><sec id="s0250"><label>8.5</label><title>Ginger</title><p id="p0625">Ginger powder supplementation was found to be effective against both RA and osteoarthritis as evidenced by several clinical studies. In the case of RA patients, on receiving 1.5&#x0202f;g ginger supplements daily for 12&#x0202f;weeks, an improvement in the clinical symptoms was observed. Ginger powder effectively regulated the levels of NF-&#x003ba;B, ROR&#x003b3;t, T-box transcription factor TBX21 (T-bet) genes thus leading to a decline in the severity of the disease. Similarly, the administration of ginger powder to osteoarthritis patients displayed potent anti-inflammatory effects <italic>via</italic> downregulating the inflammatory cytokines IL-1&#x003b2; and TNF-&#x003b1; [<xref rid="bb2095" ref-type="bibr">419</xref>], [<xref rid="bb2100" ref-type="bibr">420</xref>]. A clinical trial of ginger extract on tuberculosis patients has conveyed that administration of 3&#x0202f;g of the supplement daily for 3&#x0202f;months reduced the blood levels of inflammatory cytokine TNF-&#x003b1; and other markers of the disease such as ferritin and MDA, thus displaying anti-inflammatory and anti-oxidant properties [<xref rid="bb2105" ref-type="bibr">421</xref>].</p><p id="p0630">Furthermore, a pilot clinical study on the subjects at an increased risk of colorectal cancer (CRC) has shown that ginger extract was found to be well tolerated by the subjects and did not show any adverse side effects. It regulated the levels of arachidonic acid (AA) and leukotriene B4 (LTB4) but did not show any change in the levels of eicosanoid. Thus further studies are essential to investigate the exact mechanism behind the chemopreventive effects of this spice [<xref rid="bb2110" ref-type="bibr">422</xref>].</p></sec><sec id="s0255"><label>8.6</label><title>Ginseng</title><p id="p0635">Ginsenosides, the saponins extracted from ginseng, are found effective against many diseases. A clinical study investigating the potency of <italic>Panax notoginseng</italic> saponins (PNS) against RA, which displayed that the saponins, when administered for 28&#x0202f;days, led to significant improvement in clinical symptoms of the disease in terms of joint pain, swelling, tenderness, and stiffness. It also managed the dysregulated immune response and displayed significant anti-inflammatory and analgesic effects [<xref rid="bb2115" ref-type="bibr">423</xref>]. Further, the efficiency of ginsenosides therapy (in the form of shen-fu injection) was also evaluated against gastrointestinal mucosal injury which is associated with cardiopulmonary bypass in children suffering from congenital heart disease (CHD). It was found that administration of the intravenous injection before and during the bypass surgery resulted in a reduction of characteristic injury and inflammation post-surgery in patients [<xref rid="bb2120" ref-type="bibr">424</xref>].</p></sec><sec id="s0260"><label>8.7</label><title>Saffron</title><p id="p0640">The anti-inflammatory property of saffron is evaluated by many studies and thus it was thought to have protective effects against allergies such as asthma. Asthmatic patients, on receiving 100&#x0202f;mg/day saffron capsules for 8&#x0202f;weeks, showed improvement in clinical symptoms of the disease such as frequency of asthmatic attacks, usage of salbutamol inhaler, waking up at night due to asthmatic symptoms, and limitation in the activity. The severity of the disease declined, and the supplement was well tolerated by the patients without any adverse side-effects [<xref rid="bb2125" ref-type="bibr">425</xref>].</p><p id="p0645">Crocin, an active component of saffron, was found to be an effective therapy against multiple sclerosis due to its efficient anti-inflammatory and anti-oxidant properties. It was found that the administration of two capsules of crocin (15&#x0202f;mg) for 28&#x0202f;days showed an improvement in the antioxidant status of the body. Additionally, a reduction in inflammatory mediators such as TNF-&#x003b1; and IL-17 in the blood of the patients was also found [<xref rid="bb2130" ref-type="bibr">426</xref>].</p></sec><sec id="s0265"><label>8.8</label><title>Sesame seed</title><p id="p0650">Sesame seed therapy was found to improve the factors of inflammation and oxidation in patients suffering from osteoarthritis of the knee. Consumption of 40&#x0202f;g of sesame seed daily for 2&#x0202f;months resulted in a decrease in the level of IL-6 in the serum of patients, thus proving that it can serve as a potential supplementary therapy in patients with osteoarthritis [<xref rid="bb2135" ref-type="bibr">427</xref>].</p></sec><sec id="s0270"><label>8.9</label><title>Turmeric</title><p id="p0655">A handful of clinical studies have been performed to examine the potency of turmeric against various diseases. Curcumin and curcuminoids, the active components of turmeric, are found as effective therapies over the years. These are found to be very helpful in managing metabolic syndrome and disorders. For instance, a classic combination of curcuminoid-piperine in the ratio of 100:1 was administered daily for 8&#x0202f;weeks to patients with metabolic syndrome. It was found to regulate the levels of CRP, MDA, SOD in patients thus imparting significant anti-inflammatory and anti-oxidant effects [<xref rid="bb2140" ref-type="bibr">428</xref>]. In the case of patients with obesity/hypertension, the hot water extract of <italic>C. longa</italic> L. (WEC) was found to reduce the levels of CRP, TNF-&#x003b1;, IL-6, and soluble Vascular Cell Adhesion Molecule-1 (sVCAM-1), thereby amending chronic low-grade inflammation and overall health of patients [<xref rid="bb2145" ref-type="bibr">429</xref>]. Furthermore, in T2D patients, the uptake of curcuminoid-piperine has shown a decline in the level of TNF-&#x003b1; and an inclined level of adiponectin. Furthermore, another study evaluating the effects of curcumin against T2D showed that the compound modulated the levels of hs-CRP and TG thereby imparting significant anti-inflammatory activity [<xref rid="bb2150" ref-type="bibr">430</xref>], [<xref rid="bb2155" ref-type="bibr">431</xref>]. The compounds are further found effective against osteoarthritis and RA. In the case of osteoarthritis, <italic>Curcuma longa</italic> L. (CL) extract showed significant anti-inflammatory effects <italic>via</italic> the down-regulation of IL-1&#x003b2; and anti-oxidant effects <italic>via</italic> the down-regulation of MDA and ROS. Thus, the administration of the extract was found to improve clinical symptoms of the disease such as pain and inflammation [<xref rid="bb2160" ref-type="bibr">432</xref>]. Another clinical study showed that the administration of a combination of <italic>H. procumbens</italic>, <italic>C. longa</italic>, and bromelain in the form of AINAT capsules showed similar improvements in terms of pain in osteoarthritis patients. Further, the capsules were well tolerated and thus can be used as a safe and effective replacement for non-steroidal anti-inflammatory drugs (NSAIDs) [<xref rid="bb2165" ref-type="bibr">433</xref>]. Besides, the intake of 0.5&#x02013;1&#x0202f;g of curcumin formulation daily 90&#x0202f;days in two different treatment groups has shown significant anti-inflammatory and analgesic effects in patients suffering from RA. The treatment caused improvements in the levels of CRP and rheumatoid factor (RF) values without causing any adverse side effects [<xref rid="bb2170" ref-type="bibr">434</xref>].</p><p id="p0660">A clinical study evaluating the effects of a combination of turmeric extract and <italic>Boswellia serrata</italic> as a treatment of patients with chronic kidney disease (CKD) has reported that the supplement is well tolerated by the patients and is safe to use. The treatment efficiently enhanced the inflammatory status of the patients <italic>via</italic> the downregulation of the inflammatory cytokine, IL-6 [<xref rid="bb2175" ref-type="bibr">435</xref>]. Moreover, regular intake of curcumin was found to impart anti-inflammatory effects in patients undergoing hemodialysis. The supplement helped in reducing the levels of hs-CRP, IL-6, and TNF-&#x003b1; in plasma without causing any side-effects [<xref rid="bb2180" ref-type="bibr">436</xref>].</p><p id="p0665">Curcuminoids were also found to relieve chronic inflammation in patients suffering from chronic pulmonary complications (CPC) resulting from sulfur mustard (SM) intoxication. Treatment with curcuminoids supplement helped in modulating inflammatory responses <italic>via</italic> reducing the levels of IL-6, IL-8, TNF-&#x003b1;, TGF-&#x003b2;, hs-CRP, calcitonin gene-related peptide (CGRP), substance P, and MCP-1. The supplements were also well tolerated and did not cause any adverse side effects in the patients [<xref rid="bb2185" ref-type="bibr">437</xref>]. Also, in the case of chronic obstructive pulmonary disease (COPD), a curcumin supplement namely Theracurmin(&#x000ae;) was found to significantly amend the inflammatory status and levels of &#x003b1;1-antitrypsin-low-density lipoprotein (AT-LDL) in the blood of patients when taken for 24&#x0202f;weeks. This change might be useful in reducing the risk of any further cardiovascular events in COPD patients [<xref rid="bb2190" ref-type="bibr">438</xref>].</p><p id="p0670">Furthermore, a nano-curcumin formulation in combination with omega-3 fatty acids was found to show neuroprotective effects against migraines. The therapy significantly reduced the levels of cox-2/iNOS which is associated with neuroinflammation and pain of the CNS. Hence, a decline in the rate and duration of repeated painful attacks and the severity of the disease was observed, making this a safe and useful therapy for the treatment and prevention of migraine [<xref rid="bb2195" ref-type="bibr">439</xref>].</p></sec></sec><sec id="s0275"><label>9</label><title>Curcumin and COVID-19</title><p id="p0675">Curcumin is a multipotential compound from <italic>C. longa</italic> that possesses diverse medicinal properties. It is a potent anti-inflammatory agent that is effective against numerous chronic diseases [<xref rid="bb0070" ref-type="bibr">14</xref>,<xref rid="bb2200" ref-type="bibr">[440]</xref>, <xref rid="bb2205" ref-type="bibr">[441]</xref>, <xref rid="bb2210" ref-type="bibr">[442]</xref>, <xref rid="bb2215" ref-type="bibr">[443]</xref>].</p><p id="p0680">Elevated cytokine levels or cytokine storm is considered as one of the critical process responsible for multi-organ failure and death in COVID-19 infected patients [<xref rid="bb2220" ref-type="bibr">[444]</xref>, <xref rid="bb2225" ref-type="bibr">[445]</xref>, <xref rid="bb2230" ref-type="bibr">[446]</xref>]. TNF-&#x003b1; also plays a pivotal role in pulmonary edema caused during COVID-19-associated lung diseases. Natural compounds like curcumin downregulate the levels of TNF-&#x003b1; [<xref rid="bb2235" ref-type="bibr">447</xref>].</p><p id="p0685">Moreover, the coronavirus is also associated with the symptoms of pneumonia that causes severe respiratory distress. The treatment of the pneumonia model with curcumin was shown to decrease lung injury and inflammation through the modulation of HIF and NF-&#x003ba;B [<xref rid="bb2240" ref-type="bibr">448</xref>]. The treatment of curcumin in viral infected models has exhibited inhibition of cytokines, MMPs, and inflammatory cells. It also inhibited the fibrosis and expression of myofibroblasts in the lung tissues [<xref rid="bb2245" ref-type="bibr">449</xref>]. A study demonstrated the potency of a novel combination of vitamin C, curcumin and glycyrrhizic acid (VCG) against SARS-CoV-2 infection. System biology tools also found that VCG modulated various genes associated with immune and inflammatory responses <italic>via</italic> the regulation of crucial pathways such as NOD-like, Toll-like, PI3K/Akt, NF-&#x003ba;B and MAPK signaling pathways [<xref rid="bb2250" ref-type="bibr">450</xref>]. TMPRSS2 is a crucial protease involved in the priming of ACE2 receptor-bound viral S protein and thus acts a therapeutic target for COVID-19 therapy [<xref rid="bb2255" ref-type="bibr">451</xref>]. Bromolein, a cysteine protease traditionally used for the treatment of arthritis, possesses potent immunomodulatory properties. Besides, studies have demonstrated that bromolein inhibits the expression of ACE-2 and TMPRSS2 <italic>in vitro</italic>. It has been hypothesized that the combination of curcumin and bromolein might exert a beneficial synergistic effect against SARS-CoV-2 infection [<xref rid="bb2260" ref-type="bibr">452</xref>,<xref rid="bb2265" ref-type="bibr">453</xref>]. Another study reported the potential immunomodulatory and antiviral efficacy of the combination of black pepper and curcumin extract along with multiactive ingredients such as pentatricontane, sitosterol, termerone, lupeol, amyrines, and vitamin D3 (EGYVIR). The administration of EGYVIR in SARS-CoV-2 infected cells decreased the levels of inflammatory mediators such as TNF-&#x003b1; and IL-6 which might be effective in attenuating the virus-induced cytokine storm [<xref rid="bb2270" ref-type="bibr">454</xref>]. The combination of curcumin and zinc has also been hypothesized as an effective therapeutic strategy against COVID-19 [455,456].</p><p id="p0690">A randomized clinical trial has been initiated to investigate the potency of the co-administration of curcumin and piperine on COVID-19 patients [457]. Another randomized clinical trial has been initiated to determine the efficacy of that nano micelles containing curcumin on the levels of various serum cytokines such as IFN-&#x003b3;, IL-17, IL-4, and TGF-&#x003b2; in COVID-19 patients [458]. Nanonutraceuticals of vitamins, antioxidants, probiotics, <italic>etc.</italic> can modulate immune responses and therefore effectively strengthen the immune system of COVID-19 patients [459]. Nano-curcumin also significantly reduced the expression of serum IL-6 and IL-1&#x003b2; in COVID-19 patients [460]. Furthermore, nano-formulation of curcumin is also associated with faster recovery of COVID-19 patients [461]. It also exerted immunomodulatory effects and also decreased the levels of Th17 cell-related cytokines in the patients [462]. Therefore, it might be useful as a traditional medicine to treat COVID-19-associated complications such as cytokine storm, acute lung injury or acute respiratory distress syndrome, pneumonia [463-464].</p><p id="p0695">Apart from the anti-inflammatory effects, several studies have also reported that curcumin exhibits antiviral effects [465-467]. Curcumin was reported to inhibit the replication of the SARS-CoV <italic>in vitro</italic>. Therefore, the potency of curcumin as an antiviral agent might also be effective against the SARS-CoV-2 [465]. Numerous molecular docking studies have shown the efficacy of curcumin to target various key components of the novel SARS-CoV-2 <italic>in silico</italic>. A study reported that curcumin showed high-affinity binding towards the viral spike glycoprotein and ACE2 receptor [<xref rid="bb0925" ref-type="bibr">185</xref>]. Another study demonstrated its binding affinity towards the viral Nsp15 protein which is associated with replication. Therefore, curcumin might cause the inhibition of the viral replication by binding with Nsp15 [<xref rid="bb0910" ref-type="bibr">182</xref>]. Curcumin has also been reported as a potential inhibitor of Mpro protein of SARS-CoV-2 [468-472]. It inhibits the human cellular transmembrane serine proteinase [473]. Furthermore, curcumin and catechin also bind to the RBD of the viral S protein and inhibit the entry of SARS-CoV-2 in the host cell [474]. Multi-omics analyses have also demonstrated the potential of compounds such as curcumin, resveratrol, <italic>etc.</italic>, as effective agents to inhibit SARS-CoV-2 viral infection [475].</p><p id="p0700">Thus, several studies have hypothesized that the immunomodulatory and anti-viral activities of curcumin might be beneficial in the treatment of SARS-CoV-2 and COVID-19 associated diseases [<xref rid="bb0910" ref-type="bibr">182</xref>,<xref rid="bb2200" ref-type="bibr">440</xref>], [470,476-481]. Curcumin possesses a huge potential as a drug against SARS-CoV-2 as well as COVID-19-associated diseases. Therefore, it should be further evaluated in the pre-clinical and clinical studies to determine its efficacy [479].</p></sec><sec id="s0280"><label>10</label><title>Discussion and conclusion</title><p id="p0705">The COVID-19 pandemic has posed a great threat to healthcare across the globe. The causative pathogen is a novel coronavirus and there are currently no specific treatment strategies against it. Although several studies are going on to develop a specific drug targeted towards SARS-CoV-2, it might take some more time. Several vaccine development trials are also underway, but the end products will require some time to clear the safety studies. Moreover, a new variant of the SARS-CoV-2 had been reported for the first time on 14th December 2020 in the United Kingdom (UK). This variant of concern (VOC) had been labeled as the VOC 202012/01 and had been detected in over 50 countries in the UK. Other variants such as 501Y.V2 and B.1.1.28 were also reported from South Africa (18th December 2020) and Japan (9th January 2021), respectively. Therefore, considering the rapid evolution of this virus and urgency of the situation, one of the best options for management and treatment is repurposed drugs. These drugs are already approved for the treatment of some diseases in humans and are thus readily available in the market. In the paucity of SARS-CoV-2 specific drugs, these repurposed drugs with anti-viral or inhibitory effects are prescribed to hospitalized patients [<xref rid="bb0020" ref-type="bibr">4</xref>,<xref rid="bb0485" ref-type="bibr">97</xref>]. Cytokine storm or hyper inflammation is commonly observed in severe COVID-19 patients. It is associated with the progression of the disease and poor clinical outcome [482]. Respiratory failure, ARDS, and pneumonia are some of the most common and fatal COVID-19 associated complications. Therefore, some repurposed drugs are known to exhibit potent anti-inflammatory effects and are thus used to combat COVID-19-associated inflammatory complications [<xref rid="bb0380" ref-type="bibr">76</xref>,<xref rid="bb0485" ref-type="bibr">97</xref>].</p><p id="p0710">Some of these repurposed drugs show very promising results. However, most of them raise serious concerns as they are reported to have adverse side-effects [<xref rid="bb0485" ref-type="bibr">97</xref>]. Therefore, it is necessary to look for alternative medicines that may be effective against the novel virus and associated health complications which cause little or no side effects.</p><p id="p0715">Mother Nature has provided us with several natural compounds that have been used throughout the ages for the treatment of various diseases like cancer, asthma, diabetes, respiratory and cardiovascular disorder, <italic>etc.</italic> Spices are nature's most potent anti-inflammatory and antioxidant agents. Besides enhancing the taste, flavor, aroma, and color of food and beverages but also imparts protection against various health ailments. These therapeutic properties of spices and culinary herbs are due to the presence of various bioactive components with significant biological activities. Besides, the consumption of spices has been proven to reduce inflammation and boost our immune response [<xref rid="bb0070" ref-type="bibr">14</xref>]. Therefore, in the absence of a drug or vaccine against SARS-CoV-2, spices might serve as an alternative treatment for infected patients. It can serve a dual purpose of both as a means of primary prevention, as well as help mitigate the exaggerated immune response and cytokine storm. However, pre-clinical and clinical studies should be conducted to validate its efficacy in COVID-19 patients.</p></sec><sec id="s0285"><title>CRediT authorship contribution statement</title><p id="p0720">BBA and ABK contributed to the conceptualization of the study design. VR, DP, SG, HS, KB and KKT performed the bibliographic search and contributed to the writing of the manuscript. VR, DP, SG, and HS contributed to the tables. VR and DP contributed to the reference editing. KB contributed to the figures. BBA, ABK, UD, PG, and SCG contributed in the reviewing and proofreading of the manuscript.</p></sec><sec sec-type="COI-statement"><title>Declaration of competing interest</title><p id="p0725">The authors declare no conflict of interests related to this study.</p></sec></body><back><ref-list id="bi0005"><title>References</title><ref id="bb0005"><label>1</label><element-citation publication-type="journal" id="rf0005"><person-group person-group-type="author"><name><surname>Du Toit</surname><given-names>A.</given-names></name></person-group><article-title>Outbreak of a novel coronavirus</article-title><source>Nat. Rev. Microbiol.</source><volume>18</volume><year>2020</year><fpage>123</fpage><pub-id pub-id-type="pmid">31988490</pub-id></element-citation></ref><ref id="bb0010"><label>2</label><element-citation publication-type="journal" id="rf0010"><person-group person-group-type="author"><name><surname>Velavan</surname><given-names>T.P.</given-names></name><name><surname>Meyer</surname><given-names>C.G.</given-names></name></person-group><article-title>The COVID-19 epidemic</article-title><source>Tropical Med. Int. Health</source><volume>25</volume><year>2020</year><fpage>278</fpage><lpage>280</lpage></element-citation></ref><ref id="bb0015"><label>3</label><element-citation publication-type="journal" id="rf0015"><person-group person-group-type="author"><name><surname>Cucinotta</surname><given-names>D.</given-names></name><name><surname>Vanelli</surname><given-names>M.</given-names></name></person-group><article-title>WHO declares COVID-19 a pandemic</article-title><source>Acta Biomed</source><volume>91</volume><year>2020</year><fpage>157</fpage><lpage>160</lpage><pub-id pub-id-type="pmid">32191675</pub-id></element-citation></ref><ref id="bb0020"><label>4</label><element-citation publication-type="other" id="rf0020"><person-group person-group-type="author"><name><surname>WHO</surname></name></person-group><article-title>COVID-19 Weekly epidemiological update</article-title><ext-link ext-link-type="uri" xlink:href="https://www.who.int/publications/m/item/weekly-epidemiological-update---12-january-2021" id="ir0020">https://www.who.int/publications/m/item/weekly-epidemiological-update---12-january-2021</ext-link><comment>(2021, accessed 15 January 2021)</comment></element-citation></ref><ref id="bb0025"><label>5</label><element-citation publication-type="other" id="rf0025"><person-group person-group-type="author"><name><surname>European Centre for Disease and Prevention Control</surname></name></person-group><article-title>COVID-19 situation update worldwide, as of week 1 2021</article-title><ext-link ext-link-type="uri" xlink:href="https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases" id="ir0025">https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases</ext-link><comment>(2021, accessed 19 January 2021)</comment></element-citation></ref><ref id="bb0030"><label>6</label><element-citation publication-type="journal" id="rf0030"><person-group person-group-type="author"><name><surname>Rabi</surname><given-names>F.A.</given-names></name><name><surname>Al Zoubi</surname><given-names>M.S.</given-names></name><name><surname>Kasasbeh</surname><given-names>G.A.</given-names></name><name><surname>Salameh</surname><given-names>D.M.</given-names></name><name><surname>Al-Nasser</surname><given-names>A.D.</given-names></name></person-group><article-title>SARS-CoV-2 and coronavirus disease 2019: what we know so far</article-title><source>Pathogens</source><volume>9</volume><year>2020</year><fpage>231</fpage></element-citation></ref><ref id="bb0035"><label>7</label><element-citation publication-type="journal" id="rf0035"><person-group person-group-type="author"><name><surname>Singhal</surname><given-names>T.A.</given-names></name></person-group><article-title>Review of coronavirus disease-2019 (COVID-19)</article-title><source>Indian J. Pediatr.</source><volume>87</volume><year>2020</year><fpage>281</fpage><lpage>286</lpage><pub-id pub-id-type="pmid">32166607</pub-id></element-citation></ref><ref id="bb0040"><label>8</label><element-citation publication-type="journal" id="rf0040"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>P.</given-names></name><name><surname>Yang</surname><given-names>X.L.</given-names></name><name><surname>Wang</surname><given-names>X.G.</given-names></name><name><surname>Hu</surname><given-names>B.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Si</surname><given-names>H.R.</given-names></name><name><surname>Zhu</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>B.</given-names></name><name><surname>Huang</surname><given-names>C.L.</given-names></name><name><surname>Chen</surname><given-names>H.D.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Luo</surname><given-names>Y.</given-names></name><name><surname>Guo</surname><given-names>H.</given-names></name><name><surname>Jiang</surname><given-names>R.D.</given-names></name><name><surname>Liu</surname><given-names>M.Q.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Shen</surname><given-names>X.R.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Zheng</surname><given-names>X.S.</given-names></name><name><surname>Zhao</surname><given-names>K.</given-names></name><name><surname>Chen</surname><given-names>Q.J.</given-names></name><name><surname>Deng</surname><given-names>F.</given-names></name><name><surname>Liu</surname><given-names>L.L.</given-names></name><name><surname>Yan</surname><given-names>B.</given-names></name><name><surname>Zhan</surname><given-names>F.X.</given-names></name><name><surname>Wang</surname><given-names>Y.Y.</given-names></name><name><surname>Xiao</surname><given-names>G.F.</given-names></name><name><surname>Shi</surname><given-names>Z.L.</given-names></name></person-group><article-title>A pneumonia outbreak associated with a new coronavirus of probable bat origin</article-title><source>Nature</source><volume>579</volume><year>2020</year><fpage>270</fpage><lpage>273</lpage><pub-id pub-id-type="pmid">32015507</pub-id></element-citation></ref><ref id="bb0045"><label>9</label><element-citation publication-type="journal" id="rf0045"><person-group person-group-type="author"><name><surname>Guan</surname><given-names>W.J.</given-names></name><name><surname>Liang</surname><given-names>W.H.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Liang</surname><given-names>H.R.</given-names></name><name><surname>Chen</surname><given-names>Z.S.</given-names></name><name><surname>Li</surname><given-names>Y.M.</given-names></name><name><surname>Liu</surname><given-names>X.Q.</given-names></name><name><surname>Chen</surname><given-names>R.C.</given-names></name><name><surname>Tang</surname><given-names>C.L.</given-names></name><name><surname>Wang</surname><given-names>T.</given-names></name><name><surname>Ou</surname><given-names>C.Q.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>P.Y.</given-names></name><name><surname>Sang</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>J.F.</given-names></name><name><surname>Li</surname><given-names>C.C.</given-names></name><name><surname>Ou</surname><given-names>L.M.</given-names></name><name><surname>Cheng</surname><given-names>B.</given-names></name><name><surname>Xiong</surname><given-names>S.</given-names></name><name><surname>Ni</surname><given-names>Z.Y.</given-names></name><name><surname>Xiang</surname><given-names>J.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Shan</surname><given-names>H.</given-names></name><name><surname>Lei</surname><given-names>C.L.</given-names></name><name><surname>Peng</surname><given-names>Y.X.</given-names></name><name><surname>Wei</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Hu</surname><given-names>Y.H.</given-names></name><name><surname>Peng</surname><given-names>P.</given-names></name><name><surname>Wang</surname><given-names>J.M.</given-names></name><name><surname>Liu</surname><given-names>J.Y.</given-names></name><name><surname>Chen</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>G.</given-names></name><name><surname>Zheng</surname><given-names>Z.J.</given-names></name><name><surname>Qiu</surname><given-names>S.Q.</given-names></name><name><surname>Luo</surname><given-names>J.</given-names></name><name><surname>Ye</surname><given-names>C.J.</given-names></name><name><surname>Zhu</surname><given-names>S.Y.</given-names></name><name><surname>Cheng</surname><given-names>L.L.</given-names></name><name><surname>Ye</surname><given-names>F.</given-names></name><name><surname>Li</surname><given-names>S.Y.</given-names></name><name><surname>Zheng</surname><given-names>J.P.</given-names></name><name><surname>Zhang</surname><given-names>N.F.</given-names></name><name><surname>Zhong</surname><given-names>N.S.</given-names></name><name><surname>He</surname><given-names>J.X.</given-names></name><name><surname>China Medical Treatment Expert Group for COVID-19</surname></name></person-group><article-title>Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis</article-title><source>Eur. Respir. J.</source><volume>55</volume><year>2020</year><object-id pub-id-type="publisher-id">2000547</object-id></element-citation></ref><ref id="bb0050"><label>10</label><element-citation publication-type="journal" id="rf0050"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>B.</given-names></name><name><surname>Mao</surname><given-names>J.</given-names></name></person-group><article-title>The pathogenesis and treatment of the &#x02018;cytokine storm&#x02019; in COVID-19</article-title><source>J. Inf. Secur.</source><volume>80</volume><year>2020</year><fpage>607</fpage><lpage>613</lpage></element-citation></ref><ref id="bb0055"><label>11</label><element-citation publication-type="journal" id="rf0055"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>B.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Zhou</surname><given-names>Z.</given-names></name><name><surname>Guan</surname><given-names>X.</given-names></name><name><surname>Xiang</surname><given-names>Y.</given-names></name></person-group><article-title>Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?</article-title><source>J. Autoimmun.</source><volume>111</volume><year>2020</year><object-id pub-id-type="publisher-id">102452</object-id></element-citation></ref><ref id="bb0060"><label>12</label><element-citation publication-type="journal" id="rf0060"><person-group person-group-type="author"><name><surname>Anand</surname><given-names>P.</given-names></name><name><surname>Sundaram</surname><given-names>C.</given-names></name><name><surname>Jhurani</surname><given-names>S.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><article-title>Curcumin and cancer: an &#x0201c;old-age&#x0201d; disease with an &#x0201c;age-old&#x0201d; solution</article-title><source>Cancer Lett.</source><volume>267</volume><year>2008</year><fpage>133</fpage><lpage>164</lpage><pub-id pub-id-type="pmid">18462866</pub-id></element-citation></ref><ref id="bb0065"><label>13</label><element-citation publication-type="journal" id="rf0065"><person-group person-group-type="author"><name><surname>Khwairakpam</surname><given-names>A.D.</given-names></name><name><surname>Bordoloi</surname><given-names>D.</given-names></name><name><surname>Thakur</surname><given-names>K.K.</given-names></name><name><surname>Monisha</surname><given-names>J.</given-names></name><name><surname>Arfuso</surname><given-names>F.</given-names></name><name><surname>Sethi</surname><given-names>G.</given-names></name><name><surname>Mishra</surname><given-names>S.</given-names></name><name><surname>Kumar</surname><given-names>A.P.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name></person-group><article-title>Possible use of <italic>Punica granatum</italic> (pomegranate) in cancer therapy</article-title><source>Pharmacol. Res.</source><volume>133</volume><year>2018</year><fpage>53</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">29729421</pub-id></element-citation></ref><ref id="bb0070"><label>14</label><element-citation publication-type="journal" id="rf0070"><person-group person-group-type="author"><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name><surname>Sailo</surname><given-names>B.L.</given-names></name><name><surname>Banik</surname><given-names>K.</given-names></name><name><surname>Harsha</surname><given-names>C.</given-names></name><name><surname>Prasad</surname><given-names>S.</given-names></name><name><surname>Gupta</surname><given-names>S.C.</given-names></name><name><surname>Bharti</surname><given-names>A.C.</given-names></name><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><article-title>Chronic diseases, inflammation, and spices: how are they linked?</article-title><source>J. Transl. Med.</source><volume>16</volume><issue>14</issue><year>2018</year></element-citation></ref><ref id="bb0075"><label>15</label><element-citation publication-type="journal" id="rf0075"><person-group person-group-type="author"><name><surname>Elsayed</surname><given-names>Y.</given-names></name><name><surname>Khan</surname><given-names>N.A.</given-names></name></person-group><article-title>Immunity-boosting spices and the novel coronavirus</article-title><source>ACS Chem. Neurosci.</source><volume>11</volume><year>2020</year><fpage>1696</fpage><lpage>1698</lpage><pub-id pub-id-type="pmid">32452670</pub-id></element-citation></ref><ref id="bb0080"><label>16</label><element-citation publication-type="other" id="rf0080"><person-group person-group-type="author"><name><surname>COVID19 INDIA</surname></name></person-group><ext-link ext-link-type="uri" xlink:href="https://www.covid19india.org/" id="ir0030">https://www.covid19india.org/</ext-link><comment>(2021, accessed 20 January 2021)</comment></element-citation></ref><ref id="bb0085"><label>17</label><element-citation publication-type="journal" id="rf0085"><person-group person-group-type="author"><name><surname>S</surname><given-names>J.</given-names></name><name><surname>Sreedharan</surname><given-names>S.</given-names></name></person-group><article-title>Analysing the Covid-19 cases in Kerala: a visual exploratory data analysis approach</article-title><source>SN Compr. Clin. Med.</source><year>2020</year><fpage>1</fpage><lpage>12</lpage></element-citation></ref><ref id="bb0090"><label>18</label><element-citation publication-type="journal" id="rf0090"><person-group person-group-type="author"><name><surname>Lv</surname><given-names>J.</given-names></name><name><surname>Qi</surname><given-names>L.</given-names></name><name><surname>Yu</surname><given-names>C.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Guo</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Bian</surname><given-names>Z.</given-names></name><name><surname>Sun</surname><given-names>D.</given-names></name><name><surname>Du</surname><given-names>J.</given-names></name><name><surname>Ge</surname><given-names>P.</given-names></name><name><surname>Tang</surname><given-names>Z.</given-names></name><name><surname>Hou</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><collab>China Kadoorie Biobank Collaborative Group</collab></person-group><article-title>Consumption of spicy foods and total and cause specific mortality: population based cohort study</article-title><source>BMJ</source><volume>351</volume><year>2015</year><fpage>h3942</fpage><pub-id pub-id-type="pmid">26242395</pub-id></element-citation></ref><ref id="bb0095"><label>19</label><element-citation publication-type="journal" id="rf0095"><person-group person-group-type="author"><name><surname>Lau</surname><given-names>H.</given-names></name><name><surname>Khosrawipour</surname><given-names>V.</given-names></name><name><surname>Kocbach</surname><given-names>P.</given-names></name><name><surname>Mikolajczyk</surname><given-names>A.</given-names></name><name><surname>Schubert</surname><given-names>J.</given-names></name><name><surname>Bania</surname><given-names>J.</given-names></name><name><surname>Khosrawipour</surname><given-names>T.</given-names></name></person-group><article-title>The positive impact of lockdown in Wuhan on containing the COVID-19 outbreak in China</article-title><source>J. Travel. Med.</source><volume>27</volume><year>2020</year><object-id pub-id-type="publisher-id">taaa037</object-id></element-citation></ref><ref id="bb0100"><label>20</label><element-citation publication-type="journal" id="rf0100"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>J.T.</given-names></name><name><surname>Leung</surname><given-names>K.</given-names></name><name><surname>Leung</surname><given-names>G.M.</given-names></name></person-group><article-title>Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study</article-title><source>Lancet</source><volume>395</volume><year>2020</year><fpage>689</fpage><lpage>697</lpage><pub-id pub-id-type="pmid">32014114</pub-id></element-citation></ref><ref id="bb0105"><label>21</label><element-citation publication-type="journal" id="rf0105"><person-group person-group-type="author"><name><surname>Paital</surname><given-names>B.</given-names></name><name><surname>Das</surname><given-names>K.</given-names></name><name><surname>Parida</surname><given-names>S.K.</given-names></name></person-group><article-title>Inter nation social lockdown versus medical care against COVID-19, a mild environmental insight with special reference to India</article-title><source>Sci. Total Environ.</source><volume>728</volume><year>2020</year><object-id pub-id-type="publisher-id">138914</object-id></element-citation></ref><ref id="bb0110"><label>22</label><element-citation publication-type="journal" id="rf0110"><person-group person-group-type="author"><name><surname>The Lancet</surname></name></person-group><article-title>India under COVID-19 lockdown</article-title><source>Lancet</source><volume>395</volume><year>2020</year><fpage>1315</fpage><pub-id pub-id-type="pmid">32334687</pub-id></element-citation></ref><ref id="bb0115"><label>23</label><element-citation publication-type="journal" id="rf0115"><person-group person-group-type="author"><name><surname>Bowers</surname><given-names>K.W.</given-names></name></person-group><article-title>Balancing individual and communal needs: plague and public health in early modern Seville</article-title><source>Bull. Hist. Med.</source><volume>81</volume><year>2007</year><fpage>335</fpage><lpage>358</lpage><pub-id pub-id-type="pmid">17844719</pub-id></element-citation></ref><ref id="bb0120"><label>24</label><element-citation publication-type="journal" id="rf0120"><person-group person-group-type="author"><name><surname>Peak</surname><given-names>C.M.</given-names></name><name><surname>Wesolowski</surname><given-names>A.</given-names></name><name><surname>Zu Erbach-Schoenberg</surname><given-names>E.</given-names></name><name><surname>Tatem</surname><given-names>A.J.</given-names></name><name><surname>Wetter</surname><given-names>E.</given-names></name><name><surname>Lu</surname><given-names>X.</given-names></name><name><surname>Power</surname><given-names>D.</given-names></name><name><surname>Weidman-Grunewald</surname><given-names>E.</given-names></name><name><surname>Ramos</surname><given-names>S.</given-names></name><name><surname>Moritz</surname><given-names>S.</given-names></name><name><surname>Buckee</surname><given-names>C.O.</given-names></name><name><surname>Bengtsson</surname><given-names>L.</given-names></name></person-group><article-title>Population mobility reductions associated with travel restrictions during the Ebola epidemic in Sierra Leone: use of mobile phone data</article-title><source>Int. J. Epidemiol.</source><volume>47</volume><year>2018</year><fpage>1562</fpage><lpage>1570</lpage><pub-id pub-id-type="pmid">29947788</pub-id></element-citation></ref><ref id="bb0125"><label>25</label><element-citation publication-type="journal" id="rf0125"><person-group person-group-type="author"><name><surname>Camitz</surname><given-names>M.</given-names></name><name><surname>Liljeros</surname><given-names>F.</given-names></name></person-group><article-title>The effect of travel restrictions on the spread of a moderately contagious disease</article-title><source>BMC Med.</source><volume>4</volume><issue>32</issue><year>2006</year></element-citation></ref><ref id="bb0130"><label>26</label><element-citation publication-type="journal" id="rf0130"><person-group person-group-type="author"><name><surname>Ghosal</surname><given-names>S.</given-names></name><name><surname>Bhattacharyya</surname><given-names>R.</given-names></name><name><surname>Majumder</surname><given-names>M.</given-names></name></person-group><article-title>Impact of complete lockdown on total infection and death rates: a hierarchical cluster analysis</article-title><source>Diabetes Metab. Syndr.</source><volume>14</volume><year>2020</year><fpage>707</fpage><lpage>711</lpage><pub-id pub-id-type="pmid">32426062</pub-id></element-citation></ref><ref id="bb0135"><label>27</label><element-citation publication-type="journal" id="rf0135"><person-group person-group-type="author"><name><surname>Lindeman</surname><given-names>R.J.</given-names></name><name><surname>Sund</surname><given-names>M.</given-names></name><name><surname>L&#x000f6;fgren</surname><given-names>J.</given-names></name><name><surname>Basso</surname><given-names>T.</given-names></name><name><surname>S&#x000f8;reide</surname><given-names>K.</given-names></name></person-group><article-title>Preventing spread of SARS-CoV-2 and preparing for the COVID-19 outbreak in the surgical department: perspectives from two Scandinavian countries</article-title><source>J. Surg. Case Rep.</source><volume>2020</volume><year>2020</year><object-id pub-id-type="publisher-id">rjaa131</object-id></element-citation></ref><ref id="bb0140"><label>28</label><element-citation publication-type="journal" id="rf0140"><person-group person-group-type="author"><name><surname>Kicska</surname><given-names>G.</given-names></name><name><surname>Litmanovich</surname><given-names>D.E.</given-names></name><name><surname>Ordovas</surname><given-names>K.G.</given-names></name><name><surname>Young</surname><given-names>P.M.</given-names></name><name><surname>Dennie</surname><given-names>C.</given-names></name><name><surname>Truong</surname><given-names>Q.A.</given-names></name><name><surname>Abbara</surname><given-names>S.</given-names></name><name><surname>Kirsch</surname><given-names>J.</given-names></name></person-group><article-title>Statement from the North American Society for Cardiovascular Imaging on imaging strategies to reduce the scarcity of healthcare resources during the COVID-19 outbreak</article-title><source>Int. J. Cardiovasc. Imaging</source><volume>36</volume><year>2020</year><fpage>1387</fpage><lpage>1393</lpage><pub-id pub-id-type="pmid">32474676</pub-id></element-citation></ref><ref id="bb0145"><label>29</label><element-citation publication-type="journal" id="rf0145"><person-group person-group-type="author"><name><surname>M&#x000f6;hn</surname><given-names>N.</given-names></name><name><surname>Pul</surname><given-names>R.</given-names></name><name><surname>Kleinschnitz</surname><given-names>C.</given-names></name><name><surname>Pr&#x000fc;ss</surname><given-names>H.</given-names></name><name><surname>Witte</surname><given-names>T.</given-names></name><name><surname>Stangel</surname><given-names>M.</given-names></name><name><surname>Skripuletz</surname><given-names>T.</given-names></name></person-group><article-title>Implications of COVID-19 outbreak on immune therapies in multiple sclerosis patients-lessons learned from SARS and MERS</article-title><source>Front. Immunol.</source><volume>11</volume><year>2020</year><fpage>1059</fpage><pub-id pub-id-type="pmid">32477373</pub-id></element-citation></ref><ref id="bb0150"><label>30</label><element-citation publication-type="journal" id="rf0150"><person-group person-group-type="author"><name><surname>Vellingiri</surname><given-names>B.</given-names></name><name><surname>Jayaramayya</surname><given-names>K.</given-names></name><name><surname>Iyer</surname><given-names>M.</given-names></name><name><surname>Narayanasamy</surname><given-names>A.</given-names></name><name><surname>Govindasamy</surname><given-names>V.</given-names></name><name><surname>Giridharan</surname><given-names>B.</given-names></name><name><surname>Ganesan</surname><given-names>S.</given-names></name><name><surname>Venugopal</surname><given-names>A.</given-names></name><name><surname>Venkatesan</surname><given-names>D.</given-names></name><name><surname>Ganesan</surname><given-names>H.</given-names></name><name><surname>Rajagopalan</surname><given-names>K.</given-names></name><name><surname>Rahman</surname><given-names>P.K.S.M.</given-names></name><name><surname>Cho</surname><given-names>S.G.</given-names></name><name><surname>Kumar</surname><given-names>N.S.</given-names></name><name><surname>Subramaniam</surname><given-names>M.D.</given-names></name></person-group><article-title>COVID-19: a promising cure for the global panic</article-title><source>Sci. Total Environ.</source><volume>725</volume><year>2020</year><object-id pub-id-type="publisher-id">138277</object-id></element-citation></ref><ref id="bb0155"><label>31</label><element-citation publication-type="journal" id="rf0155"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>F.</given-names></name><name><surname>Yu</surname><given-names>T.</given-names></name><name><surname>Du</surname><given-names>R.</given-names></name><name><surname>Fan</surname><given-names>G.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Xiang</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Song</surname><given-names>B.</given-names></name><name><surname>Gu</surname><given-names>X.</given-names></name><name><surname>Guan</surname><given-names>L.</given-names></name><name><surname>Wei</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Tu</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Cao</surname><given-names>B.</given-names></name></person-group><article-title>Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study</article-title><source>Lancet</source><volume>395</volume><year>2020</year><fpage>1054</fpage><lpage>1062</lpage><pub-id pub-id-type="pmid">32171076</pub-id></element-citation></ref><ref id="bb0160"><label>32</label><element-citation publication-type="journal" id="rf0160"><person-group person-group-type="author"><name><surname>Pietrobelli</surname><given-names>A.</given-names></name><name><surname>Pecoraro</surname><given-names>L.</given-names></name><name><surname>Ferruzzi</surname><given-names>A.</given-names></name><name><surname>Heo</surname><given-names>M.</given-names></name><name><surname>Faith</surname><given-names>M.</given-names></name><name><surname>Zoller</surname><given-names>T.</given-names></name><name><surname>Antoniazzi</surname><given-names>F.</given-names></name><name><surname>Piacentini</surname><given-names>G.</given-names></name><name><surname>Fearnbach</surname><given-names>S.N.</given-names></name><name><surname>Heymsfield</surname><given-names>S.B.</given-names></name></person-group><article-title>Effects of COVID-19 lockdown on lifestyle behaviors in children with obesity living in Verona, Italy: a longitudinal study</article-title><source>Obesity (Silver Spring)</source><volume>28</volume><year>2020</year><fpage>1382</fpage><lpage>1385</lpage><pub-id pub-id-type="pmid">32352652</pub-id></element-citation></ref><ref id="bb0165"><label>33</label><element-citation publication-type="journal" id="rf0165"><person-group person-group-type="author"><name><surname>Reis</surname><given-names>R.F.</given-names></name><name><surname>de Melo Quintela</surname><given-names>B.</given-names></name><name><surname>de Oliveira Campos</surname><given-names>J.</given-names></name><name><surname>Gomes</surname><given-names>J.M.</given-names></name><name><surname>Rocha</surname><given-names>B.M.</given-names></name><name><surname>Lobosco</surname><given-names>M.</given-names></name><name><surname>Weber Dos Santos</surname><given-names>R.</given-names></name></person-group><article-title>Characterization of the COVID-19 pandemic and the impact of uncertainties, mitigation strategies, and underreporting of cases in South Korea, Italy, and Brazil</article-title><source>Chaos Solitons Fractals</source><volume>136</volume><year>2020</year><object-id pub-id-type="publisher-id">109888</object-id></element-citation></ref><ref id="bb0170"><label>34</label><element-citation publication-type="journal" id="rf0170"><person-group person-group-type="author"><name><surname>Webb</surname><given-names>L.</given-names></name></person-group><article-title>COVID-19 lockdown: a perfect storm for older people's mental health</article-title><source>J. Psychiatr. Ment. Health Nurs.</source><year>2020</year><pub-id pub-id-type="doi">10.1111/jpm.12644</pub-id></element-citation></ref><ref id="bb0175"><label>35</label><element-citation publication-type="journal" id="rf0175"><person-group person-group-type="author"><name><surname>Kahn</surname><given-names>J.S.</given-names></name><name><surname>McIntosh</surname><given-names>K.</given-names></name></person-group><article-title>History and recent advances in coronavirus discovery</article-title><source>Pediatr. Infect. Dis. J.</source><volume>24</volume><year>2005</year><fpage>223</fpage><lpage>227</lpage></element-citation></ref><ref id="bb0180"><label>36</label><element-citation publication-type="journal" id="rf0180"><person-group person-group-type="author"><name><surname>Kendall</surname><given-names>E.J.</given-names></name><name><surname>Bynoe</surname><given-names>M.L.</given-names></name><name><surname>Tyrrell</surname><given-names>D.A.</given-names></name></person-group><article-title>Virus isolations from common colds occurring in a residential school</article-title><source>Br. Med. J.</source><volume>2</volume><year>1962</year><fpage>82</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">14455113</pub-id></element-citation></ref><ref id="bb0185"><label>37</label><element-citation publication-type="journal" id="rf0185"><person-group person-group-type="author"><name><surname>Tyrrell</surname><given-names>D.A.</given-names></name><name><surname>Bynoe</surname><given-names>M.L.</given-names></name></person-group><article-title>Cultivation of a novel type of common-cold virus in organ cultures</article-title><source>Br. Med. J.</source><volume>1</volume><year>1965</year><fpage>1467</fpage><lpage>1470</lpage><pub-id pub-id-type="pmid">14288084</pub-id></element-citation></ref><ref id="bb0190"><label>38</label><element-citation publication-type="journal" id="rf0190"><person-group person-group-type="author"><name><surname>Tyrrell</surname><given-names>D.A.</given-names></name><name><surname>Bynoe</surname><given-names>M.L.</given-names></name></person-group><article-title>Cultivation of viruses from a high proportion of patients with colds</article-title><source>Lancet</source><volume>1</volume><year>1966</year><fpage>76</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">4158999</pub-id></element-citation></ref><ref id="bb0195"><label>39</label><element-citation publication-type="journal" id="rf0195"><person-group person-group-type="author"><name><surname>Hamre</surname><given-names>D.</given-names></name><name><surname>Procknow</surname><given-names>J.J.</given-names></name></person-group><article-title>A new virus isolated from the human respiratory tract</article-title><source>Proc. Soc. Exp. Biol. Med.</source><volume>121</volume><year>1966</year><fpage>190</fpage><lpage>193</lpage><pub-id pub-id-type="pmid">4285768</pub-id></element-citation></ref><ref id="bb0200"><label>40</label><element-citation publication-type="journal" id="rf0200"><person-group person-group-type="author"><name><surname>Almeida</surname><given-names>J.D.</given-names></name><name><surname>Tyrrell</surname><given-names>D.A.</given-names></name></person-group><article-title>The morphology of three previously uncharacterized human respiratory viruses that grow in organ culture</article-title><source>J. Gen. Virol.</source><volume>1</volume><year>1967</year><fpage>175</fpage><lpage>178</lpage><pub-id pub-id-type="pmid">4293939</pub-id></element-citation></ref><ref id="bb0205"><label>41</label><element-citation publication-type="journal" id="rf0205"><person-group person-group-type="author"><name><surname>Almeida</surname><given-names>J.D.</given-names></name><name><surname>Berry</surname><given-names>D.M.</given-names></name><name><surname>Cunningham</surname><given-names>C.H.</given-names></name><name><surname>Hamre</surname><given-names>D.</given-names></name><name><surname>Hofstad</surname><given-names>M.S.</given-names></name><name><surname>Mallucci</surname><given-names>L.</given-names></name><name><surname>McIntosh</surname><given-names>K.</given-names></name><name><surname>Tyrrell</surname><given-names>D.A.J.</given-names></name></person-group><article-title>Coronaviruses</article-title><source>Nature</source><volume>220</volume><year>1968</year><fpage>650</fpage></element-citation></ref><ref id="bb0210"><label>42</label><element-citation publication-type="journal" id="rf0210"><person-group person-group-type="author"><name><surname>Tyrrell</surname><given-names>D.A.</given-names></name><name><surname>Almeida</surname><given-names>J.D.</given-names></name><name><surname>Cunningham</surname><given-names>C.H.</given-names></name><name><surname>Dowdle</surname><given-names>W.R.</given-names></name><name><surname>Hofstad</surname><given-names>M.S.</given-names></name><name><surname>McIntosh</surname><given-names>K.</given-names></name><name><surname>Tajima</surname><given-names>M.</given-names></name><name><surname>Zakstelskaya</surname><given-names>L.Y.</given-names></name><name><surname>Easterday</surname><given-names>B.C.</given-names></name><name><surname>Kapikian</surname><given-names>A.</given-names></name><name><surname>Bingham</surname><given-names>R.W.</given-names></name></person-group><article-title>Coronaviridae</article-title><source>Intervirology</source><volume>5</volume><issue>76</issue><year>1975</year></element-citation></ref><ref id="bb0215"><label>43</label><element-citation publication-type="journal" id="rf0215"><person-group person-group-type="author"><name><surname>van der Hoek</surname><given-names>L.</given-names></name></person-group><article-title>Human coronaviruses: what do they cause?</article-title><source>Antivir. Ther.</source><volume>12</volume><year>2007</year><fpage>651</fpage><lpage>658</lpage><pub-id pub-id-type="pmid">17944272</pub-id></element-citation></ref><ref id="bb0220"><label>44</label><element-citation publication-type="journal" id="rf0220"><person-group person-group-type="author"><name><surname>Su</surname><given-names>S.</given-names></name><name><surname>Wong</surname><given-names>G.</given-names></name><name><surname>Shi</surname><given-names>W.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Lai</surname><given-names>A.C.K.</given-names></name><name><surname>Zhou</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Bi</surname><given-names>Y.</given-names></name><name><surname>Gao</surname><given-names>G.F.</given-names></name></person-group><article-title>Epidemiology, genetic recombination, and pathogenesis of coronaviruses</article-title><source>Trends Microbiol.</source><volume>24</volume><year>2016</year><fpage>490</fpage><lpage>502</lpage><pub-id pub-id-type="pmid">27012512</pub-id></element-citation></ref><ref id="bb0225"><label>45</label><element-citation publication-type="journal" id="rf0225"><person-group person-group-type="author"><name><surname>Ludwig</surname><given-names>S.</given-names></name><name><surname>Zarbock</surname><given-names>A.</given-names></name></person-group><article-title>Coronaviruses and SARS-CoV-2: a brief overview</article-title><source>Anesth. Analg.</source><volume>131</volume><year>2020</year><fpage>93</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">32243297</pub-id></element-citation></ref><ref id="bb0230"><label>46</label><element-citation publication-type="journal" id="rf0230"><person-group person-group-type="author"><name><surname>Corman</surname><given-names>V.M.</given-names></name><name><surname>Lienau</surname><given-names>J.</given-names></name><name><surname>Witzenrath</surname><given-names>M.</given-names></name></person-group><article-title>Coronaviren als Ursache respiratorischer Infektionen [Coronaviruses as the cause of respiratory infections]</article-title><source>Internist (Berl)</source><volume>60</volume><year>2019</year><fpage>1136</fpage><lpage>1145</lpage><comment>(German)</comment><pub-id pub-id-type="pmid">31455974</pub-id></element-citation></ref><ref id="bb0235"><label>47</label><element-citation publication-type="journal" id="rf0235"><person-group person-group-type="author"><name><surname>Drosten</surname><given-names>C.</given-names></name><name><surname>G&#x000fc;nther</surname><given-names>S.</given-names></name><name><surname>Preiser</surname><given-names>W.</given-names></name><name><surname>van der Werf</surname><given-names>S.</given-names></name><name><surname>Brodt</surname><given-names>H.R.</given-names></name><name><surname>Becker</surname><given-names>S.</given-names></name><name><surname>Rabenau</surname><given-names>H.</given-names></name><name><surname>Panning</surname><given-names>M.</given-names></name><name><surname>Kolesnikova</surname><given-names>L.</given-names></name><name><surname>Fouchier</surname><given-names>R.A.</given-names></name><name><surname>Berger</surname><given-names>A.</given-names></name><name><surname>Burgui&#x000e8;re</surname><given-names>A.M.</given-names></name><name><surname>Cinatl</surname><given-names>J.</given-names></name><name><surname>Eickmann</surname><given-names>M.</given-names></name><name><surname>Escriou</surname><given-names>N.</given-names></name><name><surname>Grywna</surname><given-names>K.</given-names></name><name><surname>Kramme</surname><given-names>S.</given-names></name><name><surname>Manuguerra</surname><given-names>J.C.</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>S.</given-names></name><name><surname>Rickerts</surname><given-names>V.</given-names></name><name><surname>St&#x000fc;rmer</surname><given-names>M.</given-names></name><name><surname>Vieth</surname><given-names>S.</given-names></name><name><surname>Klenk</surname><given-names>H.D.</given-names></name><name><surname>Osterhaus</surname><given-names>A.D.</given-names></name><name><surname>Schmitz</surname><given-names>H.</given-names></name><name><surname>Doerr</surname><given-names>H.W.</given-names></name></person-group><article-title>Identification of a novel coronavirus in patients with severe acute respiratory syndrome</article-title><source>N. Engl. J. Med.</source><volume>348</volume><year>2003</year><fpage>1967</fpage><lpage>1976</lpage><pub-id pub-id-type="pmid">12690091</pub-id></element-citation></ref><ref id="bb0240"><label>48</label><element-citation publication-type="journal" id="rf0240"><person-group person-group-type="author"><name><surname>Hui</surname><given-names>D.S.</given-names></name><name><surname>Wong</surname><given-names>P.C.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name></person-group><article-title>SARS: clinical features and diagnosis</article-title><source>Respirology</source><volume>8</volume><year>2003</year><fpage>20</fpage><lpage>24</lpage></element-citation></ref><ref id="bb0245"><label>49</label><element-citation publication-type="journal" id="rf0245"><person-group person-group-type="author"><name><surname>B&#x000e1;ez-Santos</surname><given-names>Y.M.</given-names></name><name><surname>St John</surname><given-names>S.E.</given-names></name><name><surname>Mesecar</surname><given-names>A.D.</given-names></name></person-group><article-title>The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds</article-title><source>Antivir. Res.</source><volume>115</volume><year>2015</year><fpage>21</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">25554382</pub-id></element-citation></ref><ref id="bb0250"><label>50</label><element-citation publication-type="journal" id="rf0250"><person-group person-group-type="author"><name><surname>Zaki</surname><given-names>A.M.</given-names></name><name><surname>van Boheemen</surname><given-names>S.</given-names></name><name><surname>Bestebroer</surname><given-names>T.M.</given-names></name><name><surname>Osterhaus</surname><given-names>A.D.</given-names></name><name><surname>Fouchier</surname><given-names>R.A.</given-names></name></person-group><article-title>Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia</article-title><source>N. Engl. J. Med.</source><volume>367</volume><year>2012</year><fpage>1814</fpage><lpage>1820</lpage><pub-id pub-id-type="pmid">23075143</pub-id></element-citation></ref><ref id="bb0255"><label>51</label><element-citation publication-type="journal" id="rf0255"><person-group person-group-type="author"><name><surname>Zumla</surname><given-names>A.</given-names></name><name><surname>Hui</surname><given-names>D.S.</given-names></name><name><surname>Perlman</surname><given-names>S.</given-names></name></person-group><article-title>Middle East respiratory syndrome</article-title><source>Lancet</source><volume>386</volume><year>2015</year><fpage>995</fpage><lpage>1007</lpage><pub-id pub-id-type="pmid">26049252</pub-id></element-citation></ref><ref id="bb0260"><label>52</label><element-citation publication-type="journal" id="rf0260"><person-group person-group-type="author"><name><surname>Chafekar</surname><given-names>A.</given-names></name><name><surname>Fielding</surname><given-names>B.C.</given-names></name></person-group><article-title>MERS-CoV: understanding the latest human coronavirus threat</article-title><source>Viruses</source><volume>10</volume><issue>93</issue><year>2018</year></element-citation></ref><ref id="bb0265"><label>53</label><element-citation publication-type="journal" id="rf0265"><person-group person-group-type="author"><name><surname>Killerby</surname><given-names>M.E.</given-names></name><name><surname>Biggs</surname><given-names>H.M.</given-names></name><name><surname>Midgley</surname><given-names>C.M.</given-names></name><name><surname>Gerber</surname><given-names>S.I.</given-names></name><name><surname>Watson</surname><given-names>J.T.</given-names></name></person-group><article-title>Middle East respiratory syndrome coronavirus transmission</article-title><source>Emerg. Infect. Dis.</source><volume>26</volume><year>2020</year><fpage>191</fpage><lpage>198</lpage><pub-id pub-id-type="pmid">31961300</pub-id></element-citation></ref><ref id="bb0270"><label>54</label><element-citation publication-type="journal" id="rf0270"><person-group person-group-type="author"><name><surname>Naqvi</surname><given-names>A.A.T.</given-names></name><name><surname>Fatima</surname><given-names>K.</given-names></name><name><surname>Mohammad</surname><given-names>T.</given-names></name><name><surname>Fatima</surname><given-names>U.</given-names></name><name><surname>Singh</surname><given-names>I.K.</given-names></name><name><surname>Singh</surname><given-names>A.</given-names></name><name><surname>Atif</surname><given-names>S.M.</given-names></name><name><surname>Hariprasad</surname><given-names>G.</given-names></name><name><surname>Hasan</surname><given-names>G.M.</given-names></name><name><surname>Hassan</surname><given-names>M.I.</given-names></name></person-group><article-title>Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: structural genomics approach</article-title><source>Biochim. Biophys. Acta Mol. basis Dis.</source><volume>1866</volume><year>2020</year><object-id pub-id-type="publisher-id">165878</object-id></element-citation></ref><ref id="bb0275"><label>55</label><element-citation publication-type="journal" id="rf0275"><person-group person-group-type="author"><name><surname>Ashour</surname><given-names>H.M.</given-names></name><name><surname>Elkhatib</surname><given-names>W.F.</given-names></name><name><surname>Rahman</surname><given-names>M.M.</given-names></name><name><surname>Elshabrawy</surname><given-names>H.A.</given-names></name></person-group><article-title>Insights into the recent 2019 novel coronavirus (SARS-CoV-2) in light of past human coronavirus outbreaks</article-title><source>Pathogens</source><volume>9</volume><year>2020</year><fpage>186</fpage></element-citation></ref><ref id="bb0280"><label>56</label><element-citation publication-type="journal" id="rf0280"><person-group person-group-type="author"><name><surname>Fehr</surname><given-names>A.R.</given-names></name><name><surname>Perlman</surname><given-names>S.</given-names></name></person-group><article-title>Coronaviruses: an overview of their replication and pathogenesis</article-title><source>Methods Mol. Biol.</source><volume>1282</volume><year>2015</year><fpage>1</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">25720466</pub-id></element-citation></ref><ref id="bb0285"><label>57</label><element-citation publication-type="journal" id="rf0285"><person-group person-group-type="author"><name><surname>Masters</surname><given-names>P.S.</given-names></name></person-group><article-title>The molecular biology of coronaviruses</article-title><source>Adv. Virus Res.</source><volume>66</volume><year>2006</year><fpage>193</fpage><lpage>292</lpage><pub-id pub-id-type="pmid">16877062</pub-id></element-citation></ref><ref id="bb0290"><label>58</label><element-citation publication-type="journal" id="rf0290"><person-group person-group-type="author"><name><surname>Astuti</surname><given-names>I.</given-names></name><name><surname>Ysrafil</surname></name></person-group><article-title>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): an overview of viral structure and host response</article-title><source>Diabetes Metab. Syndr.</source><volume>14</volume><year>2020</year><fpage>407</fpage><lpage>412</lpage><pub-id pub-id-type="pmid">32335367</pub-id></element-citation></ref><ref id="bb0295"><label>59</label><element-citation publication-type="journal" id="rf0295"><person-group person-group-type="author"><name><surname>Sungnak</surname><given-names>W.</given-names></name><name><surname>Huang</surname><given-names>N.</given-names></name><name><surname>B&#x000e9;cavin</surname><given-names>C.</given-names></name><name><surname>Berg</surname><given-names>M.</given-names></name><name><surname>Queen</surname><given-names>R.</given-names></name><name><surname>Litvinukova</surname><given-names>M.</given-names></name><name><surname>Talavera-L&#x000f3;pez</surname><given-names>C.</given-names></name><name><surname>Maatz</surname><given-names>H.</given-names></name><name><surname>Reichart</surname><given-names>D.</given-names></name><name><surname>Sampaziotis</surname><given-names>F.</given-names></name><name><surname>Worlock</surname><given-names>K.B.</given-names></name><name><surname>Yoshida</surname><given-names>M.</given-names></name><name><surname>Barnes</surname><given-names>J.L.</given-names></name><name><surname>HCA Lung Biological Network</surname></name></person-group><article-title>SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes</article-title><source>Nat. Med.</source><volume>26</volume><year>2020</year><fpage>681</fpage><lpage>687</lpage><pub-id pub-id-type="pmid">32327758</pub-id></element-citation></ref><ref id="bb0300"><label>60</label><element-citation publication-type="journal" id="rf0300"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>H.</given-names></name><name><surname>Zhong</surname><given-names>L.</given-names></name><name><surname>Deng</surname><given-names>J.</given-names></name><name><surname>Peng</surname><given-names>J.</given-names></name><name><surname>Dan</surname><given-names>H.</given-names></name><name><surname>Zeng</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>T.</given-names></name><name><surname>Chen</surname><given-names>Q.</given-names></name></person-group><article-title>High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa</article-title><source>Int. J. Oral Sci.</source><volume>12</volume><issue>8</issue><year>2020</year></element-citation></ref><ref id="bb0305"><label>61</label><element-citation publication-type="journal" id="rf0305"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Ma</surname><given-names>Y.</given-names></name><name><surname>Zuo</surname><given-names>W.</given-names></name></person-group><article-title>Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov</article-title><source>BioRxiv</source><year>2020</year></element-citation></ref><ref id="bb0310"><label>62</label><element-citation publication-type="journal" id="rf0310"><person-group person-group-type="author"><name><surname>Zou</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>K.</given-names></name><name><surname>Zou</surname><given-names>J.</given-names></name><name><surname>Han</surname><given-names>P.</given-names></name><name><surname>Hao</surname><given-names>J.</given-names></name><name><surname>Han</surname><given-names>Z.</given-names></name></person-group><article-title>Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection</article-title><source>Front. Med.</source><volume>14</volume><year>2020</year><fpage>185</fpage><lpage>192</lpage><pub-id pub-id-type="pmid">32170560</pub-id></element-citation></ref><ref id="bb0315"><label>63</label><element-citation publication-type="journal" id="rf0315"><person-group person-group-type="author"><name><surname>Shang</surname><given-names>J.</given-names></name><name><surname>Ye</surname><given-names>G.</given-names></name><name><surname>Shi</surname><given-names>K.</given-names></name><name><surname>Wan</surname><given-names>Y.</given-names></name><name><surname>Luo</surname><given-names>C.</given-names></name><name><surname>Aihara</surname><given-names>H.</given-names></name><name><surname>Geng</surname><given-names>Q.</given-names></name><name><surname>Auerbach</surname><given-names>A.</given-names></name><name><surname>Li</surname><given-names>F.</given-names></name></person-group><article-title>Structural basis of receptor recognition by SARS-CoV-2</article-title><source>Nature</source><volume>581</volume><year>2020</year><fpage>221</fpage><lpage>224</lpage><pub-id pub-id-type="pmid">32225175</pub-id></element-citation></ref><ref id="bb0320"><label>64</label><element-citation publication-type="journal" id="rf0320"><person-group person-group-type="author"><name><surname>Shang</surname><given-names>J.</given-names></name><name><surname>Wan</surname><given-names>Y.</given-names></name><name><surname>Luo</surname><given-names>C.</given-names></name><name><surname>Ye</surname><given-names>G.</given-names></name><name><surname>Geng</surname><given-names>Q.</given-names></name><name><surname>Auerbach</surname><given-names>A.</given-names></name><name><surname>Li</surname><given-names>F.</given-names></name></person-group><article-title>Cell entry mechanisms of SARS-CoV-2</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>117</volume><year>2020</year><fpage>11727</fpage><lpage>11734</lpage><pub-id pub-id-type="pmid">32376634</pub-id></element-citation></ref><ref id="bb0325"><label>65</label><element-citation publication-type="journal" id="rf0325"><person-group person-group-type="author"><name><surname>Shulla</surname><given-names>A.</given-names></name><name><surname>Heald-Sargent</surname><given-names>T.</given-names></name><name><surname>Subramanya</surname><given-names>G.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Perlman</surname><given-names>S.</given-names></name><name><surname>Gallagher</surname><given-names>T.</given-names></name></person-group><article-title>A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry</article-title><source>J. Virol.</source><volume>85</volume><year>2011</year><fpage>873</fpage><lpage>882</lpage><pub-id pub-id-type="pmid">21068237</pub-id></element-citation></ref><ref id="bb0330"><label>66</label><element-citation publication-type="journal" id="rf0330"><person-group person-group-type="author"><name><surname>Hoffmann</surname><given-names>M.</given-names></name><name><surname>Kleine-Weber</surname><given-names>H.</given-names></name><name><surname>Schroeder</surname><given-names>S.</given-names></name><name><surname>Kr&#x000fc;ger</surname><given-names>N.</given-names></name><name><surname>Herrler</surname><given-names>T.</given-names></name><name><surname>Erichsen</surname><given-names>S.</given-names></name><name><surname>Schiergens</surname><given-names>T.S.</given-names></name><name><surname>Herrler</surname><given-names>G.</given-names></name><name><surname>Wu</surname><given-names>N.H.</given-names></name><name><surname>Nitsche</surname><given-names>A.</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>M.A.</given-names></name><name><surname>Drosten</surname><given-names>C.</given-names></name><name><surname>P&#x000f6;hlmann</surname><given-names>S.</given-names></name></person-group><article-title>SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and Is blocked by a clinically proven protease inhibitor</article-title><source>Cell</source><volume>181</volume><year>2020</year><fpage>271</fpage><lpage>280</lpage><comment>(e8)</comment><pub-id pub-id-type="pmid">32142651</pub-id></element-citation></ref><ref id="bb0335"><label>67</label><element-citation publication-type="journal" id="rf0335"><person-group person-group-type="author"><name><surname>Coperchini</surname><given-names>F.</given-names></name><name><surname>Chiovato</surname><given-names>L.</given-names></name><name><surname>Croce</surname><given-names>L.</given-names></name><name><surname>Magri</surname><given-names>F.</given-names></name><name><surname>Rotondi</surname><given-names>M.</given-names></name></person-group><article-title>The cytokine storm in COVID-19: an overview of the involvement of the chemokine/chemokine-receptor system</article-title><source>Cytokine Growth Factor Rev.</source><volume>53</volume><year>2020</year><fpage>25</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">32446778</pub-id></element-citation></ref><ref id="bb0340"><label>68</label><element-citation publication-type="journal" id="rf0340"><person-group person-group-type="author"><name><surname>Ragab</surname><given-names>D.</given-names></name><name><surname>Salah Eldin</surname><given-names>H.</given-names></name><name><surname>Taeimah</surname><given-names>M.</given-names></name><name><surname>Khattab</surname><given-names>R.</given-names></name><name><surname>Salem</surname><given-names>R.</given-names></name></person-group><article-title>The COVID-19 cytokine storm; what we know so far</article-title><source>Front. Immunol.</source><volume>11</volume><year>2020</year><fpage>1446</fpage><pub-id pub-id-type="pmid">32612617</pub-id></element-citation></ref><ref id="bb0345"><label>69</label><element-citation publication-type="journal" id="rf0345"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Ren</surname><given-names>L.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Fan</surname><given-names>G.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Gu</surname><given-names>X.</given-names></name><name><surname>Cheng</surname><given-names>Z.</given-names></name><name><surname>Yu</surname><given-names>T.</given-names></name><name><surname>Xia</surname><given-names>J.</given-names></name><name><surname>Wei</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>W.</given-names></name><name><surname>Xie</surname><given-names>X.</given-names></name><name><surname>Yin</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>M.</given-names></name><name><surname>Xiao</surname><given-names>Y.</given-names></name><name><surname>Gao</surname><given-names>H.</given-names></name><name><surname>Guo</surname><given-names>L.</given-names></name><name><surname>Xie</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>G.</given-names></name><name><surname>Jiang</surname><given-names>R.</given-names></name><name><surname>Gao</surname><given-names>Z.</given-names></name><name><surname>Jin</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Cao</surname><given-names>B.</given-names></name></person-group><article-title>Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China</article-title><source>Lancet</source><volume>395</volume><year>2020</year><fpage>497</fpage><lpage>506</lpage><pub-id pub-id-type="pmid">31986264</pub-id></element-citation></ref><ref id="bb0350"><label>70</label><element-citation publication-type="journal" id="rf0350"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Liang</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Tong</surname><given-names>Q.</given-names></name><name><surname>Yi</surname><given-names>J.</given-names></name><name><surname>Zhao</surname><given-names>L.</given-names></name><name><surname>Xiong</surname><given-names>L.</given-names></name><name><surname>Guo</surname><given-names>C.</given-names></name><name><surname>Tian</surname><given-names>J.</given-names></name><name><surname>Luo</surname><given-names>J.</given-names></name><name><surname>Yao</surname><given-names>J.</given-names></name><name><surname>Pang</surname><given-names>R.</given-names></name><name><surname>Shen</surname><given-names>H.</given-names></name><name><surname>Peng</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>T.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Xu</surname><given-names>L.</given-names></name><name><surname>Lu</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>B.</given-names></name><name><surname>Weng</surname><given-names>Z.</given-names></name><name><surname>Han</surname><given-names>C.</given-names></name><name><surname>Zhu</surname><given-names>H.</given-names></name><name><surname>Zhou</surname><given-names>R.</given-names></name><name><surname>Zhou</surname><given-names>H.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Ye</surname><given-names>P.</given-names></name><name><surname>Zhu</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Zhou</surname><given-names>W.</given-names></name><name><surname>He</surname><given-names>S.</given-names></name><name><surname>He</surname><given-names>Y.</given-names></name><name><surname>Jie</surname><given-names>S.</given-names></name><name><surname>Wei</surname><given-names>P.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Lu</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Zhou</surname><given-names>F.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Dittmer</surname><given-names>U.</given-names></name><name><surname>Lu</surname><given-names>M.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>D.</given-names></name><name><surname>Zheng</surname><given-names>X.</given-names></name></person-group><article-title>Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients</article-title><source>EBioMedicine</source><volume>55</volume><year>2020</year><object-id pub-id-type="publisher-id">102763</object-id></element-citation></ref><ref id="bb0355"><label>71</label><element-citation publication-type="journal" id="rf0355"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>He</surname><given-names>J.</given-names></name><name><surname>Wu</surname><given-names>S.</given-names></name></person-group><article-title>The definition and risks of cytokine release syndrome-like in 11 COVID-19-infected pneumonia critically ill patients: disease characteristics and retrospective analysis</article-title><source>Medrxiv</source><year>2020</year></element-citation></ref><ref id="bb0360"><label>72</label><element-citation publication-type="journal" id="rf0360"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>G.</given-names></name><name><surname>Wu</surname><given-names>D.</given-names></name><name><surname>Guo</surname><given-names>W.</given-names></name><name><surname>Cao</surname><given-names>Y.</given-names></name><name><surname>Huang</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>T.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Yu</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Wu</surname><given-names>S.</given-names></name><name><surname>Song</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>T.</given-names></name><name><surname>Han</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Luo</surname><given-names>X.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Ning</surname><given-names>Q.</given-names></name></person-group><article-title>Clinical and immunological features of severe and moderate coronavirus disease 2019</article-title><source>J. Clin. Invest.</source><volume>130</volume><year>2020</year><fpage>2620</fpage><lpage>2629</lpage><pub-id pub-id-type="pmid">32217835</pub-id></element-citation></ref><ref id="bb0365"><label>73</label><element-citation publication-type="journal" id="rf0365"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>F.</given-names></name><name><surname>Hou</surname><given-names>H.</given-names></name><name><surname>Luo</surname><given-names>Y.</given-names></name><name><surname>Tang</surname><given-names>G.</given-names></name><name><surname>Wu</surname><given-names>S.</given-names></name><name><surname>Huang</surname><given-names>M.</given-names></name><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Zhu</surname><given-names>Y.</given-names></name><name><surname>Lin</surname><given-names>Q.</given-names></name><name><surname>Mao</surname><given-names>L.</given-names></name><name><surname>Fang</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Sun</surname><given-names>Z.</given-names></name></person-group><article-title>The laboratory tests and host immunity of COVID-19 patients with different severity of illness</article-title><source>JCI Insight</source><volume>5</volume><year>2020</year><object-id pub-id-type="publisher-id">e137799</object-id></element-citation></ref><ref id="bb0370"><label>74</label><element-citation publication-type="journal" id="rf0370"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>T.</given-names></name><name><surname>Han</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>D.</given-names></name><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Zhu</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name></person-group><article-title>Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19</article-title><source>J. Med. Virol.</source><volume>92</volume><year>2020</year><fpage>791</fpage><lpage>796</lpage><pub-id pub-id-type="pmid">32181911</pub-id></element-citation></ref><ref id="bb0375"><label>75</label><element-citation publication-type="journal" id="rf0375"><person-group person-group-type="author"><name><surname>Ruan</surname><given-names>Q.</given-names></name><name><surname>Yang</surname><given-names>K.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Jiang</surname><given-names>L.</given-names></name><name><surname>Song</surname><given-names>J.</given-names></name></person-group><article-title>Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China</article-title><source>Intensive Care Med.</source><volume>46</volume><year>2020</year><fpage>846</fpage><lpage>848</lpage><pub-id pub-id-type="pmid">32125452</pub-id></element-citation></ref><ref id="bb0380"><label>76</label><element-citation publication-type="journal" id="rf0380"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>T.</given-names></name><name><surname>Wu</surname><given-names>D.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Yan</surname><given-names>W.</given-names></name><name><surname>Yang</surname><given-names>D.</given-names></name><name><surname>Chen</surname><given-names>G.</given-names></name><name><surname>Ma</surname><given-names>K.</given-names></name><name><surname>Xu</surname><given-names>D.</given-names></name><name><surname>Yu</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>T.</given-names></name><name><surname>Guo</surname><given-names>W.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Ding</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Huang</surname><given-names>J.</given-names></name><name><surname>Han</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Luo</surname><given-names>X.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Ning</surname><given-names>Q.</given-names></name></person-group><article-title>Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study</article-title><source>BMJ</source><volume>368</volume><year>2020</year><fpage>m1091</fpage><pub-id pub-id-type="pmid">32217556</pub-id></element-citation></ref><ref id="bb0385"><label>77</label><element-citation publication-type="journal" id="rf0385"><person-group person-group-type="author"><name><surname>Xiong</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Cao</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Guo</surname><given-names>M.</given-names></name><name><surname>Jiang</surname><given-names>A.</given-names></name><name><surname>Guo</surname><given-names>D.</given-names></name><name><surname>Hu</surname><given-names>W.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Tang</surname><given-names>Z.</given-names></name><name><surname>Wu</surname><given-names>H.</given-names></name><name><surname>Lin</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Shi</surname><given-names>M.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Lan</surname><given-names>K.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name></person-group><article-title>Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients</article-title><source>Emerg. Microbes Infect.</source><volume>9</volume><year>2020</year><fpage>761</fpage><lpage>770</lpage><pub-id pub-id-type="pmid">32228226</pub-id></element-citation></ref><ref id="bb0390"><label>78</label><element-citation publication-type="journal" id="rf0390"><person-group person-group-type="author"><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Jiang</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Lin</surname><given-names>F.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>B.</given-names></name><name><surname>Jiang</surname><given-names>T.</given-names></name><name><surname>An</surname><given-names>W.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Xu</surname><given-names>P.</given-names></name><name><surname>Zhao</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Mu</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Kang</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Huang</surname><given-names>L.</given-names></name><name><surname>Zhu</surname><given-names>C.</given-names></name><name><surname>Zhao</surname><given-names>S.</given-names></name><name><surname>Lu</surname><given-names>J.</given-names></name><name><surname>Ji</surname><given-names>J.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name></person-group><article-title>Clinical and pathological investigation of patients with severe COVID-19</article-title><source>JCI Insight</source><volume>5</volume><year>2020</year><object-id pub-id-type="publisher-id">e138070</object-id></element-citation></ref><ref id="bb0395"><label>79</label><element-citation publication-type="journal" id="rf0395"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>F.</given-names></name><name><surname>Ren</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Shi</surname><given-names>X.</given-names></name><name><surname>Yu</surname><given-names>X.</given-names></name><name><surname>Dong</surname><given-names>K.</given-names></name></person-group><article-title>Clinical characteristics and outcomes of patients with severe covid-19 with diabetes</article-title><source>BMJ Open Diabetes Res. Care</source><volume>8</volume><year>2020</year><object-id pub-id-type="publisher-id">e001343</object-id></element-citation></ref><ref id="bb0400"><label>80</label><element-citation publication-type="journal" id="rf0400"><person-group person-group-type="author"><name><surname>Medzhitov</surname><given-names>R.</given-names></name></person-group><article-title>Inflammation 2010: new adventures of an old flame</article-title><source>Cell</source><volume>140</volume><year>2010</year><fpage>771</fpage><lpage>776</lpage><pub-id pub-id-type="pmid">20303867</pub-id></element-citation></ref><ref id="bb0405"><label>81</label><element-citation publication-type="journal" id="rf0405"><person-group person-group-type="author"><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><article-title>Inflammation, a silent killer in cancer is not so silent</article-title><source>Curr. Opin. Pharmacol.</source><volume>9</volume><year>2009</year><fpage>347</fpage><lpage>350</lpage><pub-id pub-id-type="pmid">19671496</pub-id></element-citation></ref><ref id="bb0410"><label>82</label><element-citation publication-type="journal" id="rf0410"><person-group person-group-type="author"><name><surname>Kawabata</surname><given-names>K.</given-names></name><name><surname>Tung</surname><given-names>N.H.</given-names></name><name><surname>Shoyama</surname><given-names>Y.</given-names></name><name><surname>Sugie</surname><given-names>S.</given-names></name><name><surname>Mori</surname><given-names>T.</given-names></name><name><surname>Tanaka</surname><given-names>T.</given-names></name></person-group><article-title>Dietary crocin inhibits colitis and colitis-associated colorectal carcinogenesis in male ICR mice</article-title><source>Evid. Based Complement. Alternat. Med.</source><volume>2012</volume><year>2012</year><object-id pub-id-type="publisher-id">820415</object-id></element-citation></ref><ref id="bb0415"><label>83</label><element-citation publication-type="journal" id="rf0415"><person-group person-group-type="author"><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name><surname>Harikumar</surname><given-names>K.B.</given-names></name><name><surname>Gupta</surname><given-names>S.R.</given-names></name><name><surname>Tharakan</surname><given-names>S.T.</given-names></name><name><surname>Koca</surname><given-names>C.</given-names></name><name><surname>Dey</surname><given-names>S.</given-names></name><name><surname>Sung</surname><given-names>B.</given-names></name></person-group><article-title>Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?</article-title><source>Ann. N. Y. Acad. Sci.</source><volume>1171</volume><year>2009</year><fpage>59</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">19723038</pub-id></element-citation></ref><ref id="bb0420"><label>84</label><element-citation publication-type="journal" id="rf0420"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>S.C.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name><surname>Aggarwal</surname><given-names>S.</given-names></name><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><article-title>Inflammation, a double-edge sword for cancer and other age-related diseases</article-title><source>Front. Immunol.</source><volume>9</volume><year>2018</year><fpage>2160</fpage><pub-id pub-id-type="pmid">30319623</pub-id></element-citation></ref><ref id="bb0425"><label>85</label><element-citation publication-type="journal" id="rf0425"><person-group person-group-type="author"><name><surname>Yadav</surname><given-names>V.R.</given-names></name><name><surname>Prasad</surname><given-names>S.</given-names></name><name><surname>Sung</surname><given-names>B.</given-names></name><name><surname>Kannappan</surname><given-names>R.</given-names></name><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><article-title>Targeting inflammatory pathways by triterpenoids for prevention and treatment of cancer</article-title><source>Toxins (Basel)</source><volume>2</volume><year>2010</year><fpage>2428</fpage><lpage>2466</lpage><pub-id pub-id-type="pmid">22069560</pub-id></element-citation></ref><ref id="bb0430"><label>86</label><element-citation publication-type="journal" id="rf0430"><person-group person-group-type="author"><name><surname>Monisha</surname><given-names>J.</given-names></name><name><surname>Padmavathi</surname><given-names>G.</given-names></name><name><surname>Roy</surname><given-names>N.K.</given-names></name><name><surname>Deka</surname><given-names>A.</given-names></name><name><surname>Bordoloi</surname><given-names>D.</given-names></name><name><surname>Anip</surname><given-names>A.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name></person-group><article-title>NF-&#x003ba;B blockers gifted by mother nature: prospectives in cancer cell chemosensitization</article-title><source>Curr. Pharm. Des.</source><volume>22</volume><year>2016</year><fpage>4173</fpage><lpage>4200</lpage><pub-id pub-id-type="pmid">27291284</pub-id></element-citation></ref><ref id="bb0435"><label>87</label><element-citation publication-type="journal" id="rf0435"><person-group person-group-type="author"><name><surname>Monisha</surname><given-names>J.</given-names></name><name><surname>Roy</surname><given-names>N.K.</given-names></name><name><surname>Bordoloi</surname><given-names>D.</given-names></name><name><surname>Kumar</surname><given-names>A.</given-names></name><name><surname>Golla</surname><given-names>R.</given-names></name><name><surname>Kotoky</surname><given-names>J.</given-names></name><name><surname>Padmavathi</surname><given-names>G.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name></person-group><article-title>Nuclear factor kappa B: a potential target to persecute head and neck cancer</article-title><source>Curr. Drug Targets</source><volume>18</volume><year>2017</year><fpage>232</fpage><lpage>253</lpage><pub-id pub-id-type="pmid">26844566</pub-id></element-citation></ref><ref id="bb0440"><label>88</label><element-citation publication-type="journal" id="rf0440"><person-group person-group-type="author"><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name><surname>Shabnam</surname><given-names>B.</given-names></name><name><surname>Girisa</surname><given-names>S.</given-names></name><name><surname>Harsha</surname><given-names>C.</given-names></name><name><surname>Banik</surname><given-names>K.</given-names></name><name><surname>Devi</surname><given-names>T.B.</given-names></name><name><surname>Choudhury</surname><given-names>R.</given-names></name><name><surname>Sahu</surname><given-names>H.</given-names></name><name><surname>Parama</surname><given-names>D.</given-names></name><name><surname>Sailo</surname><given-names>B.L.</given-names></name><name><surname>Thakur</surname><given-names>K.K.</given-names></name><name><surname>Gupta</surname><given-names>S.C.</given-names></name><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><article-title>Inflammation, NF-&#x003ba;B, and chronic diseases: how are they linked?</article-title><source>Crit. Rev. Immunol.</source><volume>40</volume><year>2020</year><fpage>1</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">32421977</pub-id></element-citation></ref><ref id="bb0445"><label>89</label><element-citation publication-type="book" id="rf0445"><person-group person-group-type="author"><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name><surname>Anand</surname><given-names>P.</given-names></name><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><chapter-title>Nuclear factor-&#x003ba;B and chemoresistance: how intertwined are they?</chapter-title><source>Drug Resistance in Cancer Cells</source><year>2009</year><publisher-name>Springer</publisher-name><publisher-loc>New York, NY</publisher-loc><fpage>177</fpage><lpage>208</lpage></element-citation></ref><ref id="bb0450"><label>90</label><element-citation publication-type="journal" id="rf0450"><person-group person-group-type="author"><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name><surname>Thakur</surname><given-names>K.K.</given-names></name><name><surname>Rana</surname><given-names>V.</given-names></name><name><surname>Bora</surname><given-names>B.</given-names></name><name><surname>Banik</surname><given-names>K.</given-names></name><name><surname>Khatoon</surname><given-names>E.</given-names></name><name><surname>Sailo</surname><given-names>B.L.</given-names></name><name><surname>Shabnam</surname><given-names>B.</given-names></name><name><surname>Girisa</surname><given-names>S.</given-names></name><name><surname>Gupta</surname><given-names>S.C.</given-names></name><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><article-title>Upside and downside of tumor necrosis factor blockers for treatment of immune/inflammatory diseases</article-title><source>Crit. Rev. Immunol.</source><volume>39</volume><year>2019</year><fpage>439</fpage><lpage>479</lpage><pub-id pub-id-type="pmid">32421957</pub-id></element-citation></ref><ref id="bb0455"><label>91</label><element-citation publication-type="book" id="rf0455"><person-group person-group-type="author"><name><surname>Sethi</surname><given-names>G.</given-names></name><name><surname>Sung</surname><given-names>B.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><chapter-title>Targeting TNF for treatment of cancer and autoimmunity</chapter-title><source>Therapeutic Targets of the TNF Superfamily</source><year>2009</year><publisher-name>Springer</publisher-name><publisher-loc>New York</publisher-loc><fpage>37</fpage><lpage>51</lpage></element-citation></ref><ref id="bb0460"><label>92</label><element-citation publication-type="other" id="rf0460"><person-group person-group-type="author"><name><surname>CISION PR Newswire</surname></name></person-group><article-title>Global Tumor Necrosis Factor (TNF) Inhibitors Market 2018&#x02013;2026: A $181.13 Billion Market Opportunity by 2026</article-title><ext-link ext-link-type="uri" xlink:href="https://www.prnewswire.com/news-releases/global-tumor-necrosis-factor-tnf-inhibitors-market-2018-2026-a-181-13-billion-market-opportunity-by-2026--300675249.html" id="ir0035">https://www.prnewswire.com/news-releases/global-tumor-necrosis-factor-tnf-inhibitors-market-2018-2026-a-181-13-billion-market-opportunity-by-2026--300675249.html</ext-link><comment>(2018, accessed 11 August 2020)</comment></element-citation></ref><ref id="bb0465"><label>93</label><element-citation publication-type="journal" id="rf0465"><person-group person-group-type="author"><name><surname>Reuter</surname><given-names>S.</given-names></name><name><surname>Gupta</surname><given-names>S.C.</given-names></name><name><surname>Chaturvedi</surname><given-names>M.M.</given-names></name><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><article-title>Oxidative stress, inflammation, and cancer: how are they linked?</article-title><source>Free Radic. Biol. Med.</source><volume>49</volume><year>2010</year><fpage>1603</fpage><lpage>1616</lpage><pub-id pub-id-type="pmid">20840865</pub-id></element-citation></ref><ref id="bb0470"><label>94</label><element-citation publication-type="journal" id="rf0470"><person-group person-group-type="author"><name><surname>Pandurangan</surname><given-names>A.K.</given-names></name><name><surname>Ismail</surname><given-names>S.</given-names></name><name><surname>Saadatdoust</surname><given-names>Z.</given-names></name><name><surname>Esa</surname><given-names>N.M.</given-names></name></person-group><article-title>Allicin alleviates dextran sodium sulfate- (DSS-) induced ulcerative colitis in BALB/c mice</article-title><source>Oxidative Med. Cell. Longev.</source><volume>2015</volume><year>2015</year><object-id pub-id-type="publisher-id">605208</object-id></element-citation></ref><ref id="bb0475"><label>95</label><element-citation publication-type="journal" id="rf0475"><person-group person-group-type="author"><name><surname>Sung</surname><given-names>B.</given-names></name><name><surname>Prasad</surname><given-names>S.</given-names></name><name><surname>Yadav</surname><given-names>V.R.</given-names></name><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><article-title>Cancer cell signaling pathways targeted by spice-derived nutraceuticals</article-title><source>Nutr. Cancer</source><volume>64</volume><year>2012</year><fpage>173</fpage><lpage>197</lpage><pub-id pub-id-type="pmid">22149093</pub-id></element-citation></ref><ref id="bb0480"><label>96</label><element-citation publication-type="journal" id="rf0480"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>Z.</given-names></name><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Wen</surname><given-names>X.</given-names></name><name><surname>Nie</surname><given-names>H.</given-names></name><name><surname>Hu</surname><given-names>T.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Chu</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Deng</surname><given-names>X.</given-names></name><name><surname>He</surname><given-names>J.</given-names></name></person-group><article-title>Rosmarinic acid attenuates airway inflammation and hyperresponsiveness in a murine model of asthma</article-title><source>Molecules</source><volume>21</volume><year>2016</year><fpage>769</fpage></element-citation></ref><ref id="bb0485"><label>97</label><element-citation publication-type="journal" id="rf0485"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Kuo</surname><given-names>H.D.</given-names></name><name><surname>Shannar</surname><given-names>A.</given-names></name><name><surname>Peter</surname><given-names>R.</given-names></name><name><surname>Chou</surname><given-names>P.J.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Hudlikar</surname><given-names>R.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Poiani</surname><given-names>G.J.</given-names></name><name><surname>Amorosa</surname><given-names>L.</given-names></name><name><surname>Brunetti</surname><given-names>L.</given-names></name><name><surname>Kong</surname><given-names>A.N.</given-names></name></person-group><article-title>An update on current therapeutic drugs treating COVID-19</article-title><source>Curr. Pharmacol. Rep.</source><year>2020</year><fpage>1</fpage><lpage>15</lpage></element-citation></ref><ref id="bb0490"><label>98</label><element-citation publication-type="journal" id="rf0490"><person-group person-group-type="author"><name><surname>Wilkinson</surname><given-names>T.</given-names></name><name><surname>Dixon</surname><given-names>R.</given-names></name><name><surname>Page</surname><given-names>C.</given-names></name><name><surname>Carroll</surname><given-names>M.</given-names></name><name><surname>Griffiths</surname><given-names>G.</given-names></name><name><surname>Ho</surname><given-names>L.P.</given-names></name><name><surname>De Soyza</surname><given-names>A.</given-names></name><name><surname>Felton</surname><given-names>T.</given-names></name><name><surname>Lewis</surname><given-names>K.E.</given-names></name><name><surname>Phekoo</surname><given-names>K.</given-names></name><name><surname>Chalmers</surname><given-names>J.D.</given-names></name><name><surname>Gordon</surname><given-names>A.</given-names></name><name><surname>McGarvey</surname><given-names>L.</given-names></name><name><surname>Doherty</surname><given-names>J.</given-names></name><name><surname>Read</surname><given-names>R.C.</given-names></name><name><surname>Shankar-Hari</surname><given-names>M.</given-names></name><name><surname>Martinez-Alier</surname><given-names>N.</given-names></name><name><surname>O'Kelly</surname><given-names>M.</given-names></name><name><surname>Duncan</surname><given-names>G.</given-names></name><name><surname>Walles</surname><given-names>R.</given-names></name><name><surname>Sykes</surname><given-names>J.</given-names></name><name><surname>Summers</surname><given-names>C.</given-names></name><name><surname>Singh</surname><given-names>D.</given-names></name><collab>ACCORD Collaborators</collab></person-group><article-title>ACCORD: a multicentre, seamless, phase 2 adaptive randomisation platform study to assess the efficacy and safety of multiple candidate agents for the treatment of COVID-19 in hospitalised patients: a structured summary of a study protocol for a randomised controlled trial</article-title><source>Trials</source><volume>21</volume><year>2020</year><fpage>691</fpage><pub-id pub-id-type="pmid">32736596</pub-id></element-citation></ref><ref id="bb0495"><label>99</label><element-citation publication-type="journal" id="rf0495"><person-group person-group-type="author"><name><surname>Qiao</surname><given-names>Z.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Ji</surname><given-names>H.F.</given-names></name><name><surname>Chen</surname><given-names>Q.</given-names></name></person-group><article-title>Computational view toward the inhibition of SARS-CoV-2 spike glycoprotein and the 3CL protease</article-title><source>Computation (Basel)</source><volume>8</volume><year>2020</year><fpage>53</fpage><pub-id pub-id-type="pmid">32661494</pub-id></element-citation></ref><ref id="bb0500"><label>100</label><element-citation publication-type="journal" id="rf0500"><person-group person-group-type="author"><name><surname>Huet</surname><given-names>T.</given-names></name><name><surname>Beaussier</surname><given-names>H.</given-names></name><name><surname>Voisin</surname><given-names>O.</given-names></name><name><surname>Jouveshomme</surname><given-names>S.</given-names></name><name><surname>Dauriat</surname><given-names>G.</given-names></name><name><surname>Lazareth</surname><given-names>I.</given-names></name><name><surname>Sacco</surname><given-names>E.</given-names></name><name><surname>Naccache</surname><given-names>J.M.</given-names></name><name><surname>B&#x000e9;zie</surname><given-names>Y.</given-names></name><name><surname>Laplanche</surname><given-names>S.</given-names></name><name><surname>Le Berre</surname><given-names>A.</given-names></name><name><surname>Le Pavec</surname><given-names>J.</given-names></name><name><surname>Salmeron</surname><given-names>S.</given-names></name><name><surname>Emmerich</surname><given-names>J.</given-names></name><name><surname>Mourad</surname><given-names>J.J.</given-names></name><name><surname>Chatellier</surname><given-names>G.</given-names></name><name><surname>Hayem</surname><given-names>G.</given-names></name></person-group><article-title>Anakinra for severe forms of COVID-19: a cohort study</article-title><source>Lancet Rheumatol.</source><volume>2</volume><year>2020</year><fpage>e393</fpage><lpage>e400</lpage><pub-id pub-id-type="pmid">32835245</pub-id></element-citation></ref><ref id="bb0505"><label>101</label><element-citation publication-type="journal" id="rf0505"><person-group person-group-type="author"><name><surname>Vankadari</surname><given-names>N.</given-names></name></person-group><article-title>Arbidol: a potential antiviral drug for the treatment of SARS-CoV-2 by blocking trimerization of the spike glycoprotein</article-title><source>Int. J. Antimicrob. Agents</source><volume>56</volume><year>2020</year><object-id pub-id-type="publisher-id">105998</object-id></element-citation></ref><ref id="bb0510"><label>102</label><element-citation publication-type="journal" id="rf0510"><person-group person-group-type="author"><name><surname>Rodriguez-Nava</surname><given-names>G.</given-names></name><name><surname>Trelles-Garcia</surname><given-names>D.P.</given-names></name><name><surname>Yanez-Bello</surname><given-names>M.A.</given-names></name><name><surname>Chung</surname><given-names>C.W.</given-names></name><name><surname>Trelles-Garcia</surname><given-names>V.P.</given-names></name><name><surname>Friedman</surname><given-names>H.J.</given-names></name></person-group><article-title>Atorvastatin associated with decreased hazard for death in COVID-19 patients admitted to an ICU: a retrospective cohort study</article-title><source>Crit. Care</source><volume>24</volume><year>2020</year><fpage>429</fpage><pub-id pub-id-type="pmid">32664990</pub-id></element-citation></ref><ref id="bb0515"><label>103</label><element-citation publication-type="journal" id="rf0515"><person-group person-group-type="author"><name><surname>Cantini</surname><given-names>F.</given-names></name><name><surname>Niccoli</surname><given-names>L.</given-names></name><name><surname>Nannini</surname><given-names>C.</given-names></name><name><surname>Matarrese</surname><given-names>D.</given-names></name><name><surname>Natale</surname><given-names>M.E.D.</given-names></name><name><surname>Lotti</surname><given-names>P.</given-names></name><name><surname>Aquilini</surname><given-names>D.</given-names></name><name><surname>Landini</surname><given-names>G.</given-names></name><name><surname>Cimolato</surname><given-names>B.</given-names></name><name><surname>Pietro</surname><given-names>M.A.D.</given-names></name><name><surname>Trezzi</surname><given-names>M.</given-names></name><name><surname>Stobbione</surname><given-names>P.</given-names></name><name><surname>Frausini</surname><given-names>G.</given-names></name><name><surname>Navarra</surname><given-names>A.</given-names></name><name><surname>Nicastri</surname><given-names>E.</given-names></name><name><surname>Sotgiu</surname><given-names>G.</given-names></name><name><surname>Goletti</surname><given-names>D.</given-names></name></person-group><article-title>Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study</article-title><source>J. Inf. Secur.</source><volume>81</volume><year>2020</year><fpage>647</fpage><lpage>679</lpage></element-citation></ref><ref id="bb0520"><label>104</label><element-citation publication-type="journal" id="rf0520"><person-group person-group-type="author"><name><surname>Maggio</surname><given-names>R.</given-names></name><name><surname>Corsini</surname><given-names>G.U.</given-names></name></person-group><article-title>Repurposing the mucolytic cough suppressant and TMPRSS2 protease inhibitor bromhexine for the prevention and management of SARS-CoV-2 infection</article-title><source>Pharmacol. Res.</source><volume>157</volume><year>2020</year><object-id pub-id-type="publisher-id">104837</object-id></element-citation></ref><ref id="bb0525"><label>105</label><element-citation publication-type="journal" id="rf0525"><person-group person-group-type="author"><name><surname>Hoffmann</surname><given-names>M.</given-names></name><name><surname>Hofmann-Winkler</surname><given-names>H.</given-names></name><name><surname>Smith</surname><given-names>J.C.</given-names></name><name><surname>Kr&#x000fc;ger</surname><given-names>N.</given-names></name><name><surname>S&#x000f8;rensen</surname><given-names>L.K.</given-names></name><name><surname>S&#x000f8;gaard</surname><given-names>O.S.</given-names></name><name><surname>Hasselstr&#x000f8;m</surname><given-names>J.B.</given-names></name><name><surname>Winkler</surname><given-names>M.</given-names></name><name><surname>Hempel</surname><given-names>T.</given-names></name><name><surname>Raich</surname><given-names>L.</given-names></name><name><surname>Olsson</surname><given-names>S.</given-names></name><name><surname>Yamazoe</surname><given-names>T.</given-names></name><name><surname>Yamatsuta</surname><given-names>K.</given-names></name><name><surname>Mizuno</surname><given-names>H.</given-names></name><name><surname>Ludwig</surname><given-names>S.</given-names></name><name><surname>No&#x000e9;</surname><given-names>F.</given-names></name><name><surname>Sheltzer</surname><given-names>J.M.</given-names></name><name><surname>Kjolby</surname><given-names>M.</given-names></name><name><surname>P&#x000f6;hlmann</surname><given-names>S.</given-names></name></person-group><article-title>Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity</article-title><source>bioRxiv</source><year>2020</year><comment>(2020.08.05.237651)</comment></element-citation></ref><ref id="bb0530"><label>106</label><element-citation publication-type="journal" id="rf0530"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Cao</surname><given-names>R.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Xu</surname><given-names>M.</given-names></name><name><surname>Shi</surname><given-names>Z.</given-names></name><name><surname>Hu</surname><given-names>Z.</given-names></name><name><surname>Zhong</surname><given-names>W.</given-names></name><name><surname>Xiao</surname><given-names>G.</given-names></name></person-group><article-title>Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro</article-title><source>Cell Res.</source><volume>30</volume><year>2020</year><fpage>269</fpage><lpage>271</lpage><pub-id pub-id-type="pmid">32020029</pub-id></element-citation></ref><ref id="bb0535"><label>107</label><element-citation publication-type="journal" id="rf0535"><person-group person-group-type="author"><name><surname>Elfiky</surname><given-names>A.A.</given-names></name></person-group><article-title>SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an in silico perspective</article-title><source>J. Biomol. Struct. Dyn.</source><year>2020</year><fpage>1</fpage><lpage>9</lpage></element-citation></ref><ref id="bb0540"><label>108</label><element-citation publication-type="journal" id="rf0540"><person-group person-group-type="author"><name><surname>Iwabuchi</surname><given-names>K.</given-names></name><name><surname>Yoshie</surname><given-names>K.</given-names></name><name><surname>Kurakami</surname><given-names>Y.</given-names></name><name><surname>Takahashi</surname><given-names>K.</given-names></name><name><surname>Kato</surname><given-names>Y.</given-names></name><name><surname>Morishima</surname><given-names>T.</given-names></name></person-group><article-title>Therapeutic potential of ciclesonide inahalation for COVID-19 pneumonia: report of three cases</article-title><source>J. Infect. Chemother.</source><volume>26</volume><year>2020</year><fpage>625</fpage><lpage>632</lpage><pub-id pub-id-type="pmid">32362440</pub-id></element-citation></ref><ref id="bb0545"><label>109</label><element-citation publication-type="journal" id="rf0545"><person-group person-group-type="author"><name><surname>Karampela</surname><given-names>I.</given-names></name><name><surname>Dalamaga</surname><given-names>M.</given-names></name></person-group><article-title>Could respiratory fluoroquinolones, levofloxacin and moxifloxacin, prove to be beneficial as an adjunct treatment in COVID-19?</article-title><source>Arch. Med. Res.</source><volume>51</volume><year>2020</year><fpage>741</fpage><lpage>742</lpage><pub-id pub-id-type="pmid">32546446</pub-id></element-citation></ref><ref id="bb0550"><label>110</label><element-citation publication-type="journal" id="rf0550"><person-group person-group-type="author"><name><surname>Mill&#x000e1;n-O&#x000f1;ate</surname><given-names>J.</given-names></name><name><surname>Millan</surname><given-names>W.</given-names></name><name><surname>Mendoza</surname><given-names>L.A.</given-names></name><name><surname>S&#x000e1;nchez</surname><given-names>C.G.</given-names></name><name><surname>Fernandez-Suarez</surname><given-names>H.</given-names></name><name><surname>Bonilla-Aldana</surname><given-names>D.K.</given-names></name><name><surname>Rodr&#x000ed;guez-Morales</surname><given-names>A.J.</given-names></name></person-group><article-title>Successful recovery of COVID-19 pneumonia in a patient from Colombia after receiving chloroquine and clarithromycin</article-title><source>Ann. Clin. Microbiol. Antimicrob.</source><volume>19</volume><issue>16</issue><year>2020</year></element-citation></ref><ref id="bb0555"><label>111</label><element-citation publication-type="journal" id="rf0555"><person-group person-group-type="author"><name><surname>Sacramento</surname><given-names>C.Q.</given-names></name><name><surname>Fintelman-Rodrigues</surname><given-names>N.</given-names></name><name><surname>Temerozo</surname><given-names>J.R.</given-names></name><name><surname>Dias</surname><given-names>S.D.</given-names></name><name><surname>Ferreira</surname><given-names>A.C.</given-names></name><name><surname>Mattos</surname><given-names>M.</given-names></name><name><surname>P&#x000e3;o</surname><given-names>C.R.</given-names></name><name><surname>de Freitas</surname><given-names>C.S.</given-names></name><name><surname>Soares</surname><given-names>V.C.</given-names></name><name><surname>Bozza</surname><given-names>F.A.</given-names></name><name><surname>Bou-Habib</surname><given-names>D.C.</given-names></name></person-group><article-title>The in vitro antiviral activity of the anti-hepatitis C virus (HCV) drugs daclatasvir and sofosbuvir against SARS-CoV-2</article-title><source>bioRxiv</source><year>2020</year></element-citation></ref><ref id="bb0560"><label>112</label><element-citation publication-type="journal" id="rf0560"><person-group person-group-type="author"><name><surname>De Meyer</surname><given-names>S.</given-names></name><name><surname>Bojkova</surname><given-names>D.</given-names></name><name><surname>Cinatl</surname><given-names>J.</given-names></name><name><surname>Van Damme</surname><given-names>E.</given-names></name><name><surname>Buyck</surname><given-names>C.</given-names></name><name><surname>Van Loock</surname><given-names>M.</given-names></name><name><surname>Woodfall</surname><given-names>B.</given-names></name><name><surname>Ciesek</surname><given-names>S.</given-names></name></person-group><article-title>Lack of antiviral activity of darunavir against SARS-CoV-2</article-title><source>Int. J. Infect. Dis.</source><volume>97</volume><year>2020</year><fpage>7</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">32479865</pub-id></element-citation></ref><ref id="bb0565"><label>113</label><element-citation publication-type="journal" id="rf0565"><person-group person-group-type="author"><name><surname>Selvaraj</surname><given-names>V.</given-names></name><name><surname>Dapaah-Afriyie</surname><given-names>K.</given-names></name><name><surname>Finn</surname><given-names>A.</given-names></name><name><surname>Flanigan</surname><given-names>T.P.</given-names></name></person-group><article-title>Short-term dexamethasone in Sars-CoV-2 patients</article-title><source>R. I. Med. J.</source><volume>103</volume><year>2020</year><fpage>39</fpage><lpage>43</lpage></element-citation></ref><ref id="bb0570"><label>114</label><element-citation publication-type="journal" id="rf0570"><person-group person-group-type="author"><name><surname>Lobo-Galo</surname><given-names>N.</given-names></name><name><surname>Terrazas-L&#x000f3;pez</surname><given-names>M.</given-names></name><name><surname>Mart&#x000ed;nez-Mart&#x000ed;nez</surname><given-names>A.</given-names></name><name><surname>D&#x000ed;az-S&#x000e1;nchez</surname><given-names>&#x000c1;.G.</given-names></name></person-group><article-title>FDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replication</article-title><source>J. Biomol. Struct. Dyn.</source><year>2020</year><fpage>1</fpage><lpage>9</lpage></element-citation></ref><ref id="bb0575"><label>115</label><element-citation publication-type="journal" id="rf0575"><person-group person-group-type="author"><name><surname>Malek</surname><given-names>A.E.</given-names></name><name><surname>Granwehr</surname><given-names>B.P.</given-names></name><name><surname>Kontoyiannis</surname><given-names>D.P.</given-names></name></person-group><article-title>Doxycycline as a potential partner of COVID-19 therapies</article-title><source>IDCases</source><volume>21</volume><year>2020</year><object-id pub-id-type="publisher-id">e00864</object-id></element-citation></ref><ref id="bb0580"><label>116</label><element-citation publication-type="journal" id="rf0580"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>Q.</given-names></name><name><surname>Yang</surname><given-names>M.</given-names></name><name><surname>Liu</surname><given-names>D.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Shu</surname><given-names>D.</given-names></name><name><surname>Xia</surname><given-names>J.</given-names></name><name><surname>Liao</surname><given-names>X.</given-names></name><name><surname>Gu</surname><given-names>Y.</given-names></name><name><surname>Cai</surname><given-names>Q.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Shen</surname><given-names>C.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Peng</surname><given-names>L.</given-names></name><name><surname>Huang</surname><given-names>D.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>F.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Cao</surname><given-names>R.</given-names></name><name><surname>Zhong</surname><given-names>W.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name></person-group><article-title>Experimental treatment with Favipiravir for COVID-19: an open-label control study</article-title><source>Engineering (Beijing)</source><year>2020</year></element-citation></ref><ref id="bb0585"><label>117</label><element-citation publication-type="journal" id="rf0585"><person-group person-group-type="author"><name><surname>Tu</surname><given-names>Y.F.</given-names></name><name><surname>Chien</surname><given-names>C.S.</given-names></name><name><surname>Yarmishyn</surname><given-names>A.A.</given-names></name><name><surname>Lin</surname><given-names>Y.Y.</given-names></name><name><surname>Luo</surname><given-names>Y.H.</given-names></name><name><surname>Lin</surname><given-names>Y.T.</given-names></name><name><surname>Lai</surname><given-names>W.Y.</given-names></name><name><surname>Yang</surname><given-names>D.M.</given-names></name><name><surname>Chou</surname><given-names>S.J.</given-names></name><name><surname>Yang</surname><given-names>Y.P.</given-names></name><name><surname>Wang</surname><given-names>M.L.</given-names></name><name><surname>Chiou</surname><given-names>S.H.A.</given-names></name></person-group><article-title>Review of SARS-CoV-2 and the ongoing clinical trials</article-title><source>Int. J. Mol. Sci.</source><volume>21</volume><year>2020</year><fpage>2657</fpage></element-citation></ref><ref id="bb0590"><label>118</label><element-citation publication-type="journal" id="rf0590"><person-group person-group-type="author"><name><surname>Elfiky</surname><given-names>A.A.</given-names></name></person-group><article-title>Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): a molecular docking study</article-title><source>Life Sci.</source><volume>253</volume><year>2020</year><object-id pub-id-type="publisher-id">117592</object-id></element-citation></ref><ref id="bb0595"><label>119</label><element-citation publication-type="journal" id="rf0595"><person-group person-group-type="author"><name><surname>Bernal-Bello</surname><given-names>D.</given-names></name><name><surname>Jaenes-Barrios</surname><given-names>B.</given-names></name><name><surname>Morales-Ortega</surname><given-names>A.</given-names></name><name><surname>Ruiz-Giardin</surname><given-names>J.M.</given-names></name><name><surname>Garc&#x000ed;a-Berm&#x000fa;dez</surname><given-names>V.</given-names></name><name><surname>Frutos-P&#x000e9;rez</surname><given-names>B.</given-names></name><name><surname>Farf&#x000e1;n-Sedano</surname><given-names>A.I.</given-names></name><name><surname>de Ancos-Aracil</surname><given-names>C.</given-names></name><name><surname>Bermejo</surname><given-names>F.</given-names></name><name><surname>Garc&#x000ed;a-Gil</surname><given-names>M.</given-names></name><name><surname>Zapatero-Gaviria</surname><given-names>A.</given-names></name><name><surname>San Mart&#x000ed;n-L&#x000f3;pez</surname><given-names>J.V.</given-names></name></person-group><article-title>Imatinib might constitute a treatment option for lung involvement in COVID-19</article-title><source>Autoimmun. Rev.</source><volume>19</volume><year>2020</year><object-id pub-id-type="publisher-id">102565</object-id></element-citation></ref><ref id="bb0600"><label>120</label><element-citation publication-type="journal" id="rf0600"><person-group person-group-type="author"><name><surname>Amici</surname><given-names>C.</given-names></name><name><surname>Di Caro</surname><given-names>A.</given-names></name><name><surname>Ciucci</surname><given-names>A.</given-names></name><name><surname>Chiappa</surname><given-names>L.</given-names></name><name><surname>Castilletti</surname><given-names>C.</given-names></name><name><surname>Martella</surname><given-names>V.</given-names></name><name><surname>Decaro</surname><given-names>N.</given-names></name><name><surname>Buonavoglia</surname><given-names>C.</given-names></name><name><surname>Capobianchi</surname><given-names>M.R.</given-names></name><name><surname>Santoro</surname><given-names>M.G.</given-names></name></person-group><article-title>Indomethacin has a potent antiviral activity against SARS coronavirus</article-title><source>Antivir. Ther.</source><volume>11</volume><year>2006</year><fpage>1021</fpage><lpage>1030</lpage><pub-id pub-id-type="pmid">17302372</pub-id></element-citation></ref><ref id="bb0605"><label>121</label><element-citation publication-type="journal" id="rf0605"><person-group person-group-type="author"><name><surname>Sainz</surname><given-names>B.</given-names><suffix>Jr.</suffix></name><name><surname>Mossel</surname><given-names>E.C.</given-names></name><name><surname>Peters</surname><given-names>C.J.</given-names></name><name><surname>Garry</surname><given-names>R.F.</given-names></name></person-group><article-title>Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV)</article-title><source>Virology</source><volume>329</volume><year>2004</year><fpage>11</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">15476870</pub-id></element-citation></ref><ref id="bb0610"><label>122</label><element-citation publication-type="journal" id="rf0610"><person-group person-group-type="author"><name><surname>Caly</surname><given-names>L.</given-names></name><name><surname>Druce</surname><given-names>J.D.</given-names></name><name><surname>Catton</surname><given-names>M.G.</given-names></name><name><surname>Jans</surname><given-names>D.A.</given-names></name><name><surname>Wagstaff</surname><given-names>K.M.</given-names></name></person-group><article-title>The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro</article-title><source>Antivir. Res.</source><volume>178</volume><year>2020</year><object-id pub-id-type="publisher-id">104787</object-id></element-citation></ref><ref id="bb0615"><label>123</label><element-citation publication-type="journal" id="rf0615"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>R.</given-names></name><name><surname>Ng</surname><given-names>T.B.</given-names></name><name><surname>Sun</surname><given-names>W.Z.</given-names></name></person-group><article-title>Lactoferrin as potential preventative and adjunct treatment for COVID-19</article-title><source>Int. J. Antimicrob. Agents</source><volume>56</volume><year>2020</year><object-id pub-id-type="publisher-id">106118</object-id></element-citation></ref><ref id="bb0620"><label>124</label><element-citation publication-type="journal" id="rf0620"><person-group person-group-type="author"><name><surname>Gurwitz</surname><given-names>D.</given-names></name></person-group><article-title>Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics</article-title><source>Drug Dev. Res.</source><volume>81</volume><year>2020</year><fpage>537</fpage><lpage>540</lpage><pub-id pub-id-type="pmid">32129518</pub-id></element-citation></ref><ref id="bb0625"><label>125</label><element-citation publication-type="journal" id="rf0625"><person-group person-group-type="author"><name><surname>Scheen</surname><given-names>A.J.</given-names></name></person-group><article-title>Metformin and COVID-19: from cellular mechanisms to reduced mortality</article-title><source>Diabetes Metab.</source><volume>46</volume><year>2020</year><fpage>423</fpage><lpage>426</lpage><pub-id pub-id-type="pmid">32750451</pub-id></element-citation></ref><ref id="bb0630"><label>126</label><element-citation publication-type="journal" id="rf0630"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>S.</given-names></name><name><surname>Ray</surname><given-names>A.</given-names></name><name><surname>Sadasivam</surname><given-names>B.</given-names></name></person-group><article-title>Metformin in COVID-19: a possible role beyond diabetes</article-title><source>Diabetes Res. Clin. Pract.</source><volume>164</volume><year>2020</year><object-id pub-id-type="publisher-id">108183</object-id></element-citation></ref><ref id="bb0635"><label>127</label><element-citation publication-type="journal" id="rf0635"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Zheng</surname><given-names>X.</given-names></name><name><surname>Huang</surname><given-names>Y.</given-names></name><name><surname>Shan</surname><given-names>H.</given-names></name><name><surname>Huang</surname><given-names>J.</given-names></name></person-group><article-title>Successful use of methylprednisolone for treating severe COVID-19</article-title><source>J. Allergy Clin. Immunol.</source><volume>146</volume><year>2020</year><fpage>325</fpage><lpage>327</lpage><pub-id pub-id-type="pmid">32479759</pub-id></element-citation></ref><ref id="bb0640"><label>128</label><element-citation publication-type="journal" id="rf0640"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>M.</given-names></name><name><surname>Kiso</surname><given-names>M.</given-names></name><name><surname>Sakai-Tagawa</surname><given-names>Y.</given-names></name><name><surname>Iwatsuki-Horimoto</surname><given-names>K.</given-names></name><name><surname>Imai</surname><given-names>M.</given-names></name><name><surname>Takeda</surname><given-names>M.</given-names></name><name><surname>Kinoshita</surname><given-names>N.</given-names></name><name><surname>Ohmagari</surname><given-names>N.</given-names></name><name><surname>Gohda</surname><given-names>J.</given-names></name><name><surname>Semba</surname><given-names>K.</given-names></name><name><surname>Matsuda</surname><given-names>Z.</given-names></name><name><surname>Kawaguchi</surname><given-names>Y.</given-names></name><name><surname>Kawaoka</surname><given-names>Y.</given-names></name><name><surname>Inoue</surname><given-names>J.I.</given-names></name></person-group><article-title>The anticoagulant Nafamostat potently inhibits SARS-CoV-2 S protein-mediated fusion in a cell fusion assay system and viral infection in vitro in a cell-type-dependent manner</article-title><source>Viruses</source><volume>12</volume><year>2020</year><fpage>629</fpage></element-citation></ref><ref id="bb0645"><label>129</label><element-citation publication-type="journal" id="rf0645"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Shi</surname><given-names>P.Y.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Zhou</surname><given-names>J.</given-names></name></person-group><article-title>Broad spectrum antiviral agent niclosamide and its therapeutic potential</article-title><source>ACS Infect. Dis.</source><volume>6</volume><year>2020</year><fpage>909</fpage><lpage>915</lpage><pub-id pub-id-type="pmid">32125140</pub-id></element-citation></ref><ref id="bb0650"><label>130</label><element-citation publication-type="journal" id="rf0650"><person-group person-group-type="author"><name><surname>Siddiqui</surname><given-names>A.J.</given-names></name><name><surname>Jahan</surname><given-names>S.</given-names></name><name><surname>Ashraf</surname><given-names>S.A.</given-names></name><name><surname>Alreshidi</surname><given-names>M.</given-names></name><name><surname>Ashraf</surname><given-names>M.S.</given-names></name><name><surname>Patel</surname><given-names>M.</given-names></name><name><surname>Snoussi</surname><given-names>M.</given-names></name><name><surname>Singh</surname><given-names>R.</given-names></name><name><surname>Adnan</surname><given-names>M.</given-names></name></person-group><article-title>Current status and strategic possibilities on potential use of combinational drug therapy against COVID-19 caused by SARS-CoV-2</article-title><source>J. Biomol. Struct. Dyn.</source><year>2020</year><fpage>1</fpage><lpage>14</lpage></element-citation></ref><ref id="bb0655"><label>131</label><element-citation publication-type="journal" id="rf0655"><person-group person-group-type="author"><name><surname>Seifirad</surname><given-names>S.</given-names></name></person-group><article-title>Pirfenidone: a novel hypothetical treatment for COVID-19</article-title><source>Med. Hypotheses</source><volume>144</volume><year>2020</year><object-id pub-id-type="publisher-id">110005</object-id></element-citation></ref><ref id="bb0660"><label>132</label><element-citation publication-type="journal" id="rf0660"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>D.E.</given-names></name><name><surname>Sivalingam</surname><given-names>V.</given-names></name><name><surname>Kang</surname><given-names>A.E.Z.</given-names></name><name><surname>Ananthanarayanan</surname><given-names>A.</given-names></name><name><surname>Arumugam</surname><given-names>H.</given-names></name><name><surname>Jenkins</surname><given-names>T.M.</given-names></name><name><surname>Hadjiat</surname><given-names>Y.</given-names></name><name><surname>Eggers</surname><given-names>M.</given-names></name></person-group><article-title>Povidone-iodine demonstrates rapid in vitro virucidal activity against SARS-CoV-2, the virus causing COVID-19 disease</article-title><source>Infect. Dis. Ther.</source><volume>9</volume><year>2020</year><fpage>669</fpage><lpage>675</lpage><pub-id pub-id-type="pmid">32643111</pub-id></element-citation></ref><ref id="bb0665"><label>133</label><element-citation publication-type="journal" id="rf0665"><person-group person-group-type="author"><name><surname>Amirian</surname><given-names>E.S.</given-names></name><name><surname>Levy</surname><given-names>J.K.</given-names></name></person-group><article-title>Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses</article-title><source>One Health</source><volume>9</volume><year>2020</year><object-id pub-id-type="publisher-id">100128</object-id></element-citation></ref><ref id="bb0670"><label>134</label><element-citation publication-type="journal" id="rf0670"><person-group person-group-type="author"><name><surname>Acanfora</surname><given-names>D.</given-names></name><name><surname>Ciccone</surname><given-names>M.M.</given-names></name><name><surname>Scicchitano</surname><given-names>P.</given-names></name><name><surname>Acanfora</surname><given-names>C.</given-names></name><name><surname>Casucci</surname><given-names>G.</given-names></name></person-group><article-title>Neprilysin inhibitor-angiotensin II receptor blocker combination (sacubitril/valsartan): rationale for adoption in SARS-CoV-2 patients</article-title><source>Eur. Heart J. Cardiovasc. Pharmacother.</source><volume>6</volume><year>2020</year><fpage>135</fpage><lpage>136</lpage><pub-id pub-id-type="pmid">32282032</pub-id></element-citation></ref><ref id="bb0675"><label>135</label><element-citation publication-type="journal" id="rf0675"><person-group person-group-type="author"><name><surname>Palanques-Pastor</surname><given-names>T.</given-names></name><name><surname>L&#x000f3;pez-Briz</surname><given-names>E.</given-names></name><name><surname>Poveda Andr&#x000e9;s</surname><given-names>J.L.</given-names></name></person-group><article-title>Involvement of interleukin 6 in SARS-CoV-2 infection: siltuximab as a therapeutic option against COVID-19</article-title><source>Eur. J. Hosp. Pharm.</source><volume>27</volume><year>2020</year><fpage>297</fpage><lpage>298</lpage><pub-id pub-id-type="pmid">32499314</pub-id></element-citation></ref><ref id="bb0680"><label>136</label><element-citation publication-type="journal" id="rf0680"><person-group person-group-type="author"><name><surname>Carbajo-Lozoya</surname><given-names>J.</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>M.A.</given-names></name><name><surname>Kallies</surname><given-names>S.</given-names></name><name><surname>Thiel</surname><given-names>V.</given-names></name><name><surname>Drosten</surname><given-names>C.</given-names></name><name><surname>von Brunn</surname><given-names>A.</given-names></name></person-group><article-title>Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506</article-title><source>Virus Res.</source><volume>165</volume><year>2012</year><fpage>112</fpage><lpage>117</lpage><pub-id pub-id-type="pmid">22349148</pub-id></element-citation></ref><ref id="bb0685"><label>137</label><element-citation publication-type="journal" id="rf0685"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Pan</surname><given-names>Y.</given-names></name><name><surname>Hu</surname><given-names>Z.</given-names></name><name><surname>Wu</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Feng</surname><given-names>Z.</given-names></name><name><surname>Mao</surname><given-names>C.</given-names></name><name><surname>Tan</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>G.</given-names></name><name><surname>Yuan</surname><given-names>Z.</given-names></name><name><surname>Diao</surname><given-names>B.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name></person-group><article-title>Thymosin alpha 1 reduces the mortality of severe coronavirus disease 2019 by restoration of lymphocytopenia and reversion of exhausted T cells</article-title><source>Clin. Infect. Dis.</source><volume>71</volume><year>2020</year><fpage>2150</fpage><lpage>2157</lpage><pub-id pub-id-type="pmid">32442287</pub-id></element-citation></ref><ref id="bb0690"><label>138</label><element-citation publication-type="journal" id="rf0690"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>J.</given-names></name><name><surname>Pitsillou</surname><given-names>E.</given-names></name><name><surname>Karagiannis</surname><given-names>C.</given-names></name><name><surname>Darmawan</surname><given-names>K.K.</given-names></name><name><surname>Ng</surname><given-names>K.</given-names></name><name><surname>Hung</surname><given-names>A.</given-names></name><name><surname>Karagiannis</surname><given-names>T.C.</given-names></name></person-group><article-title>Interaction of the prototypical &#x003b1;-ketoamide inhibitor with the SARS-CoV-2 main protease active site in silico: molecular dynamic simulations highlight the stability of the ligand-protein complex</article-title><source>Comput. Biol. Chem.</source><volume>87</volume><year>2020</year><object-id pub-id-type="publisher-id">107292</object-id></element-citation></ref><ref id="bb0695"><label>139</label><element-citation publication-type="journal" id="rf0695"><person-group person-group-type="author"><name><surname>Devaux</surname><given-names>C.A.</given-names></name><name><surname>Rolain</surname><given-names>J.M.</given-names></name><name><surname>Colson</surname><given-names>P.</given-names></name><name><surname>Raoult</surname><given-names>D.</given-names></name></person-group><article-title>New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?</article-title><source>Int. J. Antimicrob. Agents</source><volume>55</volume><year>2020</year><object-id pub-id-type="publisher-id">105938</object-id></element-citation></ref><ref id="bb0700"><label>140</label><element-citation publication-type="journal" id="rf0700"><person-group person-group-type="author"><name><surname>Saha</surname><given-names>A.</given-names></name><name><surname>Sharma</surname><given-names>A.R.</given-names></name><name><surname>Bhattacharya</surname><given-names>M.</given-names></name><name><surname>Sharma</surname><given-names>G.</given-names></name><name><surname>Lee</surname><given-names>S.S.</given-names></name><name><surname>Chakraborty</surname><given-names>C.</given-names></name></person-group><article-title>Probable molecular mechanism of Remdesivir for the treatment of COVID-19: need to know more</article-title><source>Arch. Med. Res.</source><volume>51</volume><year>2020</year><fpage>585</fpage><lpage>586</lpage><pub-id pub-id-type="pmid">32439198</pub-id></element-citation></ref><ref id="bb0705"><label>141</label><element-citation publication-type="journal" id="rf0705"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Cao</surname><given-names>R.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Xu</surname><given-names>M.</given-names></name><name><surname>Hu</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Sun</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Shi</surname><given-names>Z.</given-names></name><name><surname>Deng</surname><given-names>F.</given-names></name><name><surname>Hu</surname><given-names>Z.</given-names></name><name><surname>Zhong</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name></person-group><article-title>The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro</article-title><source>Cell Discov.</source><volume>6</volume><issue>28</issue><year>2020</year></element-citation></ref><ref id="bb0710"><label>142</label><element-citation publication-type="journal" id="rf0710"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>N.</given-names></name><name><surname>Zhou</surname><given-names>M.</given-names></name><name><surname>Dong</surname><given-names>X.</given-names></name><name><surname>Qu</surname><given-names>J.</given-names></name><name><surname>Gong</surname><given-names>F.</given-names></name><name><surname>Han</surname><given-names>Y.</given-names></name><name><surname>Qiu</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Wei</surname><given-names>Y.</given-names></name><name><surname>Xia</surname><given-names>J.</given-names></name><name><surname>Yu</surname><given-names>T.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name></person-group><article-title>Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study</article-title><source>Lancet</source><volume>395</volume><year>2020</year><fpage>507</fpage><lpage>513</lpage><pub-id pub-id-type="pmid">32007143</pub-id></element-citation></ref><ref id="bb0715"><label>143</label><element-citation publication-type="journal" id="rf0715"><person-group person-group-type="author"><name><surname>Blaising</surname><given-names>J.</given-names></name><name><surname>Polyak</surname><given-names>S.J.</given-names></name><name><surname>P&#x000e9;cheur</surname><given-names>E.I.</given-names></name></person-group><article-title>Arbidol as a broad-spectrum antiviral: an update</article-title><source>Antivir. Res.</source><volume>107</volume><year>2014</year><fpage>84</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">24769245</pub-id></element-citation></ref><ref id="bb0720"><label>144</label><element-citation publication-type="journal" id="rf0720"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Yang</surname><given-names>B.</given-names></name><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Wen</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>R.</given-names></name></person-group><article-title>Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China</article-title><source>Clin. Infect. Dis.</source><volume>71</volume><year>2020</year><fpage>769</fpage><lpage>777</lpage><pub-id pub-id-type="pmid">32176772</pub-id></element-citation></ref><ref id="bb0725"><label>145</label><element-citation publication-type="journal" id="rf0725"><person-group person-group-type="author"><name><surname>Lian</surname><given-names>N.</given-names></name><name><surname>Xie</surname><given-names>H.</given-names></name><name><surname>Lin</surname><given-names>S.</given-names></name><name><surname>Huang</surname><given-names>J.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Lin</surname><given-names>Q.</given-names></name></person-group><article-title>Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study</article-title><source>Clin. Microbiol. Infect.</source><volume>26</volume><year>2020</year><fpage>917</fpage><lpage>921</lpage><pub-id pub-id-type="pmid">32344167</pub-id></element-citation></ref><ref id="bb0730"><label>146</label><element-citation publication-type="journal" id="rf0730"><person-group person-group-type="author"><name><surname>Romanelli</surname><given-names>F.</given-names></name><name><surname>Smith</surname><given-names>K.M.</given-names></name><name><surname>Hoven</surname><given-names>A.D.</given-names></name></person-group><article-title>Chloroquine and hydroxychloroquine as inhibitors of human immunodeficiency virus (HIV-1) activity</article-title><source>Curr. Pharm. Des.</source><volume>10</volume><year>2004</year><fpage>2643</fpage><lpage>2648</lpage><pub-id pub-id-type="pmid">15320751</pub-id></element-citation></ref><ref id="bb0735"><label>147</label><element-citation publication-type="journal" id="rf0735"><person-group person-group-type="author"><name><surname>Keyaerts</surname><given-names>E.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Vijgen</surname><given-names>L.</given-names></name><name><surname>Rysman</surname><given-names>E.</given-names></name><name><surname>Verbeeck</surname><given-names>J.</given-names></name><name><surname>Van Ranst</surname><given-names>M.</given-names></name><name><surname>Maes</surname><given-names>P.</given-names></name></person-group><article-title>Antiviral activity of chloroquine against human coronavirus OC43 infection in newborn mice</article-title><source>Antimicrob. Agents Chemother.</source><volume>53</volume><year>2009</year><fpage>3416</fpage><lpage>3421</lpage><pub-id pub-id-type="pmid">19506054</pub-id></element-citation></ref><ref id="bb0740"><label>148</label><element-citation publication-type="journal" id="rf0740"><person-group person-group-type="author"><name><surname>Andreani</surname><given-names>J.</given-names></name><name><surname>Le Bideau</surname><given-names>M.</given-names></name><name><surname>Duflot</surname><given-names>I.</given-names></name><name><surname>Jardot</surname><given-names>P.</given-names></name><name><surname>Rolland</surname><given-names>C.</given-names></name><name><surname>Boxberger</surname><given-names>M.</given-names></name><name><surname>Wurtz</surname><given-names>N.</given-names></name><name><surname>Rolain</surname><given-names>J.M.</given-names></name><name><surname>Colson</surname><given-names>P.</given-names></name><name><surname>La Scola</surname><given-names>B.</given-names></name><name><surname>Raoult</surname><given-names>D.</given-names></name></person-group><article-title>In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect</article-title><source>Microb. Pathog.</source><volume>145</volume><year>2020</year><object-id pub-id-type="publisher-id">104228</object-id></element-citation></ref><ref id="bb0745"><label>149</label><element-citation publication-type="journal" id="rf0745"><person-group person-group-type="author"><name><surname>Million</surname><given-names>M.</given-names></name><name><surname>Lagier</surname><given-names>J.C.</given-names></name><name><surname>Gautret</surname><given-names>P.</given-names></name><name><surname>Colson</surname><given-names>P.</given-names></name><name><surname>Fournier</surname><given-names>P.E.</given-names></name><name><surname>Amrane</surname><given-names>S.</given-names></name><name><surname>Hocquart</surname><given-names>M.</given-names></name><name><surname>Mailhe</surname><given-names>M.</given-names></name><name><surname>Esteves-Vieira</surname><given-names>V.</given-names></name><name><surname>Doudier</surname><given-names>B.</given-names></name><name><surname>Aubry</surname><given-names>C.</given-names></name><name><surname>Correard</surname><given-names>F.</given-names></name><name><surname>Giraud-Gatineau</surname><given-names>A.</given-names></name><name><surname>Roussel</surname><given-names>Y.</given-names></name><name><surname>Berenger</surname><given-names>C.</given-names></name><name><surname>Cassir</surname><given-names>N.</given-names></name><name><surname>Seng</surname><given-names>P.</given-names></name><name><surname>Zandotti</surname><given-names>C.</given-names></name><name><surname>Dhiver</surname><given-names>C.</given-names></name><name><surname>Ravaux</surname><given-names>I.</given-names></name><name><surname>Tomei</surname><given-names>C.</given-names></name><name><surname>Eldin</surname><given-names>C.</given-names></name><name><surname>Tissot-Dupont</surname><given-names>H.</given-names></name><name><surname>Honor&#x000e9;</surname><given-names>S.</given-names></name><name><surname>Stein</surname><given-names>A.</given-names></name><name><surname>Jacquier</surname><given-names>A.</given-names></name><name><surname>Deharo</surname><given-names>J.C.</given-names></name><name><surname>Chabri&#x000e8;re</surname><given-names>E.</given-names></name><name><surname>Levasseur</surname><given-names>A.</given-names></name><name><surname>Fenollar</surname><given-names>F.</given-names></name><name><surname>Rolain</surname><given-names>J.M.</given-names></name><name><surname>Obadia</surname><given-names>Y.</given-names></name><name><surname>Brouqui</surname><given-names>P.</given-names></name><name><surname>Drancourt</surname><given-names>M.</given-names></name><name><surname>La Scola</surname><given-names>B.</given-names></name><name><surname>Parola</surname><given-names>P.</given-names></name><name><surname>Raoult</surname><given-names>D.</given-names></name></person-group><article-title>Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: a retrospective analysis of 1061 cases in Marseille, France</article-title><source>Travel Med. Infect. Dis.</source><volume>35</volume><year>2020</year><object-id pub-id-type="publisher-id">101738</object-id></element-citation></ref><ref id="bb0750"><label>150</label><element-citation publication-type="journal" id="rf0750"><person-group person-group-type="author"><name><surname>Gautret</surname><given-names>P.</given-names></name><name><surname>Lagier</surname><given-names>J.C.</given-names></name><name><surname>Parola</surname><given-names>P.</given-names></name><name><surname>Hoang</surname><given-names>V.T.</given-names></name><name><surname>Meddeb</surname><given-names>L.</given-names></name><name><surname>Mailhe</surname><given-names>M.</given-names></name><name><surname>Doudier</surname><given-names>B.</given-names></name><name><surname>Courjon</surname><given-names>J.</given-names></name><name><surname>Giordanengo</surname><given-names>V.</given-names></name><name><surname>Vieira</surname><given-names>V.E.</given-names></name><name><surname>Tissot Dupont</surname><given-names>H.</given-names></name><name><surname>Honor&#x000e9;</surname><given-names>S.</given-names></name><name><surname>Colson</surname><given-names>P.</given-names></name><name><surname>Chabri&#x000e8;re</surname><given-names>E.</given-names></name><name><surname>La Scola</surname><given-names>B.</given-names></name><name><surname>Rolain</surname><given-names>J.M.</given-names></name><name><surname>Brouqui</surname><given-names>P.</given-names></name><name><surname>Raoult</surname><given-names>D.</given-names></name></person-group><article-title>Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial</article-title><source>Int. J. Antimicrob. Agents</source><volume>56</volume><year>2020</year><object-id pub-id-type="publisher-id">105949</object-id></element-citation></ref><ref id="bb0755"><label>151</label><element-citation publication-type="journal" id="rf0755"><person-group person-group-type="author"><name><surname>Parra-Lara</surname><given-names>L.G.</given-names></name><name><surname>Mart&#x000ed;nez-Arboleda</surname><given-names>J.J.</given-names></name><name><surname>Rosso</surname><given-names>F.</given-names></name></person-group><article-title>Azithromycin and SARS-CoV-2 infection: where we are now and where we are going</article-title><source>J. Glob. Antimicrob. Resis.</source><volume>22</volume><year>2020</year><fpage>680</fpage><lpage>684</lpage></element-citation></ref><ref id="bb0760"><label>152</label><element-citation publication-type="other" id="rf0760"><person-group person-group-type="author"><name><surname>WHO</surname></name></person-group><article-title>WHO discontinues hydroxychloroquine and lopinavir/ritonavir treatment arms for COVID-19</article-title><ext-link ext-link-type="uri" xlink:href="https://www.who.int/news-room/detail/04-07-2020-who-discontinues-hydroxychloroquine-and-lopinavir-ritonavir-treatment-arms-for-covid-19" id="ir0040">https://www.who.int/news-room/detail/04-07-2020-who-discontinues-hydroxychloroquine-and-lopinavir-ritonavir-treatment-arms-for-covid-19</ext-link><comment>(2020, accessed 15 August, 2020)</comment></element-citation></ref><ref id="bb0765"><label>153</label><element-citation publication-type="journal" id="rf0765"><person-group person-group-type="author"><name><surname>de Wilde</surname><given-names>A.H.</given-names></name><name><surname>Jochmans</surname><given-names>D.</given-names></name><name><surname>Posthuma</surname><given-names>C.C.</given-names></name><name><surname>Zevenhoven-Dobbe</surname><given-names>J.C.</given-names></name><name><surname>van Nieuwkoop</surname><given-names>S.</given-names></name><name><surname>Bestebroer</surname><given-names>T.M.</given-names></name><name><surname>van den Hoogen</surname><given-names>B.G.</given-names></name><name><surname>Neyts</surname><given-names>J.</given-names></name><name><surname>Snijder</surname><given-names>E.J.</given-names></name></person-group><article-title>Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture</article-title><source>Antimicrob. Agents Chemother.</source><volume>58</volume><year>2014</year><fpage>4875</fpage><lpage>4884</lpage><pub-id pub-id-type="pmid">24841269</pub-id></element-citation></ref><ref id="bb0770"><label>154</label><element-citation publication-type="journal" id="rf0770"><person-group person-group-type="author"><name><surname>Choy</surname><given-names>K.T.</given-names></name><name><surname>Wong</surname><given-names>A.Y.</given-names></name><name><surname>Kaewpreedee</surname><given-names>P.</given-names></name><name><surname>Sia</surname><given-names>S.F.</given-names></name><name><surname>Chen</surname><given-names>D.</given-names></name><name><surname>Hui</surname><given-names>K.P.Y.</given-names></name><name><surname>Chu</surname><given-names>D.K.W.</given-names></name><name><surname>Chan</surname><given-names>M.C.W.</given-names></name><name><surname>Cheung</surname><given-names>P.P.</given-names></name><name><surname>Huang</surname><given-names>X.</given-names></name><name><surname>Peiris</surname><given-names>M.</given-names></name><name><surname>Yen</surname><given-names>H.L.</given-names></name></person-group><article-title>Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro</article-title><source>Antivir. Res.</source><volume>178</volume><year>2020</year><object-id pub-id-type="publisher-id">104786</object-id></element-citation></ref><ref id="bb0775"><label>155</label><element-citation publication-type="journal" id="rf0775"><person-group person-group-type="author"><name><surname>Warren</surname><given-names>T.K.</given-names></name><name><surname>Jordan</surname><given-names>R.</given-names></name><name><surname>Lo</surname><given-names>M.K.</given-names></name><name><surname>Ray</surname><given-names>A.S.</given-names></name><name><surname>Mackman</surname><given-names>R.L.</given-names></name><name><surname>Soloveva</surname><given-names>V.</given-names></name><name><surname>Siegel</surname><given-names>D.</given-names></name><name><surname>Perron</surname><given-names>M.</given-names></name><name><surname>Bannister</surname><given-names>R.</given-names></name><name><surname>Hui</surname><given-names>H.C.</given-names></name><name><surname>Larson</surname><given-names>N.</given-names></name><name><surname>Strickley</surname><given-names>R.</given-names></name><name><surname>Wells</surname><given-names>J.</given-names></name><name><surname>Stuthman</surname><given-names>K.S.</given-names></name><name><surname>Van Tongeren</surname><given-names>S.A.</given-names></name><name><surname>Garza</surname><given-names>N.L.</given-names></name><name><surname>Donnelly</surname><given-names>G.</given-names></name><name><surname>Shurtleff</surname><given-names>A.C.</given-names></name><name><surname>Retterer</surname><given-names>C.J.</given-names></name><name><surname>Gharaibeh</surname><given-names>D.</given-names></name><name><surname>Zamani</surname><given-names>R.</given-names></name><name><surname>Kenny</surname><given-names>T.</given-names></name><name><surname>Eaton</surname><given-names>B.P.</given-names></name><name><surname>Grimes</surname><given-names>E.</given-names></name><name><surname>Welch</surname><given-names>L.S.</given-names></name><name><surname>Gomba</surname><given-names>L.</given-names></name><name><surname>Wilhelmsen</surname><given-names>C.L.</given-names></name><name><surname>Nichols</surname><given-names>D.K.</given-names></name><name><surname>Nuss</surname><given-names>J.E.</given-names></name><name><surname>Nagle</surname><given-names>E.R.</given-names></name><name><surname>Kugelman</surname><given-names>J.R.</given-names></name><name><surname>Palacios</surname><given-names>G.</given-names></name><name><surname>Doerffler</surname><given-names>E.</given-names></name><name><surname>Neville</surname><given-names>S.</given-names></name><name><surname>Carra</surname><given-names>E.</given-names></name><name><surname>Clarke</surname><given-names>M.O.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Lew</surname><given-names>W.</given-names></name><name><surname>Ross</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Chun</surname><given-names>K.</given-names></name><name><surname>Wolfe</surname><given-names>L.</given-names></name><name><surname>Babusis</surname><given-names>D.</given-names></name><name><surname>Park</surname><given-names>Y.</given-names></name><name><surname>Stray</surname><given-names>K.M.</given-names></name><name><surname>Trancheva</surname><given-names>I.</given-names></name><name><surname>Feng</surname><given-names>J.Y.</given-names></name><name><surname>Barauskas</surname><given-names>O.</given-names></name><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Wong</surname><given-names>P.</given-names></name><name><surname>Braun</surname><given-names>M.R.</given-names></name><name><surname>Flint</surname><given-names>M.</given-names></name><name><surname>McMullan</surname><given-names>L.K.</given-names></name><name><surname>Chen</surname><given-names>S.S.</given-names></name><name><surname>Fearns</surname><given-names>R.</given-names></name><name><surname>Swaminathan</surname><given-names>S.</given-names></name><name><surname>Mayers</surname><given-names>D.L.</given-names></name><name><surname>Spiropoulou</surname><given-names>C.F.</given-names></name><name><surname>Lee</surname><given-names>W.A.</given-names></name><name><surname>Nichol</surname><given-names>S.T.</given-names></name><name><surname>Cihlar</surname><given-names>T.</given-names></name><name><surname>Bavari</surname><given-names>S.</given-names></name></person-group><article-title>Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys</article-title><source>Nature</source><volume>531</volume><year>2016</year><fpage>381</fpage><lpage>385</lpage><pub-id pub-id-type="pmid">26934220</pub-id></element-citation></ref><ref id="bb0780"><label>156</label><element-citation publication-type="journal" id="rf0780"><person-group person-group-type="author"><name><surname>Lo</surname><given-names>M.K.</given-names></name><name><surname>Jordan</surname><given-names>R.</given-names></name><name><surname>Arvey</surname><given-names>A.</given-names></name><name><surname>Sudhamsu</surname><given-names>J.</given-names></name><name><surname>Shrivastava-Ranjan</surname><given-names>P.</given-names></name><name><surname>Hotard</surname><given-names>A.L.</given-names></name><name><surname>Flint</surname><given-names>M.</given-names></name><name><surname>McMullan</surname><given-names>L.K.</given-names></name><name><surname>Siegel</surname><given-names>D.</given-names></name><name><surname>Clarke</surname><given-names>M.O.</given-names></name><name><surname>Mackman</surname><given-names>R.L.</given-names></name><name><surname>Hui</surname><given-names>H.C.</given-names></name><name><surname>Perron</surname><given-names>M.</given-names></name><name><surname>Ray</surname><given-names>A.S.</given-names></name><name><surname>Cihlar</surname><given-names>T.</given-names></name><name><surname>Nichol</surname><given-names>S.T.</given-names></name><name><surname>Spiropoulou</surname><given-names>C.F.</given-names></name></person-group><article-title>GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses</article-title><source>Sci. Rep.</source><volume>7</volume><year>2017</year><object-id pub-id-type="publisher-id">43395</object-id></element-citation></ref><ref id="bb0785"><label>157</label><element-citation publication-type="journal" id="rf0785"><person-group person-group-type="author"><name><surname>Sheahan</surname><given-names>T.P.</given-names></name><name><surname>Sims</surname><given-names>A.C.</given-names></name><name><surname>Graham</surname><given-names>R.L.</given-names></name><name><surname>Menachery</surname><given-names>V.D.</given-names></name><name><surname>Gralinski</surname><given-names>L.E.</given-names></name><name><surname>Case</surname><given-names>J.B.</given-names></name><name><surname>Leist</surname><given-names>S.R.</given-names></name><name><surname>Pyrc</surname><given-names>K.</given-names></name><name><surname>Feng</surname><given-names>J.Y.</given-names></name><name><surname>Trantcheva</surname><given-names>I.</given-names></name><name><surname>Bannister</surname><given-names>R.</given-names></name><name><surname>Park</surname><given-names>Y.</given-names></name><name><surname>Babusis</surname><given-names>D.</given-names></name><name><surname>Clarke</surname><given-names>M.O.</given-names></name><name><surname>Mackman</surname><given-names>R.L.</given-names></name><name><surname>Spahn</surname><given-names>J.E.</given-names></name><name><surname>Palmiotti</surname><given-names>C.A.</given-names></name><name><surname>Siegel</surname><given-names>D.</given-names></name><name><surname>Ray</surname><given-names>A.S.</given-names></name><name><surname>Cihlar</surname><given-names>T.</given-names></name><name><surname>Jordan</surname><given-names>R.</given-names></name><name><surname>Denison</surname><given-names>M.R.</given-names></name><name><surname>Baric</surname><given-names>R.S.</given-names></name></person-group><article-title>Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses</article-title><source>Sci. Transl. Med.</source><volume>9</volume><year>2017</year><object-id pub-id-type="publisher-id">eaal3653</object-id></element-citation></ref><ref id="bb0790"><label>158</label><element-citation publication-type="journal" id="rf0790"><person-group person-group-type="author"><name><surname>Williamson</surname><given-names>B.N.</given-names></name><name><surname>Feldmann</surname><given-names>F.</given-names></name><name><surname>Schwarz</surname><given-names>B.</given-names></name><name><surname>Meade-White</surname><given-names>K.</given-names></name><name><surname>Porter</surname><given-names>D.P.</given-names></name><name><surname>Schulz</surname><given-names>J.</given-names></name><name><surname>van Doremalen</surname><given-names>N.</given-names></name><name><surname>Leighton</surname><given-names>I.</given-names></name><name><surname>Yinda</surname><given-names>C.K.</given-names></name><name><surname>P&#x000e9;rez-P&#x000e9;rez</surname><given-names>L.</given-names></name><name><surname>Okumura</surname><given-names>A.</given-names></name><name><surname>Lovaglio</surname><given-names>J.</given-names></name><name><surname>Hanley</surname><given-names>P.W.</given-names></name><name><surname>Saturday</surname><given-names>G.</given-names></name><name><surname>Bosio</surname><given-names>C.M.</given-names></name><name><surname>Anzick</surname><given-names>S.</given-names></name><name><surname>Barbian</surname><given-names>K.</given-names></name><name><surname>Cihlar</surname><given-names>T.</given-names></name><name><surname>Martens</surname><given-names>C.</given-names></name><name><surname>Scott</surname><given-names>D.P.</given-names></name><name><surname>Munster</surname><given-names>V.J.</given-names></name><name><surname>de Wit</surname><given-names>E.</given-names></name></person-group><article-title>Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2</article-title><source>Nature</source><volume>585</volume><year>2020</year><fpage>273</fpage><lpage>276</lpage><pub-id pub-id-type="pmid">32516797</pub-id></element-citation></ref><ref id="bb0795"><label>159</label><element-citation publication-type="journal" id="rf0795"><person-group person-group-type="author"><name><surname>Grein</surname><given-names>J.</given-names></name><name><surname>Ohmagari</surname><given-names>N.</given-names></name><name><surname>Shin</surname><given-names>D.</given-names></name><name><surname>Diaz</surname><given-names>G.</given-names></name><name><surname>Asperges</surname><given-names>E.</given-names></name><name><surname>Castagna</surname><given-names>A.</given-names></name><name><surname>Feldt</surname><given-names>T.</given-names></name><name><surname>Green</surname><given-names>G.</given-names></name><name><surname>Green</surname><given-names>M.L.</given-names></name><name><surname>Lescure</surname><given-names>F.X.</given-names></name><name><surname>Nicastri</surname><given-names>E.</given-names></name><name><surname>Oda</surname><given-names>R.</given-names></name><name><surname>Yo</surname><given-names>K.</given-names></name><name><surname>Quiros-Roldan</surname><given-names>E.</given-names></name><name><surname>Studemeister</surname><given-names>A.</given-names></name><name><surname>Redinski</surname><given-names>J.</given-names></name><name><surname>Ahmed</surname><given-names>S.</given-names></name><name><surname>Bernett</surname><given-names>J.</given-names></name><name><surname>Chelliah</surname><given-names>D.</given-names></name><name><surname>Chen</surname><given-names>D.</given-names></name><name><surname>Chihara</surname><given-names>S.</given-names></name><name><surname>Cohen</surname><given-names>S.H.</given-names></name><name><surname>Cunningham</surname><given-names>J.</given-names></name><name><surname>D'Arminio Monforte</surname><given-names>A.</given-names></name><name><surname>Ismail</surname><given-names>S.</given-names></name><name><surname>Kato</surname><given-names>H.</given-names></name><name><surname>Lapadula</surname><given-names>G.</given-names></name><name><surname>L'Her</surname><given-names>E.</given-names></name><name><surname>Maeno</surname><given-names>T.</given-names></name><name><surname>Majumder</surname><given-names>S.</given-names></name><name><surname>Massari</surname><given-names>M.</given-names></name><name><surname>Mora-Rillo</surname><given-names>M.</given-names></name><name><surname>Mutoh</surname><given-names>Y.</given-names></name><name><surname>Nguyen</surname><given-names>D.</given-names></name><name><surname>Verweij</surname><given-names>E.</given-names></name><name><surname>Zoufaly</surname><given-names>A.</given-names></name><name><surname>Osinusi</surname><given-names>A.O.</given-names></name><name><surname>DeZure</surname><given-names>A.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Zhong</surname><given-names>L.</given-names></name><name><surname>Chokkalingam</surname><given-names>A.</given-names></name><name><surname>Elboudwarej</surname><given-names>E.</given-names></name><name><surname>Telep</surname><given-names>L.</given-names></name><name><surname>Timbs</surname><given-names>L.</given-names></name><name><surname>Henne</surname><given-names>I.</given-names></name><name><surname>Sellers</surname><given-names>S.</given-names></name><name><surname>Cao</surname><given-names>H.</given-names></name><name><surname>Tan</surname><given-names>S.K.</given-names></name><name><surname>Winterbourne</surname><given-names>L.</given-names></name><name><surname>Desai</surname><given-names>P.</given-names></name><name><surname>Mera</surname><given-names>R.</given-names></name><name><surname>Gaggar</surname><given-names>A.</given-names></name><name><surname>Myers</surname><given-names>R.P.</given-names></name><name><surname>Brainard</surname><given-names>D.M.</given-names></name><name><surname>Childs</surname><given-names>R.</given-names></name><name><surname>Flanigan</surname><given-names>T.</given-names></name></person-group><article-title>Compassionate use of Remdesivir for patients with severe Covid-19</article-title><source>N. Engl. J. Med.</source><volume>382</volume><year>2020</year><fpage>2327</fpage><lpage>2336</lpage><pub-id pub-id-type="pmid">32275812</pub-id></element-citation></ref><ref id="bb0800"><label>160</label><element-citation publication-type="journal" id="rf0800"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Wu</surname><given-names>Z.</given-names></name><name><surname>Shang</surname><given-names>Y.</given-names></name><name><surname>Dong</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>G.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Ye</surname><given-names>X.</given-names></name><name><surname>Du</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>T.</given-names></name><name><surname>Huang</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Wen</surname><given-names>Z.</given-names></name><name><surname>Qu</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>D.</given-names></name></person-group><article-title>Clinical outcomes of COVID-19 in Wuhan, China: a large cohort study</article-title><source>Ann. Intensive Care</source><volume>10</volume><issue>99</issue><year>2020</year></element-citation></ref><ref id="bb0805"><label>161</label><element-citation publication-type="journal" id="rf0805"><person-group person-group-type="author"><name><surname>Capra</surname><given-names>R.</given-names></name><name><surname>De Rossi</surname><given-names>N.</given-names></name><name><surname>Mattioli</surname><given-names>F.</given-names></name><name><surname>Romanelli</surname><given-names>G.</given-names></name><name><surname>Scarpazza</surname><given-names>C.</given-names></name><name><surname>Sormani</surname><given-names>M.P.</given-names></name><name><surname>Cossi</surname><given-names>S.</given-names></name></person-group><article-title>Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia</article-title><source>Eur. J. Intern. Med.</source><volume>76</volume><year>2020</year><fpage>31</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">32405160</pub-id></element-citation></ref><ref id="bb0810"><label>162</label><element-citation publication-type="journal" id="rf0810"><person-group person-group-type="author"><name><surname>Somers</surname><given-names>E.C.</given-names></name><name><surname>Eschenauer</surname><given-names>G.A.</given-names></name><name><surname>Troost</surname><given-names>J.P.</given-names></name><name><surname>Golob</surname><given-names>J.L.</given-names></name><name><surname>Gandhi</surname><given-names>T.N.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Zhou</surname><given-names>N.</given-names></name><name><surname>Petty</surname><given-names>L.A.</given-names></name><name><surname>Baang</surname><given-names>J.H.</given-names></name><name><surname>Dillman</surname><given-names>N.O.</given-names></name><name><surname>Frame</surname><given-names>D.</given-names></name><name><surname>Gregg</surname><given-names>K.S.</given-names></name><name><surname>Kaul</surname><given-names>D.R.</given-names></name><name><surname>Nagel</surname><given-names>J.</given-names></name><name><surname>Patel</surname><given-names>T.S.</given-names></name><name><surname>Zhou</surname><given-names>S.</given-names></name><name><surname>Lauring</surname><given-names>A.S.</given-names></name><name><surname>Hanauer</surname><given-names>D.A.</given-names></name><name><surname>Martin</surname><given-names>E.</given-names></name><name><surname>Sharma</surname><given-names>P.</given-names></name><name><surname>Fung</surname><given-names>C.M.</given-names></name><name><surname>Pogue</surname><given-names>J.M.</given-names></name></person-group><article-title>Tocilizumab for treatment of mechanically ventilated patients with COVID-19</article-title><source>Clin. Infect. Dis.</source><year>2020</year><object-id pub-id-type="publisher-id">ciaa954</object-id></element-citation></ref><ref id="bb0815"><label>163</label><element-citation publication-type="journal" id="rf0815"><person-group person-group-type="author"><name><surname>Gremese</surname><given-names>E.</given-names></name><name><surname>Cingolani</surname><given-names>A.</given-names></name><name><surname>Bosello</surname><given-names>S.L.</given-names></name><name><surname>Alivernini</surname><given-names>S.</given-names></name><name><surname>Tolusso</surname><given-names>B.</given-names></name><name><surname>Perniola</surname><given-names>S.</given-names></name><name><surname>Landi</surname><given-names>F.</given-names></name><name><surname>Pompili</surname><given-names>M.</given-names></name><name><surname>Murri</surname><given-names>R.</given-names></name><name><surname>Santoliquido</surname><given-names>A.</given-names></name><name><surname>Garcovich</surname><given-names>M.</given-names></name><name><surname>Sali</surname><given-names>M.</given-names></name><name><surname>De Pascale</surname><given-names>G.</given-names></name><name><surname>Gabrielli</surname><given-names>M.</given-names></name><name><surname>Biscetti</surname><given-names>F.</given-names></name><name><surname>Montalto</surname><given-names>M.</given-names></name><name><surname>Tosoni</surname><given-names>A.</given-names></name><name><surname>Gambassi</surname><given-names>G.</given-names></name><name><surname>Rapaccini</surname><given-names>G.L.</given-names></name><name><surname>Iaconelli</surname><given-names>A.</given-names></name><name><surname>Zileri Del Verme</surname><given-names>L.</given-names></name><name><surname>Petricca</surname><given-names>L.</given-names></name><name><surname>Fedele</surname><given-names>A.L.</given-names></name><name><surname>Lizzio</surname><given-names>M.M.</given-names></name><name><surname>Tamburrini</surname><given-names>E.</given-names></name><name><surname>Natalello</surname><given-names>G.</given-names></name><name><surname>Gigante</surname><given-names>L.</given-names></name><name><surname>Bruno</surname><given-names>D.</given-names></name><name><surname>Verardi</surname><given-names>L.</given-names></name><name><surname>Taddei</surname><given-names>E.</given-names></name><name><surname>Calabrese</surname><given-names>A.</given-names></name><name><surname>Lombardi</surname><given-names>F.</given-names></name><name><surname>Bernabei</surname><given-names>R.</given-names></name><name><surname>Cauda</surname><given-names>R.</given-names></name><name><surname>Franceschi</surname><given-names>F.</given-names></name><name><surname>Landolfi</surname><given-names>R.</given-names></name><name><surname>Richeldi</surname><given-names>L.</given-names></name><name><surname>Sanguinetti</surname><given-names>M.</given-names></name><name><surname>Fantoni</surname><given-names>M.</given-names></name><name><surname>Antonelli</surname><given-names>M.</given-names></name><name><surname>Gasbarrini</surname><given-names>A.</given-names></name><name><surname>GEMELLI AGAINST COVID-19 Group</surname></name></person-group><article-title>Sarilumab use in severe SARS-CoV-2 pneumonia</article-title><source>EClinicalMedicine</source><volume>27</volume><year>2020</year><fpage>100553</fpage><pub-id pub-id-type="pmid">33043284</pub-id></element-citation></ref><ref id="bb0820"><label>164</label><element-citation publication-type="journal" id="rf0820"><person-group person-group-type="author"><name><surname>Dinarello</surname><given-names>C.A.</given-names></name><name><surname>Simon</surname><given-names>A.</given-names></name><name><surname>van der Meer</surname><given-names>J.W.</given-names></name></person-group><article-title>Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases</article-title><source>Nat. Rev. Drug Discov.</source><volume>11</volume><year>2012</year><fpage>633</fpage><lpage>652</lpage><pub-id pub-id-type="pmid">22850787</pub-id></element-citation></ref><ref id="bb0825"><label>165</label><element-citation publication-type="journal" id="rf0825"><person-group person-group-type="author"><name><surname>Cingolani</surname><given-names>A.</given-names></name><name><surname>Tummolo</surname><given-names>A.M.</given-names></name><name><surname>Montemurro</surname><given-names>G.</given-names></name><name><surname>Gremese</surname><given-names>E.</given-names></name><name><surname>Larosa</surname><given-names>L.</given-names></name><name><surname>Cipriani</surname><given-names>M.C.</given-names></name><name><surname>Pasciuto</surname><given-names>G.</given-names></name><name><surname>Liperoti</surname><given-names>R.</given-names></name><name><surname>Murri</surname><given-names>R.</given-names></name><name><surname>Pirronti</surname><given-names>T.</given-names></name><name><surname>Cauda</surname><given-names>R.</given-names></name><name><surname>Fantoni</surname><given-names>M.</given-names></name><name><surname>for COVID 2 Columbus Working Group</surname></name></person-group><article-title>Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab</article-title><source>Infection</source><volume>48</volume><year>2020</year><fpage>767</fpage><lpage>771</lpage><pub-id pub-id-type="pmid">32642806</pub-id></element-citation></ref><ref id="bb0830"><label>166</label><element-citation publication-type="journal" id="rf0830"><person-group person-group-type="author"><name><surname>Li</surname><given-names>C.C.</given-names></name><name><surname>Wang</surname><given-names>X.J.</given-names></name><name><surname>Wang</surname><given-names>H.R.</given-names></name></person-group><article-title>Repurposing host-based therapeutics to control coronavirus and influenza virus</article-title><source>Drug Discov. Today</source><volume>24</volume><year>2019</year><fpage>726</fpage><lpage>736</lpage><pub-id pub-id-type="pmid">30711575</pub-id></element-citation></ref><ref id="bb0835"><label>167</label><element-citation publication-type="journal" id="rf0835"><person-group person-group-type="author"><name><surname>Rosa</surname><given-names>S.G.V.</given-names></name><name><surname>Santos</surname><given-names>W.C.</given-names></name></person-group><article-title>Clinical trials on drug repositioning for COVID-19 treatment</article-title><source>Rev. Panam. Salud Publica</source><volume>44</volume><year>2020</year><fpage>e40</fpage><pub-id pub-id-type="pmid">32256547</pub-id></element-citation></ref><ref id="bb0840"><label>168</label><element-citation publication-type="journal" id="rf0840"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>A.K.</given-names></name><name><surname>Singh</surname><given-names>R.</given-names></name></person-group><article-title>Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19?</article-title><source>Diabetes Res. Clin. Pract.</source><volume>165</volume><year>2020</year><object-id pub-id-type="publisher-id">108268</object-id></element-citation></ref><ref id="bb0845"><label>169</label><element-citation publication-type="journal" id="rf0845"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>D.</given-names></name><name><surname>Cheng</surname><given-names>B.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Peng</surname><given-names>A.</given-names></name><name><surname>Yang</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>C.</given-names></name><name><surname>Xiong</surname><given-names>M.</given-names></name><name><surname>Deng</surname><given-names>A.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Zheng</surname><given-names>L.</given-names></name><name><surname>Huang</surname><given-names>K.</given-names></name></person-group><article-title>Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication</article-title><source>Diabetes Care</source><volume>43</volume><year>2020</year><fpage>1399</fpage><lpage>1407</lpage><pub-id pub-id-type="pmid">32409498</pub-id></element-citation></ref><ref id="bb0850"><label>170</label><element-citation publication-type="journal" id="rf0850"><person-group person-group-type="author"><name><surname>Bramante</surname><given-names>C.</given-names></name><name><surname>Ingraham</surname><given-names>N.</given-names></name><name><surname>Murray</surname><given-names>T.</given-names></name><name><surname>Marmor</surname><given-names>S.</given-names></name><name><surname>Hoversten</surname><given-names>S.</given-names></name><name><surname>Gronski</surname><given-names>J.</given-names></name><name><surname>McNeil</surname><given-names>C.</given-names></name><name><surname>Feng</surname><given-names>R.</given-names></name><name><surname>Guzman</surname><given-names>G.</given-names></name><name><surname>Abdelwahab</surname><given-names>N.</given-names></name><name><surname>King</surname><given-names>S.</given-names></name><name><surname>Meehan</surname><given-names>T.</given-names></name><name><surname>Benson</surname><given-names>B.</given-names></name><name><surname>Pendleton</surname><given-names>K.</given-names></name><name><surname>Vojta</surname><given-names>D.</given-names></name><name><surname>Tignanelli</surname><given-names>C.J.</given-names></name></person-group><article-title>Observational Study of Metformin and Risk of Mortality in Patients Hospitalized with Covid-19</article-title><source>medRxiv</source><year>2020</year><comment>(2020.06.19.20135095)</comment></element-citation></ref><ref id="bb0855"><label>171</label><element-citation publication-type="journal" id="rf0855"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>P.</given-names></name><name><surname>Qiu</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>X.L.</given-names></name><name><surname>Zheng</surname><given-names>J.L.</given-names></name><name><surname>Xue</surname><given-names>H.Y.</given-names></name><name><surname>Liu</surname><given-names>W.H.</given-names></name><name><surname>Liu</surname><given-names>D.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name></person-group><article-title>Metformin treatment was associated with decreased mortality in COVID-19 patients with diabetes in a retrospective analysis</article-title><source>Am. J. Trop. Med. Hyg.</source><volume>103</volume><year>2020</year><fpage>69</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">32446312</pub-id></element-citation></ref><ref id="bb0860"><label>172</label><element-citation publication-type="journal" id="rf0860"><person-group person-group-type="author"><name><surname>Squillace</surname><given-names>N.</given-names></name><name><surname>Bozzi</surname><given-names>G.</given-names></name><name><surname>Colella</surname><given-names>E.</given-names></name><name><surname>Gori</surname><given-names>A.</given-names></name><name><surname>Bandera</surname><given-names>A.</given-names></name></person-group><article-title>Darunavir-cobicistat-emtricitabine-tenofovir alafenamide: safety and efficacy of a protease inhibitor in the modern era</article-title><source>Drug Des. Devel. Ther.</source><volume>12</volume><year>2018</year><fpage>3635</fpage><lpage>3643</lpage></element-citation></ref><ref id="bb0865"><label>173</label><element-citation publication-type="journal" id="rf0865"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Xia</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Xu</surname><given-names>Q.</given-names></name><name><surname>Ling</surname><given-names>Y.</given-names></name><name><surname>Huang</surname><given-names>D.</given-names></name><name><surname>Huang</surname><given-names>W.</given-names></name><name><surname>Song</surname><given-names>S.</given-names></name><name><surname>Xu</surname><given-names>S.</given-names></name><name><surname>Shen</surname><given-names>Y.</given-names></name><name><surname>Lu</surname><given-names>H.</given-names></name></person-group><article-title>Antiviral activity and safety of Darunavir/Cobicistat for the treatment of COVID-19</article-title><source>Open Forum Infect. Dis.</source><volume>7</volume><year>2020</year><object-id pub-id-type="publisher-id">ofaa241</object-id></element-citation></ref><ref id="bb0870"><label>174</label><element-citation publication-type="journal" id="rf0870"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>T.</given-names></name><name><surname>Gao</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>Z.</given-names></name><name><surname>Selinger</surname><given-names>D.W.</given-names></name><name><surname>Zhou</surname><given-names>Z.</given-names></name></person-group><article-title>Indomethacin has a potent antiviral activity against SARS CoV-2 in vitro and canine coronavirus in vivo</article-title><source>bioRxiv</source><year>2020</year></element-citation></ref><ref id="bb0875"><label>175</label><element-citation publication-type="journal" id="rf0875"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>P.</given-names></name><name><surname>Zhong</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Zheng</surname><given-names>M.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name></person-group><article-title>Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods</article-title><source>Acta Pharm. Sin. B</source><volume>10</volume><year>2020</year><fpage>766</fpage><lpage>788</lpage><pub-id pub-id-type="pmid">32292689</pub-id></element-citation></ref><ref id="bb0880"><label>176</label><element-citation publication-type="journal" id="rf0880"><person-group person-group-type="author"><name><surname>Matsuyama</surname><given-names>S.</given-names></name><name><surname>Kawase</surname><given-names>M.</given-names></name><name><surname>Nao</surname><given-names>N.</given-names></name><name><surname>Shirato</surname><given-names>K.</given-names></name><name><surname>Ujike</surname><given-names>M.</given-names></name><name><surname>Kamitani</surname><given-names>W.</given-names></name><name><surname>Shimojima</surname><given-names>M.</given-names></name><name><surname>Fukushi</surname><given-names>S.</given-names></name></person-group><article-title>The inhaled steroid ciclesonide blocks SARS-CoV-2 RNA replication by targeting the viral replication-transcription complex in cultured cells</article-title><source>J. Virol.</source><year>2020</year><comment>(JVI.01648-20)</comment></element-citation></ref><ref id="bb0885"><label>177</label><element-citation publication-type="journal" id="rf0885"><person-group person-group-type="author"><name><surname>Coleman</surname><given-names>C.M.</given-names></name><name><surname>Sisk</surname><given-names>J.M.</given-names></name><name><surname>Mingo</surname><given-names>R.M.</given-names></name><name><surname>Nelson</surname><given-names>E.A.</given-names></name><name><surname>White</surname><given-names>J.M.</given-names></name><name><surname>Frieman</surname><given-names>M.B.</given-names></name></person-group><article-title>Abelson kinase inhibitors are potent inhibitors of severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus fusion</article-title><source>J. Virol.</source><volume>90</volume><year>2016</year><fpage>8924</fpage><lpage>8933</lpage><pub-id pub-id-type="pmid">27466418</pub-id></element-citation></ref><ref id="bb0890"><label>178</label><element-citation publication-type="journal" id="rf0890"><person-group person-group-type="author"><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Han</surname><given-names>R.</given-names></name><name><surname>Kang</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Gao</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>He</surname><given-names>J.</given-names></name><name><surname>Tian</surname><given-names>J.</given-names></name></person-group><article-title>Pirfenidone controls the feedback loop of the AT1R/p38 MAPK/renin-angiotensin system axis by regulating liver X receptor-&#x003b1; in myocardial infarction-induced cardiac fibrosis</article-title><source>Sci. Rep.</source><volume>7</volume><year>2017</year><object-id pub-id-type="publisher-id">40523</object-id></element-citation></ref><ref id="bb0895"><label>179</label><element-citation publication-type="journal" id="rf0895"><person-group person-group-type="author"><name><surname>Kindrachuk</surname><given-names>J.</given-names></name><name><surname>Ork</surname><given-names>B.</given-names></name><name><surname>Hart</surname><given-names>B.J.</given-names></name><name><surname>Mazur</surname><given-names>S.</given-names></name><name><surname>Holbrook</surname><given-names>M.R.</given-names></name><name><surname>Frieman</surname><given-names>M.B.</given-names></name><name><surname>Traynor</surname><given-names>D.</given-names></name><name><surname>Johnson</surname><given-names>R.F.</given-names></name><name><surname>Dyall</surname><given-names>J.</given-names></name><name><surname>Kuhn</surname><given-names>J.H.</given-names></name><name><surname>Olinger</surname><given-names>G.G.</given-names></name><name><surname>Hensley</surname><given-names>L.E.</given-names></name><name><surname>Jahrling</surname><given-names>P.B.</given-names></name></person-group><article-title>Antiviral potential of ERK/MAPK and PI3K/AKT/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis</article-title><source>Antimicrob. Agents Chemother.</source><volume>59</volume><year>2015</year><fpage>1088</fpage><lpage>1099</lpage><pub-id pub-id-type="pmid">25487801</pub-id></element-citation></ref><ref id="bb0900"><label>180</label><element-citation publication-type="other" id="rf0900"><person-group person-group-type="author"><name><surname>ClinicalTrials.gov</surname></name></person-group><article-title>Sirolimus treatment in hospitalized patients with covid-19 pneumonia</article-title><ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT04341675" id="ir0045">https://clinicaltrials.gov/ct2/show/NCT04341675</ext-link><comment>(2020, accessed 11 November 2020)</comment></element-citation></ref><ref id="bb0905"><label>181</label><element-citation publication-type="journal" id="rf0905"><person-group person-group-type="author"><name><surname>Dargad</surname><given-names>R.R.</given-names></name><name><surname>Prajapati</surname><given-names>M.R.</given-names></name><name><surname>Dargad</surname><given-names>R.R.</given-names></name><name><surname>Parekh</surname><given-names>J.D.</given-names></name></person-group><article-title>Sacubitril/valsartan: a novel angiotensin receptor-neprilysin inhibitor</article-title><source>Indian Heart J.</source><volume>70</volume><year>2018</year><fpage>102</fpage><lpage>110</lpage></element-citation></ref><ref id="bb0910"><label>182</label><element-citation publication-type="journal" id="rf0910"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>S.</given-names></name><name><surname>Kashyap</surname><given-names>P.</given-names></name><name><surname>Chowdhury</surname><given-names>S.</given-names></name><name><surname>Kumar</surname><given-names>S.</given-names></name><name><surname>Panwar</surname><given-names>A.</given-names></name><name><surname>Kumar</surname><given-names>A.</given-names></name></person-group><article-title>Identification of phytochemicals as potential therapeutic agents that binds to Nsp15 protein target of coronavirus (SARS-CoV-2) that are capable of inhibiting virus replication</article-title><source>Phytomedicine</source><year>2020</year><object-id pub-id-type="publisher-id">153317</object-id></element-citation></ref><ref id="bb0915"><label>183</label><element-citation publication-type="journal" id="rf0915"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Omarini</surname><given-names>A.B.</given-names></name><name><surname>Li</surname><given-names>B.</given-names></name></person-group><article-title>Virtual screening for functional foods against the main protease of SARS-CoV-2</article-title><source>J. Food Biochem.</source><year>2020</year><object-id pub-id-type="publisher-id">e13481</object-id></element-citation></ref><ref id="bb0920"><label>184</label><element-citation publication-type="journal" id="rf0920"><person-group person-group-type="author"><name><surname>Oso</surname><given-names>B.J.</given-names></name><name><surname>Adeoye</surname><given-names>A.O.</given-names></name><name><surname>Olaoye</surname><given-names>I.F.</given-names></name></person-group><article-title>Pharmacoinformatics and hypothetical studies on allicin, curcumin, and gingerol as potential candidates against COVID-19-associated proteases</article-title><source>J. Biomol. Struct. Dyn.</source><year>2020</year><fpage>1</fpage><lpage>12</lpage></element-citation></ref><ref id="bb0925"><label>185</label><element-citation publication-type="journal" id="rf0925"><person-group person-group-type="author"><name><surname>Maurya</surname><given-names>V.K.</given-names></name><name><surname>Kumar</surname><given-names>S.</given-names></name><name><surname>Prasad</surname><given-names>A.K.</given-names></name><name><surname>Bhatt</surname><given-names>M.L.B.</given-names></name><name><surname>Saxena</surname><given-names>S.K.</given-names></name></person-group><article-title>Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor</article-title><source>Virusdisease</source><volume>31</volume><year>2020</year><fpage>179</fpage><lpage>193</lpage><pub-id pub-id-type="pmid">32656311</pub-id></element-citation></ref><ref id="bb0930"><label>186</label><element-citation publication-type="journal" id="rf0930"><person-group person-group-type="author"><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name><surname>Koca</surname><given-names>C.</given-names></name><name><surname>Dey</surname><given-names>S.</given-names></name><name><surname>Gehlot</surname><given-names>P.</given-names></name><name><surname>Yodkeeree</surname><given-names>S.</given-names></name><name><surname>Danda</surname><given-names>D.</given-names></name><name><surname>Sung</surname><given-names>B.</given-names></name><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><article-title>Traditional uses of spices: an overview. Molecular targets and therapeutic uses of spices: modern uses for ancient medicine</article-title><source>World Sci.</source><year>2009</year><fpage>1</fpage><lpage>24</lpage></element-citation></ref><ref id="bb0935"><label>187</label><element-citation publication-type="journal" id="rf0935"><person-group person-group-type="author"><name><surname>Monisha</surname><given-names>J.</given-names></name><name><surname>Padmavathi</surname><given-names>G.</given-names></name><name><surname>Bakliwal</surname><given-names>V.</given-names></name><name><surname>Katre</surname><given-names>N.</given-names></name><name><surname>Padikkala</surname><given-names>J.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name></person-group><article-title>Cancer preventive and therapeutic properties of fruits and vegetables against commonly occurring cancers in humans. Anticancer properties of fruits and vegetables: a scientific review</article-title><source>World Sci.</source><year>2015</year><fpage>337</fpage><lpage>366</lpage></element-citation></ref><ref id="bb0940"><label>188</label><element-citation publication-type="journal" id="rf0940"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>D.</given-names></name><name><surname>Govindhan</surname><given-names>S.</given-names></name><name><surname>Baiju</surname><given-names>E.C.</given-names></name><name><surname>Padmavathi</surname><given-names>G.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name><surname>Padikkala</surname><given-names>J.</given-names></name></person-group><article-title>Cyperus rotundus L. prevents non-steroidal anti-inflammatory drug-induced gastric mucosal damage by inhibiting oxidative stress</article-title><source>J. Basic Clin. Physiol. Pharmacol.</source><volume>26</volume><year>2015</year><fpage>485</fpage><lpage>490</lpage><pub-id pub-id-type="pmid">25915081</pub-id></element-citation></ref><ref id="bb0945"><label>189</label><element-citation publication-type="journal" id="rf0945"><person-group person-group-type="author"><name><surname>Harsha</surname><given-names>C.</given-names></name><name><surname>Banik</surname><given-names>K.</given-names></name><name><surname>Bordoloi</surname><given-names>D.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name></person-group><article-title>Antiulcer properties of fruits and vegetables: a mechanism based perspective</article-title><source>Food Chem. Toxicol.</source><volume>108</volume><year>2017</year><fpage>104</fpage><lpage>119</lpage><pub-id pub-id-type="pmid">28711545</pub-id></element-citation></ref><ref id="bb0950"><label>190</label><element-citation publication-type="journal" id="rf0950"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>S.C.</given-names></name><name><surname>Prasad</surname><given-names>S.</given-names></name><name><surname>Tyagi</surname><given-names>A.K.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><article-title>Neem (<italic>Azadirachta indica</italic>): an indian traditional panacea with modern molecular basis</article-title><source>Phytomedicine</source><volume>34</volume><year>2017</year><fpage>14</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">28899496</pub-id></element-citation></ref><ref id="bb0955"><label>191</label><element-citation publication-type="journal" id="rf0955"><person-group person-group-type="author"><name><surname>Khwairakpam</surname><given-names>A.D.</given-names></name><name><surname>Damayenti</surname><given-names>Y.D.</given-names></name><name><surname>Deka</surname><given-names>A.</given-names></name><name><surname>Monisha</surname><given-names>J.</given-names></name><name><surname>Roy</surname><given-names>N.K.</given-names></name><name><surname>Padmavathi</surname><given-names>G.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name></person-group><article-title>Acorus calamus: a bio-reserve of medicinal values</article-title><source>J. Basic Clin. Physiol. Pharmacol.</source><volume>29</volume><year>2018</year><fpage>107</fpage><lpage>122</lpage><pub-id pub-id-type="pmid">29389665</pub-id></element-citation></ref><ref id="bb0960"><label>192</label><element-citation publication-type="journal" id="rf0960"><person-group person-group-type="author"><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name><surname>Banik</surname><given-names>K.</given-names></name><name><surname>Bordoloi</surname><given-names>D.</given-names></name><name><surname>Harsha</surname><given-names>C.</given-names></name><name><surname>Sailo</surname><given-names>B.L.</given-names></name><name><surname>Padmavathi</surname><given-names>G.</given-names></name><name><surname>Roy</surname><given-names>N.K.</given-names></name><name><surname>Gupta</surname><given-names>S.C.</given-names></name><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><article-title>Googling the guggul (commiphora and boswellia) for prevention of chronic diseases</article-title><source>Front. Pharmacol.</source><volume>9</volume><year>2018</year><fpage>686</fpage><pub-id pub-id-type="pmid">30127736</pub-id></element-citation></ref><ref id="bb0965"><label>193</label><element-citation publication-type="journal" id="rf0965"><person-group person-group-type="author"><name><surname>Devi Khwairakpam</surname><given-names>A.</given-names></name><name><surname>Monisha</surname><given-names>J.</given-names></name><name><surname>Roy</surname><given-names>N.K.</given-names></name><name><surname>Bordoloi</surname><given-names>D.</given-names></name><name><surname>Padmavathi</surname><given-names>G.</given-names></name><name><surname>Banik</surname><given-names>K.</given-names></name><name><surname>Khatoon</surname><given-names>E.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name></person-group><article-title>Vietnamese coriander inhibits cell proliferation, survival and migration via suppression of Akt/mTOR pathway in oral squamous cell carcinoma</article-title><source>J. Basic Clin. Physiol. Pharmacol.</source><volume>31</volume><year>2019</year><comment>(/j/jbcpp.2020.31.issue-3/jbcpp-2019-0162/jbcpp-2019-0162.xml)</comment></element-citation></ref><ref id="bb0970"><label>194</label><element-citation publication-type="journal" id="rf0970"><person-group person-group-type="author"><name><surname>Banik</surname><given-names>K.</given-names></name><name><surname>Ranaware</surname><given-names>A.M.</given-names></name><name><surname>Harsha</surname><given-names>C.</given-names></name><name><surname>Nitesh</surname><given-names>T.</given-names></name><name><surname>Girisa</surname><given-names>S.</given-names></name><name><surname>Deshpande</surname><given-names>V.</given-names></name><name><surname>Fan</surname><given-names>L.</given-names></name><name><surname>Nalawade</surname><given-names>S.P.</given-names></name><name><surname>Sethi</surname><given-names>G.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name></person-group><article-title>Piceatannol: a natural stilbene for the prevention and treatment of cancer</article-title><source>Pharmacol. Res.</source><volume>153</volume><year>2020</year><object-id pub-id-type="publisher-id">104635</object-id></element-citation></ref><ref id="bb0975"><label>195</label><element-citation publication-type="journal" id="rf0975"><person-group person-group-type="author"><name><surname>Jagadeeshan</surname><given-names>S.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name><surname>Ramachandran</surname><given-names>I.</given-names></name><name><surname>Nair</surname><given-names>S.A.</given-names></name></person-group><article-title>Anticancer activities of fruits and vegetables against gynecological cancers. Anticancer properties of fruits and vegetables: a scientific review</article-title><source>World Sci.</source><year>2015</year><fpage>131</fpage><lpage>159</lpage></element-citation></ref><ref id="bb0980"><label>196</label><element-citation publication-type="journal" id="rf0980"><person-group person-group-type="author"><name><surname>Choudhury</surname><given-names>B.</given-names></name><name><surname>Kandimalla</surname><given-names>R.</given-names></name><name><surname>Bharali</surname><given-names>R.</given-names></name><name><surname>Monisha</surname><given-names>J.</given-names></name><name><surname>Kunnumakara</surname><given-names>A.B.</given-names></name><name><surname>Kalita</surname><given-names>K.</given-names></name><name><surname>Kotoky</surname><given-names>J.</given-names></name></person-group><article-title>Anticancer Activity of Garcinia morella on T-cell murine lymphoma via apoptotic induction</article-title><source>Front. Pharmacol.</source><volume>7</volume><issue>3</issue><year>2016</year></element-citation></ref><ref id="bb0985"><label>197</label><element-citation publication-type="journal" id="rf0985"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>N.K.</given-names></name><name><surname>Deka</surname><given-names>A.</given-names></name><name><surname>Bordoloi</surname><given-names>D.</given-names></name><name><surname>Mishra</surname><given-names>S.</given-names></name><name><surname>Kumar</surname><given-names>A.P.</given-names></name><name><surname>Sethi</surname><given-names>G.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name></person-group><article-title>The potential role of boswellic acids in cancer prevention and treatment</article-title><source>Cancer Lett.</source><volume>377</volume><year>2016</year><fpage>74</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">27091399</pub-id></element-citation></ref><ref id="bb0990"><label>198</label><element-citation publication-type="journal" id="rf0990"><person-group person-group-type="author"><name><surname>Sailo</surname><given-names>B.L.</given-names></name><name><surname>Banik</surname><given-names>K.</given-names></name><name><surname>Padmavathi</surname><given-names>G.</given-names></name><name><surname>Javadi</surname><given-names>M.</given-names></name><name><surname>Bordoloi</surname><given-names>D.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name></person-group><article-title>Tocotrienols: the promising analogues of vitamin E for cancer therapeutics</article-title><source>Pharmacol. Res.</source><volume>130</volume><year>2018</year><fpage>259</fpage><lpage>272</lpage><pub-id pub-id-type="pmid">29496592</pub-id></element-citation></ref><ref id="bb0995"><label>199</label><element-citation publication-type="journal" id="rf0995"><person-group person-group-type="author"><name><surname>Babu</surname><given-names>B.H.</given-names></name><name><surname>Jayram</surname><given-names>H.N.</given-names></name><name><surname>Nair</surname><given-names>M.G.</given-names></name><name><surname>Ajaikumar</surname><given-names>K.B.</given-names></name><name><surname>Padikkala</surname><given-names>J.</given-names></name></person-group><article-title>Free radical scavenging, antitumor and anticarcinogenic activity of gossypin</article-title><source>J. Exp. Clin. Cancer Res.</source><volume>22</volume><year>2003</year><fpage>581</fpage><lpage>589</lpage><pub-id pub-id-type="pmid">15053300</pub-id></element-citation></ref><ref id="bb1000"><label>200</label><element-citation publication-type="journal" id="rf1000"><person-group person-group-type="author"><name><surname>Ajaikumar</surname><given-names>K.B.</given-names></name><name><surname>Asheef</surname><given-names>M.</given-names></name><name><surname>Babu</surname><given-names>B.H.</given-names></name><name><surname>Padikkala</surname><given-names>J.</given-names></name></person-group><article-title>The inhibition of gastric mucosal injury by <italic>Punica granatum</italic> L.(pomegranate) methanolic extract</article-title><source>J. Ethnopharmacol.</source><volume>96</volume><year>2005</year><fpage>171</fpage><lpage>176</lpage><pub-id pub-id-type="pmid">15588667</pub-id></element-citation></ref><ref id="bb1005"><label>201</label><element-citation publication-type="journal" id="rf1005"><person-group person-group-type="author"><name><surname>Khanna</surname><given-names>D.</given-names></name><name><surname>Sethi</surname><given-names>G.</given-names></name><name><surname>Ahn</surname><given-names>K.S.</given-names></name><name><surname>Pandey</surname><given-names>M.K.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name><surname>Sung</surname><given-names>B.</given-names></name><name><surname>Aggarwal</surname><given-names>A.</given-names></name><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><article-title>Natural products as a gold mine for arthritis treatment</article-title><source>Curr. Opin. Pharmacol.</source><volume>7</volume><year>2007</year><fpage>344</fpage><lpage>351</lpage><pub-id pub-id-type="pmid">17475558</pub-id></element-citation></ref><ref id="bb1010"><label>202</label><element-citation publication-type="journal" id="rf1010"><person-group person-group-type="author"><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name><surname>Nair</surname><given-names>A.S.</given-names></name><name><surname>Ahn</surname><given-names>K.S.</given-names></name><name><surname>Pandey</surname><given-names>M.K.</given-names></name><name><surname>Yi</surname><given-names>Z.</given-names></name><name><surname>Liu</surname><given-names>M.</given-names></name><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><article-title>Gossypin, a pentahydroxy glucosyl flavone, inhibits the transforming growth factor beta-activated kinase-1-mediated NF-kappaB activation pathway, leading to potentiation of apoptosis, suppression of invasion, and abrogation of osteoclastogenesis</article-title><source>Blood</source><volume>109</volume><year>2007</year><fpage>5112</fpage><lpage>5121</lpage><pub-id pub-id-type="pmid">17332240</pub-id></element-citation></ref><ref id="bb1015"><label>203</label><element-citation publication-type="journal" id="rf1015"><person-group person-group-type="author"><name><surname>Padmavathi</surname><given-names>G.</given-names></name><name><surname>Roy</surname><given-names>N.K.</given-names></name><name><surname>Bordoloi</surname><given-names>D.</given-names></name><name><surname>Arfuso</surname><given-names>F.</given-names></name><name><surname>Mishra</surname><given-names>S.</given-names></name><name><surname>Sethi</surname><given-names>G.</given-names></name><name><surname>Bishayee</surname><given-names>A.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name></person-group><article-title>Butein in health and disease: a comprehensive review</article-title><source>Phytomedicine</source><volume>25</volume><year>2017</year><fpage>118</fpage><lpage>127</lpage><pub-id pub-id-type="pmid">28190465</pub-id></element-citation></ref><ref id="bb1020"><label>204</label><element-citation publication-type="journal" id="rf1020"><person-group person-group-type="author"><name><surname>Banik</surname><given-names>K.</given-names></name><name><surname>Harsha</surname><given-names>C.</given-names></name><name><surname>Bordoloi</surname><given-names>D.</given-names></name><name><surname>Lalduhsaki Sailo</surname><given-names>B.</given-names></name><name><surname>Sethi</surname><given-names>G.</given-names></name><name><surname>Leong</surname><given-names>H.C.</given-names></name><name><surname>Arfuso</surname><given-names>F.</given-names></name><name><surname>Mishra</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Kumar</surname><given-names>A.P.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name></person-group><article-title>Therapeutic potential of gambogic acid, a caged xanthone, to target cancer</article-title><source>Cancer Lett.</source><volume>416</volume><year>2018</year><fpage>75</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">29246645</pub-id></element-citation></ref><ref id="bb1025"><label>205</label><element-citation publication-type="journal" id="rf1025"><person-group person-group-type="author"><name><surname>Ranaware</surname><given-names>A.M.</given-names></name><name><surname>Banik</surname><given-names>K.</given-names></name><name><surname>Deshpande</surname><given-names>V.</given-names></name><name><surname>Padmavathi</surname><given-names>G.</given-names></name><name><surname>Roy</surname><given-names>N.K.</given-names></name><name><surname>Sethi</surname><given-names>G.</given-names></name><name><surname>Fan</surname><given-names>L.</given-names></name><name><surname>Kumar</surname><given-names>A.P.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name></person-group><article-title>Magnolol: a neolignan from the Magnolia family for the prevention and treatment of cancer</article-title><source>Int. J. Mol. Sci.</source><volume>19</volume><year>2018</year><fpage>2362</fpage></element-citation></ref><ref id="bb1030"><label>206</label><element-citation publication-type="journal" id="rf1030"><person-group person-group-type="author"><name><surname>Banik</surname><given-names>K.</given-names></name><name><surname>Ranaware</surname><given-names>A.M.</given-names></name><name><surname>Deshpande</surname><given-names>V.</given-names></name><name><surname>Nalawade</surname><given-names>S.P.</given-names></name><name><surname>Padmavathi</surname><given-names>G.</given-names></name><name><surname>Bordoloi</surname><given-names>D.</given-names></name><name><surname>Sailo</surname><given-names>B.L.</given-names></name><name><surname>Shanmugam</surname><given-names>M.K.</given-names></name><name><surname>Fan</surname><given-names>L.</given-names></name><name><surname>Arfuso</surname><given-names>F.</given-names></name><name><surname>Sethi</surname><given-names>G.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name></person-group><article-title>Honokiol for cancer therapeutics: a traditional medicine that can modulate multiple oncogenic targets</article-title><source>Pharmacol. Res.</source><volume>144</volume><year>2019</year><fpage>192</fpage><lpage>209</lpage><pub-id pub-id-type="pmid">31002949</pub-id></element-citation></ref><ref id="bb1035"><label>207</label><element-citation publication-type="journal" id="rf1035"><person-group person-group-type="author"><name><surname>Bordoloi</surname><given-names>D.</given-names></name><name><surname>Monisha</surname><given-names>J.</given-names></name><name><surname>Roy</surname><given-names>N.K.</given-names></name><name><surname>Padmavathi</surname><given-names>G.</given-names></name><name><surname>Banik</surname><given-names>K.</given-names></name><name><surname>Harsha</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Kumar</surname><given-names>A.P.</given-names></name><name><surname>Arfuso</surname><given-names>F.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name></person-group><article-title>An investigation on the therapeutic potential of butein, a tretrahydroxychalcone against human oral squamous cell carcinoma</article-title><source>Asian Pac. J. Cancer Prev.</source><volume>20</volume><year>2019</year><fpage>3437</fpage><lpage>3446</lpage><pub-id pub-id-type="pmid">31759370</pub-id></element-citation></ref><ref id="bb1040"><label>208</label><element-citation publication-type="journal" id="rf1040"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>N.K.</given-names></name><name><surname>Parama</surname><given-names>D.</given-names></name><name><surname>Banik</surname><given-names>K.</given-names></name><name><surname>Bordoloi</surname><given-names>D.</given-names></name><name><surname>Devi</surname><given-names>A.K.</given-names></name><name><surname>Thakur</surname><given-names>K.K.</given-names></name><name><surname>Padmavathi</surname><given-names>G.</given-names></name><name><surname>Shakibaei</surname><given-names>M.</given-names></name><name><surname>Fan</surname><given-names>L.</given-names></name><name><surname>Sethi</surname><given-names>G.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name></person-group><article-title>An update on pharmacological potential of boswellic acids against chronic diseases</article-title><source>Int. J. Mol. Sci.</source><volume>20</volume><year>2019</year><fpage>4101</fpage></element-citation></ref><ref id="bb1045"><label>209</label><element-citation publication-type="journal" id="rf1045"><person-group person-group-type="author"><name><surname>Girisa</surname><given-names>S.</given-names></name><name><surname>Shabnam</surname><given-names>B.</given-names></name><name><surname>Monisha</surname><given-names>J.</given-names></name><name><surname>Fan</surname><given-names>L.</given-names></name><name><surname>Halim</surname><given-names>C.E.</given-names></name><name><surname>Arfuso</surname><given-names>F.</given-names></name><name><surname>Ahn</surname><given-names>K.S.</given-names></name><name><surname>Sethi</surname><given-names>G.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name></person-group><article-title>Potential of zerumbone as an anti-cancer agent</article-title><source>Molecules</source><volume>24</volume><year>2019</year><fpage>734</fpage></element-citation></ref><ref id="bb1050"><label>210</label><element-citation publication-type="journal" id="rf1050"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>Y.P.</given-names></name><name><surname>Girisa</surname><given-names>S.</given-names></name><name><surname>Banik</surname><given-names>K.</given-names></name><name><surname>Ghosh</surname><given-names>S.</given-names></name><name><surname>Swathi</surname><given-names>P.</given-names></name><name><surname>Deka</surname><given-names>M.</given-names></name><name><surname>Padmavathi</surname><given-names>G.</given-names></name><name><surname>Kotoky</surname><given-names>J.</given-names></name><name><surname>Sethi</surname><given-names>G.</given-names></name><name><surname>Fan</surname><given-names>L.</given-names></name><name><surname>Mao</surname><given-names>X.</given-names></name><name><surname>Halim</surname><given-names>C.E.</given-names></name><name><surname>Arfuso</surname><given-names>F.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name></person-group><article-title>Potential application of zerumbone in the prevention and therapy of chronic human diseases</article-title><source>J. Funct. Foods</source><volume>53</volume><year>2019</year><fpage>248</fpage><lpage>258</lpage></element-citation></ref><ref id="bb1055"><label>211</label><element-citation publication-type="journal" id="rf1055"><person-group person-group-type="author"><name><surname>Henamayee</surname><given-names>S.</given-names></name><name><surname>Banik</surname><given-names>K.</given-names></name><name><surname>Sailo</surname><given-names>B.L.</given-names></name><name><surname>Shabnam</surname><given-names>B.</given-names></name><name><surname>Harsha</surname><given-names>C.</given-names></name><name><surname>Srilakshmi</surname><given-names>S.</given-names></name><name><surname>Vgm</surname><given-names>N.</given-names></name><name><surname>Baek</surname><given-names>S.H.</given-names></name><name><surname>Ahn</surname><given-names>K.S.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name></person-group><article-title>Therapeutic emergence of rhein as a potential anticancer drug: a review of its molecular targets and anticancer properties</article-title><source>Molecules</source><volume>25</volume><year>2020</year><fpage>2278</fpage></element-citation></ref><ref id="bb1060"><label>212</label><element-citation publication-type="journal" id="rf1060"><person-group person-group-type="author"><name><surname>Khatoon</surname><given-names>E.</given-names></name><name><surname>Banik</surname><given-names>K.</given-names></name><name><surname>Harsha</surname><given-names>C.</given-names></name><name><surname>Sailo</surname><given-names>B.L.</given-names></name><name><surname>Thakur</surname><given-names>K.K.</given-names></name><name><surname>Khwairakpam</surname><given-names>A.D.</given-names></name><name><surname>Vikkurthi</surname><given-names>R.</given-names></name><name><surname>Devi</surname><given-names>T.B.</given-names></name><name><surname>Gupta</surname><given-names>S.C.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name></person-group><article-title>Phytochemicals in cancer cell chemosensitization: current knowledge and future perspectives</article-title><source>Semin. Cancer Biol.</source><year>2020</year><comment>(S1044-579X(20)30150-4)</comment></element-citation></ref><ref id="bb1065"><label>213</label><element-citation publication-type="journal" id="rf1065"><person-group person-group-type="author"><name><surname>Parama</surname><given-names>D.</given-names></name><name><surname>Boruah</surname><given-names>M.</given-names></name><name><surname>Yachna</surname><given-names>K.</given-names></name><name><surname>Rana</surname><given-names>V.</given-names></name><name><surname>Banik</surname><given-names>K.</given-names></name><name><surname>Harsha</surname><given-names>C.</given-names></name><name><surname>Thakur</surname><given-names>K.K.</given-names></name><name><surname>Dutta</surname><given-names>U.</given-names></name><name><surname>Arya</surname><given-names>A.</given-names></name><name><surname>Mao</surname><given-names>X.</given-names></name><name><surname>Ahn</surname><given-names>K.S.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name></person-group><article-title>Diosgenin, a steroidal saponin, and its analogs: effective therapies against different chronic diseases</article-title><source>Life Sci.</source><volume>260</volume><year>2020</year><object-id pub-id-type="publisher-id">118182</object-id></element-citation></ref><ref id="bb1070"><label>214</label><element-citation publication-type="journal" id="rf1070"><person-group person-group-type="author"><name><surname>Tapsell</surname><given-names>L.C.</given-names></name><name><surname>Hemphill</surname><given-names>I.</given-names></name><name><surname>Cobiac</surname><given-names>L.</given-names></name><name><surname>Patch</surname><given-names>C.S.</given-names></name><name><surname>Sullivan</surname><given-names>D.R.</given-names></name><name><surname>Fenech</surname><given-names>M.</given-names></name><name><surname>Roodenrys</surname><given-names>S.</given-names></name><name><surname>Keogh</surname><given-names>J.B.</given-names></name><name><surname>Clifton</surname><given-names>P.M.</given-names></name><name><surname>Williams</surname><given-names>P.G.</given-names></name><name><surname>Fazio</surname><given-names>V.A.</given-names></name><name><surname>Inge</surname><given-names>K.E.</given-names></name></person-group><article-title>Health benefits of herbs and spices: the past, the present, the future</article-title><source>Med. J. Aust.</source><volume>185</volume><year>2006</year><fpage>1</fpage><lpage>24</lpage></element-citation></ref><ref id="bb1075"><label>215</label><element-citation publication-type="journal" id="rf1075"><person-group person-group-type="author"><name><surname>Buhrmann</surname><given-names>C.</given-names></name><name><surname>Shayan</surname><given-names>P.</given-names></name><name><surname>Banik</surname><given-names>K.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name><surname>Kubatka</surname><given-names>P.</given-names></name><name><surname>Koklesova</surname><given-names>L.</given-names></name><name><surname>Shakibaei</surname><given-names>M.</given-names></name></person-group><article-title>Targeting NF-&#x003ba;B signaling by Calebin A, a compound of turmeric, in multicellular tumor microenvironment: potential role of apoptosis induction in CRC cells</article-title><source>Biomedicines</source><volume>8</volume><year>2020</year><fpage>236</fpage></element-citation></ref><ref id="bb1080"><label>216</label><element-citation publication-type="journal" id="rf1080"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>M.K.</given-names></name><name><surname>Sandur</surname><given-names>S.K.</given-names></name><name><surname>Sung</surname><given-names>B.</given-names></name><name><surname>Sethi</surname><given-names>G.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><article-title>Butein, a tetrahydroxychalcone, inhibits nuclear factor (NF)-kappaB and NF-kappaB-regulated gene expression through direct inhibition of IkappaBalpha kinase beta on cysteine 179 residue</article-title><source>J. Biol. Chem.</source><volume>282</volume><year>2007</year><fpage>17340</fpage><lpage>17350</lpage><pub-id pub-id-type="pmid">17439942</pub-id></element-citation></ref><ref id="bb1085"><label>217</label><element-citation publication-type="journal" id="rf1085"><person-group person-group-type="author"><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name><surname>Harikumar</surname><given-names>K.B.</given-names></name><name><surname>Tharakan</surname><given-names>S.T.</given-names></name><name><surname>Sung</surname><given-names>B.</given-names></name><name><surname>Anand</surname><given-names>P.</given-names></name></person-group><article-title>Potential of spice-derived phytochemicals for cancer prevention</article-title><source>Planta Med.</source><volume>74</volume><year>2008</year><fpage>1560</fpage><lpage>1569</lpage><pub-id pub-id-type="pmid">18612945</pub-id></element-citation></ref><ref id="bb1090"><label>218</label><element-citation publication-type="journal" id="rf1090"><person-group person-group-type="author"><name><surname>Nilius</surname><given-names>B.</given-names></name><name><surname>Appendino</surname><given-names>G.</given-names></name></person-group><article-title>Spices: the savory and beneficial science of pungency</article-title><source>Rev. Physiol. Biochem. Pharmacol.</source><volume>164</volume><year>2013</year><fpage>1</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">23605179</pub-id></element-citation></ref><ref id="bb1095"><label>219</label><element-citation publication-type="journal" id="rf1095"><person-group person-group-type="author"><name><surname>Opara</surname><given-names>E.I.</given-names></name><name><surname>Chohan</surname><given-names>M.</given-names></name></person-group><article-title>Culinary herbs and spices: their bioactive properties, the contribution of polyphenols and the challenges in deducing their true health benefits</article-title><source>Int. J. Mol. Sci.</source><volume>15</volume><year>2014</year><fpage>19183</fpage><lpage>19202</lpage><pub-id pub-id-type="pmid">25340982</pub-id></element-citation></ref><ref id="bb1100"><label>220</label><element-citation publication-type="journal" id="rf1100"><person-group person-group-type="author"><name><surname>Krishnaswamy</surname><given-names>K.</given-names></name></person-group><article-title>Traditional Indian spices and their health significance</article-title><source>Asia Pac. J. Clin. Nutr.</source><volume>17</volume><year>2008</year><fpage>265</fpage><lpage>268</lpage><pub-id pub-id-type="pmid">18296352</pub-id></element-citation></ref><ref id="bb1105"><label>221</label><element-citation publication-type="journal" id="rf1105"><person-group person-group-type="author"><name><surname>Verma</surname><given-names>S.</given-names></name><name><surname>Khambhala</surname><given-names>P.</given-names></name><name><surname>Joshi</surname><given-names>S.</given-names></name><name><surname>Kothari</surname><given-names>V.</given-names></name><name><surname>Patel</surname><given-names>T.</given-names></name><name><surname>Seshadri</surname><given-names>S.</given-names></name></person-group><article-title>Evaluating the role of dithiolane rich fraction of Ferula asafoetida (apiaceae) for its antiproliferative and apoptotic properties: in vitro studies</article-title><source>Exp. Oncol.</source><volume>41</volume><year>2019</year><fpage>90</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">31262162</pub-id></element-citation></ref><ref id="bb1110"><label>222</label><element-citation publication-type="journal" id="rf1110"><person-group person-group-type="author"><name><surname>Bagheri</surname><given-names>S.M.</given-names></name><name><surname>Abdian-Asl</surname><given-names>A.</given-names></name><name><surname>Moghadam</surname><given-names>M.T.</given-names></name><name><surname>Yadegari</surname><given-names>M.</given-names></name><name><surname>Mirjalili</surname><given-names>A.</given-names></name><name><surname>Zare-Mohazabieh</surname><given-names>F.</given-names></name><name><surname>Momeni</surname><given-names>H.</given-names></name></person-group><article-title>Antitumor effect of Ferula assa foetida oleo gum resin against breast cancer induced by 4T1 cells in BALB/c mice</article-title><source>J. Ayurveda Integr. Med.</source><volume>8</volume><year>2017</year><fpage>152</fpage><lpage>158</lpage><pub-id pub-id-type="pmid">28690055</pub-id></element-citation></ref><ref id="bb1115"><label>223</label><element-citation publication-type="journal" id="rf1115"><person-group person-group-type="author"><name><surname>Mallikarjuna</surname><given-names>G.U.</given-names></name><name><surname>Dhanalakshmi</surname><given-names>S.</given-names></name><name><surname>Raisuddin</surname><given-names>S.</given-names></name><name><surname>Rao</surname><given-names>A.R.</given-names></name></person-group><article-title>Chemomodulatory influence of Ferula asafoetida on mammary epithelial differentiation, hepatic drug metabolizing enzymes, antioxidant profiles and N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats</article-title><source>Breast Cancer Res. Treat.</source><volume>81</volume><year>2003</year><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">14531492</pub-id></element-citation></ref><ref id="bb1120"><label>224</label><element-citation publication-type="journal" id="rf1120"><person-group person-group-type="author"><name><surname>Bagheri</surname><given-names>S.M.</given-names></name><name><surname>Hedesh</surname><given-names>S.T.</given-names></name><name><surname>Mirjalili</surname><given-names>A.</given-names></name><name><surname>Dashti-R</surname><given-names>M.H.</given-names></name></person-group><article-title>Evaluation of anti-inflammatory and some possible mechanisms of antinociceptive effect of Ferula assa foetida oleo gum resin</article-title><source>J. Evid. Based Complement. Altern. Med.</source><volume>21</volume><year>2016</year><fpage>271</fpage><lpage>276</lpage></element-citation></ref><ref id="bb1125"><label>225</label><element-citation publication-type="journal" id="rf1125"><person-group person-group-type="author"><name><surname>Eftekhar</surname><given-names>N.</given-names></name><name><surname>Moghimi</surname><given-names>A.</given-names></name><name><surname>Mohammadian Roshan</surname><given-names>N.</given-names></name><name><surname>Saadat</surname><given-names>S.</given-names></name><name><surname>Boskabady</surname><given-names>M.H.</given-names></name></person-group><article-title>Immunomodulatory and anti-inflammatory effects of hydro-ethanolic extract of <italic>Ocimum basilicum</italic> leaves and its effect on lung pathological changes in an ovalbumin-induced rat model of asthma</article-title><source>BMC Complement. Altern. Med.</source><volume>19</volume><year>2019</year><fpage>349</fpage><pub-id pub-id-type="pmid">31801507</pub-id></element-citation></ref><ref id="bb1130"><label>226</label><element-citation publication-type="journal" id="rf1130"><person-group person-group-type="author"><name><surname>Abd El-Ghffar</surname><given-names>E.A.</given-names></name><name><surname>Al-Sayed</surname><given-names>E.</given-names></name><name><surname>Shehata</surname><given-names>S.M.</given-names></name><name><surname>Eldahshan</surname><given-names>O.A.</given-names></name><name><surname>Efferth</surname><given-names>T.</given-names></name></person-group><article-title>The protective role of <italic>Ocimum basilicum</italic> L. (basil) against aspirin-induced gastric ulcer in mice: impact on oxidative stress, inflammation, motor deficits and anxiety-like behavior</article-title><source>Food Funct.</source><volume>9</volume><year>2018</year><fpage>4457</fpage><lpage>4468</lpage><pub-id pub-id-type="pmid">30073231</pub-id></element-citation></ref><ref id="bb1135"><label>227</label><element-citation publication-type="journal" id="rf1135"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>E.H.</given-names></name><name><surname>Shin</surname><given-names>J.H.</given-names></name><name><surname>Kim</surname><given-names>S.S.</given-names></name><name><surname>Lee</surname><given-names>H.</given-names></name><name><surname>Yang</surname><given-names>S.R.</given-names></name><name><surname>Seo</surname><given-names>S.R.</given-names></name></person-group><article-title>Laurus nobilis leaf extract controls inflammation by suppressing NLRP3 inflammasome activation</article-title><source>J. Cell. Physiol.</source><volume>234</volume><year>2019</year><fpage>6854</fpage><lpage>6864</lpage><pub-id pub-id-type="pmid">30387132</pub-id></element-citation></ref><ref id="bb1140"><label>228</label><element-citation publication-type="journal" id="rf1140"><person-group person-group-type="author"><name><surname>Mokhtari-Zaer</surname><given-names>A.</given-names></name><name><surname>Norouzi</surname><given-names>F.</given-names></name><name><surname>Askari</surname><given-names>V.R.</given-names></name><name><surname>Khazdair</surname><given-names>M.R.</given-names></name><name><surname>Roshan</surname><given-names>N.M.</given-names></name><name><surname>Boskabady</surname><given-names>M.</given-names></name><name><surname>Hosseini</surname><given-names>M.</given-names></name><name><surname>Boskabady</surname><given-names>M.H.</given-names></name></person-group><article-title>The protective effect of Nigella sativa extract on lung inflammation and oxidative stress induced by lipopolysaccharide in rats</article-title><source>J. Ethnopharmacol.</source><volume>253</volume><year>2020</year><object-id pub-id-type="publisher-id">112653</object-id></element-citation></ref><ref id="bb1145"><label>229</label><element-citation publication-type="journal" id="rf1145"><person-group person-group-type="author"><name><surname>Bordoni</surname><given-names>L.</given-names></name><name><surname>Fedeli</surname><given-names>D.</given-names></name><name><surname>Fiorini</surname><given-names>D.</given-names></name><name><surname>Gabbianelli</surname><given-names>R.</given-names></name></person-group><article-title>Extra virgin olive oil and Nigella sativa oil produced in Central Italy: a comparison of the nutrigenomic effects of two Mediterranean oils in a low-grade inflammation model</article-title><source>Antioxidants (Basel)</source><volume>9</volume><year>2019</year><fpage>20</fpage></element-citation></ref><ref id="bb1150"><label>230</label><element-citation publication-type="journal" id="rf1150"><person-group person-group-type="author"><name><surname>Abbasnezhad</surname><given-names>A.</given-names></name><name><surname>Niazmand</surname><given-names>S.</given-names></name><name><surname>Mahmoudabady</surname><given-names>M.</given-names></name><name><surname>Rezaee</surname><given-names>S.A.</given-names></name><name><surname>Soukhtanloo</surname><given-names>M.</given-names></name><name><surname>Mosallanejad</surname><given-names>R.</given-names></name><name><surname>Hayatdavoudi</surname><given-names>P.</given-names></name></person-group><article-title>Nigella sativa L. seed regulated eNOS, VCAM-1 and LOX-1 genes expression and improved vasoreactivity in aorta of diabetic rat</article-title><source>J. Ethnopharmacol.</source><volume>228</volume><year>2019</year><fpage>142</fpage><lpage>147</lpage><pub-id pub-id-type="pmid">30223051</pub-id></element-citation></ref><ref id="bb1155"><label>231</label><element-citation publication-type="journal" id="rf1155"><person-group person-group-type="author"><name><surname>Beheshti</surname><given-names>F.</given-names></name><name><surname>Norouzi</surname><given-names>F.</given-names></name><name><surname>Abareshi</surname><given-names>A.</given-names></name><name><surname>Khazaei</surname><given-names>M.</given-names></name><name><surname>Alikhani</surname><given-names>V.</given-names></name><name><surname>Moussavi</surname><given-names>S.</given-names></name><name><surname>Biglari</surname><given-names>G.</given-names></name><name><surname>Soukhtanloo</surname><given-names>M.</given-names></name><name><surname>Hosseini</surname><given-names>M.</given-names></name></person-group><article-title>Nigella sativa prevented liver and renal tissue damage in lipopolysaccharide-treated rats</article-title><source>Saudi J. Kidney Dis. Transpl.</source><volume>29</volume><year>2018</year><fpage>554</fpage><lpage>566</lpage><pub-id pub-id-type="pmid">29970731</pub-id></element-citation></ref><ref id="bb1160"><label>232</label><element-citation publication-type="journal" id="rf1160"><person-group person-group-type="author"><name><surname>Khaldi</surname><given-names>T.</given-names></name><name><surname>Chekchaki</surname><given-names>N.</given-names></name><name><surname>Boumendjel</surname><given-names>M.</given-names></name><name><surname>Taibi</surname><given-names>F.</given-names></name><name><surname>Abdellaoui</surname><given-names>M.</given-names></name><name><surname>Messarah</surname><given-names>M.</given-names></name><name><surname>Boumendjel</surname><given-names>A.</given-names></name></person-group><article-title>Ameliorating effects of Nigella sativa oil on aggravation of inflammation, oxidative stress and cytotoxicity induced by smokeless tobacco extract in an allergic asthma model in Wistar rats</article-title><source>Allergol Immunopathol (Madr)</source><volume>46</volume><year>2018</year><fpage>472</fpage><lpage>481</lpage><pub-id pub-id-type="pmid">29739684</pub-id></element-citation></ref><ref id="bb1165"><label>233</label><element-citation publication-type="journal" id="rf1165"><person-group person-group-type="author"><name><surname>Abulfadl</surname><given-names>Y.S.</given-names></name><name><surname>El-Maraghy</surname><given-names>N.N.</given-names></name><name><surname>Ahmed</surname><given-names>A.E.</given-names></name><name><surname>Nofal</surname><given-names>S.</given-names></name><name><surname>Abdel-Mottaleb</surname><given-names>Y.</given-names></name><name><surname>Badary</surname><given-names>O.A.</given-names></name></person-group><article-title>Thymoquinone alleviates the experimentally induced Alzheimer's disease inflammation by modulation of TLRs signaling</article-title><source>Hum. Exp. Toxicol.</source><volume>37</volume><year>2018</year><fpage>1092</fpage><lpage>1104</lpage><pub-id pub-id-type="pmid">29405769</pub-id></element-citation></ref><ref id="bb1170"><label>234</label><element-citation publication-type="journal" id="rf1170"><person-group person-group-type="author"><name><surname>Bui</surname><given-names>T.T.</given-names></name><name><surname>Piao</surname><given-names>C.H.</given-names></name><name><surname>Song</surname><given-names>C.H.</given-names></name><name><surname>Shin</surname><given-names>H.S.</given-names></name><name><surname>Shon</surname><given-names>D.H.</given-names></name><name><surname>Chai</surname><given-names>O.H.</given-names></name></person-group><article-title>Piper nigrum extract ameliorated allergic inflammation through inhibiting Th2/Th17 responses and mast cells activation</article-title><source>Cell. Immunol.</source><volume>322</volume><year>2017</year><fpage>64</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">29066080</pub-id></element-citation></ref><ref id="bb1175"><label>235</label><element-citation publication-type="journal" id="rf1175"><person-group person-group-type="author"><name><surname>Bui</surname><given-names>T.T.</given-names></name><name><surname>Fan</surname><given-names>Y.</given-names></name><name><surname>Piao</surname><given-names>C.H.</given-names></name><name><surname>Van Nguyen</surname><given-names>T.</given-names></name><name><surname>Shin</surname><given-names>D.U.</given-names></name><name><surname>Jung</surname><given-names>S.Y.</given-names></name><name><surname>Hyeon</surname><given-names>E.</given-names></name><name><surname>Song</surname><given-names>C.H.</given-names></name><name><surname>Lee</surname><given-names>S.Y.</given-names></name><name><surname>Shin</surname><given-names>H.S.</given-names></name><name><surname>Chai</surname><given-names>O.H.</given-names></name></person-group><article-title>Piper Nigrum extract improves OVA-induced nasal epithelial barrier dysfunction via activating Nrf2/HO-1 signaling</article-title><source>Cell. Immunol.</source><volume>351</volume><year>2020</year><object-id pub-id-type="publisher-id">104035</object-id></element-citation></ref><ref id="bb1180"><label>236</label><element-citation publication-type="journal" id="rf1180"><person-group person-group-type="author"><name><surname>Bui</surname><given-names>T.T.</given-names></name><name><surname>Piao</surname><given-names>C.H.</given-names></name><name><surname>Hyeon</surname><given-names>E.</given-names></name><name><surname>Fan</surname><given-names>Y.</given-names></name><name><surname>Van Nguyen</surname><given-names>T.</given-names></name><name><surname>Jung</surname><given-names>S.Y.</given-names></name><name><surname>Choi</surname><given-names>D.W.</given-names></name><name><surname>Lee</surname><given-names>S.Y.</given-names></name><name><surname>Shin</surname><given-names>H.S.</given-names></name><name><surname>Song</surname><given-names>C.H.</given-names></name><name><surname>Chai</surname><given-names>O.H.</given-names></name></person-group><article-title>The protective role of Piper nigrum fruit extract in an ovalbumin-induced allergic rhinitis by targeting of NF&#x003ba;Bp65 and STAT3 signalings</article-title><source>Biomed. Pharmacother.</source><volume>109</volume><year>2019</year><fpage>1915</fpage><lpage>1923</lpage><pub-id pub-id-type="pmid">30551446</pub-id></element-citation></ref><ref id="bb1185"><label>237</label><element-citation publication-type="journal" id="rf1185"><person-group person-group-type="author"><name><surname>Pei</surname><given-names>H.</given-names></name><name><surname>Xue</surname><given-names>L.</given-names></name><name><surname>Tang</surname><given-names>M.</given-names></name><name><surname>Tang</surname><given-names>H.</given-names></name><name><surname>Kuang</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Ma</surname><given-names>X.</given-names></name><name><surname>Cai</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>M.</given-names></name><name><surname>Peng</surname><given-names>A.</given-names></name></person-group><article-title>Alkaloids from black pepper (Piper nigrum L.) exhibit anti-inflammatory activity in murine macrophages by inhibiting activation of NF-&#x003ba;B pathway</article-title><source>J. Agric. Food Chem.</source><volume>68</volume><year>2020</year><fpage>2406</fpage><lpage>2417</lpage><pub-id pub-id-type="pmid">32031370</pub-id></element-citation></ref><ref id="bb1190"><label>238</label><element-citation publication-type="journal" id="rf1190"><person-group person-group-type="author"><name><surname>Pradeep</surname><given-names>C.R.</given-names></name><name><surname>Kuttan</surname><given-names>G.</given-names></name></person-group><article-title>Effect of piperine on the inhibition of lung metastasis induced B16F-10 melanoma cells in mice</article-title><source>Clin. Exp. Metastasis</source><volume>19</volume><year>2002</year><fpage>703</fpage><lpage>708</lpage><pub-id pub-id-type="pmid">12553376</pub-id></element-citation></ref><ref id="bb1195"><label>239</label><element-citation publication-type="journal" id="rf1195"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>Y.D.</given-names></name><name><surname>Bai</surname><given-names>W.J.</given-names></name><name><surname>Li</surname><given-names>C.G.</given-names></name><name><surname>Xu</surname><given-names>L.H.</given-names></name><name><surname>Wei</surname><given-names>H.X.</given-names></name><name><surname>Pan</surname><given-names>H.</given-names></name><name><surname>He</surname><given-names>X.H.</given-names></name><name><surname>Ouyang</surname><given-names>D.Y.</given-names></name></person-group><article-title>Piperine suppresses pyroptosis and interleukin-1&#x003b2; release upon ATP triggering and bacterial infection</article-title><source>Front. Pharmacol.</source><volume>7</volume><year>2016</year><fpage>390</fpage><pub-id pub-id-type="pmid">27812336</pub-id></element-citation></ref><ref id="bb1200"><label>240</label><element-citation publication-type="journal" id="rf1200"><person-group person-group-type="author"><name><surname>Bae</surname><given-names>G.S.</given-names></name><name><surname>Kim</surname><given-names>M.S.</given-names></name><name><surname>Jeong</surname><given-names>J.</given-names></name><name><surname>Lee</surname><given-names>H.Y.</given-names></name><name><surname>Park</surname><given-names>K.C.</given-names></name><name><surname>Koo</surname><given-names>B.S.</given-names></name><name><surname>Kim</surname><given-names>B.J.</given-names></name><name><surname>Kim</surname><given-names>T.H.</given-names></name><name><surname>Lee</surname><given-names>S.H.</given-names></name><name><surname>Hwang</surname><given-names>S.Y.</given-names></name><name><surname>Shin</surname><given-names>Y.K.</given-names></name><name><surname>Song</surname><given-names>H.J.</given-names></name><name><surname>Park</surname><given-names>S.J.</given-names></name></person-group><article-title>Piperine ameliorates the severity of cerulein-induced acute pancreatitis by inhibiting the activation of mitogen activated protein kinases</article-title><source>Biochem. Biophys. Res. Commun.</source><volume>410</volume><year>2011</year><fpage>382</fpage><lpage>388</lpage><pub-id pub-id-type="pmid">21663734</pub-id></element-citation></ref><ref id="bb1205"><label>241</label><element-citation publication-type="journal" id="rf1205"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>T.</given-names></name><name><surname>Liu</surname><given-names>G.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Peng</surname><given-names>Y.</given-names></name><name><surname>He</surname><given-names>L.</given-names></name></person-group><article-title>Piperine ameliorated lupus nephritis by targeting AMPK-mediated activation of NLRP3 inflammasome</article-title><source>Int. Immunopharmacol.</source><volume>65</volume><year>2018</year><fpage>448</fpage><lpage>457</lpage><pub-id pub-id-type="pmid">30388519</pub-id></element-citation></ref><ref id="bb1210"><label>242</label><element-citation publication-type="journal" id="rf1210"><person-group person-group-type="author"><name><surname>Ngo</surname><given-names>Q.M.</given-names></name><name><surname>Tran</surname><given-names>P.T.</given-names></name><name><surname>Tran</surname><given-names>M.H.</given-names></name><name><surname>Kim</surname><given-names>J.A.</given-names></name><name><surname>Rho</surname><given-names>S.S.</given-names></name><name><surname>Lim</surname><given-names>C.H.</given-names></name><name><surname>Kim</surname><given-names>J.C.</given-names></name><name><surname>Woo</surname><given-names>M.H.</given-names></name><name><surname>Choi</surname><given-names>J.S.</given-names></name><name><surname>Lee</surname><given-names>J.H.</given-names></name><name><surname>Min</surname><given-names>B.S.</given-names></name></person-group><article-title>Alkaloids from Piper nigrum exhibit antiinflammatory activity via activating the Nrf2/HO-1 pathway</article-title><source>Phytother. Res.</source><volume>31</volume><year>2017</year><fpage>663</fpage><lpage>670</lpage><pub-id pub-id-type="pmid">28185326</pub-id></element-citation></ref><ref id="bb1215"><label>243</label><element-citation publication-type="journal" id="rf1215"><person-group person-group-type="author"><name><surname>Das</surname><given-names>M.</given-names></name><name><surname>Basu</surname><given-names>S.</given-names></name><name><surname>Banerjee</surname><given-names>B.</given-names></name><name><surname>Sen</surname><given-names>A.</given-names></name><name><surname>Jana</surname><given-names>K.</given-names></name><name><surname>Datta</surname><given-names>G.</given-names></name></person-group><article-title>Hepatoprotective effects of green Capsicum annum against ethanol induced oxidative stress, inflammation and apoptosis in rats</article-title><source>J. Ethnopharmacol.</source><volume>227</volume><year>2018</year><fpage>69</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">30118838</pub-id></element-citation></ref><ref id="bb1220"><label>244</label><element-citation publication-type="journal" id="rf1220"><person-group person-group-type="author"><name><surname>Jang</surname><given-names>H.Y.</given-names></name><name><surname>Kim</surname><given-names>S.M.</given-names></name><name><surname>Yuk</surname><given-names>J.E.</given-names></name><name><surname>Kwon</surname><given-names>O.K.</given-names></name><name><surname>Oh</surname><given-names>S.R.</given-names></name><name><surname>Lee</surname><given-names>H.K.</given-names></name><name><surname>Jeong</surname><given-names>H.</given-names></name><name><surname>Ahn</surname><given-names>K.S.</given-names></name></person-group><article-title>Capsicum annuum L. methanolic extract inhibits ovalbumin-induced airway inflammation and oxidative stress in a mouse model of asthma</article-title><source>J. Med. Food</source><volume>14</volume><year>2011</year><fpage>1144</fpage><lpage>1151</lpage><pub-id pub-id-type="pmid">21875363</pub-id></element-citation></ref><ref id="bb1225"><label>245</label><element-citation publication-type="journal" id="rf1225"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>J.</given-names></name><name><surname>Luo</surname><given-names>K.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>Q.</given-names></name><name><surname>Tang</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Xiao</surname><given-names>J.</given-names></name></person-group><article-title>Capsaicin attenuates LPS-induced inflammatory cytokine production by upregulation of LXR&#x003b1;</article-title><source>Int. Immunopharmacol.</source><volume>28</volume><year>2015</year><fpage>264</fpage><lpage>269</lpage><pub-id pub-id-type="pmid">26093270</pub-id></element-citation></ref><ref id="bb1230"><label>246</label><element-citation publication-type="journal" id="rf1230"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>Y.H.</given-names></name><name><surname>Namkoong</surname><given-names>E.</given-names></name><name><surname>Choi</surname><given-names>S.</given-names></name><name><surname>Bae</surname><given-names>J.S.</given-names></name><name><surname>Jin</surname><given-names>M.</given-names></name><name><surname>Hwang</surname><given-names>S.M.</given-names></name><name><surname>Arote</surname><given-names>R.</given-names></name><name><surname>Choi</surname><given-names>S.Y.</given-names></name><name><surname>Park</surname><given-names>K.</given-names></name></person-group><article-title>Capsaicin regulates the NF-&#x003ba;B pathway in salivary gland inflammation</article-title><source>J. Dent. Res.</source><volume>92</volume><year>2013</year><fpage>547</fpage><lpage>552</lpage><pub-id pub-id-type="pmid">23603336</pub-id></element-citation></ref><ref id="bb1235"><label>247</label><element-citation publication-type="journal" id="rf1235"><person-group person-group-type="author"><name><surname>Abu Gazia</surname><given-names>M.</given-names></name><name><surname>El-Magd</surname><given-names>M.A.</given-names></name></person-group><article-title>Ameliorative effect of cardamom aqueous extract on doxorubicin-induced cardiotoxicity in rats</article-title><source>Cells Tissues Organs</source><volume>206</volume><year>2018</year><fpage>62</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">30716735</pub-id></element-citation></ref><ref id="bb1240"><label>248</label><element-citation publication-type="journal" id="rf1240"><person-group person-group-type="author"><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Yan</surname><given-names>H.</given-names></name><name><surname>Jiang</surname><given-names>X.</given-names></name><name><surname>Hu</surname><given-names>W.</given-names></name><name><surname>Han</surname><given-names>N.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name></person-group><article-title>Anti gouty arthritis andanti hyperuricemia properties of celery seed extracts in rodent models</article-title><source>Mol. MedRep.</source><volume>20</volume><year>2019</year><fpage>4623</fpage><lpage>4633</lpage></element-citation></ref><ref id="bb1245"><label>249</label><element-citation publication-type="journal" id="rf1245"><person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>S.L.</given-names></name><name><surname>Chen</surname><given-names>C.T.</given-names></name><name><surname>Wang</surname><given-names>J.J.</given-names></name><name><surname>Kuo</surname><given-names>Y.H.</given-names></name><name><surname>Li</surname><given-names>C.C.</given-names></name><name><surname>Hsieh</surname><given-names>L.C.</given-names></name><name><surname>Wu</surname><given-names>C.C.</given-names></name></person-group><article-title>Sedanolide inducesautophagy through the PI3K, p53 and NF-&#x003ba;B signaling pathways in human livercancer cells</article-title><source>Int. J. Oncol.</source><volume>47</volume><year>2015</year><fpage>2240</fpage><lpage>2246</lpage><pub-id pub-id-type="pmid">26500073</pub-id></element-citation></ref><ref id="bb1250"><label>250</label><element-citation publication-type="journal" id="rf1250"><person-group person-group-type="author"><name><surname>Che</surname><given-names>D.N.</given-names></name><name><surname>Cho</surname><given-names>B.O.</given-names></name><name><surname>Shin</surname><given-names>J.Y.</given-names></name><name><surname>Kang</surname><given-names>H.J.</given-names></name><name><surname>Kim</surname><given-names>J.S.</given-names></name><name><surname>Choi</surname><given-names>J.</given-names></name><name><surname>Jang</surname><given-names>S.I.</given-names></name></person-group><article-title>Anti-atopic dermatitis effects of hydrolyzed celery extract in mice</article-title><source>J. Food Biochem.</source><volume>44</volume><year>2020</year><object-id pub-id-type="publisher-id">e13198</object-id></element-citation></ref><ref id="bb1255"><label>251</label><element-citation publication-type="journal" id="rf1255"><person-group person-group-type="author"><name><surname>Si</surname><given-names>Y.</given-names></name><name><surname>Guo</surname><given-names>S.</given-names></name><name><surname>Fang</surname><given-names>Y.</given-names></name><name><surname>Qin</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>F.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Jiao</surname><given-names>P.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Gao</surname><given-names>L.</given-names></name></person-group><article-title>Celery seed extract blocks peroxide injury in macrophages via Notch1/NF-&#x003ba;B pathway</article-title><source>Am. J. Chin. Med.</source><volume>433</volume><year>2015</year><fpage>443</fpage><lpage>455</lpage></element-citation></ref><ref id="bb1260"><label>252</label><element-citation publication-type="journal" id="rf1260"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>T.</given-names></name><name><surname>Gao</surname><given-names>R.</given-names></name><name><surname>Zhou</surname><given-names>G.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Shen</surname><given-names>J.</given-names></name></person-group><article-title>Trans-cinnamaldehyde inhibits IL-1&#x003b2;-stimulated inflammation in chondrocytes by suppressing NF-&#x003ba;B and p38-JNK pathways and exerts chondrocyte protective effects in a rat model of osteoarthritis</article-title><source>Biomed. Res. Int.</source><volume>2019</volume><year>2019</year><object-id pub-id-type="publisher-id">4039472</object-id></element-citation></ref><ref id="bb1265"><label>253</label><element-citation publication-type="journal" id="rf1265"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>H.S.</given-names></name><name><surname>Kim</surname><given-names>B.S.</given-names></name><name><surname>Kim</surname><given-names>M.K.</given-names></name></person-group><article-title>Suppression effect of <italic>Cinnamomum cassia</italic> bark-derived component on nitric oxide synthase</article-title><source>J. Agric. Food Chem.</source><volume>50</volume><year>2002</year><fpage>7700</fpage><lpage>7703</lpage><pub-id pub-id-type="pmid">12475291</pub-id></element-citation></ref><ref id="bb1270"><label>254</label><element-citation publication-type="journal" id="rf1270"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>P.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Dong</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>Z.</given-names></name><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name></person-group><article-title>trans-Cinnamaldehyde inhibits microglial activation and improves neuronal survival against neuroinflammation in BV2 microglial cells with lipopolysaccharide stimulation</article-title><source>Evid. Based Complement. Alternat. Med.</source><volume>2017</volume><year>2017</year><object-id pub-id-type="publisher-id">4730878</object-id></element-citation></ref><ref id="bb1275"><label>255</label><element-citation publication-type="journal" id="rf1275"><person-group person-group-type="author"><name><surname>Han</surname><given-names>X.</given-names></name><name><surname>Parker</surname><given-names>T.L.</given-names></name></person-group><article-title>Antiinflammatory activity of cinnamon (<italic>Cinnamomum zeylanicum</italic>) bark essential oil in a human skin disease model</article-title><source>Phytother. Res.</source><volume>31</volume><year>2017</year><fpage>1034</fpage><lpage>1038</lpage><pub-id pub-id-type="pmid">28444928</pub-id></element-citation></ref><ref id="bb1280"><label>256</label><element-citation publication-type="journal" id="rf1280"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>J.W.</given-names></name><name><surname>Yang</surname><given-names>G.E.</given-names></name><name><surname>Kim</surname><given-names>Y.B.</given-names></name><name><surname>Eom</surname><given-names>S.H.</given-names></name><name><surname>Lew</surname><given-names>J.H.</given-names></name><name><surname>Kang</surname><given-names>H.</given-names></name></person-group><article-title>Anti-inflammatory activity of cinnamon water extract in vivo and in vitro LPS-induced models</article-title><source>BMC Complement. Altern. Med.</source><volume>12</volume><year>2012</year><fpage>237</fpage><pub-id pub-id-type="pmid">23190501</pub-id></element-citation></ref><ref id="bb1285"><label>257</label><element-citation publication-type="journal" id="rf1285"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>B.J.</given-names></name><name><surname>Kim</surname><given-names>Y.J.</given-names></name><name><surname>Cho</surname><given-names>D.H.</given-names></name><name><surname>Sohn</surname><given-names>N.W.</given-names></name><name><surname>Kang</surname><given-names>H.</given-names></name></person-group><article-title>Immunomodulatory effect of water extract of cinnamon on anti-CD3-induced cytokine responses and p38, JNK, ERK1/2, and STAT4 activation</article-title><source>Immunopharmacol. Immunotoxicol.</source><volume>33</volume><year>2011</year><fpage>714</fpage><lpage>722</lpage><pub-id pub-id-type="pmid">22053946</pub-id></element-citation></ref><ref id="bb1290"><label>258</label><element-citation publication-type="journal" id="rf1290"><person-group person-group-type="author"><name><surname>Koh</surname><given-names>W.S.</given-names></name><name><surname>Yoon</surname><given-names>S.Y.</given-names></name><name><surname>Kwon</surname><given-names>B.M.</given-names></name><name><surname>Jeong</surname><given-names>T.C.</given-names></name><name><surname>Nam</surname><given-names>K.S.</given-names></name><name><surname>Han</surname><given-names>M.Y.</given-names></name></person-group><article-title>Cinnamaldehyde inhibits lymphocyte proliferation and modulates T-cell differentiation</article-title><source>Int. J. Immunopharmacol.</source><volume>20</volume><year>1998</year><fpage>643</fpage><lpage>660</lpage><pub-id pub-id-type="pmid">9848396</pub-id></element-citation></ref><ref id="bb1295"><label>259</label><element-citation publication-type="journal" id="rf1295"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>T.T.</given-names></name><name><surname>Tsai</surname><given-names>C.W.</given-names></name><name><surname>Yao</surname><given-names>H.T.</given-names></name><name><surname>Lii</surname><given-names>C.K.</given-names></name><name><surname>Chen</surname><given-names>H.W.</given-names></name><name><surname>Wu</surname><given-names>Y.L.</given-names></name><name><surname>Chen</surname><given-names>P.Y.</given-names></name><name><surname>Liu</surname><given-names>K.L.</given-names></name></person-group><article-title>Suppressive effects of extracts from the aerial part of Coriandrum sativum L. on LPS-induced inflammatory responses in murine RAW 264.7 macrophages</article-title><source>J. Sci. Food Agric.</source><volume>90</volume><year>2010</year><fpage>1846</fpage><lpage>1854</lpage><pub-id pub-id-type="pmid">20549653</pub-id></element-citation></ref><ref id="bb1300"><label>260</label><element-citation publication-type="journal" id="rf1300"><person-group person-group-type="author"><name><surname>Park</surname><given-names>G.</given-names></name><name><surname>Kim</surname><given-names>H.G.</given-names></name><name><surname>Lim</surname><given-names>S.</given-names></name><name><surname>Lee</surname><given-names>W.</given-names></name><name><surname>Sim</surname><given-names>Y.</given-names></name><name><surname>Oh</surname><given-names>M.S.</given-names></name></person-group><article-title>Coriander alleviates 2,4-dinitrochlorobenzene-induced contact dermatitis-like skin lesions in mice</article-title><source>J. Med. Food</source><volume>17</volume><year>2014</year><fpage>862</fpage><lpage>868</lpage><pub-id pub-id-type="pmid">24963872</pub-id></element-citation></ref><ref id="bb1305"><label>261</label><element-citation publication-type="journal" id="rf1305"><person-group person-group-type="author"><name><surname>Nair</surname><given-names>V.</given-names></name><name><surname>Singh</surname><given-names>S.</given-names></name><name><surname>Gupta</surname><given-names>Y.K.</given-names></name></person-group><article-title>Anti-granuloma activity of Coriandrum sativum in experimental models</article-title><source>J. Ayurveda Integr. Med.</source><volume>4</volume><year>2013</year><fpage>13</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">23741156</pub-id></element-citation></ref><ref id="bb1310"><label>262</label><element-citation publication-type="journal" id="rf1310"><person-group person-group-type="author"><name><surname>Kalaivani</surname><given-names>P.</given-names></name><name><surname>Saranya</surname><given-names>R.B.</given-names></name><name><surname>Ramakrishnan</surname><given-names>G.</given-names></name><name><surname>Ranju</surname><given-names>V.</given-names></name><name><surname>Sathiya</surname><given-names>S.</given-names></name><name><surname>Gayathri</surname><given-names>V.</given-names></name><name><surname>Thiyagarajan</surname><given-names>L.K.</given-names></name><name><surname>Venkhatesh</surname><given-names>J.R.</given-names></name><name><surname>Babu</surname><given-names>C.S.</given-names></name><name><surname>Thanikachalam</surname><given-names>S.</given-names></name></person-group><article-title>Cuminum cyminum, a dietary spice, attenuates hypertension via endothelial nitric oxide synthase and NO pathway in renovascular hypertensive rats</article-title><source>Clin. Exp. Hypertens.</source><volume>35</volume><year>2013</year><fpage>534</fpage><lpage>542</lpage><pub-id pub-id-type="pmid">23402543</pub-id></element-citation></ref><ref id="bb1315"><label>263</label><element-citation publication-type="journal" id="rf1315"><person-group person-group-type="author"><name><surname>Vador</surname><given-names>N.</given-names></name><name><surname>Jagtap</surname><given-names>A.G.</given-names></name><name><surname>Damle</surname><given-names>A.</given-names></name></person-group><article-title>Vulnerability of gastric mucosa in diabetic rats, its pathogenesis and amelioration by Cuminum cyminum</article-title><source>Indian J. Pharm. Sci.</source><volume>74</volume><year>2012</year><fpage>387</fpage><lpage>396</lpage><pub-id pub-id-type="pmid">23716866</pub-id></element-citation></ref><ref id="bb1320"><label>264</label><element-citation publication-type="journal" id="rf1320"><person-group person-group-type="author"><name><surname>Khurana</surname><given-names>A.</given-names></name><name><surname>Sikha</surname><given-names>M.S.</given-names></name><name><surname>Ramesh</surname><given-names>K.</given-names></name><name><surname>Venkatesh</surname><given-names>P.</given-names></name><name><surname>Godugu</surname><given-names>C.</given-names></name></person-group><article-title>Modulation of cerulein-induced pancreatic inflammation by hydroalcoholic extract of curry leaf (Murraya koenigii)</article-title><source>Phytother. Res.</source><volume>33</volume><year>2019</year><fpage>1510</fpage><lpage>1525</lpage><pub-id pub-id-type="pmid">30883967</pub-id></element-citation></ref><ref id="bb1325"><label>265</label><element-citation publication-type="journal" id="rf1325"><person-group person-group-type="author"><name><surname>Yeap</surname><given-names>S.K.</given-names></name><name><surname>Abu</surname><given-names>N.</given-names></name><name><surname>Mohamad</surname><given-names>N.E.</given-names></name><name><surname>Beh</surname><given-names>B.K.</given-names></name><name><surname>Ho</surname><given-names>W.Y.</given-names></name><name><surname>Ebrahimi</surname><given-names>S.</given-names></name><name><surname>Yusof</surname><given-names>H.M.</given-names></name><name><surname>Ky</surname><given-names>H.</given-names></name><name><surname>Tan</surname><given-names>S.W.</given-names></name><name><surname>Alitheen</surname><given-names>N.B.</given-names></name></person-group><article-title>Chemopreventive and immunomodulatory effects of Murraya koenigii aqueous extract on 4T1 breast cancer cell-challenged mice</article-title><source>BMC Complement. Altern. Med.</source><volume>15</volume><year>2015</year><fpage>306</fpage><pub-id pub-id-type="pmid">26335427</pub-id></element-citation></ref><ref id="bb1330"><label>266</label><element-citation publication-type="journal" id="rf1330"><person-group person-group-type="author"><name><surname>Jagtap</surname><given-names>S.</given-names></name><name><surname>Khare</surname><given-names>P.</given-names></name><name><surname>Mangal</surname><given-names>P.</given-names></name><name><surname>Kondepudi</surname><given-names>K.K.</given-names></name><name><surname>Bishnoi</surname><given-names>M.</given-names></name><name><surname>Bhutani</surname><given-names>K.K.</given-names></name></person-group><article-title>Effect of mahanimbine, an alkaloid from curry leaves, on high-fat diet-induced adiposity, insulin resistance, and inflammatory alterations</article-title><source>Biofactors</source><volume>43</volume><year>2017</year><fpage>220</fpage><lpage>231</lpage><pub-id pub-id-type="pmid">27663177</pub-id></element-citation></ref><ref id="bb1335"><label>267</label><element-citation publication-type="journal" id="rf1335"><person-group person-group-type="author"><name><surname>Iman</surname><given-names>V.</given-names></name><name><surname>Mohan</surname><given-names>S.</given-names></name><name><surname>Abdelwahab</surname><given-names>S.I.</given-names></name><name><surname>Karimian</surname><given-names>H.</given-names></name><name><surname>Nordin</surname><given-names>N.</given-names></name><name><surname>Fadaeinasab</surname><given-names>M.</given-names></name><name><surname>Noordin</surname><given-names>M.I.</given-names></name><name><surname>Noor</surname><given-names>S.M.</given-names></name></person-group><article-title>Anticancer and anti-inflammatory activities of girinimbine isolated from Murraya koenigii</article-title><source>Drug Des. Devel. Ther.</source><volume>11</volume><year>2016</year><fpage>103</fpage><lpage>121</lpage></element-citation></ref><ref id="bb1340"><label>268</label><element-citation publication-type="journal" id="rf1340"><person-group person-group-type="author"><name><surname>Kandhare</surname><given-names>A.D.</given-names></name><name><surname>Bodhankar</surname><given-names>S.L.</given-names></name><name><surname>Mohan</surname><given-names>V.</given-names></name><name><surname>Thakurdesai</surname><given-names>P.A.</given-names></name></person-group><article-title>Effect of glycosides based standardized fenugreek seed extract in bleomycin-induced pulmonary fibrosis in rats: decisive role of Bax, Nrf2, NF-&#x003ba;B, Muc5ac, TNF-&#x003b1; and IL-1&#x003b2;</article-title><source>Chem. Biol. Interact.</source><volume>237</volume><year>2015</year><fpage>151</fpage><lpage>165</lpage><pub-id pub-id-type="pmid">26093215</pub-id></element-citation></ref><ref id="bb1345"><label>269</label><element-citation publication-type="journal" id="rf1345"><person-group person-group-type="author"><name><surname>Hamza</surname><given-names>A.A.</given-names></name><name><surname>Elwy</surname><given-names>H.M.</given-names></name><name><surname>Badawi</surname><given-names>A.M.</given-names></name></person-group><article-title>Fenugreek seed extract attenuates cisplatin-induced testicular damage in Wistar rats</article-title><source>Andrologia</source><volume>48</volume><year>2016</year><fpage>211</fpage><lpage>221</lpage><pub-id pub-id-type="pmid">25996647</pub-id></element-citation></ref><ref id="bb1350"><label>270</label><element-citation publication-type="journal" id="rf1350"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>S.K.</given-names></name><name><surname>Kumar</surname><given-names>B.</given-names></name><name><surname>Nag</surname><given-names>T.C.</given-names></name><name><surname>Srinivasan</surname><given-names>B.P.</given-names></name><name><surname>Srivastava</surname><given-names>S.</given-names></name><name><surname>Gaur</surname><given-names>S.</given-names></name><name><surname>Saxena</surname><given-names>R.</given-names></name></person-group><article-title>Effects of Trigonella foenum-graecum (L.) on retinal oxidative stress, and proinflammatory and angiogenic molecular biomarkers in streptozotocin-induced diabetic rats</article-title><source>Mol. Cell. Biochem.</source><volume>388</volume><year>2014</year><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">24242137</pub-id></element-citation></ref><ref id="bb1355"><label>271</label><element-citation publication-type="journal" id="rf1355"><person-group person-group-type="author"><name><surname>Sindhu</surname><given-names>G.</given-names></name><name><surname>Shyni</surname><given-names>G.L.</given-names></name><name><surname>Pushpan</surname><given-names>C.K.</given-names></name><name><surname>Nambisan</surname><given-names>B.</given-names></name><name><surname>Helen</surname><given-names>A.</given-names></name></person-group><article-title>Evaluation of anti-arthritic potential of Trigonella foenum graecum L. (fenugreek) mucilage against rheumatoid arthritis</article-title><source>Prostaglandins Other Lipid Mediat.</source><volume>138</volume><year>2018</year><fpage>48</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">30107253</pub-id></element-citation></ref><ref id="bb1360"><label>272</label><element-citation publication-type="journal" id="rf1360"><person-group person-group-type="author"><name><surname>Fahanik-Babaei</surname><given-names>J.</given-names></name><name><surname>Baluchnejadmojarad</surname><given-names>T.</given-names></name><name><surname>Nikbakht</surname><given-names>F.</given-names></name><name><surname>Roghani</surname><given-names>M.</given-names></name></person-group><article-title>Trigonelline protects hippocampus against intracerebral A&#x003b2;(1-40) as a model of Alzheimer's disease in the rat: insights into underlying mechanisms</article-title><source>Metab. Brain Dis.</source><volume>34</volume><year>2019</year><fpage>191</fpage><lpage>201</lpage><pub-id pub-id-type="pmid">30421246</pub-id></element-citation></ref><ref id="bb1365"><label>273</label><element-citation publication-type="journal" id="rf1365"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>M.L.</given-names></name><name><surname>Chiou</surname><given-names>Y.S.</given-names></name><name><surname>Chiou</surname><given-names>L.Y.</given-names></name><name><surname>Ho</surname><given-names>C.T.</given-names></name><name><surname>Pan</surname><given-names>M.H.</given-names></name></person-group><article-title>Garcinol suppresses inflammation-associated colon carcinogenesis in mice</article-title><source>Mol. Nutr. Food Res.</source><volume>58</volume><year>2014</year><fpage>1820</fpage><lpage>1829</lpage><pub-id pub-id-type="pmid">24981158</pub-id></element-citation></ref><ref id="bb1370"><label>274</label><element-citation publication-type="journal" id="rf1370"><person-group person-group-type="author"><name><surname>Li</surname><given-names>F.</given-names></name><name><surname>Shanmugam</surname><given-names>M.K.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Chatterjee</surname><given-names>S.</given-names></name><name><surname>Basha</surname><given-names>J.</given-names></name><name><surname>Kumar</surname><given-names>A.P.</given-names></name><name><surname>Kundu</surname><given-names>T.K.</given-names></name><name><surname>Sethi</surname><given-names>G.</given-names></name></person-group><article-title>Garcinol, a polyisoprenylated benzophenone modulates multiple proinflammatory signaling cascades leading to the suppression of growth and survival of head and neck carcinoma</article-title><source>Cancer Prev. Res. (Phila.)</source><volume>6</volume><year>2013</year><fpage>843</fpage><lpage>854</lpage><pub-id pub-id-type="pmid">23803415</pub-id></element-citation></ref><ref id="bb1375"><label>275</label><element-citation publication-type="journal" id="rf1375"><person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>C.C.</given-names></name><name><surname>Liu</surname><given-names>K.F.</given-names></name><name><surname>Liu</surname><given-names>P.C.</given-names></name><name><surname>Ho</surname><given-names>Y.T.</given-names></name><name><surname>Li</surname><given-names>W.S.</given-names></name><name><surname>Peng</surname><given-names>W.H.</given-names></name><name><surname>Tsai</surname><given-names>J.C.</given-names></name></person-group><article-title>Comparing the protection imparted by different fraction extracts of garlic (Allium sativum L.) against Der p-induced allergic airway iflammation in mice</article-title><source>Int. J. Mol. Sci.</source><volume>20</volume><year>2019</year><fpage>4879</fpage></element-citation></ref><ref id="bb1380"><label>276</label><element-citation publication-type="journal" id="rf1380"><person-group person-group-type="author"><name><surname>Mathan Kumar</surname><given-names>M.</given-names></name><name><surname>Tamizhselvi</surname><given-names>R.</given-names></name></person-group><article-title>Protective effect of diallyl disulfide against cerulein-induced acute pancreatitis and associated lung injury in mice</article-title><source>Int. Immunopharmacol.</source><volume>80</volume><year>2020</year><object-id pub-id-type="publisher-id">106136</object-id></element-citation></ref><ref id="bb1385"><label>277</label><element-citation publication-type="journal" id="rf1385"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>J.J.</given-names></name><name><surname>Li</surname><given-names>H.R.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Chen</surname><given-names>D.G.</given-names></name><name><surname>Liang</surname><given-names>Z.C.</given-names></name><name><surname>Shi</surname><given-names>Y.Q.</given-names></name><name><surname>Zhang</surname><given-names>L.L.</given-names></name><name><surname>Xin</surname><given-names>L.</given-names></name><name><surname>Zhao</surname><given-names>D.B.</given-names></name></person-group><article-title>Diallyl trisulfide can induce fibroblast-like synovial apoptosis and has a therapeutic effect on collagen-induced arthritis in mice via blocking NF-&#x003ba;B and Wnt pathways</article-title><source>Int. Immunopharmacol.</source><volume>71</volume><year>2019</year><fpage>132</fpage><lpage>138</lpage><pub-id pub-id-type="pmid">30897500</pub-id></element-citation></ref><ref id="bb1390"><label>278</label><element-citation publication-type="journal" id="rf1390"><person-group person-group-type="author"><name><surname>Nie</surname><given-names>Y.</given-names></name><name><surname>Yu</surname><given-names>K.</given-names></name><name><surname>Li</surname><given-names>B.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Xin</surname><given-names>R.</given-names></name><name><surname>Xiong</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>P.</given-names></name><name><surname>Chai</surname><given-names>G.</given-names></name></person-group><article-title>S-allyl-l-cysteine attenuates bleomycin-induced pulmonary fibrosis and inflammation via AKT/NF-&#x003ba;B signaling pathway in mice</article-title><source>J. Pharmacol. Sci.</source><volume>139</volume><year>2019</year><fpage>377</fpage><lpage>384</lpage><pub-id pub-id-type="pmid">30928090</pub-id></element-citation></ref><ref id="bb1395"><label>279</label><element-citation publication-type="journal" id="rf1395"><person-group person-group-type="author"><name><surname>Mo</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Dong</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Sun</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>A.</given-names></name><name><surname>Zhao</surname><given-names>Z.</given-names></name></person-group><article-title>S-allylmercaptocysteine ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting inflammation and oxidative stress via nuclear factor kappa B and Keap1/Nrf2 pathways</article-title><source>Int. Immunopharmacol.</source><volume>81</volume><year>2020</year><object-id pub-id-type="publisher-id">106273</object-id></element-citation></ref><ref id="bb1400"><label>280</label><element-citation publication-type="journal" id="rf1400"><person-group person-group-type="author"><name><surname>Annamalai</surname><given-names>G.</given-names></name><name><surname>Suresh</surname><given-names>K.</given-names></name></person-group><article-title>[6]-Shogaol attenuates inflammation, cell proliferation via modulate NF-&#x003ba;B and AP-1 oncogenic signaling in 7,12-dimethylbenz[a]anthracene induced oral carcinogenesis</article-title><source>Biomed. Pharmacother.</source><volume>98</volume><year>2018</year><fpage>484</fpage><lpage>490</lpage><pub-id pub-id-type="pmid">29287195</pub-id></element-citation></ref><ref id="bb1405"><label>281</label><element-citation publication-type="journal" id="rf1405"><person-group person-group-type="author"><name><surname>Tzeng</surname><given-names>T.F.</given-names></name><name><surname>Liou</surname><given-names>S.S.</given-names></name><name><surname>Chang</surname><given-names>C.J.</given-names></name><name><surname>Liu</surname><given-names>I.M.</given-names></name></person-group><article-title>6-Gingerol protects against nutritional steatohepatitis by regulating key genes related to inflammation and lipid metabolism</article-title><source>Nutrients</source><volume>7</volume><year>2015</year><fpage>999</fpage><lpage>1020</lpage><pub-id pub-id-type="pmid">25658238</pub-id></element-citation></ref><ref id="bb1410"><label>282</label><element-citation publication-type="journal" id="rf1410"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>L.</given-names></name><name><surname>Ying</surname><given-names>Z.H.</given-names></name><name><surname>Yu</surname><given-names>C.H.</given-names></name><name><surname>Zhang</surname><given-names>H.H.</given-names></name><name><surname>Yu</surname><given-names>W.Y.</given-names></name></person-group><article-title>Wu XN. Isofraxidin ameliorated influenza viral inflammation in rodents via inhibiting platelet aggregation</article-title><source>Int. Immunopharmacol.</source><volume>84</volume><year>2020</year><object-id pub-id-type="publisher-id">106521</object-id></element-citation></ref><ref id="bb1415"><label>283</label><element-citation publication-type="journal" id="rf1415"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>W.</given-names></name><name><surname>Ku</surname><given-names>S.K.</given-names></name><name><surname>Kim</surname><given-names>J.E.</given-names></name><name><surname>Cho</surname><given-names>S.H.</given-names></name><name><surname>Song</surname><given-names>G.Y.</given-names></name><name><surname>Bae</surname><given-names>J.S.</given-names></name></person-group><article-title>Inhibitory effects of black ginseng on particulate matter-induced pulmonary injury</article-title><source>Am. J. Chin. Med.</source><volume>47</volume><year>2019</year><fpage>1237</fpage><lpage>1251</lpage><pub-id pub-id-type="pmid">31495180</pub-id></element-citation></ref><ref id="bb1420"><label>284</label><element-citation publication-type="journal" id="rf1420"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y.J.</given-names></name><name><surname>Chen</surname><given-names>J.M.</given-names></name><name><surname>Sapkota</surname><given-names>K.</given-names></name><name><surname>Long</surname><given-names>J.Y.</given-names></name><name><surname>Liao</surname><given-names>Y.J.</given-names></name><name><surname>Jiang</surname><given-names>J.J.</given-names></name><name><surname>Liang</surname><given-names>B.Y.</given-names></name><name><surname>Wei</surname><given-names>J.B.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name></person-group><article-title>Pananx notoginseng saponins attenuate CCL2-induced cognitive deficits in rats via anti-inflammation and anti-apoptosis effects that involve suppressing over-activation of NMDA receptors</article-title><source>Biomed. Pharmacother.</source><volume>127</volume><year>2020</year><object-id pub-id-type="publisher-id">110139</object-id></element-citation></ref><ref id="bb1425"><label>285</label><element-citation publication-type="journal" id="rf1425"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>Q.G.</given-names></name><name><surname>Zeng</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>X.H.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Du</surname><given-names>X.F.</given-names></name><name><surname>Bai</surname><given-names>G.M.</given-names></name><name><surname>Yan</surname><given-names>X.</given-names></name></person-group><article-title>Protective effects of panax notoginseng saponin on dextran sulfate sodium-induced colitis in rats through phosphoinositide-3-kinase protein kinase B signaling pathway inhibition</article-title><source>World J. Gastroenterol.</source><volume>26</volume><year>2020</year><fpage>1156</fpage><lpage>1171</lpage><pub-id pub-id-type="pmid">32231420</pub-id></element-citation></ref><ref id="bb1430"><label>286</label><element-citation publication-type="journal" id="rf1430"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>C.</given-names></name><name><surname>Chen</surname><given-names>Q.</given-names></name><name><surname>Ren</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Ru</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name></person-group><article-title>Notoginsenoside R1 suppresses inflammatory signaling and rescues renal ischemia-reperfusion injury in experimental rats</article-title><source>Med. Sci. Monit.</source><volume>26</volume><year>2020</year><object-id pub-id-type="publisher-id">e920442</object-id></element-citation></ref><ref id="bb1435"><label>287</label><element-citation publication-type="journal" id="rf1435"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Song</surname><given-names>S.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Jin</surname><given-names>G.</given-names></name></person-group><article-title>Ginsenoside Rg3 alleviates complete Freund's adjuvant-induced rheumatoid arthritis in mice by regulating CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup>Treg cells</article-title><source>J. Agric. Food Chem.</source><volume>68</volume><year>2020</year><fpage>4893</fpage><lpage>4902</lpage><pub-id pub-id-type="pmid">32275817</pub-id></element-citation></ref><ref id="bb1440"><label>288</label><element-citation publication-type="journal" id="rf1440"><person-group person-group-type="author"><name><surname>Guan</surname><given-names>S.</given-names></name><name><surname>Yu</surname><given-names>P.</given-names></name><name><surname>Cao</surname><given-names>J.</given-names></name><name><surname>Xi</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Zhu</surname><given-names>C.</given-names></name><name><surname>Hu</surname><given-names>H.</given-names></name><name><surname>Gong</surname><given-names>X.</given-names></name><name><surname>Fan</surname><given-names>H.</given-names></name></person-group><article-title>Ginsenoside Rg1 protects against cigarette smoke-induced airway remodeling by suppressing the TGF-&#x003b2;1/Smad3 signaling pathway</article-title><source>Am. J. Transl. Res.</source><volume>12</volume><year>2020</year><fpage>493</fpage><lpage>506</lpage><pub-id pub-id-type="pmid">32194898</pub-id></element-citation></ref><ref id="bb1445"><label>289</label><element-citation publication-type="journal" id="rf1445"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Hu</surname><given-names>G.</given-names></name><name><surname>Zhang</surname><given-names>G.</given-names></name><name><surname>Zhao</surname><given-names>G.</given-names></name><name><surname>Shi</surname><given-names>M.</given-names></name></person-group><article-title>Ginsenoside Rd attenuates blood-brain barrier damage by suppressing proteasome-mediated signaling after transient forebrain ischemia</article-title><source>Neuroreport</source><volume>31</volume><year>2020</year><fpage>466</fpage><lpage>472</lpage><pub-id pub-id-type="pmid">32168101</pub-id></element-citation></ref><ref id="bb1450"><label>290</label><element-citation publication-type="journal" id="rf1450"><person-group person-group-type="author"><name><surname>Han</surname><given-names>J.G.</given-names></name><name><surname>Gupta</surname><given-names>S.C.</given-names></name><name><surname>Prasad</surname><given-names>S.</given-names></name></person-group><article-title>Aggarwal BB. PL chemosensitizes tumor cells through interaction with cysteine 179 of I&#x003ba;B&#x003b1; kinase, leading to suppression of NF-&#x003ba;B-regulated gene products</article-title><source>Mol. Cancer Ther.</source><volume>13</volume><year>2014</year><fpage>2422</fpage><lpage>2435</lpage><pub-id pub-id-type="pmid">25082961</pub-id></element-citation></ref><ref id="bb1455"><label>291</label><element-citation publication-type="journal" id="rf1455"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>H.P.</given-names></name><name><surname>Ma</surname><given-names>Q.</given-names></name></person-group><article-title>Piperlongumine alleviates lupus nephritis in MRL-Fas(lpr) mice by regulating the frequency of Th17 and regulatory T cells</article-title><source>Immunol. Lett.</source><volume>161</volume><year>2014</year><fpage>76</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">24837470</pub-id></element-citation></ref><ref id="bb1460"><label>292</label><element-citation publication-type="journal" id="rf1460"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>J.</given-names></name><name><surname>Xu</surname><given-names>P.</given-names></name><name><surname>Du</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Zhu</surname><given-names>Y.</given-names></name></person-group><article-title>Piperlongumine attenuates collagen-induced arthritis via expansion of myeloid-derived suppressor cells and inhibition of the activation of fibroblast-like synoviocytes</article-title><source>Mol. Med. Rep.</source><volume>11</volume><year>2015</year><fpage>2689</fpage><lpage>2694</lpage><pub-id pub-id-type="pmid">25435301</pub-id></element-citation></ref><ref id="bb1465"><label>293</label><element-citation publication-type="journal" id="rf1465"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>B.</given-names></name><name><surname>Xu</surname><given-names>T.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Bai</surname><given-names>B.</given-names></name><name><surname>Xiao</surname><given-names>Z.</given-names></name><name><surname>Wu</surname><given-names>L.</given-names></name><name><surname>Liang</surname><given-names>G.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Dai</surname><given-names>Y.</given-names></name></person-group><article-title>PL reduces ovalbumin-induced asthma and airway inflammation by regulating nuclear factor-&#x003ba;B activation</article-title><source>Int. J. Mol. Med.</source><volume>44</volume><year>2019</year><fpage>1855</fpage><lpage>1865</lpage><pub-id pub-id-type="pmid">31485644</pub-id></element-citation></ref><ref id="bb1470"><label>294</label><element-citation publication-type="journal" id="rf1470"><person-group person-group-type="author"><name><surname>Ku</surname><given-names>S.K.</given-names></name><name><surname>Kim</surname><given-names>J.A.</given-names></name><name><surname>Bae</surname><given-names>J.S.</given-names></name></person-group><article-title>Vascular barrier protective effects of piperlonguminine in vitro and in vivo</article-title><source>Inflamm. Res.</source><volume>63</volume><year>2014</year><fpage>369</fpage><lpage>379</lpage><pub-id pub-id-type="pmid">24468889</pub-id></element-citation></ref><ref id="bb1475"><label>295</label><element-citation publication-type="journal" id="rf1475"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>N.</given-names></name><name><surname>Do</surname><given-names>J.</given-names></name><name><surname>Bae</surname><given-names>J.S.</given-names></name><name><surname>Jin</surname><given-names>H.K.</given-names></name><name><surname>Kim</surname><given-names>J.H.</given-names></name><name><surname>Inn</surname><given-names>K.S.</given-names></name><name><surname>Oh</surname><given-names>M.S.</given-names></name><name><surname>Lee</surname><given-names>J.K.</given-names></name></person-group><article-title>PL inhibits neuroinflammation via regulating NF-&#x003ba;B signaling pathways in lipopolysaccharide-stimulated BV2 microglia cells</article-title><source>J. Pharmacol. Sci.</source><volume>137</volume><year>2018</year><fpage>195</fpage><lpage>201</lpage><pub-id pub-id-type="pmid">29970291</pub-id></element-citation></ref><ref id="bb1480"><label>296</label><element-citation publication-type="journal" id="rf1480"><person-group person-group-type="author"><name><surname>Devan</surname><given-names>P.</given-names></name><name><surname>Bani</surname><given-names>S.</given-names></name><name><surname>Suri</surname><given-names>K.A.</given-names></name><name><surname>Satti</surname><given-names>N.K.</given-names></name><name><surname>Qazi</surname><given-names>G.N.</given-names></name></person-group><article-title>Immunomodulation exhibited by piperinic acid through suppression of proinflammatory cytokines</article-title><source>Int. Immunopharmacol.</source><volume>7</volume><year>2007</year><fpage>889</fpage><lpage>899</lpage><pub-id pub-id-type="pmid">17499191</pub-id></element-citation></ref><ref id="bb1485"><label>297</label><element-citation publication-type="journal" id="rf1485"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>S.M.</given-names></name><name><surname>Lee</surname><given-names>H.P.</given-names></name><name><surname>Ham</surname><given-names>Y.W.</given-names></name><name><surname>Son</surname><given-names>D.J.</given-names></name><name><surname>Kim</surname><given-names>H.Y.</given-names></name><name><surname>Oh</surname><given-names>K.W.</given-names></name><name><surname>Han</surname><given-names>S.B.</given-names></name><name><surname>Yun</surname><given-names>J.</given-names></name><name><surname>Hong</surname><given-names>J.T.P.L.</given-names></name></person-group><article-title>Improves lipopolysaccharide-induced amyloidogenesis by suppressing NF-KappaB pathway</article-title><source>NeuroMolecular Med.</source><volume>20</volume><year>2018</year><fpage>312</fpage><lpage>327</lpage><pub-id pub-id-type="pmid">29802525</pub-id></element-citation></ref><ref id="bb1490"><label>298</label><element-citation publication-type="journal" id="rf1490"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>N.</given-names></name><name><surname>Kumar</surname><given-names>S.</given-names></name><name><surname>Singh</surname><given-names>P.</given-names></name><name><surname>Raj</surname><given-names>H.G.</given-names></name><name><surname>Prasad</surname><given-names>A.K.</given-names></name><name><surname>Parmar</surname><given-names>V.S.</given-names></name><name><surname>Ghosh</surname><given-names>B.</given-names></name></person-group><article-title>Piper longum Linn. extract inhibits TNF-alpha-induced expression of cell adhesion molecules by inhibiting NF-kappaB activation and microsomal lipid peroxidation</article-title><source>Phytomedicine</source><volume>15</volume><year>2008</year><fpage>284</fpage><lpage>291</lpage><pub-id pub-id-type="pmid">17689945</pub-id></element-citation></ref><ref id="bb1495"><label>299</label><element-citation publication-type="journal" id="rf1495"><person-group person-group-type="author"><name><surname>Son</surname><given-names>D.J.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name><name><surname>Han</surname><given-names>S.S.</given-names></name><name><surname>Kim</surname><given-names>C.W.</given-names></name><name><surname>Kumar</surname><given-names>S.</given-names></name><name><surname>Park</surname><given-names>B.S.</given-names></name><name><surname>Lee</surname><given-names>S.E.</given-names></name><name><surname>Yun</surname><given-names>Y.P.</given-names></name><name><surname>Jo</surname><given-names>H.</given-names></name><name><surname>Park</surname><given-names>Y.H.</given-names></name></person-group><article-title>PL inhibits atherosclerotic plaque formation and vascular smooth muscle cell proliferation by suppressing PDGF receptor signaling</article-title><source>Biochem. Biophys. Res. Commun.</source><volume>427</volume><year>2012</year><fpage>349</fpage><lpage>354</lpage><pub-id pub-id-type="pmid">22995306</pub-id></element-citation></ref><ref id="bb1500"><label>300</label><element-citation publication-type="journal" id="rf1500"><person-group person-group-type="author"><name><surname>Ku</surname><given-names>S.K.</given-names></name><name><surname>Kim</surname><given-names>J.A.</given-names></name><name><surname>Bae</surname><given-names>J.S.</given-names></name></person-group><article-title>Piperlonguminine downregulates endothelial protein C receptor shedding in vitro and in vivo</article-title><source>Inflammation</source><volume>37</volume><year>2014</year><fpage>435</fpage><lpage>442</lpage><pub-id pub-id-type="pmid">24127121</pub-id></element-citation></ref><ref id="bb1505"><label>301</label><element-citation publication-type="journal" id="rf1505"><person-group person-group-type="author"><name><surname>Sant'Ana</surname><given-names>M.</given-names></name><name><surname>Souza</surname><given-names>H.R.</given-names></name><name><surname>Possebon</surname><given-names>L.</given-names></name><name><surname>Corn&#x000e9;lio</surname><given-names>M.L.</given-names></name><name><surname>Riffo-Vasquez</surname><given-names>Y.</given-names></name><name><surname>Girol</surname><given-names>A.P.</given-names></name><name><surname>Oliani</surname><given-names>S.M.</given-names></name></person-group><article-title>Effect of PL during exposure to cigarette smoke reduces inflammation and lung injury</article-title><source>Pulm. Pharmacol. Ther.</source><volume>61</volume><year>2020</year><object-id pub-id-type="publisher-id">101896</object-id></element-citation></ref><ref id="bb1510"><label>302</label><element-citation publication-type="journal" id="rf1510"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>W.</given-names></name><name><surname>Akanda</surname><given-names>M.R.</given-names></name><name><surname>Islam</surname><given-names>A.</given-names></name><name><surname>Yang</surname><given-names>H.D.</given-names></name><name><surname>Lee</surname><given-names>S.C.</given-names></name><name><surname>Lee</surname><given-names>J.H.</given-names></name><name><surname>Kim</surname><given-names>S.K.</given-names></name><name><surname>Choi</surname><given-names>Y.J.</given-names></name><name><surname>Im</surname><given-names>S.Y.</given-names></name><name><surname>Park</surname><given-names>B.Y.</given-names></name></person-group><article-title>The anti-stress effect of <italic>Mentha arvensis</italic> in immobilized rats</article-title><source>Int. J. Mol. Sci.</source><volume>19</volume><year>2018</year><fpage>355</fpage></element-citation></ref><ref id="bb1515"><label>303</label><element-citation publication-type="journal" id="rf1515"><person-group person-group-type="author"><name><surname>Yadav</surname><given-names>N.</given-names></name><name><surname>Chandra</surname><given-names>H.</given-names></name></person-group><article-title>Modulation of alveolar macrophage innate response in proinflammatory-, pro-oxidant-, and infection-models by mint extract and chemical constituents: role of MAPKs</article-title><source>Immunobiology</source><volume>223</volume><year>2018</year><fpage>49</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">29031422</pub-id></element-citation></ref><ref id="bb1520"><label>304</label><element-citation publication-type="journal" id="rf1520"><person-group person-group-type="author"><name><surname>Xian</surname><given-names>Y.F.</given-names></name><name><surname>Hu</surname><given-names>Z.</given-names></name><name><surname>Ip</surname><given-names>S.P.</given-names></name><name><surname>Chen</surname><given-names>J.N.</given-names></name><name><surname>Su</surname><given-names>Z.R.</given-names></name><name><surname>Lai</surname><given-names>X.P.</given-names></name><name><surname>Lin</surname><given-names>Z.X.</given-names></name></person-group><article-title>Comparison of the anti-inflammatory effects of Sinapis alba and <italic>Brassica juncea</italic> in mouse models of inflammation</article-title><source>Phytomedicine</source><volume>50</volume><year>2018</year><fpage>196</fpage><lpage>204</lpage><pub-id pub-id-type="pmid">30466979</pub-id></element-citation></ref><ref id="bb1525"><label>305</label><element-citation publication-type="journal" id="rf1525"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>R.</given-names></name><name><surname>Wen</surname><given-names>C.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Zhao</surname><given-names>H.</given-names></name></person-group><article-title>Expression of NLRP3 inflammasome in BALB/c mice with imiquimod-induced psoriasis-like inflammation and therapeutic effect of mustard seed (Sinapis alba Linn)</article-title><source>Nan Fang Yi Ke Da Xue Xue Bao</source><volume>33</volume><year>2013</year><fpage>1394</fpage><lpage>1398</lpage><comment>(Chinese)</comment><pub-id pub-id-type="pmid">24067228</pub-id></element-citation></ref><ref id="bb1530"><label>306</label><element-citation publication-type="journal" id="rf1530"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>R.</given-names></name><name><surname>Zhou</surname><given-names>Q.</given-names></name><name><surname>Wen</surname><given-names>C.</given-names></name><name><surname>Hu</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Zhao</surname><given-names>M.</given-names></name><name><surname>Zhao</surname><given-names>H.</given-names></name></person-group><article-title>Mustard seed (Sinapis alba Linn) attenuates imiquimod-induced psoriasiform inflammation of BALB/c mice</article-title><source>J. Dermatol.</source><volume>40</volume><year>2013</year><fpage>543</fpage><lpage>552</lpage><pub-id pub-id-type="pmid">23682616</pub-id></element-citation></ref><ref id="bb1535"><label>307</label><element-citation publication-type="journal" id="rf1535"><person-group person-group-type="author"><name><surname>Al-Quraishy</surname><given-names>S.</given-names></name><name><surname>Dkhil</surname><given-names>M.A.</given-names></name><name><surname>Abdel-Gaber</surname><given-names>R.</given-names></name><name><surname>Zrieq</surname><given-names>R.</given-names></name><name><surname>Hafez</surname><given-names>T.A.</given-names></name><name><surname>Mubaraki</surname><given-names>M.A.</given-names></name><name><surname>Abdel Moneim</surname><given-names>A.E.</given-names></name></person-group><article-title>Myristica fragrans seed extract reverses scopolamine-induced cortical injury via stimulation of HO-1 expression in male rats</article-title><source>Environ. Sci. Pollut. Res. Int.</source><volume>27</volume><year>2020</year><fpage>12395</fpage><lpage>12404</lpage><pub-id pub-id-type="pmid">31993909</pub-id></element-citation></ref><ref id="bb1540"><label>308</label><element-citation publication-type="journal" id="rf1540"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>K.</given-names></name><name><surname>Chung</surname><given-names>H.C.</given-names></name><name><surname>Kim</surname><given-names>D.U.</given-names></name><name><surname>Hwang</surname><given-names>J.K.</given-names></name><name><surname>Lee</surname><given-names>S.H.</given-names></name></person-group><article-title>Macelignan attenuated allergic lung inflammation and airway hyper-responsiveness in murine experimental asthma</article-title><source>Life Sci.</source><volume>92</volume><year>2013</year><fpage>1093</fpage><lpage>1099</lpage><pub-id pub-id-type="pmid">23643632</pub-id></element-citation></ref><ref id="bb1545"><label>309</label><element-citation publication-type="journal" id="rf1545"><person-group person-group-type="author"><name><surname>Han</surname><given-names>Y.S.</given-names></name><name><surname>Kim</surname><given-names>M.S.</given-names></name><name><surname>Hwang</surname><given-names>J.K.</given-names></name></person-group><article-title>Macelignan inhibits histamine release and inflammatory mediator production in activated rat basophilic leukemia mast cells</article-title><source>Inflammation</source><volume>35</volume><year>2012</year><fpage>1723</fpage><lpage>1731</lpage><pub-id pub-id-type="pmid">22729280</pub-id></element-citation></ref><ref id="bb1550"><label>310</label><element-citation publication-type="journal" id="rf1550"><person-group person-group-type="author"><name><surname>Long</surname><given-names>J.</given-names></name><name><surname>Qian</surname><given-names>K.</given-names></name><name><surname>Tan</surname><given-names>S.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name></person-group><article-title>Macelignan protects against renal ischemia-reperfusion injury via inhibition of inflammation and apoptosis of renal epithelial cells</article-title><source>Cell. Mol. Biol. (Noisy-le-grand)</source><volume>66</volume><year>2020</year><fpage>55</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">32359384</pub-id></element-citation></ref><ref id="bb1555"><label>311</label><element-citation publication-type="journal" id="rf1555"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>H.</given-names></name><name><surname>Zhu</surname><given-names>Z.G.</given-names></name><name><surname>Yu</surname><given-names>P.J.</given-names></name><name><surname>Wang</surname><given-names>G.F.</given-names></name><name><surname>Zhang</surname><given-names>J.Y.</given-names></name><name><surname>Li</surname><given-names>J.R.</given-names></name><name><surname>Ai</surname><given-names>R.T.</given-names></name><name><surname>Li</surname><given-names>Z.H.</given-names></name><name><surname>Tian</surname><given-names>Y.X.</given-names></name><name><surname>Zhang</surname><given-names>W.X.</given-names></name><name><surname>Wu</surname><given-names>S.G.</given-names></name></person-group><article-title>Myrislignan attenuates lipopolysaccharide-induced inflammation reaction in murine macrophage cells through inhibition of NF-&#x003ba;B signalling pathway activation</article-title><source>Phytother. Res.</source><volume>26</volume><year>2012</year><fpage>1320</fpage><lpage>1326</lpage><pub-id pub-id-type="pmid">22294521</pub-id></element-citation></ref><ref id="bb1560"><label>312</label><element-citation publication-type="journal" id="rf1560"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.Y.</given-names></name><name><surname>Park</surname><given-names>W.</given-names></name></person-group><article-title>Anti-inflammatory effect of myristicin on RAW 264.7 macrophages stimulated with polyinosinic-polycytidylic acid</article-title><source>Molecules</source><volume>16</volume><year>2011</year><fpage>7132</fpage><lpage>7142</lpage><pub-id pub-id-type="pmid">21991618</pub-id></element-citation></ref><ref id="bb1565"><label>313</label><element-citation publication-type="journal" id="rf1565"><person-group person-group-type="author"><name><surname>Khajah</surname><given-names>M.A.</given-names></name><name><surname>Orabi</surname><given-names>K.Y.</given-names></name><name><surname>Hawai</surname><given-names>S.</given-names></name><name><surname>Sary</surname><given-names>H.G.</given-names></name><name><surname>El-Hashim</surname><given-names>A.Z.</given-names></name></person-group><article-title>Onion bulb extract reduces colitis severity in mice via modulation of colonic inflammatory pathways and the apoptotic machinery</article-title><source>J. Ethnopharmacol.</source><volume>241</volume><year>2019</year><object-id pub-id-type="publisher-id">112008</object-id></element-citation></ref><ref id="bb1570"><label>314</label><element-citation publication-type="journal" id="rf1570"><person-group person-group-type="author"><name><surname>Elberry</surname><given-names>A.A.</given-names></name><name><surname>Mufti</surname><given-names>S.</given-names></name><name><surname>Al-Maghrabi</surname><given-names>J.</given-names></name><name><surname>Abdel Sattar</surname><given-names>E.</given-names></name><name><surname>Ghareib</surname><given-names>S.A.</given-names></name><name><surname>Mosli</surname><given-names>H.A.</given-names></name><name><surname>Gabr</surname><given-names>S.A.</given-names></name></person-group><article-title>Immunomodulatory effect of red onion (Allium cepa Linn) scale extract on experimentally induced atypical prostatic hyperplasia in Wistar rats</article-title><source>Mediat. Inflamm.</source><volume>2014</volume><year>2014</year><object-id pub-id-type="publisher-id">640746</object-id></element-citation></ref><ref id="bb1575"><label>315</label><element-citation publication-type="journal" id="rf1575"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>X.L.</given-names></name><name><surname>Zhao</surname><given-names>C.H.</given-names></name><name><surname>Yao</surname><given-names>X.L.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name></person-group><article-title>Quercetin attenuates high fructose feeding-induced atherosclerosis by suppressing inflammation and apoptosis via ROS-regulated PI3K/AKT signaling pathway</article-title><source>Biomed. Pharmacother.</source><volume>85</volume><year>2017</year><fpage>658</fpage><lpage>671</lpage><pub-id pub-id-type="pmid">27919735</pub-id></element-citation></ref><ref id="bb1580"><label>316</label><element-citation publication-type="journal" id="rf1580"><person-group person-group-type="author"><name><surname>Sekhon-Loodu</surname><given-names>S.</given-names></name><name><surname>Ziaullah</surname><given-names>Z.</given-names></name><name><surname>Rupasinghe</surname><given-names>H.P.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Kulka</surname><given-names>M.</given-names></name><name><surname>Shahidi</surname><given-names>F.</given-names></name></person-group><article-title>Novel quercetin-3-O-glucoside eicosapentaenoic acid ester ameliorates inflammation and hyperlipidemia</article-title><source>Inflammopharmacology</source><volume>23</volume><year>2015</year><fpage>173</fpage><lpage>185</lpage><pub-id pub-id-type="pmid">26165697</pub-id></element-citation></ref><ref id="bb1585"><label>317</label><element-citation publication-type="journal" id="rf1585"><person-group person-group-type="author"><name><surname>Shakeri</surname><given-names>F.</given-names></name><name><surname>Eftekhar</surname><given-names>N.</given-names></name><name><surname>Roshan</surname><given-names>N.M.</given-names></name><name><surname>Rezaee</surname><given-names>R.</given-names></name><name><surname>Moghimi</surname><given-names>A.</given-names></name><name><surname>Boskabady</surname><given-names>M.H.</given-names></name></person-group><article-title>Rosmarinic acid affects immunological and inflammatory mediator levels and restores lung pathological features in asthmatic rats</article-title><source>Allergol Immunopathol (Madr)</source><volume>47</volume><year>2019</year><fpage>16</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">29983238</pub-id></element-citation></ref><ref id="bb1590"><label>318</label><element-citation publication-type="journal" id="rf1590"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>Z.</given-names></name><name><surname>Nie</surname><given-names>H.</given-names></name><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Peng</surname><given-names>J.</given-names></name><name><surname>Zeng</surname><given-names>Y.</given-names></name><name><surname>Wei</surname><given-names>Y.</given-names></name><name><surname>Wen</surname><given-names>X.</given-names></name><name><surname>Qiu</surname><given-names>J.</given-names></name><name><surname>Zhong</surname><given-names>W.</given-names></name><name><surname>Deng</surname><given-names>X.</given-names></name><name><surname>He</surname><given-names>J.</given-names></name></person-group><article-title>Therapeutic effects of rosmarinic acid on airway responses in a murine model of asthma</article-title><source>Int. Immunopharmacol.</source><volume>41</volume><year>2016</year><fpage>90</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">27825045</pub-id></element-citation></ref><ref id="bb1595"><label>319</label><element-citation publication-type="journal" id="rf1595"><person-group person-group-type="author"><name><surname>Baradaran Rahim</surname><given-names>V.</given-names></name><name><surname>Khammar</surname><given-names>M.T.</given-names></name><name><surname>Rakhshandeh</surname><given-names>H.</given-names></name><name><surname>Samzadeh-Kermani</surname><given-names>A.</given-names></name><name><surname>Hosseini</surname><given-names>A.</given-names></name><name><surname>Askari</surname><given-names>V.R.</given-names></name></person-group><article-title>Crocin protects cardiomyocytes against LPS-induced inflammation</article-title><source>Pharmacol. Rep.</source><volume>71</volume><year>2019</year><fpage>1228</fpage><lpage>1234</lpage><pub-id pub-id-type="pmid">31670059</pub-id></element-citation></ref><ref id="bb1600"><label>320</label><element-citation publication-type="journal" id="rf1600"><person-group person-group-type="author"><name><surname>Algandaby</surname><given-names>M.M.</given-names></name></person-group><article-title>Crocin attenuates metabolic syndrome-induced osteoporosis in rats</article-title><source>J. Food Biochem.</source><volume>43</volume><year>2019</year><object-id pub-id-type="publisher-id">e12895</object-id></element-citation></ref><ref id="bb1605"><label>321</label><element-citation publication-type="journal" id="rf1605"><person-group person-group-type="author"><name><surname>Lertnimitphun</surname><given-names>P.</given-names></name><name><surname>Jiang</surname><given-names>Y.</given-names></name><name><surname>Kim</surname><given-names>N.</given-names></name><name><surname>Fu</surname><given-names>W.</given-names></name><name><surname>Zheng</surname><given-names>C.</given-names></name><name><surname>Tan</surname><given-names>H.</given-names></name><name><surname>Zhou</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Pei</surname><given-names>W.</given-names></name><name><surname>Lu</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>H.</given-names></name></person-group><article-title>Safranal alleviates dextran sulfate sodium-induced colitis and suppresses macrophage-mediated inflammation</article-title><source>Front. Pharmacol.</source><volume>10</volume><year>2019</year><fpage>1281</fpage><pub-id pub-id-type="pmid">31736758</pub-id></element-citation></ref><ref id="bb1610"><label>322</label><element-citation publication-type="journal" id="rf1610"><person-group person-group-type="author"><name><surname>Baluchnejadmojarad</surname><given-names>T.</given-names></name><name><surname>Mohamadi-Zarch</surname><given-names>S.M.</given-names></name><name><surname>Roghani</surname><given-names>M.</given-names></name></person-group><article-title>Safranal, an active ingredient of saffron, attenuates cognitive deficits in amyloid &#x003b2;-induced rat model of Alzheimer's disease: underlying mechanisms</article-title><source>Metab. Brain Dis.</source><volume>34</volume><year>2019</year><fpage>1747</fpage><lpage>1759</lpage><pub-id pub-id-type="pmid">31422512</pub-id></element-citation></ref><ref id="bb1615"><label>323</label><element-citation publication-type="journal" id="rf1615"><person-group person-group-type="author"><name><surname>Tamaddonfard</surname><given-names>E.</given-names></name><name><surname>Erfanparast</surname><given-names>A.</given-names></name><name><surname>Farshid</surname><given-names>A.A.</given-names></name><name><surname>Imani</surname><given-names>M.</given-names></name><name><surname>Mirzakhani</surname><given-names>N.</given-names></name><name><surname>Salighedar</surname><given-names>R.</given-names></name><name><surname>Tamaddonfard</surname><given-names>S.</given-names></name></person-group><article-title>Safranal, a constituent of saffron, exerts gastro-protective effects against indomethacin-induced gastric ulcer</article-title><source>Life Sci.</source><volume>224</volume><year>2019</year><fpage>88</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">30914317</pub-id></element-citation></ref><ref id="bb1620"><label>324</label><element-citation publication-type="journal" id="rf1620"><person-group person-group-type="author"><name><surname>Liou</surname><given-names>C.J.</given-names></name><name><surname>Chen</surname><given-names>Y.L.</given-names></name><name><surname>Yu</surname><given-names>M.C.</given-names></name><name><surname>Yeh</surname><given-names>K.W.</given-names></name><name><surname>Shen</surname><given-names>S.C.</given-names></name><name><surname>Huang</surname><given-names>W.C.</given-names></name></person-group><article-title>Sesamol alleviates airway hyperresponsiveness and oxidative stress in asthmatic mice</article-title><source>Antioxidants (Basel)</source><volume>9</volume><year>2020</year><fpage>295</fpage></element-citation></ref><ref id="bb1625"><label>325</label><element-citation publication-type="journal" id="rf1625"><person-group person-group-type="author"><name><surname>Qiang</surname><given-names>L.</given-names></name><name><surname>Yuan</surname><given-names>J.</given-names></name><name><surname>Shouyin</surname><given-names>J.</given-names></name><name><surname>Yulin</surname><given-names>L.</given-names></name><name><surname>Libing</surname><given-names>J.</given-names></name><name><surname>Jian-An</surname><given-names>W.</given-names></name></person-group><article-title>Sesamin attenuates lipopolysaccharide-induced acute lung injury by inhibition of TLR4 signaling pathways</article-title><source>Inflammation</source><volume>39</volume><year>2016</year><fpage>467</fpage><lpage>472</lpage><pub-id pub-id-type="pmid">26468152</pub-id></element-citation></ref><ref id="bb1630"><label>326</label><element-citation publication-type="journal" id="rf1630"><person-group person-group-type="author"><name><surname>Rousta</surname><given-names>A.M.</given-names></name><name><surname>Mirahmadi</surname><given-names>S.M.</given-names></name><name><surname>Shahmohammadi</surname><given-names>A.</given-names></name><name><surname>Nourabadi</surname><given-names>D.</given-names></name><name><surname>Khajevand-Khazaei</surname><given-names>M.R.</given-names></name><name><surname>Baluchnejadmojarad</surname><given-names>T.</given-names></name><name><surname>Roghani</surname><given-names>M.</given-names></name></person-group><article-title>Protective effect of sesamin in lipopolysaccharide-induced mouse model of acute kidney injury via attenuation of oxidative stress, inflammation, and apoptosis</article-title><source>Immunopharmacol. Immunotoxicol.</source><volume>40</volume><year>2018</year><fpage>423</fpage><lpage>429</lpage><pub-id pub-id-type="pmid">30488751</pub-id></element-citation></ref><ref id="bb1635"><label>327</label><element-citation publication-type="journal" id="rf1635"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Jia</surname><given-names>M.</given-names></name><name><surname>Fu</surname><given-names>S.</given-names></name><name><surname>Pan</surname><given-names>J.</given-names></name><name><surname>Chu</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name></person-group><article-title>(+)-Sesamin attenuates chronic unpredictable mild stress-induced depressive-like behaviors and memory deficits via suppression of neuroinflammation</article-title><source>J. Nutr. Biochem.</source><volume>64</volume><year>2019</year><fpage>61</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">30445417</pub-id></element-citation></ref><ref id="bb1640"><label>328</label><element-citation publication-type="journal" id="rf1640"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>D.Z.</given-names></name><name><surname>Liu</surname><given-names>C.T.</given-names></name><name><surname>Chu</surname><given-names>P.Y.</given-names></name><name><surname>Li</surname><given-names>Y.H.</given-names></name><name><surname>Periasamy</surname><given-names>S.</given-names></name><name><surname>Liu</surname><given-names>M.Y.</given-names></name></person-group><article-title>Sesame oil attenuates ovalbumin-induced pulmonary edema and bronchial neutrophilic inflammation in mice</article-title><source>Biomed. Res. Int.</source><volume>2013</volume><year>2013</year><object-id pub-id-type="publisher-id">905670</object-id></element-citation></ref><ref id="bb1645"><label>329</label><element-citation publication-type="journal" id="rf1645"><person-group person-group-type="author"><name><surname>Park</surname><given-names>S.H.</given-names></name><name><surname>Sung</surname><given-names>Y.Y.</given-names></name><name><surname>Nho</surname><given-names>K.J.</given-names></name><name><surname>Kim</surname><given-names>H.K.</given-names></name></person-group><article-title>Protective activity ethanol extract of the fruits of Illicium verum against atherogenesis in apolipoprotein E knockout mice</article-title><source>BMC Complement. Altern. Med.</source><volume>15</volume><year>2015</year><fpage>232</fpage><pub-id pub-id-type="pmid">26174316</pub-id></element-citation></ref><ref id="bb1650"><label>330</label><element-citation publication-type="journal" id="rf1650"><person-group person-group-type="author"><name><surname>Sung</surname><given-names>Y.Y.</given-names></name><name><surname>Kim</surname><given-names>H.K.</given-names></name></person-group><article-title>Illicium verum extract suppresses IFN-&#x003b3;-induced ICAM-1 expression via blockade of JAK/STAT pathway in HaCaT human keratinocytes</article-title><source>J. Ethnopharmacol.</source><volume>149</volume><year>2013</year><fpage>626</fpage><lpage>632</lpage><pub-id pub-id-type="pmid">23872327</pub-id></element-citation></ref><ref id="bb1655"><label>331</label><element-citation publication-type="journal" id="rf1655"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>P.</given-names></name><name><surname>Kim</surname><given-names>K.Y.</given-names></name><name><surname>Lee</surname><given-names>H.S.</given-names></name><name><surname>Min</surname><given-names>S.S.</given-names></name><name><surname>Seol</surname><given-names>G.H.</given-names></name></person-group><article-title>Anti-inflammatory effects of anethole in lipopolysaccharide-induced acute lung injury in mice</article-title><source>Life Sci.</source><volume>93</volume><year>2013</year><fpage>955</fpage><lpage>961</lpage><pub-id pub-id-type="pmid">24404587</pub-id></element-citation></ref><ref id="bb1660"><label>332</label><element-citation publication-type="journal" id="rf1660"><person-group person-group-type="author"><name><surname>Sung</surname><given-names>Y.Y.</given-names></name><name><surname>Kim</surname><given-names>S.H.</given-names></name><name><surname>Kim</surname><given-names>D.S.</given-names></name><name><surname>Lee</surname><given-names>J.E.</given-names></name><name><surname>Kim</surname><given-names>H.K.</given-names></name></person-group><article-title>Illicium verum extract and trans-anethole attenuate ovalbumin-induced airway inflammation via enhancement of Foxp3<sup>+</sup> regulatory T cells and inhibition of Th2 cytokines in mice</article-title><source>Mediat. Inflamm.</source><volume>2017</volume><year>2017</year><object-id pub-id-type="publisher-id">7506808</object-id></element-citation></ref><ref id="bb1665"><label>333</label><element-citation publication-type="journal" id="rf1665"><person-group person-group-type="author"><name><surname>Ameeramja</surname><given-names>J.</given-names></name><name><surname>Perumal</surname><given-names>E.</given-names></name></person-group><article-title>Possible modulatory effect of tamarind seed coat extract on fluoride-induced pulmonary inflammation and fibrosis in rats</article-title><source>Inflammation</source><volume>41</volume><year>2018</year><fpage>886</fpage><lpage>895</lpage><pub-id pub-id-type="pmid">29508183</pub-id></element-citation></ref><ref id="bb1670"><label>334</label><element-citation publication-type="journal" id="rf1670"><person-group person-group-type="author"><name><surname>Sundaram</surname><given-names>M.S.</given-names></name><name><surname>Hemshekhar</surname><given-names>M.</given-names></name><name><surname>Santhosh</surname><given-names>M.S.</given-names></name><name><surname>Paul</surname><given-names>M.</given-names></name><name><surname>Sunitha</surname><given-names>K.</given-names></name><name><surname>Thushara</surname><given-names>R.M.</given-names></name><name><surname>NaveenKumar</surname><given-names>S.K.</given-names></name><name><surname>Naveen</surname><given-names>S.</given-names></name><name><surname>Devaraja</surname><given-names>S.</given-names></name><name><surname>Rangappa</surname><given-names>K.S.</given-names></name><name><surname>Kemparaju</surname><given-names>K.</given-names></name><name><surname>Girish</surname><given-names>K.S.</given-names></name></person-group><article-title>Tamarind seed (Tamarindus indica) extract ameliorates adjuvant-induced arthritis via regulating the mediators of cartilage/bone degeneration, inflammation and oxidative stress</article-title><source>Sci. Rep.</source><volume>5</volume><year>2015</year><object-id pub-id-type="publisher-id">11117</object-id></element-citation></ref><ref id="bb1675"><label>335</label><element-citation publication-type="journal" id="rf1675"><person-group person-group-type="author"><name><surname>Periasamy</surname><given-names>S.</given-names></name><name><surname>Lin</surname><given-names>C.H.</given-names></name><name><surname>Nagarajan</surname><given-names>B.</given-names></name><name><surname>Sankaranarayanan</surname><given-names>N.V.</given-names></name><name><surname>Desai</surname><given-names>U.R.</given-names></name><name><surname>Liu</surname><given-names>M.Y.</given-names></name></person-group><article-title>Mucoadhesive role of tamarind xyloglucan on inflammation attenuates ulcerative colitis</article-title><source>J. Funct. Foods</source><volume>47</volume><year>2018</year><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">30555535</pub-id></element-citation></ref><ref id="bb1680"><label>336</label><element-citation publication-type="journal" id="rf1680"><person-group person-group-type="author"><name><surname>Han</surname><given-names>S.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Guo</surname><given-names>X.</given-names></name><name><surname>Huang</surname><given-names>M.</given-names></name></person-group><article-title>Curcumin ameliorates severe influenza pneumonia via attenuating lung injury and regulating macrophage cytokines production</article-title><source>Clin. Exp. Pharmacol. Physiol.</source><volume>45</volume><year>2018</year><fpage>84</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">28853207</pub-id></element-citation></ref><ref id="bb1685"><label>337</label><element-citation publication-type="journal" id="rf1685"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>Z.W.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Ruan</surname><given-names>Y.C.</given-names></name><name><surname>Zhou</surname><given-names>T.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Tsang</surname><given-names>L.L.</given-names></name><name><surname>Chan</surname><given-names>H.C.</given-names></name><name><surname>Peng</surname><given-names>Y.Z.</given-names></name></person-group><article-title>CFTR-regulated MAPK/NF-&#x003ba;B signaling in pulmonary inflammation in thermal inhalation injury</article-title><source>Sci. Rep.</source><volume>5</volume><year>2015</year><object-id pub-id-type="publisher-id">15946</object-id></element-citation></ref><ref id="bb1690"><label>338</label><element-citation publication-type="journal" id="rf1690"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Yang</surname><given-names>F.</given-names></name><name><surname>Zhao</surname><given-names>H.</given-names></name><name><surname>An</surname><given-names>Y.</given-names></name></person-group><article-title>Curcumin alleviates lung injury in diabetic rats by inhibiting nuclear factor-&#x003ba;B pathway</article-title><source>Clin. Exp. Pharmacol. Physiol.</source><volume>42</volume><year>2015</year><fpage>956</fpage><lpage>963</lpage><pub-id pub-id-type="pmid">26111829</pub-id></element-citation></ref><ref id="bb1695"><label>339</label><element-citation publication-type="journal" id="rf1695"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>M.</given-names></name><name><surname>Sun</surname><given-names>D.</given-names></name><name><surname>Sun</surname><given-names>S.</given-names></name></person-group><article-title>Curcumin protects against sepsis-induced acute lung injury in rats</article-title><source>J. Surg. Res.</source><volume>176</volume><year>2012</year><fpage>e31</fpage><lpage>e39</lpage><pub-id pub-id-type="pmid">22520056</pub-id></element-citation></ref><ref id="bb1700"><label>340</label><element-citation publication-type="journal" id="rf1700"><person-group person-group-type="author"><name><surname>Chong</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Nie</surname><given-names>Y.</given-names></name><name><surname>Yu</surname><given-names>G.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Lin</surname><given-names>L.</given-names></name><name><surname>Wen</surname><given-names>S.</given-names></name><name><surname>Zhu</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name></person-group><article-title>Protective effect of curcumin on acute airway inflammation of allergic asthma in mice through Notch1-GATA3 signaling pathway</article-title><source>Inflammation</source><volume>37</volume><year>2014</year><fpage>1476</fpage><lpage>1485</lpage><pub-id pub-id-type="pmid">24706026</pub-id></element-citation></ref><ref id="bb1705"><label>341</label><element-citation publication-type="journal" id="rf1705"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name></person-group><article-title>Curcumin protects against cerebral ischemia-reperfusion injury by activating JAK2/STAT3 signaling pathway in rats</article-title><source>Int. J. Clin. Exp. Med.</source><volume>8</volume><year>2015</year><fpage>14985</fpage><lpage>14991</lpage><pub-id pub-id-type="pmid">26628981</pub-id></element-citation></ref><ref id="bb1710"><label>342</label><element-citation publication-type="journal" id="rf1710"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.L.</given-names></name><name><surname>Du</surname><given-names>Z.Y.</given-names></name><name><surname>Li</surname><given-names>P.H.</given-names></name><name><surname>Yan</surname><given-names>L.</given-names></name><name><surname>Zhou</surname><given-names>W.</given-names></name><name><surname>Tang</surname><given-names>Y.D.</given-names></name><name><surname>Liu</surname><given-names>G.R.</given-names></name><name><surname>Fang</surname><given-names>Y.X.</given-names></name><name><surname>Zhang</surname><given-names>K.</given-names></name><name><surname>Dong</surname><given-names>C.Z.</given-names></name><name><surname>Chen</surname><given-names>H.X.</given-names></name></person-group><article-title>Aromatic-turmerone ameliorates imiquimod-induced psoriasis-like inflammation of BALB/c mice</article-title><source>Int. Immunopharmacol.</source><volume>64</volume><year>2018</year><fpage>319</fpage><lpage>325</lpage><pub-id pub-id-type="pmid">30243067</pub-id></element-citation></ref><ref id="bb1715"><label>343</label><element-citation publication-type="journal" id="rf1715"><person-group person-group-type="author"><name><surname>Rajagopal</surname><given-names>H.M.</given-names></name><name><surname>Manjegowda</surname><given-names>S.B.</given-names></name><name><surname>Serkad</surname><given-names>C.</given-names></name></person-group><article-title>Dharmesh SM. A modified pectic polysaccharide from turmeric (Curcuma longa) with antiulcer effects via anti-secretary, mucoprotective and IL-10 mediated anti-inflammatory mechanisms</article-title><source>Int. J. Biol. Macromol.</source><volume>118</volume><year>2018</year><fpage>864</fpage><lpage>880</lpage><pub-id pub-id-type="pmid">29924982</pub-id></element-citation></ref><ref id="bb1720"><label>344</label><element-citation publication-type="journal" id="rf1720"><person-group person-group-type="author"><name><surname>Amalraj</surname><given-names>A.</given-names></name><name><surname>Gopi</surname><given-names>S.</given-names></name></person-group><article-title>Biological activities and medicinal properties of asafoetida: a review</article-title><source>J. Tradit. Complement. Med.</source><volume>7</volume><year>2016</year><fpage>347</fpage><lpage>359</lpage><pub-id pub-id-type="pmid">28725631</pub-id></element-citation></ref><ref id="bb1725"><label>345</label><element-citation publication-type="journal" id="rf1725"><person-group person-group-type="author"><name><surname>Mahendra</surname><given-names>P.</given-names></name><name><surname>Bisht</surname><given-names>S.</given-names></name></person-group><article-title>Ferula asafoetida: traditional uses and pharmacological activity</article-title><source>Pharmacogn. Rev.</source><volume>6</volume><year>2012</year><fpage>141</fpage><lpage>146</lpage><pub-id pub-id-type="pmid">23055640</pub-id></element-citation></ref><ref id="bb1730"><label>346</label><element-citation publication-type="journal" id="rf1730"><person-group person-group-type="author"><name><surname>Sestili</surname><given-names>P.</given-names></name><name><surname>Ismail</surname><given-names>T.</given-names></name><name><surname>Calcabrini</surname><given-names>C.</given-names></name><name><surname>Guescini</surname><given-names>M.</given-names></name><name><surname>Catanzaro</surname><given-names>E.</given-names></name><name><surname>Turrini</surname><given-names>E.</given-names></name><name><surname>Layla</surname><given-names>A.</given-names></name><name><surname>Akhtar</surname><given-names>S.</given-names></name><name><surname>Fimognari</surname><given-names>C.</given-names></name></person-group><article-title>The potential effects of <italic>Ocimum basilicum</italic> on health: a review of pharmacological and toxicological studies</article-title><source>Expert Opin. Drug Metab. Toxicol.</source><volume>14</volume><year>2018</year><fpage>679</fpage><lpage>692</lpage><pub-id pub-id-type="pmid">29865879</pub-id></element-citation></ref><ref id="bb1735"><label>347</label><element-citation publication-type="journal" id="rf1735"><person-group person-group-type="author"><name><surname>Mostafavi</surname><given-names>S.</given-names></name><name><surname>Asadi-Gharneh</surname><given-names>H.A.</given-names></name><name><surname>Miransari</surname><given-names>M.</given-names></name></person-group><article-title>The phytochemical variability of fatty acids in basil seeds (<italic>Ocimum basilicum</italic> L.) affected by genotype and geographical differences</article-title><source>Food Chem.</source><volume>276</volume><year>2019</year><fpage>700</fpage><lpage>706</lpage><pub-id pub-id-type="pmid">30409650</pub-id></element-citation></ref><ref id="bb1740"><label>348</label><element-citation publication-type="journal" id="rf1740"><person-group person-group-type="author"><name><surname>Eftekhar</surname><given-names>N.</given-names></name><name><surname>Moghimi</surname><given-names>A.</given-names></name><name><surname>Hossein Boskabady</surname><given-names>M.</given-names></name><name><surname>Kaveh</surname><given-names>M.</given-names></name><name><surname>Shakeri</surname><given-names>F.</given-names></name></person-group><article-title>Ocimum basilicum affects tracheal responsiveness, lung inflammatory cells and oxidant-antioxidant biomarkers in sensitized rats</article-title><source>Drug Chem. Toxicol.</source><volume>42</volume><year>2019</year><fpage>286</fpage><lpage>294</lpage><pub-id pub-id-type="pmid">29683006</pub-id></element-citation></ref><ref id="bb1745"><label>349</label><element-citation publication-type="journal" id="rf1745"><person-group person-group-type="author"><name><surname>Kavitha</surname><given-names>S.</given-names></name><name><surname>John</surname><given-names>F.</given-names></name><name><surname>Indira</surname><given-names>M.</given-names></name></person-group><article-title>Amelioration of inflammation by phenolic rich methanolic extract of Ocimum sanctum Linn. leaves in isoproterenol induced myocardial infarction</article-title><source>Indian J. Exp. Biol.</source><volume>53</volume><year>2015</year><fpage>632</fpage><lpage>640</lpage><pub-id pub-id-type="pmid">26665293</pub-id></element-citation></ref><ref id="bb1750"><label>350</label><element-citation publication-type="journal" id="rf1750"><person-group person-group-type="author"><name><surname>Bower</surname><given-names>A.</given-names></name><name><surname>Marquez</surname><given-names>S.</given-names></name><name><surname>de Mejia</surname><given-names>E.G.</given-names></name></person-group><article-title>The health benefits of selected culinary herbs and spices found in the traditional Mediterranean diet</article-title><source>Crit. Rev. Food Sci. Nutr.</source><volume>56</volume><year>2016</year><fpage>2728</fpage><lpage>2746</lpage><pub-id pub-id-type="pmid">25749238</pub-id></element-citation></ref><ref id="bb1755"><label>351</label><element-citation publication-type="journal" id="rf1755"><person-group person-group-type="author"><name><surname>E&#x0011f;ilmez</surname><given-names>O.K.</given-names></name><name><surname>K&#x000f6;kten</surname><given-names>N.</given-names></name><name><surname>Kalc&#x00131;o&#x0011f;lu</surname><given-names>M.T.</given-names></name><name><surname>Ekici</surname><given-names>A.I.D.</given-names></name><name><surname>&#x0015e;erifler</surname><given-names>S.</given-names></name><name><surname>Ye&#x0015f;ilada</surname><given-names>E.</given-names></name></person-group><article-title>Investigation of the protective effect of Nigella sativa oil in cisplatin induced oral mucositis: an experimental study</article-title><source>Turk. Arch. Otorhinolaryngol.</source><volume>58</volume><year>2020</year><fpage>10</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">32313889</pub-id></element-citation></ref><ref id="bb1760"><label>352</label><element-citation publication-type="journal" id="rf1760"><person-group person-group-type="author"><name><surname>Amin</surname><given-names>B.</given-names></name><name><surname>Hosseinzadeh</surname><given-names>H.</given-names></name></person-group><article-title>Black cumin (Nigella sativa) and its active constituent, thymoquinone: an overview on the analgesic and anti-inflammatory effects</article-title><source>Planta Med.</source><volume>82</volume><year>2016</year><fpage>8</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">26366755</pub-id></element-citation></ref><ref id="bb1765"><label>353</label><element-citation publication-type="journal" id="rf1765"><person-group person-group-type="author"><name><surname>Butt</surname><given-names>M.S.</given-names></name><name><surname>Pasha</surname><given-names>I.</given-names></name><name><surname>Sultan</surname><given-names>M.T.</given-names></name><name><surname>Randhawa</surname><given-names>M.A.</given-names></name><name><surname>Saeed</surname><given-names>F.</given-names></name><name><surname>Ahmed</surname><given-names>W.</given-names></name></person-group><article-title>Black pepper and health claims: a comprehensive treatise</article-title><source>Crit. Rev. Food Sci. Nutr.</source><volume>53</volume><year>2013</year><fpage>875</fpage><lpage>886</lpage><pub-id pub-id-type="pmid">23768180</pub-id></element-citation></ref><ref id="bb1770"><label>354</label><element-citation publication-type="journal" id="rf1770"><person-group person-group-type="author"><name><surname>Qiblawi</surname><given-names>S.</given-names></name><name><surname>Dhanarasu</surname><given-names>S.</given-names></name><name><surname>Faris</surname><given-names>M.A.</given-names></name></person-group><article-title>Chemopreventive effect of cardamom (Elettaria cardamomum L.) against benzo(&#x003b1;)pyrene-induced forestomach papillomagenesis in Swiss albino mice</article-title><source>J. Environ. Pathol. Toxicol. Oncol.</source><volume>34</volume><year>2015</year><fpage>95</fpage><lpage>104</lpage><pub-id pub-id-type="pmid">26081028</pub-id></element-citation></ref><ref id="bb1775"><label>355</label><element-citation publication-type="journal" id="rf1775"><person-group person-group-type="author"><name><surname>Ashokkumar</surname><given-names>K.</given-names></name><name><surname>Murugan</surname><given-names>M.</given-names></name><name><surname>Dhanya</surname><given-names>M.K.</given-names></name><name><surname>Warkentin</surname><given-names>T.D.</given-names></name></person-group><article-title>Botany, traditional uses, phytochemistry and biological activities of cardamom [Elettaria cardamomum (L.) Maton] - a critical review</article-title><source>J. Ethnopharmacol.</source><volume>246</volume><year>2020</year><fpage>112244</fpage><pub-id pub-id-type="pmid">31541721</pub-id></element-citation></ref><ref id="bb1780"><label>356</label><element-citation publication-type="journal" id="rf1780"><person-group person-group-type="author"><name><surname>Hariri</surname><given-names>M.</given-names></name><name><surname>Ghiasvand</surname><given-names>R.</given-names></name></person-group><article-title>Cinnamon and chronic diseases</article-title><source>Adv. Exp. Med. Biol.</source><volume>929</volume><year>2016</year><fpage>1</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">27771918</pub-id></element-citation></ref><ref id="bb1785"><label>357</label><element-citation publication-type="journal" id="rf1785"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>S.</given-names></name><name><surname>Kumari</surname><given-names>R.</given-names></name><name><surname>Mishra</surname><given-names>S.</given-names></name></person-group><article-title>Pharmacological properties and their medicinal uses of Cinnamomum: a review</article-title><source>J. Pharm. Pharmacol.</source><volume>71</volume><year>2019</year><fpage>1735</fpage><lpage>1761</lpage><pub-id pub-id-type="pmid">31646653</pub-id></element-citation></ref><ref id="bb1790"><label>358</label><element-citation publication-type="journal" id="rf1790"><person-group person-group-type="author"><name><surname>Heidari</surname><given-names>B.</given-names></name><name><surname>Sajjadi</surname><given-names>S.E.</given-names></name><name><surname>Minaiyan</surname><given-names>M.</given-names></name></person-group><article-title>Effect of Coriandrum sativum hydroalcoholic extract and its essential oil on acetic acid-induced acute colitis in rats</article-title><source>Avicenna J. Phytomed.</source><volume>6</volume><year>2016</year><fpage>205</fpage><lpage>214</lpage><pub-id pub-id-type="pmid">27222834</pub-id></element-citation></ref><ref id="bb1795"><label>359</label><element-citation publication-type="journal" id="rf1795"><person-group person-group-type="author"><name><surname>Prachayasittikul</surname><given-names>V.</given-names></name><name><surname>Prachayasittikul</surname><given-names>S.</given-names></name><name><surname>Ruchirawat</surname><given-names>S.</given-names></name><name><surname>Prachayasittikul</surname><given-names>V.</given-names></name></person-group><article-title>Coriander (Coriandrum sativum): a promising functional food toward the well-being</article-title><source>Food Res. Int.</source><volume>105</volume><year>2018</year><fpage>305</fpage><lpage>323</lpage><pub-id pub-id-type="pmid">29433220</pub-id></element-citation></ref><ref id="bb1800"><label>360</label><element-citation publication-type="journal" id="rf1800"><person-group person-group-type="author"><name><surname>Eguale</surname><given-names>T.</given-names></name><name><surname>Tilahun</surname><given-names>G.</given-names></name><name><surname>Debella</surname><given-names>A.</given-names></name><name><surname>Feleke</surname><given-names>A.</given-names></name><name><surname>Makonnen</surname><given-names>E.</given-names></name></person-group><article-title>In vitro and in vivo anthelmintic activity of crude extracts of Coriandrum sativum against Haemonchus contortus</article-title><source>J. Ethnopharmacol.</source><volume>110</volume><year>2007</year><fpage>428</fpage><lpage>433</lpage><pub-id pub-id-type="pmid">17113738</pub-id></element-citation></ref><ref id="bb1805"><label>361</label><element-citation publication-type="journal" id="rf1805"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>A.</given-names></name><name><surname>Bigoniya</surname><given-names>P.</given-names></name><name><surname>Raj</surname><given-names>V.</given-names></name><name><surname>Patel</surname><given-names>K.K.</given-names></name></person-group><article-title>Pharmacological screening of Coriandrum sativum Linn. for hepatoprotective activity</article-title><source>J. Pharm. Bioallied Sci.</source><volume>3</volume><year>2011</year><fpage>435</fpage><lpage>441</lpage><pub-id pub-id-type="pmid">21966166</pub-id></element-citation></ref><ref id="bb1810"><label>362</label><element-citation publication-type="journal" id="rf1810"><person-group person-group-type="author"><name><surname>Mnif</surname><given-names>S.</given-names></name><name><surname>Aifa</surname><given-names>S.</given-names></name></person-group><article-title>Cumin (Cuminum cyminum L.) from traditional uses to potential biomedical applications</article-title><source>Chem. Biodivers.</source><volume>12</volume><year>2015</year><fpage>733</fpage><lpage>742</lpage><pub-id pub-id-type="pmid">26010662</pub-id></element-citation></ref><ref id="bb1815"><label>363</label><element-citation publication-type="journal" id="rf1815"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>S.</given-names></name><name><surname>Buttar</surname><given-names>H.S.</given-names></name><name><surname>Chintameneni</surname><given-names>M.</given-names></name><name><surname>Kaur</surname><given-names>G.</given-names></name></person-group><article-title>Prevention of cardiovascular diseases with anti-inflammatory and anti-oxidant nutraceuticals and herbal products: an overview of pre-clinical and clinical studies</article-title><source>Recent Patents Inflamm. Allergy Drug Discov.</source><volume>12</volume><year>2018</year><fpage>145</fpage><lpage>157</lpage></element-citation></ref><ref id="bb1820"><label>364</label><element-citation publication-type="journal" id="rf1820"><person-group person-group-type="author"><name><surname>Nagulapalli Venkata</surname><given-names>K.C.</given-names></name><name><surname>Swaroop</surname><given-names>A.</given-names></name><name><surname>Bagchi</surname><given-names>D.</given-names></name><name><surname>Bishayee</surname><given-names>A.</given-names></name></person-group><article-title>A small plant with big benefits: fenugreek (Trigonella foenum-graecum Linn.) for disease prevention and health promotion</article-title><source>Mol. Nutr. Food Res.</source><volume>61</volume><year>2017</year></element-citation></ref><ref id="bb1825"><label>365</label><element-citation publication-type="journal" id="rf1825"><person-group person-group-type="author"><name><surname>Ouzir</surname><given-names>M.</given-names></name><name><surname>El Bairi</surname><given-names>K.</given-names></name><name><surname>Amzazi</surname><given-names>S.</given-names></name></person-group><article-title>Toxicological properties of fenugreek (Trigonella foenum graecum)</article-title><source>Food Chem. Toxicol.</source><volume>96</volume><year>2016</year><fpage>145</fpage><lpage>154</lpage><pub-id pub-id-type="pmid">27498339</pub-id></element-citation></ref><ref id="bb1830"><label>366</label><element-citation publication-type="journal" id="rf1830"><person-group person-group-type="author"><name><surname>Warriar</surname><given-names>P.</given-names></name><name><surname>Barve</surname><given-names>K.</given-names></name><name><surname>Prabhakar</surname><given-names>B.</given-names></name></person-group><article-title>Anti-arthritic effect of garcinol enriched fraction against adjuvant induced arthritis</article-title><source>Recent Patents Inflamm. Allergy Drug Discov.</source><volume>13</volume><year>2019</year><fpage>49</fpage><lpage>56</lpage></element-citation></ref><ref id="bb1835"><label>367</label><element-citation publication-type="journal" id="rf1835"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>M.K.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><article-title>Kokum (Garcinol). Molecular targets and therapeutic uses of spices: modern uses for ancient medicine</article-title><source>World Sci.</source><year>2009</year><fpage>281</fpage><lpage>309</lpage></element-citation></ref><ref id="bb1840"><label>368</label><element-citation publication-type="journal" id="rf1840"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Miao</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>J.Y.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name></person-group><article-title>Effective production of S-allyl-L-cysteine through a homogeneous reaction with activated endogenous &#x003b3;-glutamyltranspeptidase in garlic (Allium sativum)</article-title><source>J. Food Sci. Technol.</source><volume>52</volume><year>2015</year><fpage>1724</fpage><lpage>1729</lpage><pub-id pub-id-type="pmid">25745247</pub-id></element-citation></ref><ref id="bb1845"><label>369</label><element-citation publication-type="journal" id="rf1845"><person-group person-group-type="author"><name><surname>Lv</surname><given-names>Y.</given-names></name><name><surname>So</surname><given-names>K.F.</given-names></name><name><surname>Wong</surname><given-names>N.K.</given-names></name><name><surname>Xiao</surname><given-names>J.</given-names></name></person-group><article-title>Anti-cancer activities of S-allylmercaptocysteine from aged garlic</article-title><source>Chin. J. Nat. Med.</source><volume>17</volume><year>2019</year><fpage>43</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">30704623</pub-id></element-citation></ref><ref id="bb1850"><label>370</label><element-citation publication-type="journal" id="rf1850"><person-group person-group-type="author"><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Sun</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>A.</given-names></name><name><surname>Mo</surname><given-names>M.</given-names></name><name><surname>Zhao</surname><given-names>Z.</given-names></name></person-group><article-title>S-Allylmercaptocysteine attenuates bleomycin-induced pulmonary fibrosis in mice via suppressing TGF-&#x003b2;1/Smad and oxidative stress pathways</article-title><source>Int. Immunopharmacol.</source><volume>79</volume><year>2020</year><object-id pub-id-type="publisher-id">106110</object-id></element-citation></ref><ref id="bb1855"><label>371</label><element-citation publication-type="journal" id="rf1855"><person-group person-group-type="author"><name><surname>Haniadka</surname><given-names>R.</given-names></name><name><surname>Saldanha</surname><given-names>E.</given-names></name><name><surname>Sunita</surname><given-names>V.</given-names></name><name><surname>Palatty</surname><given-names>P.L.</given-names></name><name><surname>Fayad</surname><given-names>R.</given-names></name><name><surname>Baliga</surname><given-names>M.S.</given-names></name></person-group><article-title>A review of the gastroprotective effects of ginger (Zingiber officinale Roscoe)</article-title><source>Food Funct.</source><volume>4</volume><year>2013</year><fpage>845</fpage><lpage>855</lpage><pub-id pub-id-type="pmid">23612703</pub-id></element-citation></ref><ref id="bb1860"><label>372</label><element-citation publication-type="journal" id="rf1860"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J.H.</given-names></name><name><surname>Yi</surname><given-names>Y.S.</given-names></name><name><surname>Kim</surname><given-names>M.Y.</given-names></name><name><surname>Cho</surname><given-names>J.Y.</given-names></name></person-group><article-title>Role of ginsenosides, the main active components of <italic>Panax ginseng</italic>, in inflammatory responses and diseases</article-title><source>J. Ginseng Res.</source><volume>41</volume><year>2017</year><fpage>435</fpage><lpage>443</lpage><pub-id pub-id-type="pmid">29021688</pub-id></element-citation></ref><ref id="bb1865"><label>373</label><element-citation publication-type="journal" id="rf1865"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>Z.Y.</given-names></name><name><surname>Zeng</surname><given-names>J.Z.</given-names></name><name><surname>AST</surname><given-names>Wong</given-names></name></person-group><article-title>Chemical structures and pharmacological profiles of ginseng saponins</article-title><source>Molecules</source><volume>24</volume><year>2019</year><fpage>2443</fpage></element-citation></ref><ref id="bb1870"><label>374</label><element-citation publication-type="journal" id="rf1870"><person-group person-group-type="author"><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name><surname>Chung</surname><given-names>J.G.</given-names></name><name><surname>Koca</surname><given-names>C.</given-names></name><name><surname>Dey</surname><given-names>S.</given-names></name></person-group><article-title>Mint and its constituents. Molecular targets and therapeutic uses of spices: modern uses for ancient medicine</article-title><source>World Sci.</source><year>2009</year><fpage>373</fpage><lpage>401</lpage></element-citation></ref><ref id="bb1875"><label>375</label><element-citation publication-type="journal" id="rf1875"><person-group person-group-type="author"><name><surname>Brahmi</surname><given-names>F.</given-names></name><name><surname>Hadj-Ahmed</surname><given-names>S.</given-names></name><name><surname>Zarrouk</surname><given-names>A.</given-names></name><name><surname>Bezine</surname><given-names>M.</given-names></name><name><surname>Nury</surname><given-names>T.</given-names></name><name><surname>Madani</surname><given-names>K.</given-names></name><name><surname>Chibane</surname><given-names>M.</given-names></name><name><surname>Vejux</surname><given-names>A.</given-names></name><name><surname>Andreoletti</surname><given-names>P.</given-names></name><name><surname>Boulekbache-Makhlouf</surname><given-names>L.</given-names></name><name><surname>Lizard</surname><given-names>G.</given-names></name></person-group><article-title>Evidence of biological activity of Mentha species extracts on apoptotic and autophagic targets on murine RAW264.7 and human U937 monocytic cells</article-title><source>Pharm. Biol.</source><volume>55</volume><year>2017</year><fpage>286</fpage><lpage>293</lpage><pub-id pub-id-type="pmid">27927076</pub-id></element-citation></ref><ref id="bb1880"><label>376</label><element-citation publication-type="journal" id="rf1880"><person-group person-group-type="author"><name><surname>Arumugam</surname><given-names>P.</given-names></name><name><surname>Priya</surname><given-names>N.G.</given-names></name><name><surname>Subathra</surname><given-names>M.</given-names></name><name><surname>Ramesh</surname><given-names>A.</given-names></name></person-group><article-title>Anti-inflammatory activity of four solvent fractions of ethanol extract of <italic>Mentha spicata</italic> L. investigated on acute and chronic inflammation induced rats</article-title><source>Environ. Toxicol. Pharmacol.</source><volume>26</volume><year>2008</year><fpage>92</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">21783894</pub-id></element-citation></ref><ref id="bb1885"><label>377</label><element-citation publication-type="journal" id="rf1885"><person-group person-group-type="author"><name><surname>Mitrovi&#x00107;</surname><given-names>P.M.</given-names></name><name><surname>Stamenkovi&#x00107;</surname><given-names>O.S.</given-names></name><name><surname>Bankovi&#x00107;-Ili&#x00107;</surname><given-names>I.</given-names></name><name><surname>Djalovi&#x00107;</surname><given-names>I.G.</given-names></name><name><surname>Nje&#x0017e;i&#x00107;</surname><given-names>Z.B.</given-names></name><name><surname>Farooq</surname><given-names>M.</given-names></name><name><surname>Siddique</surname><given-names>K.H.M.</given-names></name><name><surname>Veljkovi&#x00107;</surname><given-names>V.B.</given-names></name></person-group><article-title>White mustard (Sinapis alba L.) oil in biodiesel production: a review</article-title><source>Front. Plant Sci.</source><volume>11</volume><year>2020</year><fpage>299</fpage><pub-id pub-id-type="pmid">32300349</pub-id></element-citation></ref><ref id="bb1890"><label>378</label><element-citation publication-type="journal" id="rf1890"><person-group person-group-type="author"><name><surname>Barceloux</surname><given-names>D.G.</given-names></name></person-group><article-title>Nutmeg (Myristica fragrans Houtt.)</article-title><source>Dis. Mon.</source><volume>55</volume><year>2009</year><fpage>373</fpage><lpage>379</lpage><pub-id pub-id-type="pmid">19446681</pub-id></element-citation></ref><ref id="bb1895"><label>379</label><element-citation publication-type="journal" id="rf1895"><person-group person-group-type="author"><name><surname>Francis</surname><given-names>S.K.</given-names></name><name><surname>James</surname><given-names>B.</given-names></name><name><surname>Varughese</surname><given-names>S.</given-names></name><name><surname>Nair</surname><given-names>M.S.</given-names></name></person-group><article-title>Phytochemical investigation on Myristica fragrans stem bark</article-title><source>Nat. Prod. Res.</source><volume>33</volume><year>2019</year><fpage>1204</fpage><lpage>1208</lpage><pub-id pub-id-type="pmid">29607669</pub-id></element-citation></ref><ref id="bb1900"><label>380</label><element-citation publication-type="journal" id="rf1900"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>X.N.</given-names></name><name><surname>Liu</surname><given-names>X.M.</given-names></name><name><surname>Fang</surname><given-names>J.H.</given-names></name><name><surname>Zhu</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>X.W.</given-names></name><name><surname>Xiao</surname><given-names>X.R.</given-names></name><name><surname>Huang</surname><given-names>J.F.</given-names></name><name><surname>Gonzalez</surname><given-names>F.J.</given-names></name><name><surname>Li</surname><given-names>F.</given-names></name></person-group><article-title>PPAR&#x003b1; mediates the hepatoprotective effects of nutmeg</article-title><source>J. Proteome Res.</source><volume>17</volume><year>2018</year><fpage>1887</fpage><lpage>1897</lpage><pub-id pub-id-type="pmid">29664296</pub-id></element-citation></ref><ref id="bb1905"><label>381</label><element-citation publication-type="journal" id="rf1905"><person-group person-group-type="author"><name><surname>Suleria</surname><given-names>H.A.</given-names></name><name><surname>Butt</surname><given-names>M.S.</given-names></name><name><surname>Anjum</surname><given-names>F.M.</given-names></name><name><surname>Saeed</surname><given-names>F.</given-names></name><name><surname>Khalid</surname><given-names>N.</given-names></name></person-group><article-title>Onion: nature protection against physiological threats</article-title><source>Crit. Rev. Food Sci. Nutr.</source><volume>55</volume><year>2015</year><fpage>50</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">24915405</pub-id></element-citation></ref><ref id="bb1910"><label>382</label><element-citation publication-type="journal" id="rf1910"><person-group person-group-type="author"><name><surname>Nieto</surname><given-names>G.</given-names></name><name><surname>Ros</surname><given-names>G.</given-names></name><name><surname>Castillo</surname><given-names>J.</given-names></name></person-group><article-title>Antioxidant and antimicrobial properties of rosemary (Rosmarinus officinalis, L.): a review</article-title><source>Medicines (Basel)</source><volume>5</volume><issue>98</issue><year>2018</year></element-citation></ref><ref id="bb1915"><label>383</label><element-citation publication-type="journal" id="rf1915"><person-group person-group-type="author"><name><surname>Rocha</surname><given-names>J.</given-names></name><name><surname>Eduardo-Figueira</surname><given-names>M.</given-names></name><name><surname>Barateiro</surname><given-names>A.</given-names></name><name><surname>Fernandes</surname><given-names>A.</given-names></name><name><surname>Brites</surname><given-names>D.</given-names></name><name><surname>Bronze</surname><given-names>R.</given-names></name><name><surname>Duarte</surname><given-names>C.M.</given-names></name><name><surname>Serra</surname><given-names>A.T.</given-names></name><name><surname>Pinto</surname><given-names>R.</given-names></name><name><surname>Freitas</surname><given-names>M.</given-names></name><name><surname>Fernandes</surname><given-names>E.</given-names></name><name><surname>Silva-Lima</surname><given-names>B.</given-names></name><name><surname>Mota-Filipe</surname><given-names>H.</given-names></name><name><surname>Sepodes</surname><given-names>B.</given-names></name></person-group><article-title>Anti-inflammatory effect of rosmarinic acid and an extract of Rosmarinus officinalis in rat models of local and systemic inflammation</article-title><source>Basic Clin. Pharmacol. Toxicol.</source><volume>116</volume><year>2015</year><fpage>398</fpage><lpage>413</lpage><pub-id pub-id-type="pmid">25287116</pub-id></element-citation></ref><ref id="bb1920"><label>384</label><element-citation publication-type="journal" id="rf1920"><person-group person-group-type="author"><name><surname>Mart&#x000ed;nez-Rodr&#x000ed;guez</surname><given-names>J.L.</given-names></name><name><surname>Guti&#x000e9;rrez-Hern&#x000e1;ndez</surname><given-names>R.</given-names></name><name><surname>Reyes-Estrada</surname><given-names>C.A.</given-names></name><name><surname>Granados-L&#x000f3;pez</surname><given-names>A.J.</given-names></name><name><surname>P&#x000e9;rez-Veyna</surname><given-names>O.</given-names></name><name><surname>Arcos-Ortega</surname><given-names>T.</given-names></name><name><surname>Hepatoprotective</surname><given-names>L&#x000f3;pez J.A.</given-names></name></person-group><article-title>Antihyperlipidemic and radical scavenging activity of hawthorn (<italic>Crataegus oxyacantha</italic>) and rosemary (Rosmarinus officinalis) on alcoholic liver disease</article-title><source>Altern. Ther. Health Med.</source><volume>25</volume><year>2019</year><fpage>54</fpage><lpage>63</lpage></element-citation></ref><ref id="bb1925"><label>385</label><element-citation publication-type="journal" id="rf1925"><person-group person-group-type="author"><name><surname>Moshiri</surname><given-names>M.</given-names></name><name><surname>Vahabzadeh</surname><given-names>M.</given-names></name><name><surname>Hosseinzadeh</surname><given-names>H.</given-names></name></person-group><article-title>Clinical applications of saffron (Crocus sativus) and its constituents: a review</article-title><source>Drug Res. (Stuttg.)</source><volume>65</volume><year>2015</year><fpage>287</fpage><lpage>295</lpage><pub-id pub-id-type="pmid">24848002</pub-id></element-citation></ref><ref id="bb1930"><label>386</label><element-citation publication-type="journal" id="rf1930"><person-group person-group-type="author"><name><surname>Majdalawieh</surname><given-names>A.F.</given-names></name><name><surname>Massri</surname><given-names>M.</given-names></name><name><surname>Nasrallah</surname><given-names>G.K.</given-names></name></person-group><article-title>A comprehensive review on the anti-cancer properties and mechanisms of action of sesamin, a lignan in sesame seeds (Sesamum indicum)</article-title><source>Eur. J. Pharmacol.</source><volume>815</volume><year>2017</year><fpage>512</fpage><lpage>521</lpage><pub-id pub-id-type="pmid">29032105</pub-id></element-citation></ref><ref id="bb1935"><label>387</label><element-citation publication-type="journal" id="rf1935"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>X.</given-names></name><name><surname>Gou</surname><given-names>X.</given-names></name><name><surname>Cai</surname><given-names>P.</given-names></name><name><surname>Xu</surname><given-names>C.</given-names></name><name><surname>Cao</surname><given-names>L.</given-names></name><name><surname>Zhao</surname><given-names>Z.</given-names></name><name><surname>Huang</surname><given-names>M.</given-names></name><name><surname>Jin</surname><given-names>J.</given-names></name></person-group><article-title>Sesamin enhances Nrf2-mediated protective defense against oxidative stress and inflammation in colitis via AKT and ERK activation</article-title><source>Oxidative Med. Cell. Longev.</source><volume>2019</volume><year>2019</year><object-id pub-id-type="publisher-id">2432416</object-id></element-citation></ref><ref id="bb1940"><label>388</label><element-citation publication-type="journal" id="rf1940"><person-group person-group-type="author"><name><surname>Domiciano</surname><given-names>T.P.</given-names></name><name><surname>Dalalio</surname><given-names>M.M.</given-names></name><name><surname>Silva</surname><given-names>E.L.</given-names></name><name><surname>Ritter</surname><given-names>A.M.</given-names></name><name><surname>Estev&#x000e3;o-Silva</surname><given-names>C.F.</given-names></name><name><surname>Ramos</surname><given-names>F.S.</given-names></name><name><surname>Caparroz-Assef</surname><given-names>S.M.</given-names></name><name><surname>Cuman</surname><given-names>R.K.</given-names></name><name><surname>Bersani-Amado</surname><given-names>C.A.</given-names></name></person-group><article-title>Inhibitory effect of anethole in nonimmune acute inflammation</article-title><source>Naunyn Schmiedeberg's Arch. Pharmacol.</source><volume>386</volume><year>2013</year><fpage>331</fpage><lpage>338</lpage><pub-id pub-id-type="pmid">23250338</pub-id></element-citation></ref><ref id="bb1945"><label>389</label><element-citation publication-type="journal" id="rf1945"><person-group person-group-type="author"><name><surname>De</surname><given-names>M.</given-names></name><name><surname>De</surname><given-names>A.K.</given-names></name><name><surname>Sen</surname><given-names>P.</given-names></name><name><surname>Banerjee</surname><given-names>A.B.</given-names></name></person-group><article-title>Antimicrobial properties of star anise (Illicium verum Hook f)</article-title><source>Phytother. Res.</source><volume>16</volume><year>2002</year><fpage>94</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">11807977</pub-id></element-citation></ref><ref id="bb1950"><label>390</label><element-citation publication-type="journal" id="rf1950"><person-group person-group-type="author"><name><surname>Patra</surname><given-names>J.K.</given-names></name><name><surname>Das</surname><given-names>G.</given-names></name><name><surname>Bose</surname><given-names>S.</given-names></name><name><surname>Banerjee</surname><given-names>S.</given-names></name><name><surname>Vishnuprasad</surname><given-names>C.N.</given-names></name><name><surname>Del Pilar Rodriguez-Torres</surname><given-names>M.</given-names></name><name><surname>Shin</surname><given-names>H.S.</given-names></name></person-group><article-title>Star anise (Illicium verum): chemical compounds, antiviral properties, and clinical relevance</article-title><source>Phytother. Res.</source><volume>34</volume><year>2020</year><fpage>1248</fpage><lpage>1267</lpage><pub-id pub-id-type="pmid">31997473</pub-id></element-citation></ref><ref id="bb1955"><label>391</label><element-citation publication-type="journal" id="rf1955"><person-group person-group-type="author"><name><surname>Kengaiah</surname><given-names>J.</given-names></name><name><surname>Nandish</surname><given-names>S.K.M.</given-names></name><name><surname>Ramachandraiah</surname><given-names>C.</given-names></name><name><surname>Chandramma</surname></name><name><surname>Shivaiah</surname><given-names>A.</given-names></name><name><surname>Vishalakshi</surname><given-names>G.J.</given-names></name><name><surname>Paul</surname><given-names>M.</given-names></name><name><surname>Santhosh</surname><given-names>M.S.</given-names></name><name><surname>Shankar</surname><given-names>R.L.</given-names></name><name><surname>Sannaningaiah</surname><given-names>D.</given-names></name></person-group><article-title>Protective effect of tamarind seed coat ethanol extract on eryptosis induced by oxidative stress</article-title><source>Biochemistry (Mosc)</source><volume>85</volume><year>2020</year><fpage>119</fpage><lpage>129</lpage><pub-id pub-id-type="pmid">32079523</pub-id></element-citation></ref><ref id="bb1960"><label>392</label><element-citation publication-type="journal" id="rf1960"><person-group person-group-type="author"><name><surname>Chong</surname><given-names>U.R.</given-names></name><name><surname>Abdul-Rahman</surname><given-names>P.S.</given-names></name><name><surname>Abdul-Aziz</surname><given-names>A.</given-names></name><name><surname>Hashim</surname><given-names>O.H.</given-names></name><name><surname>Mat-Junit</surname><given-names>S.</given-names></name></person-group><article-title>Effects of Tamarindus indica fruit pulp extract on abundance of HepG2 cell lysate proteins and their possible consequential impact on metabolism and inflammation</article-title><source>Biomed. Res. Int.</source><volume>2013</volume><year>2013</year><object-id pub-id-type="publisher-id">459017</object-id></element-citation></ref><ref id="bb1965"><label>393</label><element-citation publication-type="journal" id="rf1965"><person-group person-group-type="author"><name><surname>Goel</surname><given-names>A.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><article-title>Curcumin as &#x0201c;Curecumin&#x0201d;: from kitchen to clinic</article-title><source>Biochem. Pharmacol.</source><volume>75</volume><year>2008</year><fpage>787</fpage><lpage>809</lpage><pub-id pub-id-type="pmid">17900536</pub-id></element-citation></ref><ref id="bb1970"><label>394</label><element-citation publication-type="journal" id="rf1970"><person-group person-group-type="author"><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name><surname>Bordoloi</surname><given-names>D.</given-names></name><name><surname>Padmavathi</surname><given-names>G.</given-names></name><name><surname>Monisha</surname><given-names>J.</given-names></name><name><surname>Roy</surname><given-names>N.K.</given-names></name><name><surname>Prasad</surname><given-names>S.</given-names></name><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><article-title>Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases</article-title><source>Br. J. Pharmacol.</source><volume>174</volume><year>2017</year><fpage>1325</fpage><lpage>1348</lpage><pub-id pub-id-type="pmid">27638428</pub-id></element-citation></ref><ref id="bb1975"><label>395</label><element-citation publication-type="journal" id="rf1975"><person-group person-group-type="author"><name><surname>Arablou</surname><given-names>T.</given-names></name><name><surname>Kolahdouz-Mohammadi</surname><given-names>R.</given-names></name></person-group><article-title>Curcumin and endometriosis: review on potential roles and molecular mechanisms</article-title><source>Biomed. Pharmacother.</source><volume>97</volume><year>2018</year><fpage>91</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">29080464</pub-id></element-citation></ref><ref id="bb1980"><label>396</label><element-citation publication-type="journal" id="rf1980"><person-group person-group-type="author"><name><surname>Sandur</surname><given-names>S.K.</given-names></name><name><surname>Ichikawa</surname><given-names>H.</given-names></name><name><surname>Pandey</surname><given-names>M.K.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name><surname>Sung</surname><given-names>B.</given-names></name><name><surname>Sethi</surname><given-names>G.</given-names></name><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><article-title>Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane)</article-title><source>Free Radic. Biol. Med.</source><volume>43</volume><year>2007</year><fpage>568</fpage><lpage>580</lpage><pub-id pub-id-type="pmid">17640567</pub-id></element-citation></ref><ref id="bb1985"><label>397</label><element-citation publication-type="journal" id="rf1985"><person-group person-group-type="author"><name><surname>Anand</surname><given-names>P.</given-names></name><name><surname>Thomas</surname><given-names>S.G.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name><surname>Sundaram</surname><given-names>C.</given-names></name><name><surname>Harikumar</surname><given-names>K.B.</given-names></name><name><surname>Sung</surname><given-names>B.</given-names></name><name><surname>Tharakan</surname><given-names>S.T.</given-names></name><name><surname>Misra</surname><given-names>K.</given-names></name><name><surname>Priyadarsini</surname><given-names>I.K.</given-names></name><name><surname>Rajasekharan</surname><given-names>K.N.</given-names></name><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><article-title>Biological activities of curcumin and its analogues (congeners) made by man and mother nature</article-title><source>Biochem. Pharmacol.</source><volume>76</volume><year>2008</year><fpage>1590</fpage><lpage>1611</lpage><pub-id pub-id-type="pmid">18775680</pub-id></element-citation></ref><ref id="bb1990"><label>398</label><element-citation publication-type="journal" id="rf1990"><person-group person-group-type="author"><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name><surname>Guha</surname><given-names>S.</given-names></name><name><surname>Krishnan</surname><given-names>S.</given-names></name><name><surname>Diagaradjane</surname><given-names>P.</given-names></name><name><surname>Gelovani</surname><given-names>J.</given-names></name><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><article-title>Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products</article-title><source>Cancer Res.</source><volume>67</volume><year>2007</year><fpage>3853</fpage><lpage>3861</lpage><pub-id pub-id-type="pmid">17440100</pub-id></element-citation></ref><ref id="bb1995"><label>399</label><element-citation publication-type="journal" id="rf1995"><person-group person-group-type="author"><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name><surname>Diagaradjane</surname><given-names>P.</given-names></name><name><surname>Anand</surname><given-names>P.</given-names></name><name><surname>Harikumar</surname><given-names>K.B.</given-names></name><name><surname>Deorukhkar</surname><given-names>A.</given-names></name><name><surname>Gelovani</surname><given-names>J.</given-names></name><name><surname>Guha</surname><given-names>S.</given-names></name><name><surname>Krishnan</surname><given-names>S.</given-names></name><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><article-title>Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model</article-title><source>Int. J. Cancer</source><volume>125</volume><year>2009</year><fpage>2187</fpage><lpage>2197</lpage><pub-id pub-id-type="pmid">19623659</pub-id></element-citation></ref><ref id="bb2000"><label>400</label><element-citation publication-type="journal" id="rf2000"><person-group person-group-type="author"><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name><surname>Bordoloi</surname><given-names>D.</given-names></name><name><surname>Harsha</surname><given-names>C.</given-names></name><name><surname>Banik</surname><given-names>K.</given-names></name><name><surname>Gupta</surname><given-names>S.C.</given-names></name><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><article-title>Curcumin mediates anticancer effects by modulating multiple cell signaling pathways</article-title><source>Clin. Sci. (Lond.)</source><volume>131</volume><year>2017</year><fpage>1781</fpage><lpage>1799</lpage><pub-id pub-id-type="pmid">28679846</pub-id></element-citation></ref><ref id="bb2005"><label>401</label><element-citation publication-type="journal" id="rf2005"><person-group person-group-type="author"><name><surname>Anand</surname><given-names>P.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name><surname>Newman</surname><given-names>R.A.</given-names></name><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><article-title>Bioavailability of curcumin: problems and promises</article-title><source>Mol. Pharm.</source><volume>4</volume><year>2007</year><fpage>807</fpage><lpage>818</lpage><pub-id pub-id-type="pmid">17999464</pub-id></element-citation></ref><ref id="bb2010"><label>402</label><element-citation publication-type="journal" id="rf2010"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>Y.G.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name><surname>Nair</surname><given-names>A.</given-names></name><name><surname>Merritt</surname><given-names>W.M.</given-names></name><name><surname>Han</surname><given-names>L.Y.</given-names></name><name><surname>Armaiz-Pena</surname><given-names>G.N.</given-names></name><name><surname>Kamat</surname><given-names>A.A.</given-names></name><name><surname>Spannuth</surname><given-names>W.A.</given-names></name><name><surname>Gershenson</surname><given-names>D.M.</given-names></name><name><surname>Lutgendorf</surname><given-names>S.K.</given-names></name><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name><name><surname>Sood</surname><given-names>A.K.</given-names></name></person-group><article-title>Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway</article-title><source>Clin. Cancer Res.</source><volume>13</volume><year>2007</year><fpage>3423</fpage><lpage>3430</lpage><pub-id pub-id-type="pmid">17545551</pub-id></element-citation></ref><ref id="bb2015"><label>403</label><element-citation publication-type="book" id="rf2015"><person-group person-group-type="author"><name><surname>Shabnam</surname><given-names>B.</given-names></name><name><surname>Harsha</surname><given-names>C.</given-names></name><name><surname>Thakur</surname><given-names>K.K.</given-names></name><name><surname>Khatoon</surname><given-names>E.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name></person-group><chapter-title>Curcumin: a potential molecule for the prevention and treatment of inflammatory diseases</chapter-title><source>The Chemistry and Bioactive Components of Turmeric</source><year>2020</year><publisher-name>Royal Society of Chemistry</publisher-name><fpage>150</fpage><lpage>171</lpage></element-citation></ref><ref id="bb2020"><label>404</label><element-citation publication-type="journal" id="rf2020"><person-group person-group-type="author"><name><surname>Dhillon</surname><given-names>N.</given-names></name><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name><name><surname>Newman</surname><given-names>R.A.</given-names></name><name><surname>Wolff</surname><given-names>R.A.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name><surname>Abbruzzese</surname><given-names>J.L.</given-names></name><name><surname>Hong</surname><given-names>D.S.</given-names></name><name><surname>Camacho</surname><given-names>L.H.</given-names></name><name><surname>Ng</surname><given-names>C.</given-names></name><name><surname>Kurzrock</surname><given-names>R.</given-names></name></person-group><article-title>Curcumin and pancreatic cancer: phase II clinical trial experience</article-title><source>J. Clin. Oncol.</source><volume>25</volume><year>2007</year><fpage>4599</fpage></element-citation></ref><ref id="bb2025"><label>405</label><element-citation publication-type="journal" id="rf2025"><person-group person-group-type="author"><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name><surname>Anand</surname><given-names>P.</given-names></name><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><article-title>Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins</article-title><source>Cancer Lett.</source><volume>269</volume><year>2008</year><fpage>199</fpage><lpage>225</lpage><pub-id pub-id-type="pmid">18479807</pub-id></element-citation></ref><ref id="bb2030"><label>406</label><element-citation publication-type="journal" id="rf2030"><person-group person-group-type="author"><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name><surname>Guha</surname><given-names>S.</given-names></name><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><article-title>Curcumin and colorectal cancer: add spice to your life</article-title><source>Curr. Colorectal Cancer Rep.</source><volume>5</volume><issue>5</issue><year>2009</year></element-citation></ref><ref id="bb2035"><label>407</label><element-citation publication-type="journal" id="rf2035"><person-group person-group-type="author"><name><surname>Bordoloi</surname><given-names>D.</given-names></name><name><surname>Roy</surname><given-names>N.K.</given-names></name><name><surname>Monisha</surname><given-names>J.</given-names></name><name><surname>Padmavathi</surname><given-names>G.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name></person-group><article-title>Multi-targeted agents in cancer cell chemosensitization: what we learnt from curcumin thus far</article-title><source>Recent Pat. Anticancer Drug Discov.</source><volume>11</volume><year>2016</year><fpage>67</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">26537958</pub-id></element-citation></ref><ref id="bb2040"><label>408</label><element-citation publication-type="journal" id="rf2040"><person-group person-group-type="author"><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name><surname>Harsha</surname><given-names>C.</given-names></name><name><surname>Banik</surname><given-names>K.</given-names></name><name><surname>Vikkurthi</surname><given-names>R.</given-names></name><name><surname>Sailo</surname><given-names>B.L.</given-names></name><name><surname>Bordoloi</surname><given-names>D.</given-names></name><name><surname>Gupta</surname><given-names>S.C.</given-names></name><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><article-title>Is curcumin bioavailability a problem in humans: lessons from clinical trials</article-title><source>Expert Opin. Drug Metab. Toxicol.</source><volume>15</volume><year>2019</year><fpage>705</fpage><lpage>733</lpage><pub-id pub-id-type="pmid">31361978</pub-id></element-citation></ref><ref id="bb2045"><label>409</label><mixed-citation publication-type="other" id="or0005">Bordoloi D, Kunnumakkara AB. The potential of curcumin: a multitargeting agent in cancer cell chemosensitization. Role of Nutraceuticals in Cancer Chemosensitization. Academic Press, pp. 31&#x02013;60.</mixed-citation></ref><ref id="bb2050"><label>410</label><element-citation publication-type="journal" id="rf2045"><person-group person-group-type="author"><name><surname>Dhillon</surname><given-names>N.</given-names></name><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name><name><surname>Newman</surname><given-names>R.A.</given-names></name><name><surname>Wolff</surname><given-names>R.A.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name><surname>Abbruzzese</surname><given-names>J.L.</given-names></name><name><surname>Ng</surname><given-names>C.S.</given-names></name><name><surname>Badmaev</surname><given-names>V.</given-names></name><name><surname>Kurzrock</surname><given-names>R.</given-names></name></person-group><article-title>Phase II trial of curcumin in patients with advanced pancreatic cancer</article-title><source>Clin. Cancer Res.</source><volume>14</volume><year>2008</year><fpage>4491</fpage><lpage>4499</lpage><pub-id pub-id-type="pmid">18628464</pub-id></element-citation></ref><ref id="bb2055"><label>411</label><element-citation publication-type="journal" id="rf2050"><person-group person-group-type="author"><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name><surname>Diagaradjane</surname><given-names>P.</given-names></name><name><surname>Guha</surname><given-names>S.</given-names></name><name><surname>Deorukhkar</surname><given-names>A.</given-names></name><name><surname>Shentu</surname><given-names>S.</given-names></name><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name><name><surname>Krishnan</surname><given-names>S.</given-names></name></person-group><article-title>Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-kappaB-regulated gene products</article-title><source>Clin. Cancer Res.</source><volume>14</volume><year>2008</year><fpage>2128</fpage><lpage>2136</lpage><pub-id pub-id-type="pmid">18381954</pub-id></element-citation></ref><ref id="bb2060"><label>412</label><element-citation publication-type="journal" id="rf2055"><person-group person-group-type="author"><name><surname>Kazemi</surname><given-names>S.</given-names></name><name><surname>Yaghooblou</surname><given-names>F.</given-names></name><name><surname>Siassi</surname><given-names>F.</given-names></name><name><surname>Rahimi Foroushani</surname><given-names>A.</given-names></name><name><surname>Ghavipour</surname><given-names>M.</given-names></name><name><surname>Koohdani</surname><given-names>F.</given-names></name><name><surname>Sotoudeh</surname><given-names>G.</given-names></name></person-group><article-title>Cardamom supplementation improves inflammatory and oxidative stress biomarkers in hyperlipidemic, overweight, and obese pre-diabetic women: a randomized double-blind clinical trial</article-title><source>J. Sci. Food Agric.</source><volume>97</volume><year>2017</year><fpage>5296</fpage><lpage>5301</lpage><pub-id pub-id-type="pmid">28480505</pub-id></element-citation></ref><ref id="bb2065"><label>413</label><element-citation publication-type="journal" id="rf2060"><person-group person-group-type="author"><name><surname>Aghasi</surname><given-names>M.</given-names></name><name><surname>Koohdani</surname><given-names>F.</given-names></name><name><surname>Qorbani</surname><given-names>M.</given-names></name><name><surname>Nasli-Esfahani</surname><given-names>E.</given-names></name><name><surname>Ghazi-Zahedi</surname><given-names>S.</given-names></name><name><surname>Khoshamal</surname><given-names>H.</given-names></name><name><surname>Keshavarz</surname><given-names>A.</given-names></name><name><surname>Sotoudeh</surname><given-names>G.</given-names></name></person-group><article-title>Beneficial effects of green cardamom on serum SIRT1, glycemic indices and triglyceride levels in patients with type 2 diabetes mellitus: a randomized double-blind placebo controlled clinical trial</article-title><source>J. Sci. Food Agric.</source><volume>99</volume><year>2019</year><fpage>3933</fpage><lpage>3940</lpage><pub-id pub-id-type="pmid">30701554</pub-id></element-citation></ref><ref id="bb2070"><label>414</label><element-citation publication-type="journal" id="rf2065"><person-group person-group-type="author"><name><surname>Daneshi-Maskooni</surname><given-names>M.</given-names></name><name><surname>Keshavarz</surname><given-names>S.A.</given-names></name><name><surname>Qorbani</surname><given-names>M.</given-names></name><name><surname>Mansouri</surname><given-names>S.</given-names></name><name><surname>Alavian</surname><given-names>S.M.</given-names></name><name><surname>Badri-Fariman</surname><given-names>M.</given-names></name><name><surname>Jazayeri-Tehrani</surname><given-names>S.A.</given-names></name><name><surname>Sotoudeh</surname><given-names>G.</given-names></name></person-group><article-title>Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial</article-title><source>BMC Complement. Altern. Med.</source><volume>19</volume><issue>59</issue><year>2019</year></element-citation></ref><ref id="bb2075"><label>415</label><element-citation publication-type="journal" id="rf2070"><person-group person-group-type="author"><name><surname>Shim</surname><given-names>H.I.</given-names></name><name><surname>Song</surname><given-names>D.J.</given-names></name><name><surname>Shin</surname><given-names>C.M.</given-names></name><name><surname>Yoon</surname><given-names>H.</given-names></name><name><surname>Park</surname><given-names>Y.S.</given-names></name><name><surname>Kim</surname><given-names>N.</given-names></name><name><surname>Lee</surname><given-names>D.H.</given-names></name></person-group><article-title>Inhibitory effects of &#x003b2;-caryophyllene on helicobacter pylori infection: a randomized double-blind, placebo-controlled study</article-title><source>Kor. J. Gastroenterol.</source><volume>74</volume><year>2019</year><fpage>199</fpage><lpage>204</lpage></element-citation></ref><ref id="bb2080"><label>416</label><element-citation publication-type="journal" id="rf2075"><person-group person-group-type="author"><name><surname>Reuter</surname><given-names>J.</given-names></name><name><surname>Huyke</surname><given-names>C.</given-names></name><name><surname>Casetti</surname><given-names>F.</given-names></name><name><surname>Theek</surname><given-names>C.</given-names></name><name><surname>Frank</surname><given-names>U.</given-names></name><name><surname>Augustin</surname><given-names>M.</given-names></name><name><surname>Schempp</surname><given-names>C.</given-names></name></person-group><article-title>Anti-inflammatory potential of a lipolotion containing coriander oil in the ultraviolet erythema test</article-title><source>J. Dtsch Dermatol. Ges.</source><volume>6</volume><year>2008</year><fpage>847</fpage><lpage>851</lpage><pub-id pub-id-type="pmid">18371049</pub-id></element-citation></ref><ref id="bb2085"><label>417</label><element-citation publication-type="journal" id="rf2080"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>C.</given-names></name><name><surname>Mathews</surname><given-names>A.E.</given-names></name><name><surname>Rodrigues</surname><given-names>C.</given-names></name><name><surname>Eudy</surname><given-names>B.J.</given-names></name><name><surname>Rowe</surname><given-names>C.A.</given-names></name><name><surname>O'Donoughue</surname><given-names>A.</given-names></name><name><surname>Percival</surname><given-names>S.S.</given-names></name></person-group><article-title>Aged garlic extract supplementation modifies inflammation and immunity of adults with obesity: a randomized, double-blind, placebo-controlled clinical trial</article-title><source>Clin. Nutr. ESPEN</source><volume>24</volume><year>2018</year><fpage>148</fpage><lpage>155</lpage><pub-id pub-id-type="pmid">29576354</pub-id></element-citation></ref><ref id="bb2090"><label>418</label><element-citation publication-type="journal" id="rf2085"><person-group person-group-type="author"><name><surname>Dehghani</surname><given-names>S.</given-names></name><name><surname>Alipoor</surname><given-names>E.</given-names></name><name><surname>Salimzadeh</surname><given-names>A.</given-names></name><name><surname>Yaseri</surname><given-names>M.</given-names></name><name><surname>Hosseini</surname><given-names>M.</given-names></name><name><surname>Feinle-Bisset</surname><given-names>C.</given-names></name><name><surname>Hosseinzadeh-Attar</surname><given-names>M.J.</given-names></name></person-group><article-title>The effect of a garlic supplement on the pro-inflammatory adipocytokines, resistin and tumor necrosis factor-alpha, and on pain severity, in overweight or obese women with knee osteoarthritis</article-title><source>Phytomedicine</source><volume>48</volume><year>2018</year><fpage>70</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">30195882</pub-id></element-citation></ref><ref id="bb2095"><label>419</label><element-citation publication-type="journal" id="rf2090"><person-group person-group-type="author"><name><surname>Aryaeian</surname><given-names>N.</given-names></name><name><surname>Shahram</surname><given-names>F.</given-names></name><name><surname>Mahmoudi</surname><given-names>M.</given-names></name><name><surname>Tavakoli</surname><given-names>H.</given-names></name><name><surname>Yousefi</surname><given-names>B.</given-names></name><name><surname>Arablou</surname><given-names>T.</given-names></name><name><surname>Jafari Karegar</surname><given-names>S.</given-names></name></person-group><article-title>The effect of ginger supplementation on some immunity and inflammation intermediate genes expression in patients with active rheumatoid arthritis</article-title><source>Gene</source><volume>698</volume><year>2019</year><fpage>179</fpage><lpage>185</lpage><pub-id pub-id-type="pmid">30844477</pub-id></element-citation></ref><ref id="bb2100"><label>420</label><element-citation publication-type="journal" id="rf2095"><person-group person-group-type="author"><name><surname>Mozaffari-Khosravi</surname><given-names>H.</given-names></name><name><surname>Naderi</surname><given-names>Z.</given-names></name><name><surname>Dehghan</surname><given-names>A.</given-names></name><name><surname>Nadjarzadeh</surname><given-names>A.</given-names></name><name><surname>Fallah Huseini</surname><given-names>H.</given-names></name></person-group><article-title>Effect of ginger supplementation on proinflammatory cytokines in older patients with osteoarthritis: outcomes of a randomized controlled clinical trial</article-title><source>J. Nutr. Gerontol. Geriatr.</source><volume>35</volume><year>2016</year><fpage>209</fpage><lpage>218</lpage><pub-id pub-id-type="pmid">27559855</pub-id></element-citation></ref><ref id="bb2105"><label>421</label><element-citation publication-type="journal" id="rf2100"><person-group person-group-type="author"><name><surname>Kulkarni</surname><given-names>R.A.</given-names></name><name><surname>Deshpande</surname><given-names>A.R.</given-names></name></person-group><article-title>Anti-inflammatory and antioxidant effect of ginger in tuberculosis</article-title><source>J. Complement Integr. Med.</source><volume>13</volume><year>2016</year><fpage>201</fpage><lpage>206</lpage><pub-id pub-id-type="pmid">27089418</pub-id></element-citation></ref><ref id="bb2110"><label>422</label><element-citation publication-type="journal" id="rf2105"><person-group person-group-type="author"><name><surname>Zick</surname><given-names>S.M.</given-names></name><name><surname>Turgeon</surname><given-names>D.K.</given-names></name><name><surname>Ren</surname><given-names>J.</given-names></name><name><surname>Ruffin</surname><given-names>M.T.</given-names></name><name><surname>Wright</surname><given-names>B.D.</given-names></name><name><surname>Sen</surname><given-names>A.</given-names></name><name><surname>Djuric</surname><given-names>Z.</given-names></name><name><surname>Brenner</surname><given-names>D.E.</given-names></name></person-group><article-title>Pilot clinical study of the effects of ginger root extract on eicosanoids in colonic mucosa of subjects at increased risk for colorectal cancer</article-title><source>Mol. Carcinog.</source><volume>54</volume><year>2015</year><fpage>908</fpage><lpage>915</lpage><pub-id pub-id-type="pmid">24760534</pub-id></element-citation></ref><ref id="bb2115"><label>423</label><element-citation publication-type="journal" id="rf2110"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J.H.</given-names></name><name><surname>Wang</surname><given-names>J.P.</given-names></name><name><surname>Wang</surname><given-names>H.J.</given-names></name></person-group><article-title>Clinical study on effect of total panax notoginseng saponins on immune related inner environment imbalance in rheumatoid arthritis patients</article-title><source>Zhongguo Zhong Xi Yi Jie He Za Zhi</source><volume>27</volume><year>2007</year><fpage>589</fpage><lpage>592</lpage><comment>(Chinese)</comment><pub-id pub-id-type="pmid">17717913</pub-id></element-citation></ref><ref id="bb2120"><label>424</label><element-citation publication-type="journal" id="rf2115"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>Z.Y.</given-names></name><name><surname>Liu</surname><given-names>X.Y.</given-names></name><name><surname>Zhan</surname><given-names>L.Y.</given-names></name><name><surname>He</surname><given-names>Y.H.</given-names></name><name><surname>Luo</surname><given-names>T.</given-names></name><name><surname>Xia</surname><given-names>Z.</given-names></name></person-group><article-title>Ginsenosides compound (shen-fu) attenuates gastrointestinal injury and inhibits inflammatory response after cardiopulmonary bypass in patients with congenital heart disease</article-title><source>J. Thorac. Cardiovasc. Surg.</source><volume>130</volume><year>2005</year><fpage>258</fpage><lpage>264</lpage><pub-id pub-id-type="pmid">16077384</pub-id></element-citation></ref><ref id="bb2125"><label>425</label><element-citation publication-type="journal" id="rf2120"><person-group person-group-type="author"><name><surname>Zilaee</surname><given-names>M.</given-names></name><name><surname>Hosseini</surname><given-names>S.A.</given-names></name><name><surname>Jafarirad</surname><given-names>S.</given-names></name><name><surname>Abolnezhadian</surname><given-names>F.</given-names></name><name><surname>Cheraghian</surname><given-names>B.</given-names></name><name><surname>Namjoyan</surname><given-names>F.</given-names></name><name><surname>Ghadiri</surname><given-names>A.</given-names></name></person-group><article-title>An evaluation of the effects of saffron supplementation on the asthma clinical symptoms and asthma severity in patients with mild and moderate persistent allergic asthma: a double-blind, randomized placebo-controlled trial</article-title><source>Respir. Res.</source><volume>20</volume><issue>39</issue><year>2019</year></element-citation></ref><ref id="bb2130"><label>426</label><element-citation publication-type="journal" id="rf2125"><person-group person-group-type="author"><name><surname>Ghiasian</surname><given-names>M.</given-names></name><name><surname>Khamisabadi</surname><given-names>F.</given-names></name><name><surname>Kheiripour</surname><given-names>N.</given-names></name><name><surname>Karami</surname><given-names>M.</given-names></name><name><surname>Haddadi</surname><given-names>R.</given-names></name><name><surname>Ghaleiha</surname><given-names>A.</given-names></name><name><surname>Taghvaei</surname><given-names>B.</given-names></name><name><surname>Oliaie</surname><given-names>S.S.</given-names></name><name><surname>Salehi</surname><given-names>M.</given-names></name><name><surname>Samadi</surname><given-names>P.</given-names></name><name><surname>Ranjbar</surname><given-names>A.</given-names></name></person-group><article-title>Effects of crocin in reducing DNA damage, inflammation, and oxidative stress in multiple sclerosis patients: a double-blind, randomized, and placebo-controlled trial</article-title><source>J. Biochem. Mol. Toxicol.</source><volume>33</volume><year>2019</year><object-id pub-id-type="publisher-id">e22410</object-id></element-citation></ref><ref id="bb2135"><label>427</label><element-citation publication-type="journal" id="rf2130"><person-group person-group-type="author"><name><surname>Khadem Haghighian</surname><given-names>M.</given-names></name><name><surname>Alipoor</surname><given-names>B.</given-names></name><name><surname>Malek Mahdavi</surname><given-names>A.</given-names></name><name><surname>Eftekhar Sadat</surname><given-names>B.</given-names></name><name><surname>Asghari Jafarabadi</surname><given-names>M.</given-names></name><name><surname>Moghaddam</surname><given-names>A.</given-names></name></person-group><article-title>Effects of sesame seed supplementation on inflammatory factors and oxidative stress biomarkers in patients with knee osteoarthritis</article-title><source>Acta Med. Iran</source><volume>53</volume><year>2015</year><fpage>207</fpage><lpage>213</lpage><pub-id pub-id-type="pmid">25871017</pub-id></element-citation></ref><ref id="bb2140"><label>428</label><element-citation publication-type="journal" id="rf2135"><person-group person-group-type="author"><name><surname>Panahi</surname><given-names>Y.</given-names></name><name><surname>Hosseini</surname><given-names>M.S.</given-names></name><name><surname>Khalili</surname><given-names>N.</given-names></name><name><surname>Naimi</surname><given-names>E.</given-names></name><name><surname>Majeed</surname><given-names>M.</given-names></name><name><surname>Sahebkar</surname><given-names>A.</given-names></name></person-group><article-title>Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: a randomized controlled trial and an updated meta-analysis</article-title><source>Clin. Nutr.</source><volume>34</volume><year>2015</year><fpage>1101</fpage><lpage>1108</lpage><pub-id pub-id-type="pmid">25618800</pub-id></element-citation></ref><ref id="bb2145"><label>429</label><element-citation publication-type="journal" id="rf2140"><person-group person-group-type="author"><name><surname>Uchio</surname><given-names>R.</given-names></name><name><surname>Muroyama</surname><given-names>K.</given-names></name><name><surname>Okuda-Hanafusa</surname><given-names>C.</given-names></name><name><surname>Kawasaki</surname><given-names>K.</given-names></name><name><surname>Yamamoto</surname><given-names>Y.</given-names></name><name><surname>Murosaki</surname><given-names>S.</given-names></name></person-group><article-title>Hot water extract of <italic>Curcuma longa</italic> L. improves serum inflammatory markers and general health in subjects with overweight or prehypertension/mild hypertension: a randomized, double-blind, placebo-controlled trial</article-title><source>Nutrients</source><volume>11</volume><year>2019</year><fpage>1822</fpage></element-citation></ref><ref id="bb2150"><label>430</label><element-citation publication-type="journal" id="rf2145"><person-group person-group-type="author"><name><surname>Panahi</surname><given-names>Y.</given-names></name><name><surname>Khalili</surname><given-names>N.</given-names></name><name><surname>Sahebi</surname><given-names>E.</given-names></name><name><surname>Namazi</surname><given-names>S.</given-names></name><name><surname>Atkin</surname><given-names>S.L.</given-names></name><name><surname>Majeed</surname><given-names>M.</given-names></name><name><surname>Sahebkar</surname><given-names>A.</given-names></name></person-group><article-title>Curcuminoids plus piperine modulate adipokines in type 2 diabetes mellitus</article-title><source>Curr. Clin. Pharmacol.</source><volume>12</volume><year>2017</year><fpage>253</fpage><lpage>258</lpage><pub-id pub-id-type="pmid">29299989</pub-id></element-citation></ref><ref id="bb2155"><label>431</label><element-citation publication-type="journal" id="rf2150"><person-group person-group-type="author"><name><surname>Adibian</surname><given-names>M.</given-names></name><name><surname>Hodaei</surname><given-names>H.</given-names></name><name><surname>Nikpayam</surname><given-names>O.</given-names></name><name><surname>Sohrab</surname><given-names>G.</given-names></name><name><surname>Hekmatdoost</surname><given-names>A.</given-names></name><name><surname>Hedayati</surname><given-names>M.</given-names></name></person-group><article-title>The effects of curcumin supplementation on high-sensitivity C-reactive protein, serum adiponectin, and lipid profile in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial</article-title><source>Phytother. Res.</source><volume>33</volume><year>2019</year><fpage>1374</fpage><lpage>1383</lpage><pub-id pub-id-type="pmid">30864188</pub-id></element-citation></ref><ref id="bb2160"><label>432</label><element-citation publication-type="journal" id="rf2155"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>S.</given-names></name><name><surname>Saksena</surname><given-names>A.K.</given-names></name><name><surname>Khattri</surname><given-names>S.</given-names></name><name><surname>Kumar</surname><given-names>S.</given-names></name><name><surname>Dagur</surname><given-names>R.S.</given-names></name></person-group><article-title>Curcuma longa extract reduces inflammatory and oxidative stress biomarkers in osteoarthritis of knee: a four-month, double-blind, randomized, placebo-controlled trial</article-title><source>Inflammopharmacology</source><volume>24</volume><year>2016</year><fpage>377</fpage><lpage>388</lpage><pub-id pub-id-type="pmid">27761693</pub-id></element-citation></ref><ref id="bb2165"><label>433</label><element-citation publication-type="journal" id="rf2160"><person-group person-group-type="author"><name><surname>Conrozier</surname><given-names>T.</given-names></name><name><surname>Mathieu</surname><given-names>P.</given-names></name><name><surname>Bonjean</surname><given-names>M.</given-names></name><name><surname>Marc</surname><given-names>J.F.</given-names></name><name><surname>Renevier</surname><given-names>J.L.</given-names></name><name><surname>Balblanc</surname><given-names>J.C.</given-names></name></person-group><article-title>A complex of three natural anti-inflammatory agents provides relief of osteoarthritis pain</article-title><source>Altern. Ther. Health Med.</source><volume>20</volume><year>2014</year><fpage>32</fpage><lpage>37</lpage></element-citation></ref><ref id="bb2170"><label>434</label><element-citation publication-type="journal" id="rf2165"><person-group person-group-type="author"><name><surname>Amalraj</surname><given-names>A.</given-names></name><name><surname>Varma</surname><given-names>K.</given-names></name><name><surname>Jacob</surname><given-names>J.</given-names></name><name><surname>Divya</surname><given-names>C.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name><surname>Stohs</surname><given-names>S.J.</given-names></name><name><surname>Gopi</surname><given-names>S.A.</given-names></name></person-group><article-title>Novel highly bioavailable curcumin formulation improves symptoms and diagnostic indicators in rheumatoid arthritis patients: a randomized, double-blind, placebo-controlled, two-dose, three-arm, and parallel-group study</article-title><source>J. Med. Food</source><volume>20</volume><year>2017</year><fpage>1022</fpage><lpage>1030</lpage><pub-id pub-id-type="pmid">28850308</pub-id></element-citation></ref><ref id="bb2175"><label>435</label><element-citation publication-type="journal" id="rf2170"><person-group person-group-type="author"><name><surname>Moreillon</surname><given-names>J.J.</given-names></name><name><surname>Bowden</surname><given-names>R.G.</given-names></name><name><surname>Deike</surname><given-names>E.</given-names></name><name><surname>Griggs</surname><given-names>J.</given-names></name><name><surname>Wilson</surname><given-names>R.</given-names></name><name><surname>Shelmadine</surname><given-names>B.</given-names></name><name><surname>Cooke</surname><given-names>M.</given-names></name><name><surname>Beaujean</surname><given-names>A.</given-names></name></person-group><article-title>The use of an anti-inflammatory supplement in patients with chronic kidney disease</article-title><source>J. Complement. Integr. Med.</source><volume>10</volume><year>2013</year><comment>(/j/jcim.2013.10.issue-1/jcim-2012-0011/jcim-2012-0011.xml)</comment></element-citation></ref><ref id="bb2180"><label>436</label><element-citation publication-type="journal" id="rf2175"><person-group person-group-type="author"><name><surname>Samadian</surname><given-names>F.</given-names></name><name><surname>Dalili</surname><given-names>N.</given-names></name><name><surname>Poor-Reza Gholi</surname><given-names>F.</given-names></name><name><surname>Fattah</surname><given-names>M.</given-names></name><name><surname>Malih</surname><given-names>N.</given-names></name><name><surname>Nafar</surname><given-names>M.</given-names></name><name><surname>Firoozan</surname><given-names>A.</given-names></name><name><surname>Ahmadpoor</surname><given-names>P.</given-names></name><name><surname>Samavat</surname><given-names>S.</given-names></name><name><surname>Ziaie</surname><given-names>S.</given-names></name></person-group><article-title>Evaluation of Curcumin's effect on inflammation in hemodialysis patients</article-title><source>Clin. Nutr. ESPEN</source><volume>22</volume><year>2017</year><fpage>19</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">29415829</pub-id></element-citation></ref><ref id="bb2185"><label>437</label><element-citation publication-type="journal" id="rf2180"><person-group person-group-type="author"><name><surname>Panahi</surname><given-names>Y.</given-names></name><name><surname>Ghanei</surname><given-names>M.</given-names></name><name><surname>Bashiri</surname><given-names>S.</given-names></name><name><surname>Hajihashemi</surname><given-names>A.</given-names></name><name><surname>Sahebkar</surname><given-names>A.</given-names></name></person-group><article-title>Short-term curcuminoid supplementation for chronic pulmonary complications due to sulfur mustard intoxication: positive results of a randomized double-blind placebo-controlled trial</article-title><source>Drug Res. (Stuttg.)</source><volume>65</volume><year>2015</year><fpage>567</fpage><lpage>573</lpage><pub-id pub-id-type="pmid">25268878</pub-id></element-citation></ref><ref id="bb2190"><label>438</label><element-citation publication-type="journal" id="rf2185"><person-group person-group-type="author"><name><surname>Funamoto</surname><given-names>M.</given-names></name><name><surname>Sunagawa</surname><given-names>Y.</given-names></name><name><surname>Katanasaka</surname><given-names>Y.</given-names></name><name><surname>Miyazaki</surname><given-names>Y.</given-names></name><name><surname>Imaizumi</surname><given-names>A.</given-names></name><name><surname>Kakeya</surname><given-names>H.</given-names></name><name><surname>Yamakage</surname><given-names>H.</given-names></name><name><surname>Satoh-Asahara</surname><given-names>N.</given-names></name><name><surname>Komiyama</surname><given-names>M.</given-names></name><name><surname>Wada</surname><given-names>H.</given-names></name><name><surname>Hasegawa</surname><given-names>K.</given-names></name><name><surname>Morimoto</surname><given-names>T.</given-names></name></person-group><article-title>Highly absorptive curcumin reduces serum atherosclerotic low-density lipoprotein levels in patients with mild COPD</article-title><source>Int. J. Chron. Obstruct. Pulmon. Dis.</source><volume>11</volume><year>2016</year><fpage>2029</fpage><lpage>2034</lpage><pub-id pub-id-type="pmid">27616885</pub-id></element-citation></ref><ref id="bb2195"><label>439</label><element-citation publication-type="journal" id="rf2190"><person-group person-group-type="author"><name><surname>Abdolahi</surname><given-names>M.</given-names></name><name><surname>Jafarieh</surname><given-names>A.</given-names></name><name><surname>Sarraf</surname><given-names>P.</given-names></name><name><surname>Sedighiyan</surname><given-names>M.</given-names></name><name><surname>Yousefi</surname><given-names>A.</given-names></name><name><surname>Tafakhori</surname><given-names>A.</given-names></name><name><surname>Abdollahi</surname><given-names>H.</given-names></name><name><surname>Salehinia</surname><given-names>F.</given-names></name><name><surname>Djalali</surname><given-names>M.</given-names></name></person-group><article-title>The neuromodulatory effects of &#x003c9;-3 fatty acids and nano-curcumin on the COX-2/iNOS network in migraines: a clinical trial study from gene expression to clinical symptoms</article-title><source>Endocr Metab Immune Disord Drug Targets</source><volume>19</volume><year>2019</year><fpage>874</fpage><lpage>884</lpage><pub-id pub-id-type="pmid">30760195</pub-id></element-citation></ref><ref id="bb2200"><label>440</label><element-citation publication-type="journal" id="rf2195"><person-group person-group-type="author"><name><surname>Babaei</surname><given-names>F.</given-names></name><name><surname>Nassiri-Asl</surname><given-names>M.</given-names></name><name><surname>Hosseinzadeh</surname><given-names>H.</given-names></name></person-group><article-title>Curcumin (a constituent of turmeric): new treatment option against COVID-19</article-title><source>Food Sci. Nutr.</source><volume>8</volume><year>2020</year><fpage>5215</fpage><lpage>5227</lpage><pub-id pub-id-type="pmid">33133525</pub-id></element-citation></ref><ref id="bb2205"><label>441</label><element-citation publication-type="journal" id="rf2200"><person-group person-group-type="author"><name><surname>Hooper</surname><given-names>P.L.</given-names></name></person-group><article-title>COVID-19 and heme oxygenase: novel insight into the disease and potential therapies</article-title><source>Cell Stress Chaperones</source><volume>25</volume><year>2020</year><fpage>707</fpage><lpage>710</lpage><pub-id pub-id-type="pmid">32500379</pub-id></element-citation></ref><ref id="bb2210"><label>442</label><element-citation publication-type="journal" id="rf2205"><person-group person-group-type="author"><name><surname>Eisenhut</surname><given-names>M.</given-names></name><name><surname>Shin</surname><given-names>J.I.</given-names></name></person-group><article-title>Pathways in the pathophysiology of coronavirus 19 lung disease accessible to prevention and treatment</article-title><source>Front. Physiol.</source><volume>11</volume><year>2020</year><fpage>872</fpage><pub-id pub-id-type="pmid">32922301</pub-id></element-citation></ref><ref id="bb2215"><label>443</label><element-citation publication-type="journal" id="rf2210"><person-group person-group-type="author"><name><surname>He</surname><given-names>Y.Q.</given-names></name><name><surname>Zhou</surname><given-names>C.C.</given-names></name><name><surname>Yu</surname><given-names>L.Y.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Deng</surname><given-names>J.L.</given-names></name><name><surname>Tao</surname><given-names>Y.L.</given-names></name><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Chen</surname><given-names>W.S.</given-names></name></person-group><article-title>Natural product derived phytochemicals in managing acute lung injury by multiple mechanisms</article-title><source>Pharmacol. Res.</source><year>2020</year><object-id pub-id-type="publisher-id">105224</object-id></element-citation></ref><ref id="bb2220"><label>444</label><element-citation publication-type="journal" id="rf2215"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>C.Y.</given-names></name><name><surname>Yao</surname><given-names>C.A.</given-names></name></person-group><article-title>Potential role of Nrf2 activators with dual antiviral and anti-inflammatory properties in the management of viral pneumonia</article-title><source>Infect Drug Resist</source><volume>13</volume><year>2020</year><fpage>1735</fpage><lpage>1741</lpage><pub-id pub-id-type="pmid">32606823</pub-id></element-citation></ref><ref id="bb2225"><label>445</label><element-citation publication-type="journal" id="rf2220"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Ying</surname><given-names>Y.</given-names></name></person-group><article-title>The inhibitory effect of curcumin on virus-induced cytokine storm and its potential use in the associated severe pneumonia</article-title><source>Front. Cell Dev. Biol.</source><volume>8</volume><year>2020</year><fpage>479</fpage><pub-id pub-id-type="pmid">32596244</pub-id></element-citation></ref><ref id="bb2230"><label>446</label><element-citation publication-type="journal" id="rf2225"><person-group person-group-type="author"><name><surname>Soni</surname><given-names>V.K.</given-names></name><name><surname>Mehta</surname><given-names>A.</given-names></name><name><surname>Ratre</surname><given-names>Y.K.</given-names></name><name><surname>Tiwari</surname><given-names>A.K.</given-names></name><name><surname>Amit</surname><given-names>A.</given-names></name><name><surname>Singh</surname><given-names>R.P.</given-names></name><name><surname>Sonkar</surname><given-names>S.C.</given-names></name><name><surname>Chaturvedi</surname><given-names>N.</given-names></name><name><surname>Shukla</surname><given-names>D.</given-names></name><name><surname>Vishvakarma</surname><given-names>N.K.</given-names></name></person-group><article-title>Curcumin, a traditional spice component, can hold the promise against COVID-19?</article-title><source>Eur. J. Pharmacol.</source><volume>886</volume><year>2020</year><object-id pub-id-type="publisher-id">173551</object-id></element-citation></ref><ref id="bb2235"><label>447</label><element-citation publication-type="journal" id="rf2230"><person-group person-group-type="author"><name><surname>Wen</surname><given-names>C.C.</given-names></name><name><surname>Kuo</surname><given-names>Y.H.</given-names></name><name><surname>Jan</surname><given-names>J.T.</given-names></name><name><surname>Liang</surname><given-names>P.H.</given-names></name><name><surname>Wang</surname><given-names>S.Y.</given-names></name><name><surname>Liu</surname><given-names>H.G.</given-names></name><name><surname>Lee</surname><given-names>C.K.</given-names></name><name><surname>Chang</surname><given-names>S.T.</given-names></name><name><surname>Kuo</surname><given-names>C.J.</given-names></name><name><surname>Lee</surname><given-names>S.S.</given-names></name><name><surname>Hou</surname><given-names>C.C.</given-names></name><name><surname>Hsiao</surname><given-names>P.W.</given-names></name><name><surname>Chien</surname><given-names>S.C.</given-names></name><name><surname>Shyur</surname><given-names>L.F.</given-names></name><name><surname>Yang</surname><given-names>N.S.</given-names></name></person-group><article-title>Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus</article-title><source>J. Med. Chem.</source><volume>50</volume><year>2007</year><fpage>4087</fpage><lpage>4095</lpage><pub-id pub-id-type="pmid">17663539</pub-id></element-citation></ref><ref id="bb2240"><label>448</label><element-citation publication-type="journal" id="rf2235"><person-group person-group-type="author"><name><surname>Moghadamtousi</surname><given-names>S.Z.</given-names></name><name><surname>Kadir</surname><given-names>H.A.</given-names></name><name><surname>Hassandarvish</surname><given-names>P.</given-names></name><name><surname>Tajik</surname><given-names>H.</given-names></name><name><surname>Abubakar</surname><given-names>S.</given-names></name><name><surname>Zandi</surname><given-names>K.</given-names></name></person-group><article-title>A review on antibacterial, antiviral, and antifungal activity of curcumin</article-title><source>Biomed. Res. Int.</source><volume>2014</volume><year>2014</year><object-id pub-id-type="publisher-id">186864</object-id></element-citation></ref><ref id="bb2245"><label>449</label><element-citation publication-type="journal" id="rf2240"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Luo</surname><given-names>X.</given-names></name><name><surname>Lei</surname><given-names>W.</given-names></name><name><surname>Xie</surname><given-names>L.</given-names></name></person-group><article-title>Antiviral and virucidal effects of curcumin on transmissible gastroenteritis virus in vitro</article-title><source>J. Gen. Virol.</source><volume>101</volume><year>2020</year><fpage>1079</fpage><lpage>1084</lpage><pub-id pub-id-type="pmid">32677610</pub-id></element-citation></ref><ref id="bb2250"><label>450</label><element-citation publication-type="journal" id="rf2245"><person-group person-group-type="author"><name><surname>Kandeel</surname><given-names>M.</given-names></name><name><surname>Al-Nazawi</surname><given-names>M.</given-names></name></person-group><article-title>Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease</article-title><source>Life Sci.</source><volume>251</volume><year>2020</year><object-id pub-id-type="publisher-id">117627</object-id></element-citation></ref><ref id="bb2255"><label>451</label><element-citation publication-type="journal" id="rf2250"><person-group person-group-type="author"><name><surname>Mrityunjaya</surname><given-names>M.</given-names></name><name><surname>Pavithra</surname><given-names>V.</given-names></name><name><surname>Neelam</surname><given-names>R.</given-names></name><name><surname>Janhavi</surname><given-names>P.</given-names></name><name><surname>Halami</surname><given-names>P.M.</given-names></name><name><surname>Ravindra</surname><given-names>P.V.</given-names></name></person-group><article-title>Immune-boosting, antioxidant and anti-inflammatory food supplements targeting pathogenesis of COVID-19</article-title><source>Front. Immunol.</source><volume>11</volume><year>2020</year><object-id pub-id-type="publisher-id">570122</object-id></element-citation></ref><ref id="bb2260"><label>452</label><element-citation publication-type="journal" id="rf2255"><person-group person-group-type="author"><name><surname>Rocha</surname><given-names>F.A.C.</given-names></name><name><surname>de Assis</surname><given-names>M.R.</given-names></name></person-group><article-title>Curcumin as a potential treatment for COVID-19</article-title><source>Phytother. Res.</source><volume>34</volume><year>2020</year><fpage>2085</fpage><lpage>2087</lpage><pub-id pub-id-type="pmid">32442323</pub-id></element-citation></ref><ref id="bb2265"><label>453</label><element-citation publication-type="journal" id="rf2260"><person-group person-group-type="author"><name><surname>Zahedipour</surname><given-names>F.</given-names></name><name><surname>Hosseini</surname><given-names>S.A.</given-names></name><name><surname>Sathyapalan</surname><given-names>T.</given-names></name><name><surname>Majeed</surname><given-names>M.</given-names></name><name><surname>Jamialahmadi</surname><given-names>T.</given-names></name><name><surname>Al-Rasadi</surname><given-names>K.</given-names></name><name><surname>Banach</surname><given-names>M.</given-names></name><name><surname>Sahebkar</surname><given-names>A.</given-names></name></person-group><article-title>Potential effects of curcumin in the treatment of COVID-19 infection</article-title><source>Phytother. Res.</source><volume>34</volume><year>2020</year><fpage>2911</fpage><lpage>2920</lpage><pub-id pub-id-type="pmid">32430996</pub-id></element-citation></ref><ref id="bb2270"><label>454</label><element-citation publication-type="journal" id="rf2265"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>B.</given-names></name><name><surname>Huang</surname><given-names>S.</given-names></name><name><surname>Yin</surname><given-names>L.</given-names></name></person-group><article-title>The cytokine storm and COVID-19</article-title><source>J. Med. Virol.</source><year>2020</year><pub-id pub-id-type="doi">10.1002/jmv.26232</pub-id></element-citation></ref></ref-list><ack id="ac0005"><title>Acknowledgements</title><p id="p0730">This work was supported by the DBT-AIST International CENter for Translational and Environmental Research (<funding-source id="gts0005">DAICENTER</funding-source>) grant awarded to Professor Ajaikumar B. Kunnumakkara. The author Kishore Banik acknowledges the UGC New Delhi, India for providing him the fellowship.</p></ack></back></article>